GO.ID,Term,Annotated,Significant,Expected,classicFisher,bonferroni,bh,foldEnrichment,Ontology
GO:0006996,organelle organization,3599,152,72.34,4.8e-21,2.30976e-17,2.30976e-17,2.1,BP
GO:0071840,cellular component organization or bioge...,6181,214,124.24,2.3e-20,1.10676e-16,5.5338e-17,1.72,BP
GO:0016043,cellular component organization,6004,206,120.68,8.3e-19,3.99396e-15,1.3313200000000001e-15,1.71,BP
GO:0007010,cytoskeleton organization,1323,74,26.59,7.8e-16,3.75336e-12,9.3834e-13,2.78,BP
GO:0009987,cellular process,15679,380,315.15,2.7e-15,1.2992400000000001e-11,2.59848e-12,1.21,BP
GO:0051128,regulation of cellular component organiz...,2590,110,52.06,7.9e-15,3.80148e-11,6.3358e-12,2.11,BP
GO:0043170,macromolecule metabolic process,8366,240,168.16,9.3e-13,4.47516e-9,6.393085714285715e-10,1.43,BP
GO:0044085,cellular component biogenesis,3057,117,61.45,1.2e-12,5.7743999999999994e-9,7.217999999999999e-10,1.9,BP
GO:0044237,cellular metabolic process,9392,260,188.78,1.9e-12,9.1428e-9,1.0158666666666666e-9,1.38,BP
GO:0007017,microtubule-based process,770,48,15.48,3.7e-12,1.78044e-8,1.6623272727272726e-9,3.1,BP
GO:0006807,nitrogen compound metabolic process,8802,247,176.92,3.8e-12,1.82856e-8,1.6623272727272726e-9,1.4,BP
GO:0044260,cellular macromolecule metabolic process,7120,211,143.11,5.3e-12,2.55036e-8,2.1252999999999997e-9,1.47,BP
GO:0022607,cellular component assembly,2829,109,56.86,6.5e-12,3.1278000000000004e-8,2.337257142857143e-9,1.92,BP
GO:0033043,regulation of organelle organization,1260,64,25.33,6.8e-12,3.27216e-8,2.337257142857143e-9,2.53,BP
GO:0044238,primary metabolic process,9317,256,187.27,1.0e-11,4.812e-8,3.208e-9,1.37,BP
GO:0022402,cell cycle process,1128,59,22.67,1.6e-11,7.699199999999999e-8,4.8119999999999995e-9,2.6,BP
GO:0034641,cellular nitrogen compound metabolic pro...,5536,173,111.27,3.4e-11,1.63608e-7,9.623999999999999e-9,1.55,BP
GO:0007049,cell cycle,1659,74,33.35,6.0e-11,2.8872e-7,1.519578947368421e-8,2.22,BP
GO:0051641,cellular localization,2629,101,52.84,6.0e-11,2.8872e-7,1.519578947368421e-8,1.91,BP
GO:0010467,gene expression,4801,155,96.5,6.4e-11,3.0796799999999997e-7,1.53984e-8,1.61,BP
GO:0044267,cellular protein metabolic process,4573,149,91.92,9.8e-11,4.71576e-7,2.2456e-8,1.62,BP
GO:0010564,regulation of cell cycle process,598,39,12.02,1.2e-10,5.7744e-7,2.6247272727272726e-8,3.24,BP
GO:0048522,positive regulation of cellular process,5410,167,108.74,2.7e-10,1.29924e-6,5.4135e-8,1.54,BP
GO:0031323,regulation of cellular metabolic process,5454,168,109.63,2.7e-10,1.29924e-6,5.4135e-8,1.53,BP
GO:0016070,RNA metabolic process,3787,127,76.12,8.2e-10,3.94584e-6,1.578336e-7,1.67,BP
GO:0051246,regulation of protein metabolic process,2720,100,54.67,8.9e-10,4.28268e-6,1.6471846153846153e-7,1.83,BP
GO:0090304,nucleic acid metabolic process,4304,139,86.51,1.1e-09,5.2931999999999996e-6,1.9604444444444444e-7,1.61,BP
GO:0051726,regulation of cell cycle,976,50,19.62,1.3e-09,6.2556e-6,2.2341428571428572e-7,2.55,BP
GO:0034613,cellular protein localization,1709,72,34.35,1.4e-09,6.7368e-6,2.3230344827586208e-7,2.1,BP
GO:0033554,cellular response to stress,1781,74,35.8,1.5e-09,7.218e-6,2.406e-7,2.07,BP
GO:0070727,cellular macromolecule localization,1719,72,34.55,1.8e-09,8.6616e-6,2.794064516129032e-7,2.08,BP
GO:0051171,regulation of nitrogen compound metaboli...,5150,157,103.52,3.6e-09,1.73232e-5,5.4135e-7,1.52,BP
GO:0071704,organic substance metabolic process,9887,258,198.73,4.0e-09,1.9248000000000003e-5,5.802705882352942e-7,1.3,BP
GO:0032268,regulation of cellular protein metabolic...,2529,93,50.83,4.1e-09,1.97292e-5,5.802705882352942e-7,1.83,BP
GO:0019538,protein metabolic process,5210,158,104.72,4.6e-09,2.2135199999999998e-5,6.324342857142858e-7,1.51,BP
GO:0009059,macromolecule biosynthetic process,4105,132,82.51,5.1e-09,2.45412e-5,6.762810810810811e-7,1.6,BP
GO:0008152,metabolic process,10362,267,208.28,5.2e-09,2.50224e-5,6.762810810810811e-7,1.28,BP
GO:0048518,positive regulation of biological proces...,6114,178,122.89,5.8e-09,2.7909599999999998e-5,7.344631578947369e-7,1.45,BP
GO:0034645,cellular macromolecule biosynthetic proc...,4006,129,80.52,7.7e-09,3.70524e-5,9.500615384615385e-7,1.6,BP
GO:0080090,regulation of primary metabolic process,5295,159,106.43,8.2e-09,3.94584e-5,9.624e-7,1.49,BP
GO:0000278,mitotic cell cycle,813,43,16.34,8.2e-09,3.94584e-5,9.624e-7,2.63,BP
GO:0019222,regulation of metabolic process,6009,175,120.78,8.6e-09,4.1383199999999994e-5,9.853142857142857e-7,1.45,BP
GO:0048519,negative regulation of biological proces...,5347,160,107.47,9.2e-09,4.4270399999999995e-5,1.0295441860465117e-6,1.49,BP
GO:0030036,actin cytoskeleton organization,670,38,13.47,1.0e-08,4.812e-5,1.0693333333333335e-6,2.82,BP
GO:0051130,positive regulation of cellular componen...,1303,58,26.19,1.0e-08,4.812e-5,1.0693333333333335e-6,2.21,BP
GO:0006139,nucleobase-containing compound metabolic...,4840,148,97.28,1.1e-08,5.2931999999999994e-5,1.150695652173913e-6,1.52,BP
GO:0012501,programmed cell death,1947,76,39.13,1.3e-08,6.2556e-5,1.3309787234042552e-6,1.94,BP
GO:0050794,regulation of cellular process,10724,272,215.55,1.8e-08,8.6616e-5,1.8044999999999998e-6,1.26,BP
GO:0048523,negative regulation of cellular process,4750,145,95.48,2.0e-08,9.624e-5,1.9640816326530614e-6,1.52,BP
GO:0010638,positive regulation of organelle organiz...,604,35,12.14,2.3e-08,1.1067600000000001e-4,2.2135199999999998e-6,2.88,BP
GO:0006915,apoptotic process,1905,74,38.29,2.5e-08,1.203e-4,2.3588235294117646e-6,1.93,BP
GO:0000226,microtubule cytoskeleton organization,578,34,11.62,2.6e-08,1.25112e-4,2.406e-6,2.93,BP
GO:0008104,protein localization,2633,93,52.92,3.0e-08,1.4435999999999998e-4,2.7237735849056603e-6,1.76,BP
GO:0060255,regulation of macromolecule metabolic pr...,5534,162,111.23,3.4e-08,1.63608e-4,3.0297777777777778e-6,1.46,BP
GO:0008219,cell death,2108,79,42.37,3.7e-08,1.78044e-4,3.2371636363636362e-6,1.86,BP
GO:0050789,regulation of biological process,11466,285,230.47,3.9e-08,1.87668e-4,3.3512142857142858e-6,1.24,BP
GO:0016071,mRNA metabolic process,647,36,13,4.1e-08,1.97292e-4,3.461263157894737e-6,2.77,BP
GO:0051301,cell division,590,34,11.86,4.3e-08,2.06916e-4,3.5070508474576273e-6,2.87,BP
GO:0031399,regulation of protein modification proce...,1783,70,35.84,4.3e-08,2.06916e-4,3.5070508474576273e-6,1.95,BP
GO:0044087,regulation of cellular component biogene...,957,46,19.24,4.4e-08,2.1172799999999998e-4,3.5288e-6,2.39,BP
GO:0006397,mRNA processing,453,29,9.11,4.7e-08,2.26164e-4,3.7076065573770494e-6,3.18,BP
GO:0006412,translation,572,33,11.5,6.6e-08,3.17592e-4,5.122451612903225e-6,2.87,BP
GO:0046483,heterocycle metabolic process,4969,148,99.88,6.8e-08,3.27216e-4,5.193904761904762e-6,1.48,BP
GO:0030029,actin filament-based process,758,39,15.24,8.7e-08,4.1864399999999997e-4,6.5413124999999996e-6,2.56,BP
GO:0044271,cellular nitrogen compound biosynthetic ...,3970,124,79.8,1.0e-07,4.812e-4,7.2909090909090905e-6,1.55,BP
GO:1903827,regulation of cellular protein localizat...,526,31,10.57,1.0e-07,4.812e-4,7.2909090909090905e-6,2.93,BP
GO:0033036,macromolecule localization,2958,99,59.46,1.4e-07,6.736800000000001e-4,9.907058823529413e-6,1.66,BP
GO:0007346,regulation of mitotic cell cycle,505,30,10.15,1.4e-07,6.736800000000001e-4,9.907058823529413e-6,2.96,BP
GO:0006464,cellular protein modification process,3496,112,70.27,1.5e-07,7.218e-4,1.0311428571428571e-5,1.59,BP
GO:0036211,protein modification process,3496,112,70.27,1.5e-07,7.218e-4,1.0311428571428571e-5,1.59,BP
GO:0034622,cellular protein-containing complex asse...,1000,46,20.1,1.6e-07,7.6992e-4,1.0843943661971831e-5,2.29,BP
GO:0043043,peptide biosynthetic process,595,33,11.96,1.7e-07,8.180399999999999e-4,1.1206027397260273e-5,2.76,BP
GO:0006725,cellular aromatic compound metabolic pro...,5041,148,101.32,1.7e-07,8.180399999999999e-4,1.1206027397260273e-5,1.46,BP
GO:1903047,mitotic cell cycle process,658,35,13.23,1.9e-07,9.142800000000001e-4,1.21904e-5,2.65,BP
GO:0051179,localization,5896,167,118.51,1.9e-07,9.142800000000001e-4,1.21904e-5,1.41,BP
GO:0043933,protein-containing complex subunit organ...,1969,73,39.58,2.1e-07,0.00101052,1.3296315789473685e-5,1.84,BP
GO:0031324,negative regulation of cellular metaboli...,2476,86,49.77,2.4e-07,0.0011548799999999998,1.4998441558441557e-5,1.73,BP
GO:0006396,RNA processing,822,40,16.52,2.6e-07,0.00125112,1.5836962025316457e-5,2.42,BP
GO:0051493,regulation of cytoskeleton organization,548,31,11.01,2.6e-07,0.00125112,1.5836962025316457e-5,2.82,BP
GO:1901564,organonitrogen compound metabolic proces...,6107,171,122.75,2.7e-07,0.0012992400000000001,1.62405e-5,1.39,BP
GO:0033044,regulation of chromosome organization,358,24,7.2,3.0e-07,0.0014436,1.782222222222222e-5,3.33,BP
GO:0051172,negative regulation of nitrogen compound...,2297,81,46.17,3.2e-07,0.00153984,1.8778536585365854e-5,1.75,BP
GO:1901360,organic cyclic compound metabolic proces...,5235,151,105.22,3.7e-07,0.00178044,2.14510843373494e-5,1.44,BP
GO:0051276,chromosome organization,1105,48,22.21,4.5e-07,0.0021654,2.5778571428571425e-5,2.16,BP
GO:0009892,negative regulation of metabolic process,2874,95,57.77,4.7e-07,0.00226164,2.6607529411764706e-5,1.64,BP
GO:0065007,biological regulation,12076,292,242.73,4.9e-07,0.0023578799999999997,2.741720930232558e-5,1.2,BP
GO:0006518,peptide metabolic process,749,37,15.05,5.1e-07,0.0024541199999999997,2.8208275862068965e-5,2.46,BP
GO:0097435,supramolecular fiber organization,687,35,13.81,5.2e-07,0.00250224,2.8434545454545452e-5,2.53,BP
GO:0000910,cytokinesis,158,15,3.18,7.4e-07,0.00356088,4.000988764044944e-5,4.72,BP
GO:0070925,organelle assembly,801,38,16.1,9.6e-07,0.004619519999999999,5.1328e-5,2.36,BP
GO:0010556,regulation of macromolecule biosynthetic...,3333,105,66.99,9.9e-07,0.00476388,5.235032967032967e-5,1.57,BP
GO:0044249,cellular biosynthetic process,4923,142,98.95,1.1e-06,0.0052932000000000005,5.631063829787234e-5,1.44,BP
GO:0043412,macromolecule modification,3676,113,73.89,1.1e-06,0.0052932000000000005,5.631063829787234e-5,1.53,BP
GO:0060341,regulation of cellular localization,971,43,19.52,1.1e-06,0.0052932000000000005,5.631063829787234e-5,2.2,BP
GO:0010948,negative regulation of cell cycle proces...,232,18,4.66,1.2e-06,0.0057744,6.015e-5,3.86,BP
GO:0010605,negative regulation of macromolecule met...,2612,87,52.5,1.2e-06,0.0057744,6.015e-5,1.66,BP
GO:1901988,negative regulation of cell cycle phase ...,165,15,3.32,1.3e-06,0.0062556,6.449072164948454e-5,4.52,BP
GO:0051252,regulation of RNA metabolic process,3073,98,61.77,1.5e-06,0.0072180000000000005,7.36530612244898e-5,1.59,BP
GO:2000112,regulation of cellular macromolecule bio...,3241,102,65.14,1.6e-06,0.0076992,7.6992e-5,1.57,BP
GO:0008380,RNA splicing,366,23,7.36,1.6e-06,0.0076992,7.6992e-5,3.12,BP
GO:1901991,negative regulation of mitotic cell cycl...,147,14,2.95,1.7e-06,0.0081804000000000009,8.020000000000001e-5,4.75,BP
GO:0045930,negative regulation of mitotic cell cycl...,238,18,4.78,1.7e-06,0.0081804000000000009,8.020000000000001e-5,3.77,BP
GO:0010468,regulation of gene expression,3892,117,78.23,2.1e-06,0.010105199999999998,9.810873786407766e-5,1.5,BP
GO:0043604,amide biosynthetic process,701,34,14.09,2.3e-06,0.0110676,1.0641923076923076e-4,2.41,BP
GO:0043067,regulation of programmed cell death,1573,59,31.62,2.5e-06,0.01203,1.1457142857142859e-4,1.87,BP
GO:1901987,regulation of cell cycle phase transitio...,297,20,5.97,2.8e-06,0.013473599999999999,1.2710943396226413e-4,3.35,BP
GO:0031056,regulation of histone modification,154,14,3.1,2.9e-06,0.013954800000000002,1.3041869158878506e-4,4.52,BP
GO:1901576,organic substance biosynthetic process,5019,142,100.88,3.3e-06,0.0158796,1.4703333333333335e-4,1.41,BP
GO:0042981,regulation of apoptotic process,1552,58,31.2,3.5e-06,0.016842,1.531090909090909e-4,1.86,BP
GO:0009058,biosynthetic process,5115,144,102.81,3.5e-06,0.016842,1.531090909090909e-4,1.4,BP
GO:0051649,establishment of localization in cell,1933,68,38.85,3.7e-06,0.0178044,1.6040000000000002e-4,1.75,BP
GO:0007018,microtubule-based movement,278,19,5.59,3.9e-06,0.0187668,1.675607142857143e-4,3.4,BP
GO:0006351,"transcription, DNA-templated",2897,92,58.23,4.2e-06,0.020210399999999996,1.7885309734513272e-4,1.58,BP
GO:0009889,regulation of biosynthetic process,3570,108,71.76,4.5e-06,0.021654,1.8994736842105263e-4,1.51,BP
GO:0097659,nucleic acid-templated transcription,2905,92,58.39,4.7e-06,0.0226164,1.9666434782608696e-4,1.58,BP
GO:2001252,positive regulation of chromosome organi...,184,15,3.7,5.0e-06,0.02406,2.074137931034483e-4,4.05,BP
GO:0031326,regulation of cellular biosynthetic proc...,3496,106,70.27,5.2e-06,0.0250224,2.1027226890756303e-4,1.51,BP
GO:0010941,regulation of cell death,1723,62,34.63,5.2e-06,0.0250224,2.1027226890756303e-4,1.79,BP
GO:0051129,negative regulation of cellular componen...,761,35,15.3,5.2e-06,0.0250224,2.1027226890756303e-4,2.29,BP
GO:0032774,RNA biosynthetic process,2918,92,58.65,5.6e-06,0.026947199999999998,2.2456e-4,1.57,BP
GO:0019219,regulation of nucleobase-containing comp...,3382,103,67.98,6.1e-06,0.0293532,2.4258842975206612e-4,1.52,BP
GO:0043603,cellular amide metabolic process,970,41,19.5,6.3e-06,0.030315599999999998,2.4848852459016395e-4,2.1,BP
GO:0006355,"regulation of transcription, DNA-templat...",2805,89,56.38,6.5e-06,0.031278,2.542926829268293e-4,1.58,BP
GO:0065003,protein-containing complex assembly,1740,62,34.97,7.1e-06,0.0341652,2.755258064516129e-4,1.77,BP
GO:1903506,regulation of nucleic acid-templated tra...,2813,89,56.54,7.3e-06,0.0351276,2.8102080000000005e-4,1.57,BP
GO:1901990,regulation of mitotic cell cycle phase t...,265,18,5.33,7.7e-06,0.037052400000000006,2.940666666666667e-4,3.38,BP
GO:0071824,protein-DNA complex subunit organization,215,16,4.32,7.9e-06,0.0380148,2.993291338582677e-4,3.7,BP
GO:2001141,regulation of RNA biosynthetic process,2822,89,56.72,8.3e-06,0.0399396,3.12028125e-4,1.57,BP
GO:0044770,cell cycle phase transition,404,23,8.12,8.4e-06,0.04042079999999999,3.133395348837209e-4,2.83,BP
GO:0032879,regulation of localization,2869,90,57.67,9.0e-06,0.043308,3.331384615384616e-4,1.56,BP
GO:0019220,regulation of phosphate metabolic proces...,1720,61,34.57,9.8e-06,0.047157599999999994,3.572545454545454e-4,1.76,BP
GO:1902903,regulation of supramolecular fiber organ...,351,21,7.06,9.8e-06,0.047157599999999994,3.572545454545454e-4,2.97,BP
GO:0051174,regulation of phosphorus metabolic proce...,1721,61,34.59,1.0e-05,0.04812,3.6180451127819553e-4,1.76,BP
GO:0006928,movement of cell or subcellular componen...,2039,69,40.98,1.1e-05,0.052932,3.950149253731343e-4,1.68,BP
GO:1903829,positive regulation of cellular protein ...,302,19,6.07,1.3e-05,0.062556,4.599705882352941e-4,3.13,BP
GO:1902275,regulation of chromatin organization,199,15,4,1.3e-05,0.062556,4.599705882352941e-4,3.75,BP
GO:0006325,chromatin organization,735,33,14.77,1.6e-05,0.07699199999999999,5.61985401459854e-4,2.23,BP
GO:0090068,positive regulation of cell cycle proces...,254,17,5.11,1.7e-05,0.081804,5.885179856115108e-4,3.33,BP
GO:0046907,intracellular transport,1523,55,30.61,1.7e-05,0.081804,5.885179856115108e-4,1.8,BP
GO:0044772,mitotic cell cycle phase transition,365,21,7.34,1.8e-05,0.086616,6.099718309859154e-4,2.86,BP
GO:0080135,regulation of cellular response to stres...,674,31,13.55,1.8e-05,0.086616,6.099718309859154e-4,2.29,BP
GO:0070507,regulation of microtubule cytoskeleton o...,205,15,4.12,1.8e-05,0.086616,6.099718309859154e-4,3.64,BP
GO:0010629,negative regulation of gene expression,1800,62,36.18,2.0e-05,0.09624,6.730069930069931e-4,1.71,BP
GO:0016310,phosphorylation,2198,72,44.18,2.1e-05,0.10105199999999999,7.017499999999999e-4,1.63,BP
GO:0010970,transport along microtubule,160,13,3.22,2.2e-05,0.105864,7.250958904109589e-4,4.04,BP
GO:0099111,microtubule-based transport,160,13,3.22,2.2e-05,0.105864,7.250958904109589e-4,4.04,BP
GO:0070647,protein modification by small protein co...,748,33,15.03,2.3e-05,0.110676,7.528979591836736e-4,2.2,BP
GO:0008088,axo-dendritic transport,77,9,1.55,2.4e-05,0.11548800000000001,7.750872483221477e-4,5.81,BP
GO:0045786,negative regulation of cell cycle,462,24,9.29,2.4e-05,0.11548800000000001,7.750872483221477e-4,2.58,BP
GO:1901653,cellular response to peptide,290,18,5.83,2.6e-05,0.125112,8.3408e-4,3.09,BP
GO:0007015,actin filament organization,405,22,8.14,2.7e-05,0.12992399999999998,8.547631578947368e-4,2.7,BP
GO:0033365,protein localization to organelle,789,34,15.86,2.7e-05,0.12992399999999998,8.547631578947368e-4,2.14,BP
GO:0032270,positive regulation of cellular protein ...,1551,55,31.18,2.8e-05,0.134736,8.806274509803921e-4,1.76,BP
GO:0030030,cell projection organization,1590,56,31.96,2.9e-05,0.139548,9.061558441558441e-4,1.75,BP
GO:0050793,regulation of developmental process,2753,85,55.34,3.1e-05,0.149172,9.624000000000001e-4,1.54,BP
GO:0042325,regulation of phosphorylation,1559,55,31.34,3.3e-05,0.15879600000000002,0.001017923076923077,1.75,BP
GO:0042274,ribosomal small subunit biogenesis,63,8,1.27,3.7e-05,0.17804399999999998,0.0011268607594936708,6.3,BP
GO:0009893,positive regulation of metabolic process,3528,103,70.91,3.7e-05,0.17804399999999998,0.0011268607594936708,1.45,BP
GO:1990778,protein localization to cell periphery,355,20,7.14,3.8e-05,0.18285600000000002,0.0011500377358490566,2.8,BP
GO:1902905,positive regulation of supramolecular fi...,195,14,3.92,4.3e-05,0.20691600000000002,0.001285192546583851,3.57,BP
GO:0016482,cytosolic transport,147,12,2.95,4.3e-05,0.20691600000000002,0.001285192546583851,4.07,BP
GO:0022603,regulation of anatomical structure morph...,1091,42,21.93,4.4e-05,0.211728,0.001306962962962963,1.92,BP
GO:0030705,cytoskeleton-dependent intracellular tra...,172,13,3.46,4.7e-05,0.22616399999999998,0.0013875092024539875,3.76,BP
GO:0051247,positive regulation of protein metabolic...,1659,57,33.35,4.8e-05,0.23097600000000001,0.001408390243902439,1.71,BP
GO:0120036,plasma membrane bounded cell projection ...,1544,54,31.03,4.9e-05,0.235788,0.0014290181818181818,1.74,BP
GO:0051253,negative regulation of RNA metabolic pro...,1281,47,25.75,5.0e-05,0.2406,0.001449397590361446,1.83,BP
GO:0043065,positive regulation of apoptotic process,647,29,13,5.4e-05,0.25984799999999997,0.0015467142857142856,2.23,BP
GO:0006974,cellular response to DNA damage stimulus,748,32,15.03,5.4e-05,0.25984799999999997,0.0015467142857142856,2.13,BP
GO:0051983,regulation of chromosome segregation,106,10,2.13,5.5e-05,0.26466,0.0015660355029585799,4.69,BP
GO:0007098,centrosome cycle,128,11,2.57,5.6e-05,0.269472,0.0015851294117647059,4.28,BP
GO:0120035,regulation of plasma membrane bounded ce...,784,33,15.76,5.7e-05,0.27428400000000003,0.0016040000000000002,2.09,BP
GO:0043068,positive regulation of programmed cell d...,652,29,13.11,6.2e-05,0.298344,0.0017345581395348838,2.21,BP
GO:0009890,negative regulation of biosynthetic proc...,1524,53,30.63,6.7e-05,0.322404,0.001863606936416185,1.73,BP
GO:0045934,negative regulation of nucleobase-contai...,1410,50,28.34,6.8e-05,0.327216,0.001880551724137931,1.76,BP
GO:0071826,ribonucleoprotein complex subunit organi...,230,15,4.62,6.9e-05,0.332028,0.0018973028571428571,3.25,BP
GO:0034330,cell junction organization,257,16,5.17,7.0e-05,0.33684,0.001913863636363636,3.09,BP
GO:0031344,regulation of cell projection organizati...,793,33,15.94,7.1e-05,0.341652,0.0019193932584269666,2.07,BP
GO:0000281,mitotic cytokinesis,69,8,1.39,7.1e-05,0.341652,0.0019193932584269666,5.76,BP
GO:0045892,"negative regulation of transcription, DN...",1189,44,23.9,7.3e-05,0.351276,0.0019515333333333335,1.84,BP
GO:1903311,regulation of mRNA metabolic process,258,16,5.19,7.3e-05,0.351276,0.0019515333333333335,3.08,BP
GO:0006468,protein phosphorylation,1842,61,37.02,7.4e-05,0.35608799999999996,0.0019673370165745854,1.65,BP
GO:0010604,positive regulation of macromolecule met...,3247,95,65.26,7.6e-05,0.36571200000000004,0.0020094065934065934,1.46,BP
GO:1903507,negative regulation of nucleic acid-temp...,1193,44,23.98,7.9e-05,0.380148,0.002077311475409836,1.83,BP
GO:1902679,negative regulation of RNA biosynthetic ...,1194,44,24,8.0e-05,0.38496,0.002092173913043478,1.83,BP
GO:0010639,negative regulation of organelle organiz...,407,21,8.18,8.6e-05,0.41383200000000003,0.002213005347593583,2.57,BP
GO:0034329,cell junction assembly,208,14,4.18,8.6e-05,0.41383200000000003,0.002213005347593583,3.35,BP
GO:0006357,regulation of transcription by RNA polym...,2012,65,40.44,8.6e-05,0.41383200000000003,0.002213005347593583,1.61,BP
GO:0051302,regulation of cell division,159,12,3.2,9.3e-05,0.44751599999999997,0.0023804042553191487,3.75,BP
GO:2000113,negative regulation of cellular macromol...,1391,49,27.96,9.4e-05,0.45232799999999995,0.002393269841269841,1.75,BP
GO:0006986,response to unfolded protein,113,10,2.27,9.5e-05,0.45714000000000005,0.002406,4.41,BP
GO:0001932,regulation of protein phosphorylation,1431,50,28.76,9.7e-05,0.466764,0.0024437905759162304,1.74,BP
GO:0044089,positive regulation of cellular componen...,538,25,10.81,0.00010,0.4812,0.0024804123711340206,2.31,BP
GO:0045022,early endosome to late endosome transpor...,38,6,0.76,0.00010,0.4812,0.0024804123711340206,7.89,BP
GO:0031023,microtubule organizing center organizati...,137,11,2.75,0.00010,0.4812,0.0024804123711340206,4,BP
GO:0032502,developmental process,6278,162,126.19,0.00011,0.52932,0.0026733333333333336,1.28,BP
GO:0008283,cell proliferation,2027,65,40.74,0.00011,0.52932,0.0026733333333333336,1.6,BP
GO:0043069,negative regulation of programmed cell d...,955,37,19.2,0.00011,0.52932,0.0026733333333333336,1.93,BP
GO:0045787,positive regulation of cell cycle,355,19,7.14,0.00011,0.52932,0.0026733333333333336,2.66,BP
GO:0010942,positive regulation of cell death,710,30,14.27,0.00012,0.5774400000000001,0.002816780487804878,2.1,BP
GO:0061640,cytoskeleton-dependent cytokinesis,94,9,1.89,0.00012,0.5774400000000001,0.002816780487804878,4.76,BP
GO:0032886,regulation of microtubule-based process,241,15,4.84,0.00012,0.5774400000000001,0.002816780487804878,3.1,BP
GO:0034654,nucleobase-containing compound biosynthe...,3328,96,66.89,0.00012,0.5774400000000001,0.002816780487804878,1.44,BP
GO:0031060,regulation of histone methylation,74,8,1.49,0.00012,0.5774400000000001,0.002816780487804878,5.37,BP
GO:0031329,regulation of cellular catabolic process,711,30,14.29,0.00012,0.5774400000000001,0.002816780487804878,2.1,BP
GO:0042127,regulation of cell proliferation,1676,56,33.69,0.00012,0.5774400000000001,0.002816780487804878,1.66,BP
GO:0098927,vesicle-mediated transport between endos...,40,6,0.8,0.00014,0.67368,0.003270291262135922,7.5,BP
GO:0006796,phosphate-containing compound metabolic ...,2963,87,59.56,0.00015,0.7217999999999999,0.0034701923076923074,1.46,BP
GO:0006338,chromatin remodeling,143,11,2.87,0.00015,0.7217999999999999,0.0034701923076923074,3.83,BP
GO:0051495,positive regulation of cytoskeleton orga...,220,14,4.42,0.00016,0.76992,0.0035977570093457946,3.17,BP
GO:0010595,positive regulation of endothelial cell ...,98,9,1.97,0.00016,0.76992,0.0035977570093457946,4.57,BP
GO:0009653,anatomical structure morphogenesis,2759,82,55.46,0.00016,0.76992,0.0035977570093457946,1.48,BP
GO:0006333,chromatin assembly or disassembly,144,11,2.89,0.00016,0.76992,0.0035977570093457946,3.81,BP
GO:0010634,positive regulation of epithelial cell m...,144,11,2.89,0.00016,0.76992,0.0035977570093457946,3.81,BP
GO:0043066,negative regulation of apoptotic process,937,36,18.83,0.00016,0.76992,0.0035977570093457946,1.91,BP
GO:0065009,regulation of molecular function,2513,76,50.51,0.00017,0.8180400000000001,0.003804837209302326,1.5,BP
GO:0006950,response to stress,3538,100,71.11,0.00018,0.86616,0.003973211009174312,1.41,BP
GO:0010558,negative regulation of macromolecule bio...,1428,49,28.7,0.00018,0.86616,0.003973211009174312,1.71,BP
GO:0008286,insulin receptor signaling pathway,122,10,2.45,0.00018,0.86616,0.003973211009174312,4.08,BP
GO:0006366,transcription by RNA polymerase II,2067,65,41.55,0.00019,0.9142800000000001,0.004118378378378379,1.56,BP
GO:0006793,phosphorus metabolic process,2985,87,60,0.00019,0.9142800000000001,0.004118378378378379,1.45,BP
GO:0032535,regulation of cellular component size,400,20,8.04,0.00019,0.9142800000000001,0.004118378378378379,2.49,BP
GO:0009894,regulation of catabolic process,837,33,16.82,0.00019,0.9142800000000001,0.004118378378378379,1.96,BP
GO:0032269,negative regulation of cellular protein ...,1020,38,20.5,0.00020,0.9624,0.004296428571428572,1.85,BP
GO:0032880,regulation of protein localization,1057,39,21.25,0.00020,0.9624,0.004296428571428572,1.84,BP
GO:0050790,regulation of catalytic activity,1833,59,36.84,0.00021,1,0.0044912,1.6,BP
GO:0042255,ribosome assembly,61,7,1.23,0.00022,1,0.004663612334801762,5.69,BP
GO:0032273,positive regulation of protein polymeriz...,125,10,2.51,0.00022,1,0.004663612334801762,3.98,BP
GO:0010631,epithelial cell migration,285,16,5.73,0.00023,1,0.00485421052631579,2.79,BP
GO:0018130,heterocycle biosynthetic process,3392,96,68.18,0.00024,1,0.00499948051948052,1.41,BP
GO:0031327,negative regulation of cellular biosynth...,1485,50,29.85,0.00024,1,0.00499948051948052,1.68,BP
GO:0060548,negative regulation of cell death,1067,39,21.45,0.00024,1,0.00499948051948052,1.82,BP
GO:0072659,protein localization to plasma membrane,287,16,5.77,0.00025,1,0.005097457627118645,2.77,BP
GO:0090132,epithelium migration,287,16,5.77,0.00025,1,0.005097457627118645,2.77,BP
GO:0043542,endothelial cell migration,203,13,4.08,0.00025,1,0.005097457627118645,3.19,BP
GO:0031401,positive regulation of protein modificat...,1219,43,24.5,0.00025,1,0.005097457627118645,1.76,BP
GO:0051173,positive regulation of nitrogen compound...,3096,89,62.23,0.00025,1,0.005097457627118645,1.43,BP
GO:0001934,positive regulation of protein phosphory...,996,37,20.02,0.00026,1,0.005213,1.85,BP
GO:0033045,regulation of sister chromatid segregati...,83,8,1.67,0.00026,1,0.005213,4.79,BP
GO:0031346,positive regulation of cell projection o...,474,22,9.53,0.00026,1,0.005213,2.31,BP
GO:0045595,regulation of cell differentiation,1930,61,38.79,0.00026,1,0.005213,1.57,BP
GO:0090130,tissue migration,289,16,5.81,0.00027,1,0.005346666666666666,2.75,BP
GO:0019438,aromatic compound biosynthetic process,3405,96,68.44,0.00027,1,0.005346666666666666,1.4,BP
GO:0001667,ameboidal-type cell migration,411,20,8.26,0.00027,1,0.005346666666666666,2.42,BP
GO:0048856,anatomical structure development,5881,151,118.21,0.00028,1,0.005499428571428571,1.28,BP
GO:1902531,regulation of intracellular signal trans...,1733,56,34.83,0.00028,1,0.005499428571428571,1.61,BP
GO:0031325,positive regulation of cellular metaboli...,3240,92,65.12,0.00030,1,0.005820967741935483,1.41,BP
GO:0031400,negative regulation of protein modificat...,578,25,11.62,0.00030,1,0.005820967741935483,2.15,BP
GO:0045010,actin nucleation,46,6,0.92,0.00030,1,0.005820967741935483,6.52,BP
GO:0034248,regulation of cellular amide metabolic p...,384,19,7.72,0.00031,1,0.005990843373493975,2.46,BP
GO:1902115,regulation of organelle assembly,208,13,4.18,0.00032,1,0.006159360000000001,3.11,BP
GO:0009057,macromolecule catabolic process,1235,43,24.82,0.00033,1,0.006326533864541833,1.73,BP
GO:0097193,intrinsic apoptotic signaling pathway,296,16,5.95,0.00035,1,0.00665691699604743,2.69,BP
GO:0051248,negative regulation of protein metabolic...,1087,39,21.85,0.00035,1,0.00665691699604743,1.78,BP
GO:0061024,membrane organization,655,27,13.17,0.00037,1,0.007009606299212598,2.05,BP
GO:0000122,negative regulation of transcription by ...,869,33,17.47,0.00038,1,0.007142812500000001,1.89,BP
GO:0034976,response to endoplasmic reticulum stress,240,14,4.82,0.00038,1,0.007142812500000001,2.9,BP
GO:0072657,protein localization to membrane,555,24,11.16,0.00040,1,0.007489494163424125,2.15,BP
GO:0031331,positive regulation of cellular cataboli...,361,18,7.26,0.00041,1,0.007646976744186047,2.48,BP
GO:0035966,response to topologically incorrect prot...,136,10,2.73,0.00043,1,0.007958307692307693,3.66,BP
GO:0032446,protein modification by small protein co...,627,26,12.6,0.00043,1,0.007958307692307693,2.06,BP
GO:0044265,cellular macromolecule catabolic process,1024,37,20.58,0.00044,1,0.0080812213740458,1.8,BP
GO:0022613,ribonucleoprotein complex biogenesis,427,20,8.58,0.00044,1,0.0080812213740458,2.33,BP
GO:0009896,positive regulation of catabolic process,428,20,8.6,0.00046,1,0.008352905660377358,2.33,BP
GO:0034728,nucleosome organization,137,10,2.75,0.00046,1,0.008352905660377358,3.64,BP
GO:0006417,regulation of translation,334,17,6.71,0.00046,1,0.008352905660377358,2.53,BP
GO:1905269,positive regulation of chromatin organiz...,113,9,2.27,0.00047,1,0.008376444444444445,3.96,BP
GO:0033047,regulation of mitotic sister chromatid s...,69,7,1.39,0.00047,1,0.008376444444444445,5.04,BP
GO:1904377,positive regulation of protein localizat...,69,7,1.39,0.00047,1,0.008376444444444445,5.04,BP
GO:0007163,establishment or maintenance of cell pol...,217,13,4.36,0.00047,1,0.008376444444444445,2.98,BP
GO:0022618,ribonucleoprotein complex assembly,217,13,4.36,0.00047,1,0.008376444444444445,2.98,BP
GO:0034314,Arp2/3 complex-mediated actin nucleation,33,5,0.66,0.00048,1,0.008429781021897809,7.58,BP
GO:0030865,cortical cytoskeleton organization,50,6,1.01,0.00048,1,0.008429781021897809,5.94,BP
GO:0120193,tight junction organization,50,6,1.01,0.00048,1,0.008429781021897809,5.94,BP
GO:0040017,positive regulation of locomotion,597,25,12,0.00048,1,0.008429781021897809,2.08,BP
GO:0032970,regulation of actin filament-based proce...,398,19,8,0.00049,1,0.008543043478260869,2.38,BP
GO:0071375,cellular response to peptide hormone sti...,246,14,4.94,0.00049,1,0.008543043478260869,2.83,BP
GO:0032271,regulation of protein polymerization,218,13,4.38,0.00050,1,0.008685920577617329,2.97,BP
GO:2000147,positive regulation of cell motility,565,24,11.36,0.00051,1,0.008827769784172664,2.11,BP
GO:0032784,regulation of DNA-templated transcriptio...,51,6,1.03,0.00053,1,0.009108428571428571,5.83,BP
GO:2000059,negative regulation of ubiquitin-depende...,51,6,1.03,0.00053,1,0.009108428571428571,5.83,BP
GO:0016192,vesicle-mediated transport,1382,46,27.78,0.00054,1,0.009247259786476869,1.66,BP
GO:0071539,protein localization to centrosome,34,5,0.68,0.00055,1,0.009385106382978724,7.35,BP
GO:0032869,cellular response to insulin stimulus,194,12,3.9,0.00058,1,0.009862049469964664,3.08,BP
GO:1902750,negative regulation of cell cycle G2/M p...,52,6,1.05,0.00059,1,0.009996760563380282,5.71,BP
GO:0023014,signal transduction by protein phosphory...,819,31,16.46,0.00060,1,0.010059930313588851,1.88,BP
GO:0030182,neuron differentiation,1507,49,30.29,0.00060,1,0.010059930313588851,1.62,BP
GO:0008090,retrograde axonal transport,20,4,0.4,0.00060,1,0.010059930313588851,10,BP
GO:1901362,organic cyclic compound biosynthetic pro...,3529,97,70.93,0.00061,1,0.010192083333333333,1.37,BP
GO:0031330,negative regulation of cellular cataboli...,252,14,5.07,0.00062,1,0.010323321799307958,2.76,BP
GO:1901342,regulation of vasculature development,343,17,6.89,0.00063,1,0.010417731958762888,2.47,BP
GO:1905508,protein localization to microtubule orga...,35,5,0.7,0.00063,1,0.010417731958762888,7.14,BP
GO:0016567,protein ubiquitination,575,24,11.56,0.00065,1,0.010711643835616439,2.08,BP
GO:1903051,negative regulation of proteolysis invol...,73,7,1.47,0.00066,1,0.010802448979591837,4.76,BP
GO:1902749,regulation of cell cycle G2/M phase tran...,95,8,1.91,0.00066,1,0.010802448979591837,4.19,BP
GO:0061572,actin filament bundle organization,170,11,3.42,0.00067,1,0.010928949152542375,3.22,BP
GO:0030335,positive regulation of cell migration,543,23,10.91,0.00069,1,0.011179393939393939,2.11,BP
GO:0042327,positive regulation of phosphorylation,1050,37,21.11,0.00069,1,0.011179393939393939,1.75,BP
GO:0032956,regulation of actin cytoskeleton organiz...,348,17,6.99,0.00073,1,0.01178778523489933,2.43,BP
GO:0048646,anatomical structure formation involved ...,1168,40,23.48,0.00074,1,0.0118696,1.7,BP
GO:0032386,regulation of intracellular transport,445,20,8.94,0.00074,1,0.0118696,2.24,BP
GO:0000375,"RNA splicing, via transesterification re...",257,14,5.17,0.00075,1,0.011910891089108911,2.71,BP
GO:0000377,"RNA splicing, via transesterification re...",257,14,5.17,0.00075,1,0.011910891089108911,2.71,BP
GO:0000398,"mRNA splicing, via spliceosome",257,14,5.17,0.00075,1,0.011910891089108911,2.71,BP
GO:0000070,mitotic sister chromatid segregation,146,10,2.93,0.00076,1,0.01199055737704918,3.41,BP
GO:0050684,regulation of mRNA processing,146,10,2.93,0.00076,1,0.01199055737704918,3.41,BP
GO:0110053,regulation of actin filament organizatio...,258,14,5.19,0.00078,1,0.012225928338762215,2.7,BP
GO:0007399,nervous system development,2347,69,47.17,0.00078,1,0.012225928338762215,1.46,BP
GO:0048699,generation of neurons,1687,53,33.91,0.00079,1,0.012342467532467533,1.56,BP
GO:0034250,positive regulation of cellular amide me...,147,10,2.95,0.00080,1,0.012418064516129033,3.39,BP
GO:0035556,intracellular signal transduction,2646,76,53.18,0.00080,1,0.012418064516129033,1.43,BP
GO:0051272,positive regulation of cellular componen...,584,24,11.74,0.00081,1,0.012532861736334406,2.04,BP
GO:2001242,regulation of intrinsic apoptotic signal...,174,11,3.5,0.00082,1,0.012606517571884983,3.14,BP
GO:0034243,regulation of transcription elongation f...,37,5,0.74,0.00082,1,0.012606517571884983,6.76,BP
GO:0044093,positive regulation of molecular functio...,1450,47,29.15,0.00083,1,0.012719617834394905,1.61,BP
GO:0098813,nuclear chromosome segregation,260,14,5.23,0.00084,1,0.012832000000000001,2.68,BP
GO:1903320,regulation of protein modification by sm...,232,13,4.66,0.00088,1,0.013400506329113925,2.79,BP
GO:1902904,negative regulation of supramolecular fi...,149,10,2.99,0.00089,1,0.013510031545741324,3.34,BP
GO:0048588,developmental cell growth,263,14,5.29,0.00094,1,0.014224150943396227,2.65,BP
GO:0051338,regulation of transferase activity,843,31,16.94,0.00096,1,0.014481253918495297,1.83,BP
GO:0048869,cellular developmental process,4475,117,89.95,0.00098,1,0.01473675,1.3,BP
GO:0031032,actomyosin structure organization,206,12,4.14,0.00099,1,0.014840747663551403,2.9,BP
GO:0007169,transmembrane receptor protein tyrosine ...,559,23,11.24,0.00102,1,0.015242981366459627,2.05,BP
GO:0051270,regulation of cellular component movemen...,1035,36,20.8,0.00103,1,0.015344767801857586,1.73,BP
GO:0014002,astrocyte development,39,5,0.78,0.00105,1,0.015404268292682925,6.41,BP
GO:0043254,regulation of protein complex assembly,458,20,9.21,0.00105,1,0.015404268292682925,2.17,BP
GO:0010389,regulation of G2/M transition of mitotic...,79,7,1.59,0.00105,1,0.015404268292682925,4.4,BP
GO:0032465,regulation of cytokinesis,79,7,1.59,0.00105,1,0.015404268292682925,4.4,BP
GO:0050772,positive regulation of axonogenesis,102,8,2.05,0.00105,1,0.015404268292682925,3.9,BP
GO:1901652,response to peptide,392,18,7.88,0.00106,1,0.015410030211480361,2.28,BP
GO:0032870,cellular response to hormone stimulus,526,22,10.57,0.00106,1,0.015410030211480361,2.08,BP
GO:0120031,plasma membrane bounded cell projection ...,492,21,9.89,0.00106,1,0.015410030211480361,2.12,BP
GO:2000026,regulation of multicellular organismal d...,2207,65,44.36,0.00108,1,0.015559760479041916,1.47,BP
GO:0006457,protein folding,153,10,3.08,0.00108,1,0.015559760479041916,3.25,BP
GO:0008360,regulation of cell shape,153,10,3.08,0.00108,1,0.015559760479041916,3.25,BP
GO:0022008,neurogenesis,1793,55,36.04,0.00109,1,0.015656955223880598,1.53,BP
GO:0010628,positive regulation of gene expression,2000,60,40.2,0.00110,1,0.01575357142857143,1.49,BP
GO:0000819,sister chromatid segregation,181,11,3.64,0.00113,1,0.01613519287833828,3.02,BP
GO:0051781,positive regulation of cell division,80,7,1.61,0.00114,1,0.016181946902654867,4.35,BP
GO:0061387,regulation of extent of cell growth,128,9,2.57,0.00114,1,0.016181946902654867,3.5,BP
GO:0022604,regulation of cell morphogenesis,530,22,10.65,0.00116,1,0.016417411764705882,2.07,BP
GO:0010562,positive regulation of phosphorus metabo...,1120,38,22.51,0.00118,1,0.016554402332361516,1.69,BP
GO:0045937,positive regulation of phosphate metabol...,1120,38,22.51,0.00118,1,0.016554402332361516,1.69,BP
GO:0120032,regulation of plasma membrane bounded ce...,182,11,3.66,0.00118,1,0.016554402332361516,3.01,BP
GO:0051960,regulation of nervous system development,1082,37,21.75,0.00119,1,0.01659791304347826,1.7,BP
GO:0009725,response to hormone,708,27,14.23,0.00119,1,0.01659791304347826,1.9,BP
GO:1901222,regulation of NIK/NF-kappaB signaling,104,8,2.09,0.00120,1,0.01664092219020173,3.83,BP
GO:0022411,cellular component disassembly,364,17,7.32,0.00120,1,0.01664092219020173,2.32,BP
GO:0043408,regulation of MAPK cascade,746,28,14.99,0.00123,1,0.017007931034482757,1.87,BP
GO:1901699,cellular response to nitrogen compound,638,25,12.82,0.00124,1,0.01709707736389685,1.95,BP
GO:0007093,mitotic cell cycle checkpoint,130,9,2.61,0.00127,1,0.017312294617563742,3.45,BP
GO:0044839,cell cycle G2/M phase transition,130,9,2.61,0.00127,1,0.017312294617563742,3.45,BP
GO:0031122,cytoplasmic microtubule organization,60,6,1.21,0.00127,1,0.017312294617563742,4.96,BP
GO:1902017,regulation of cilium assembly,60,6,1.21,0.00127,1,0.017312294617563742,4.96,BP
GO:0060491,regulation of cell projection assembly,184,11,3.7,0.00129,1,0.017535254237288134,2.97,BP
GO:0007275,multicellular organism development,5380,136,108.14,0.00130,1,0.017621408450704226,1.26,BP
GO:0010972,negative regulation of G2/M transition o...,41,5,0.82,0.00132,1,0.017842247191011237,6.1,BP
GO:0060560,developmental growth involved in morphog...,273,14,5.49,0.00134,1,0.0180618487394958,2.55,BP
GO:0030334,regulation of cell migration,899,32,18.07,0.00135,1,0.018145810055865925,1.77,BP
GO:1903078,positive regulation of protein localizat...,61,6,1.23,0.00139,1,0.018579666666666668,4.88,BP
GO:0009967,positive regulation of signal transducti...,1527,48,30.69,0.00139,1,0.018579666666666668,1.56,BP
GO:0002181,cytoplasmic translation,83,7,1.67,0.00141,1,0.018794792243767313,4.19,BP
GO:1902533,positive regulation of intracellular sig...,1016,35,20.42,0.00142,1,0.018875801104972376,1.71,BP
GO:0010594,regulation of endothelial cell migration,159,10,3.2,0.00145,1,0.019168681318681317,3.12,BP
GO:0008284,positive regulation of cell proliferatio...,979,34,19.68,0.00145,1,0.019168681318681317,1.73,BP
GO:0030031,cell projection assembly,505,21,10.15,0.00146,1,0.019247999999999998,2.07,BP
GO:0010765,positive regulation of sodium ion transp...,42,5,0.84,0.00148,1,0.019247999999999998,5.95,BP
GO:0030866,cortical actin cytoskeleton organization,42,5,0.84,0.00148,1,0.019247999999999998,5.95,BP
GO:0031647,regulation of protein stability,276,14,5.55,0.00148,1,0.019247999999999998,2.52,BP
GO:0032984,protein-containing complex disassembly,216,12,4.34,0.00148,1,0.019247999999999998,2.76,BP
GO:0042886,amide transport,1859,56,37.37,0.00148,1,0.019247999999999998,1.5,BP
GO:1903321,negative regulation of protein modificat...,84,7,1.69,0.00151,1,0.01953258064516129,4.14,BP
GO:0046605,regulation of centrosome cycle,62,6,1.25,0.00151,1,0.01953258064516129,4.8,BP
GO:0006511,ubiquitin-dependent protein catabolic pr...,577,23,11.6,0.00154,1,0.019867238605898122,1.98,BP
GO:0045765,regulation of angiogenesis,309,15,6.21,0.00157,1,0.02020010695187166,2.42,BP
GO:2000145,regulation of cell motility,946,33,19.01,0.00158,1,0.02022063829787234,1.74,BP
GO:0042254,ribosome biogenesis,278,14,5.59,0.00158,1,0.02022063829787234,2.5,BP
GO:1903363,negative regulation of cellular protein ...,85,7,1.71,0.00162,1,0.02067755968169761,4.09,BP
GO:0051258,protein polymerization,279,14,5.61,0.00164,1,0.020877460317460315,2.5,BP
GO:0040012,regulation of locomotion,1025,35,20.6,0.00165,1,0.02094934036939314,1.7,BP
GO:1902806,regulation of cell cycle G1/S phase tran...,135,9,2.71,0.00166,1,0.02102084210526316,3.32,BP
GO:0031334,positive regulation of protein complex a...,249,13,5,0.00167,1,0.02109196850393701,2.6,BP
GO:0038061,NIK/NF-kappaB signaling,110,8,2.21,0.00172,1,0.021666596858638743,3.62,BP
GO:0060284,regulation of cell development,1106,37,22.23,0.00174,1,0.021861305483028722,1.66,BP
GO:0000165,MAPK cascade,802,29,16.12,0.00178,1,0.022305625,1.8,BP
GO:0033048,negative regulation of mitotic sister ch...,44,5,0.88,0.00183,1,0.02281336787564767,5.68,BP
GO:0070830,bicellular tight junction assembly,44,5,0.88,0.00183,1,0.02281336787564767,5.68,BP
GO:0015833,peptide transport,1838,55,36.94,0.00190,1,0.02362480620155039,1.49,BP
GO:0030010,establishment of cell polarity,138,9,2.77,0.00193,1,0.023752327365728902,3.25,BP
GO:0048675,axon extension,138,9,2.77,0.00193,1,0.023752327365728902,3.25,BP
GO:0006354,"DNA-templated transcription, elongation",65,6,1.31,0.00193,1,0.023752327365728902,4.58,BP
GO:2000134,negative regulation of G1/S transition o...,65,6,1.31,0.00193,1,0.023752327365728902,4.58,BP
GO:0001525,angiogenesis,517,21,10.39,0.00194,1,0.023814489795918367,2.02,BP
GO:0019941,modification-dependent protein catabolic...,589,23,11.84,0.00200,1,0.0244821052631579,1.94,BP
GO:0043044,ATP-dependent chromatin remodeling,45,5,0.9,0.00202,1,0.0244821052631579,5.56,BP
GO:0120192,tight junction assembly,45,5,0.9,0.00202,1,0.0244821052631579,5.56,BP
GO:1904375,regulation of protein localization to ce...,139,9,2.79,0.00203,1,0.0244821052631579,3.23,BP
GO:0000086,G2/M transition of mitotic cell cycle,113,8,2.27,0.00203,1,0.0244821052631579,3.52,BP
GO:0030516,regulation of axon extension,113,8,2.27,0.00203,1,0.0244821052631579,3.52,BP
GO:1903076,regulation of protein localization to pl...,113,8,2.27,0.00203,1,0.0244821052631579,3.52,BP
GO:0051017,actin filament bundle assembly,167,10,3.36,0.00209,1,0.025142699999999997,2.98,BP
GO:0043549,regulation of kinase activity,737,27,14.81,0.00211,1,0.02532,1.82,BP
GO:0016049,cell growth,521,21,10.47,0.00213,1,0.02549641791044776,2.01,BP
GO:0033046,negative regulation of sister chromatid ...,46,5,0.92,0.00223,1,0.026561287128712877,5.43,BP
GO:0044257,cellular protein catabolic process,740,27,14.87,0.00223,1,0.026561287128712877,1.82,BP
GO:0050767,regulation of neurogenesis,967,33,19.44,0.00224,1,0.0266019656019656,1.7,BP
GO:0010632,regulation of epithelial cell migration,227,12,4.56,0.00225,1,0.0266019656019656,2.63,BP
GO:0032868,response to insulin,227,12,4.56,0.00225,1,0.0266019656019656,2.63,BP
GO:2000378,negative regulation of reactive oxygen s...,67,6,1.35,0.00226,1,0.02665470588235294,4.44,BP
GO:0010720,positive regulation of cell development,669,25,13.45,0.00235,1,0.027648410757946214,1.86,BP
GO:0140014,mitotic nuclear division,260,13,5.23,0.00245,1,0.02875463414634146,2.49,BP
GO:0048870,cell motility,1612,49,32.4,0.00247,1,0.02884864077669903,1.51,BP
GO:0051674,localization of cell,1612,49,32.4,0.00247,1,0.02884864077669903,1.51,BP
GO:0043632,modification-dependent macromolecule cat...,599,23,12.04,0.00248,1,0.028895302663438257,1.91,BP
GO:0065008,regulation of biological quality,4092,106,82.25,0.00252,1,0.029219855421686747,1.29,BP
GO:0090066,regulation of anatomical structure size,564,22,11.34,0.00252,1,0.029219855421686747,1.94,BP
GO:0043534,blood vessel endothelial cell migration,117,8,2.35,0.00253,1,0.02926528846153846,3.4,BP
GO:0002028,regulation of sodium ion transport,92,7,1.85,0.00255,1,0.0293555023923445,3.78,BP
GO:0030838,positive regulation of actin filament po...,92,7,1.85,0.00255,1,0.0293555023923445,3.78,BP
GO:0015031,protein transport,1784,53,35.86,0.00267,1,0.030642452830188682,1.48,BP
GO:0016570,histone modification,427,18,8.58,0.00269,1,0.030642452830188682,2.1,BP
GO:0006368,transcription elongation from RNA polyme...,48,5,0.96,0.00270,1,0.030642452830188682,5.21,BP
GO:0047496,vesicle transport along microtubule,48,5,0.96,0.00270,1,0.030642452830188682,5.21,BP
GO:0065004,protein-DNA complex assembly,173,10,3.48,0.00270,1,0.030642452830188682,2.87,BP
GO:0051239,regulation of multicellular organismal p...,3294,88,66.21,0.00270,1,0.030642452830188682,1.33,BP
GO:0051050,positive regulation of transport,1096,36,22.03,0.00272,1,0.030724507042253525,1.63,BP
GO:0030163,protein catabolic process,902,31,18.13,0.00272,1,0.030724507042253525,1.71,BP
GO:0016358,dendrite development,296,14,5.95,0.00282,1,0.03170523364485981,2.35,BP
GO:1902807,negative regulation of cell cycle G1/S p...,70,6,1.41,0.00282,1,0.03170523364485981,4.26,BP
GO:2001251,negative regulation of chromosome organi...,146,9,2.93,0.00283,1,0.031743496503496504,3.07,BP
GO:0016242,negative regulation of macroautophagy,30,4,0.6,0.00292,1,0.032676837209302326,6.67,BP
GO:0009966,regulation of signal transduction,2819,77,56.66,0.00294,1,0.03282431554524362,1.36,BP
GO:0051985,negative regulation of chromosome segreg...,49,5,0.98,0.00295,1,0.03285972222222222,5.1,BP
GO:2000045,regulation of G1/S transition of mitotic...,120,8,2.41,0.00296,1,0.03289496535796767,3.32,BP
GO:0001944,vasculature development,756,27,15.2,0.00300,1,0.03326267281105991,1.78,BP
GO:0032388,positive regulation of intracellular tra...,205,11,4.12,0.00301,1,0.0332968275862069,2.67,BP
GO:0006949,syncytium formation,71,6,1.43,0.00303,1,0.03344119266055046,4.2,BP
GO:0043085,positive regulation of catalytic activit...,1065,35,21.41,0.00307,1,0.033805125858123564,1.63,BP
GO:0009895,negative regulation of catabolic process,299,14,6.01,0.00308,1,0.03383780821917808,2.33,BP
GO:0050770,regulation of axonogenesis,206,11,4.14,0.00313,1,0.03430879271070615,2.66,BP
GO:0006479,protein methylation,177,10,3.56,0.00318,1,0.03469877551020408,2.81,BP
GO:0008213,protein alkylation,177,10,3.56,0.00318,1,0.03469877551020408,2.81,BP
GO:0016055,Wnt signaling pathway,434,18,8.72,0.00320,1,0.03483800904977376,2.06,BP
GO:0010975,regulation of neuron projection developm...,612,23,12.3,0.00323,1,0.035085237020316025,1.87,BP
GO:0198738,cell-cell signaling by wnt,436,18,8.76,0.00335,1,0.036306756756756764,2.05,BP
GO:0051049,regulation of transport,1973,57,39.66,0.00339,1,0.03665770786516854,1.44,BP
GO:0010921,regulation of phosphatase activity,123,8,2.47,0.00344,1,0.03703194630872483,3.24,BP
GO:0045727,positive regulation of translation,123,8,2.47,0.00344,1,0.03703194630872483,3.24,BP
GO:0010976,positive regulation of neuron projection...,369,16,7.42,0.00346,1,0.037164107142857145,2.16,BP
GO:0060271,cilium assembly,303,14,6.09,0.00347,1,0.037188507795100224,2.3,BP
GO:0008361,regulation of cell size,209,11,4.2,0.00349,1,0.037319733333333334,2.62,BP
GO:0045860,positive regulation of protein kinase ac...,438,18,8.8,0.00352,1,0.03755707317073171,2.05,BP
GO:0000902,cell morphogenesis,1114,36,22.39,0.00354,1,0.03768690265486726,1.61,BP
GO:1901698,response to nitrogen compound,997,33,20.04,0.00359,1,0.03813483443708609,1.65,BP
GO:0071103,DNA conformation change,210,11,4.22,0.00362,1,0.03836881057268722,2.61,BP
GO:0031058,positive regulation of histone modificat...,98,7,1.97,0.00364,1,0.038496,3.55,BP
GO:0080134,regulation of response to stress,1357,42,27.28,0.00365,1,0.038517105263157894,1.54,BP
GO:0010608,posttranscriptional regulation of gene e...,510,20,10.25,0.00366,1,0.03853811816192561,1.95,BP
GO:0010033,response to organic substance,3108,83,62.47,0.00368,1,0.03866410480349346,1.33,BP
GO:0048668,collateral sprouting,32,4,0.64,0.00371,1,0.038809826086956524,6.25,BP
GO:0051642,centrosome localization,32,4,0.64,0.00371,1,0.038809826086956524,6.25,BP
GO:0072358,cardiovascular system development,769,27,15.46,0.00377,1,0.039266753246753244,1.75,BP
GO:0033674,positive regulation of kinase activity,476,19,9.57,0.00377,1,0.039266753246753244,1.99,BP
GO:0010001,glial cell differentiation,242,12,4.86,0.00378,1,0.0392858747300216,2.47,BP
GO:0030071,regulation of mitotic metaphase/anaphase...,52,5,1.05,0.00383,1,0.03971974137931035,4.76,BP
GO:0071495,cellular response to endogenous stimulus,1241,39,24.94,0.00391,1,0.0404621935483871,1.56,BP
GO:0051603,proteolysis involved in cellular protein...,696,25,13.99,0.00392,1,0.04047862660944206,1.79,BP
GO:0018107,peptidyl-threonine phosphorylation,126,8,2.53,0.00399,1,0.04111323340471092,3.16,BP
GO:0030154,cell differentiation,4243,108,85.28,0.00401,1,0.04123102564102564,1.27,BP
GO:0016569,covalent chromatin modification,444,18,8.92,0.00405,1,0.04155351812366738,2.02,BP
GO:0007026,negative regulation of microtubule depol...,33,4,0.66,0.00415,1,0.04232118393234672,6.06,BP
GO:0061842,microtubule organizing center localizati...,33,4,0.66,0.00415,1,0.04232118393234672,6.06,BP
GO:0051347,positive regulation of transferase activ...,552,21,11.1,0.00416,1,0.04232118393234672,1.89,BP
GO:0099518,vesicle cytoskeletal trafficking,53,5,1.07,0.00416,1,0.04232118393234672,4.67,BP
GO:0032147,activation of protein kinase activity,247,12,4.96,0.00444,1,0.045074430379746844,2.42,BP
GO:0043268,positive regulation of potassium ion tra...,54,5,1.09,0.00452,1,0.045502594142259406,4.59,BP
GO:0043297,apical junction assembly,54,5,1.09,0.00452,1,0.045502594142259406,4.59,BP
GO:0045839,negative regulation of mitotic nuclear d...,54,5,1.09,0.00452,1,0.045502594142259406,4.59,BP
GO:0072698,protein localization to microtubule cyto...,54,5,1.09,0.00452,1,0.045502594142259406,4.59,BP
GO:0006892,post-Golgi vesicle-mediated transport,102,7,2.05,0.00454,1,0.04560851774530271,3.41,BP
GO:0045859,regulation of protein kinase activity,667,24,13.41,0.00456,1,0.045714,1.79,BP
GO:0051494,negative regulation of cytoskeleton orga...,158,9,3.18,0.00476,1,0.0476197920997921,2.83,BP
GO:1905897,regulation of response to endoplasmic re...,78,6,1.57,0.00484,1,0.04821860655737706,3.82,BP
GO:0071705,nitrogen compound transport,2178,61,43.78,0.00485,1,0.04821860655737706,1.39,BP
GO:0051668,localization within membrane,188,10,3.78,0.00487,1,0.04821860655737706,2.65,BP
GO:0031175,neuron projection development,1097,35,22.05,0.00488,1,0.04821860655737706,1.59,BP
GO:0045773,positive regulation of axon extension,55,5,1.11,0.00489,1,0.04821860655737706,4.5,BP
GO:1901799,negative regulation of proteasomal prote...,55,5,1.11,0.00489,1,0.04821860655737706,4.5,BP
GO:1902099,regulation of metaphase/anaphase transit...,55,5,1.11,0.00489,1,0.04821860655737706,4.5,BP
GO:0016477,cell migration,1463,44,29.41,0.00493,1,0.048512016293279024,1.5,BP
GO:0042176,regulation of protein catabolic process,383,16,7.7,0.00494,1,0.048512016293279024,2.08,BP
GO:0045664,regulation of neuron differentiation,785,27,15.78,0.00495,1,0.048512016293279024,1.71,BP
GO:0032435,negative regulation of proteasomal ubiqu...,35,4,0.7,0.00515,1,0.05036951219512196,5.71,BP
GO:0007091,metaphase/anaphase transition of mitotic...,56,5,1.13,0.00528,1,0.05153622718052738,4.42,BP
GO:0040007,growth,1103,35,22.17,0.00531,1,0.05161258064516129,1.58,BP
GO:0006413,translational initiation,105,7,2.11,0.00531,1,0.05161258064516129,3.32,BP
GO:0006810,transport,4327,109,86.97,0.00532,1,0.05161258064516129,1.25,BP
GO:1905114,cell surface receptor signaling pathway ...,528,20,10.61,0.00535,1,0.05179919517102616,1.89,BP
GO:0032989,cellular component morphogenesis,1225,38,24.62,0.00540,1,0.052178313253012046,1.54,BP
GO:0009719,response to endogenous stimulus,1430,43,28.74,0.00544,1,0.052459478957915834,1.5,BP
GO:0010923,negative regulation of phosphatase activ...,80,6,1.61,0.00547,1,0.05253820359281437,3.73,BP
GO:1902117,positive regulation of organelle assembl...,80,6,1.61,0.00547,1,0.05253820359281437,3.73,BP
GO:0051234,establishment of localization,4469,112,89.83,0.00549,1,0.052625258964143426,1.25,BP
GO:0009408,response to heat,106,7,2.13,0.00559,1,0.05346666666666666,3.29,BP
GO:0030833,regulation of actin filament polymerizat...,162,9,3.26,0.00560,1,0.05346666666666666,2.76,BP
GO:0010965,regulation of mitotic sister chromatid s...,57,5,1.15,0.00569,1,0.05388683693516699,4.35,BP
GO:0043536,positive regulation of blood vessel endo...,57,5,1.15,0.00569,1,0.05388683693516699,4.35,BP
GO:0044773,mitotic DNA damage checkpoint,57,5,1.15,0.00569,1,0.05388683693516699,4.35,BP
GO:0072678,T cell migration,57,5,1.15,0.00569,1,0.05388683693516699,4.35,BP
GO:0031114,regulation of microtubule depolymerizati...,36,4,0.72,0.00570,1,0.05388683693516699,5.56,BP
GO:0007059,chromosome segregation,321,14,6.45,0.00574,1,0.054158588235294125,2.17,BP
GO:0018210,peptidyl-threonine modification,134,8,2.69,0.00577,1,0.054228984375,2.97,BP
GO:0045184,establishment of protein localization,1896,54,38.11,0.00577,1,0.054228984375,1.42,BP
GO:0072384,organelle transport along microtubule,81,6,1.63,0.00581,1,0.054498479532163746,3.68,BP
GO:0070646,protein modification by small protein re...,135,8,2.71,0.00603,1,0.05643588349514564,2.95,BP
GO:0000209,protein polyubiquitination,194,10,3.9,0.00604,1,0.05643588349514564,2.56,BP
GO:0098930,axonal transport,58,5,1.17,0.00613,1,0.057165813953488374,4.27,BP
GO:0044843,cell cycle G1/S phase transition,195,10,3.92,0.00626,1,0.05826522243713733,2.55,BP
GO:0048169,regulation of long-term neuronal synapti...,37,4,0.74,0.00629,1,0.058318843930635834,5.41,BP
GO:0007034,vacuolar transport,136,8,2.73,0.00629,1,0.058318843930635834,2.93,BP
GO:0048666,neuron development,1238,38,24.88,0.00638,1,0.05903953846153847,1.53,BP
GO:1902532,negative regulation of intracellular sig...,537,20,10.79,0.00641,1,0.059203301343570054,1.85,BP
GO:1990138,neuron projection extension,196,10,3.94,0.00648,1,0.0597351724137931,2.54,BP
GO:0097190,apoptotic signaling pathway,612,22,12.3,0.00654,1,0.059832226415094336,1.79,BP
GO:0009266,response to temperature stimulus,166,9,3.34,0.00654,1,0.059832226415094336,2.69,BP
GO:0043242,negative regulation of protein complex d...,83,6,1.67,0.00654,1,0.059832226415094336,3.59,BP
GO:0042063,gliogenesis,326,14,6.55,0.00655,1,0.059832226415094336,2.14,BP
GO:0071417,cellular response to organonitrogen comp...,575,21,11.56,0.00656,1,0.059832226415094336,1.82,BP
GO:0044784,metaphase/anaphase transition of cell cy...,59,5,1.19,0.00659,1,0.059832226415094336,4.2,BP
GO:0051148,negative regulation of muscle cell diffe...,59,5,1.19,0.00659,1,0.059832226415094336,4.2,BP
GO:2000401,regulation of lymphocyte migration,59,5,1.19,0.00659,1,0.059832226415094336,4.2,BP
GO:0016072,rRNA metabolic process,228,11,4.58,0.00665,1,0.06026327683615819,2.4,BP
GO:0007249,I-kappaB kinase/NF-kappaB signaling,197,10,3.96,0.00671,1,0.0606927067669173,2.53,BP
GO:0007088,regulation of mitotic nuclear division,167,9,3.36,0.00679,1,0.061186292134831455,2.68,BP
GO:0035303,regulation of dephosphorylation,167,9,3.36,0.00679,1,0.061186292134831455,2.68,BP
GO:0016571,histone methylation,138,8,2.77,0.00686,1,0.061701532710280366,2.89,BP
GO:0051093,negative regulation of developmental pro...,1082,34,21.75,0.00688,1,0.061765970149253724,1.56,BP
GO:0043434,response to peptide hormone,328,14,6.59,0.00690,1,0.06180468401486989,2.12,BP
GO:0006897,endocytosis,615,22,12.36,0.00691,1,0.06180468401486989,1.78,BP
GO:0051783,regulation of nuclear division,198,10,3.98,0.00694,1,0.0619578478664193,2.51,BP
GO:0051240,positive regulation of multicellular org...,1957,55,39.34,0.00696,1,0.06202133333333334,1.4,BP
GO:0050678,regulation of epithelial cell proliferat...,363,15,7.3,0.00702,1,0.0624403696857671,2.05,BP
GO:0044380,protein localization to cytoskeleton,60,5,1.21,0.00707,1,0.06265348066298343,4.13,BP
GO:0051306,mitotic sister chromatid separation,60,5,1.21,0.00707,1,0.06265348066298343,4.13,BP
GO:0071157,negative regulation of cell cycle arrest,20,3,0.4,0.00713,1,0.06283802197802198,7.5,BP
GO:0098840,protein transport along microtubule,20,3,0.4,0.00713,1,0.06283802197802198,7.5,BP
GO:0099118,microtubule-based protein transport,20,3,0.4,0.00713,1,0.06283802197802198,7.5,BP
GO:0034333,adherens junction assembly,85,6,1.71,0.00733,1,0.06448255941499086,3.51,BP
GO:0050679,positive regulation of epithelial cell p...,200,10,4.02,0.00743,1,0.06521180327868853,2.49,BP
GO:0044782,cilium organization,331,14,6.65,0.00744,1,0.06521180327868853,2.11,BP
GO:0061564,axon development,509,19,10.23,0.00759,1,0.06625217391304349,1.86,BP
GO:0007051,spindle organization,170,9,3.42,0.00760,1,0.06625217391304349,2.63,BP
GO:0050821,protein stabilization,170,9,3.42,0.00760,1,0.06625217391304349,2.63,BP
GO:0007044,cell-substrate junction assembly,86,6,1.73,0.00775,1,0.0674376130198915,3.47,BP
GO:0051962,positive regulation of nervous system de...,660,23,13.27,0.00786,1,0.06823502702702704,1.73,BP
GO:0048193,Golgi vesicle transport,266,12,5.35,0.00787,1,0.06823502702702704,2.24,BP
GO:0044248,cellular catabolic process,2013,56,40.46,0.00792,1,0.06854503597122302,1.38,BP
GO:0031396,regulation of protein ubiquitination,202,10,4.06,0.00795,1,0.06868114901256733,2.46,BP
GO:0008285,negative regulation of cell proliferatio...,700,24,14.07,0.00811,1,0.06993784946236557,1.71,BP
GO:0048708,astrocyte differentiation,87,6,1.75,0.00819,1,0.0703755,3.43,BP
GO:0007095,mitotic G2 DNA damage checkpoint,21,3,0.42,0.00819,1,0.0703755,7.14,BP
GO:0048731,system development,4759,117,95.66,0.00822,1,0.07050737967914439,1.22,BP
GO:0008630,intrinsic apoptotic signaling pathway in...,114,7,2.29,0.00825,1,0.07059879218472469,3.06,BP
GO:0048514,blood vessel morphogenesis,625,22,12.56,0.00826,1,0.07059879218472469,1.75,BP
GO:1901214,regulation of neuron death,370,15,7.44,0.00830,1,0.07064968197879859,2.02,BP
GO:0032594,protein transport within lipid bilayer,40,4,0.8,0.00831,1,0.07064968197879859,5,BP
GO:0045841,negative regulation of mitotic metaphase...,40,4,0.8,0.00831,1,0.07064968197879859,5,BP
GO:0032101,regulation of response to external stimu...,779,26,15.66,0.00836,1,0.07094941798941799,1.66,BP
GO:0007050,cell cycle arrest,143,8,2.87,0.00843,1,0.0714175352112676,2.79,BP
GO:0007160,cell-matrix adhesion,204,10,4.1,0.00849,1,0.07150699300699302,2.44,BP
GO:1904018,positive regulation of vasculature devel...,204,10,4.1,0.00849,1,0.07150699300699302,2.44,BP
GO:0048583,regulation of response to stimulus,3798,96,76.34,0.00849,1,0.07150699300699302,1.26,BP
GO:0050769,positive regulation of neurogenesis,589,21,11.84,0.00850,1,0.07150699300699302,1.77,BP
GO:1905818,regulation of chromosome separation,63,5,1.27,0.00867,1,0.07280984293193718,3.94,BP
GO:0048585,negative regulation of response to stimu...,1599,46,32.14,0.00896,1,0.07511414634146342,1.43,BP
GO:1903828,negative regulation of cellular protein ...,116,7,2.33,0.00903,1,0.07555757365684576,3,BP
GO:1903672,positive regulation of sprouting angioge...,41,4,0.82,0.00906,1,0.07555757365684576,4.88,BP
GO:2000816,negative regulation of mitotic sister ch...,41,4,0.82,0.00906,1,0.07555757365684576,4.88,BP
GO:0010557,positive regulation of macromolecule bio...,1813,51,36.44,0.00912,1,0.07592636678200691,1.4,BP
GO:0051094,positive regulation of developmental pro...,1560,45,31.36,0.00926,1,0.07695875647668392,1.43,BP
GO:0002183,cytoplasmic translational initiation,22,3,0.44,0.00935,1,0.0770414383561644,6.82,BP
GO:0006353,"DNA-templated transcription, termination",22,3,0.44,0.00935,1,0.0770414383561644,6.82,BP
GO:0007063,regulation of sister chromatid cohesion,22,3,0.44,0.00935,1,0.0770414383561644,6.82,BP
GO:0031579,membrane raft organization,22,3,0.44,0.00935,1,0.0770414383561644,6.82,BP
GO:1901223,negative regulation of NIK/NF-kappaB sig...,22,3,0.44,0.00935,1,0.0770414383561644,6.82,BP
GO:0007155,cell adhesion,1311,39,26.35,0.00942,1,0.0773357142857143,1.48,BP
GO:0070997,neuron death,411,16,8.26,0.00943,1,0.0773357142857143,1.94,BP
GO:0016579,protein deubiquitination,117,7,2.35,0.00945,1,0.0773357142857143,2.98,BP
GO:0043244,regulation of protein complex disassembl...,117,7,2.35,0.00945,1,0.0773357142857143,2.98,BP
GO:0000280,nuclear division,412,16,8.28,0.00963,1,0.07867497453310696,1.93,BP
GO:0051099,positive regulation of binding,208,10,4.18,0.00965,1,0.07870474576271187,2.39,BP
GO:0043409,negative regulation of MAPK cascade,177,9,3.56,0.00976,1,0.0794672081218274,2.53,BP
GO:1902100,negative regulation of metaphase/anaphas...,42,4,0.84,0.00986,1,0.07982258823529412,4.76,BP
GO:0044774,mitotic DNA integrity checkpoint,65,5,1.31,0.00986,1,0.07982258823529412,3.82,BP
GO:0051784,negative regulation of nuclear division,65,5,1.31,0.00986,1,0.07982258823529412,3.82,BP
GO:0045216,cell-cell junction organization,147,8,2.95,0.00987,1,0.07982258823529412,2.71,BP
GO:0048589,developmental growth,790,26,15.88,0.00990,1,0.07993087248322149,1.64,BP
GO:0000075,cell cycle checkpoint,178,9,3.58,0.01011,1,0.08135337792642139,2.51,BP
GO:0030041,actin filament polymerization,178,9,3.58,0.01011,1,0.08135337792642139,2.51,BP
GO:0010563,negative regulation of phosphorus metabo...,563,20,11.32,0.01046,1,0.08361049833887044,1.77,BP
GO:0045936,negative regulation of phosphate metabol...,563,20,11.32,0.01046,1,0.08361049833887044,1.77,BP
GO:0008064,regulation of actin polymerization or de...,179,9,3.6,0.01046,1,0.08361049833887044,2.5,BP
GO:0043524,negative regulation of neuron apoptotic ...,179,9,3.6,0.01046,1,0.08361049833887044,2.5,BP
GO:0032968,positive regulation of transcription elo...,23,3,0.46,0.01059,1,0.08422988429752067,6.52,BP
GO:0051220,cytoplasmic sequestering of protein,23,3,0.46,0.01059,1,0.08422988429752067,6.52,BP
GO:1904469,positive regulation of tumor necrosis fa...,23,3,0.46,0.01059,1,0.08422988429752067,6.52,BP
GO:1905819,negative regulation of chromosome separa...,43,4,0.86,0.01070,1,0.08496435643564355,4.65,BP
GO:1903362,regulation of cellular protein catabolic...,244,11,4.9,0.01075,1,0.08522075782537067,2.24,BP
GO:0000082,G1/S transition of mitotic cell cycle,180,9,3.62,0.01082,1,0.08557300492610836,2.49,BP
GO:0022610,biological adhesion,1323,39,26.59,0.01083,1,0.08557300492610836,1.47,BP
GO:0007166,cell surface receptor signaling pathway,2396,64,48.16,0.01089,1,0.08590603278688524,1.33,BP
GO:0046777,protein autophosphorylation,245,11,4.92,0.01106,1,0.08696196078431373,2.24,BP
GO:1901215,negative regulation of neuron death,245,11,4.92,0.01106,1,0.08696196078431373,2.24,BP
GO:0046824,positive regulation of nucleocytoplasmic...,67,5,1.35,0.01116,1,0.08760508972267536,3.7,BP
GO:0035305,negative regulation of dephosphorylation,93,6,1.87,0.01119,1,0.08766106969205835,3.21,BP
GO:0071902,positive regulation of protein serine/th...,279,12,5.61,0.01123,1,0.08766106969205835,2.14,BP
GO:0018022,peptidyl-lysine methylation,121,7,2.43,0.01124,1,0.08766106969205835,2.88,BP
GO:0031497,chromatin assembly,121,7,2.43,0.01124,1,0.08766106969205835,2.88,BP
GO:0033157,regulation of intracellular protein tran...,213,10,4.28,0.01128,1,0.08783067961165049,2.34,BP
GO:0040011,locomotion,1837,51,36.92,0.01155,1,0.08964290322580645,1.38,BP
GO:0001568,blood vessel development,722,24,14.51,0.01155,1,0.08964290322580645,1.65,BP
GO:0030832,regulation of actin filament length,182,9,3.66,0.01157,1,0.08965352657004831,2.46,BP
GO:2001233,regulation of apoptotic signaling pathwa...,421,16,8.46,0.01166,1,0.09020565916398715,1.89,BP
GO:0010508,positive regulation of autophagy,122,7,2.45,0.01173,1,0.09060154093097914,2.86,BP
GO:0006402,mRNA catabolic process,215,10,4.32,0.01198,1,0.09238423076923076,2.31,BP
GO:1900180,regulation of protein localization to nu...,123,7,2.47,0.01223,1,0.094161216,2.83,BP
GO:0010647,positive regulation of cell communicatio...,1887,52,37.93,0.01234,1,0.09485635782747603,1.37,BP
GO:0048285,organelle fission,461,17,9.27,0.01251,1,0.09593496038034864,1.83,BP
GO:0045596,negative regulation of cell differentiat...,806,26,16.2,0.01255,1,0.09593496038034864,1.6,BP
GO:0000768,syncytium formation by plasma membrane f...,69,5,1.39,0.01258,1,0.09593496038034864,3.6,BP
GO:0051298,centrosome duplication,69,5,1.39,0.01258,1,0.09593496038034864,3.6,BP
GO:0140253,cell-cell fusion,69,5,1.39,0.01258,1,0.09593496038034864,3.6,BP
GO:0009628,response to abiotic stimulus,1048,32,21.06,0.01270,1,0.09669683544303796,1.52,BP
GO:0045766,positive regulation of angiogenesis,185,9,3.72,0.01277,1,0.09707620853080569,2.42,BP
GO:0000045,autophagosome assembly,96,6,1.93,0.01295,1,0.09813448818897638,3.11,BP
GO:1901989,positive regulation of cell cycle phase ...,96,6,1.93,0.01295,1,0.09813448818897638,3.11,BP
GO:0023056,positive regulation of signaling,1893,52,38.05,0.01305,1,0.0987367924528302,1.37,BP
GO:0010770,positive regulation of cell morphogenesi...,186,9,3.74,0.01319,1,0.09963937205651492,2.41,BP
GO:1903670,regulation of sprouting angiogenesis,70,5,1.41,0.01333,1,0.09998183514774495,3.55,BP
GO:2001244,positive regulation of intrinsic apoptot...,70,5,1.41,0.01333,1,0.09998183514774495,3.55,BP
GO:0031100,animal organ regeneration,25,3,0.5,0.01336,1,0.09998183514774495,6,BP
GO:0032515,negative regulation of phosphoprotein ph...,25,3,0.5,0.01336,1,0.09998183514774495,6,BP
GO:0046688,response to copper ion,25,3,0.5,0.01336,1,0.09998183514774495,6,BP
GO:2000679,positive regulation of transcription reg...,25,3,0.5,0.01336,1,0.09998183514774495,6,BP
GO:0006378,mRNA polyadenylation,46,4,0.92,0.01351,1,0.10047931993817619,4.35,BP
GO:0031111,negative regulation of microtubule polym...,46,4,0.92,0.01351,1,0.10047931993817619,4.35,BP
GO:0042307,positive regulation of protein import in...,46,4,0.92,0.01351,1,0.10047931993817619,4.35,BP
GO:2000404,regulation of T cell migration,46,4,0.92,0.01351,1,0.10047931993817619,4.35,BP
GO:0000904,cell morphogenesis involved in different...,813,26,16.34,0.01387,1,0.10299759259259259,1.59,BP
GO:0060249,anatomical structure homeostasis,394,15,7.92,0.01411,1,0.10461836671802774,1.89,BP
GO:0050673,epithelial cell proliferation,431,16,8.66,0.01428,1,0.10571593846153846,1.85,BP
GO:0045666,positive regulation of neuron differenti...,468,17,9.41,0.01431,1,0.10577529953917052,1.81,BP
GO:0061013,regulation of mRNA catabolic process,127,7,2.55,0.01438,1,0.10612969325153374,2.75,BP
GO:0051489,regulation of filopodium assembly,47,4,0.94,0.01454,1,0.10696598473282443,4.26,BP
GO:0061028,establishment of endothelial barrier,47,4,0.94,0.01454,1,0.10696598473282443,4.26,BP
GO:0071900,regulation of protein serine/threonine k...,432,16,8.68,0.01456,1,0.10696598473282443,1.84,BP
GO:0010243,response to organonitrogen compound,898,28,18.05,0.01486,1,0.10900353658536585,1.55,BP
GO:0006364,rRNA processing,191,9,3.84,0.01545,1,0.11288849772382398,2.34,BP
GO:1905475,regulation of protein localization to me...,191,9,3.84,0.01545,1,0.11288849772382398,2.34,BP
GO:0006886,intracellular protein transport,901,28,18.11,0.01546,1,0.11288849772382398,1.55,BP
GO:0051092,positive regulation of NF-kappaB transcr...,129,7,2.59,0.01555,1,0.11312548192771085,2.7,BP
GO:1905037,autophagosome organization,100,6,2.01,0.01558,1,0.11312548192771085,2.99,BP
GO:0008089,anterograde axonal transport,48,4,0.96,0.01561,1,0.11312548192771085,4.17,BP
GO:0043631,RNA polyadenylation,48,4,0.96,0.01561,1,0.11312548192771085,4.17,BP
GO:1902808,positive regulation of cell cycle G1/S p...,48,4,0.96,0.01561,1,0.11312548192771085,4.17,BP
GO:0007409,axonogenesis,473,17,9.51,0.01572,1,0.11375133834586466,1.79,BP
GO:0007167,enzyme linked receptor protein signaling...,903,28,18.15,0.01587,1,0.11466432432432432,1.54,BP
GO:0031098,stress-activated protein kinase signalin...,293,12,5.89,0.01597,1,0.11521385307346327,2.04,BP
GO:0007041,lysosomal transport,101,6,2.03,0.01629,1,0.11724304932735426,2.96,BP
GO:0009314,response to radiation,401,15,8.06,0.01630,1,0.11724304932735426,1.86,BP
GO:0035987,endodermal cell differentiation,27,3,0.54,0.01649,1,0.11825615499254845,5.56,BP
GO:0039694,viral RNA genome replication,27,3,0.54,0.01649,1,0.11825615499254845,5.56,BP
GO:0031328,positive regulation of cellular biosynth...,1919,52,38.57,0.01656,1,0.1185534222222222,1.35,BP
GO:0031397,negative regulation of protein ubiquitin...,74,5,1.49,0.01663,1,0.1185534222222222,3.36,BP
GO:0046626,regulation of insulin receptor signaling...,74,5,1.49,0.01663,1,0.1185534222222222,3.36,BP
GO:1901880,negative regulation of protein depolymer...,74,5,1.49,0.01663,1,0.1185534222222222,3.36,BP
GO:0001558,regulation of cell growth,439,16,8.82,0.01669,1,0.11880514792899408,1.81,BP
GO:0042177,negative regulation of protein catabolic...,131,7,2.63,0.01679,1,0.11934044313146233,2.66,BP
GO:0000077,DNA damage checkpoint,102,6,2.05,0.01703,1,0.12086778761061946,2.93,BP
GO:0098657,import into cell,749,24,15.05,0.01728,1,0.12246150220913107,1.59,BP
GO:0030902,hindbrain development,163,8,3.28,0.01750,1,0.12383823529411765,2.44,BP
GO:0035239,tube morphogenesis,911,28,18.31,0.01762,1,0.12450431718061673,1.53,BP
GO:0048638,regulation of developmental growth,405,15,8.14,0.01766,1,0.12456245973645681,1.84,BP
GO:1901565,organonitrogen compound catabolic proces...,1158,34,23.28,0.01768,1,0.12456245973645681,1.46,BP
GO:0043488,regulation of mRNA stability,103,6,2.07,0.01779,1,0.12515421052631578,2.9,BP
GO:0099173,postsynapse organization,196,9,3.94,0.01797,1,0.12619224489795916,2.28,BP
GO:0051402,neuron apoptotic process,298,12,5.99,0.01799,1,0.12619224489795916,2,BP
GO:0051656,establishment of organelle localization,481,17,9.67,0.01820,1,0.12710943396226415,1.76,BP
GO:0031440,regulation of mRNA 3'-end processing,28,3,0.56,0.01820,1,0.12710943396226415,5.36,BP
GO:0045724,positive regulation of cilium assembly,28,3,0.56,0.01820,1,0.12710943396226415,5.36,BP
GO:0051098,regulation of binding,407,15,8.18,0.01837,1,0.12811078260869566,1.83,BP
GO:0043410,positive regulation of MAPK cascade,520,18,10.45,0.01857,1,0.12875913544668588,1.72,BP
GO:0030038,contractile actin filament bundle assemb...,104,6,2.09,0.01857,1,0.12875913544668588,2.87,BP
GO:0032231,regulation of actin filament bundle asse...,104,6,2.09,0.01857,1,0.12875913544668588,2.87,BP
GO:0043149,stress fiber assembly,104,6,2.09,0.01857,1,0.12875913544668588,2.87,BP
GO:0090316,positive regulation of intracellular pro...,134,7,2.69,0.01878,1,0.13002785611510792,2.6,BP
GO:0032206,positive regulation of telomere maintena...,51,4,1.03,0.01914,1,0.13214014347202296,3.88,BP
GO:1904591,positive regulation of protein import,51,4,1.03,0.01914,1,0.13214014347202296,3.88,BP
GO:1901701,cellular response to oxygen-containing c...,1207,35,24.26,0.01918,1,0.13222659025787964,1.44,BP
GO:0043523,regulation of neuron apoptotic process,266,11,5.35,0.01927,1,0.13265699570815448,2.06,BP
GO:1905477,positive regulation of protein localizat...,105,6,2.11,0.01937,1,0.13287681818181818,2.84,BP
GO:0001894,tissue homeostasis,232,10,4.66,0.01939,1,0.13287681818181818,2.15,BP
GO:0000380,"alternative mRNA splicing, via spliceoso...",77,5,1.55,0.01944,1,0.13287681818181818,3.23,BP
GO:0014855,striated muscle cell proliferation,77,5,1.55,0.01944,1,0.13287681818181818,3.23,BP
GO:1901224,positive regulation of NIK/NF-kappaB sig...,77,5,1.55,0.01944,1,0.13287681818181818,3.23,BP
GO:0051336,regulation of hydrolase activity,1001,30,20.12,0.01954,1,0.13337089361702126,1.49,BP
GO:0016236,macroautophagy,199,9,4,0.01963,1,0.13379541076487253,2.25,BP
GO:0051222,positive regulation of protein transport,448,16,9,0.01977,1,0.13455903818953324,1.78,BP
GO:0071310,cellular response to organic substance,2470,64,49.65,0.01989,1,0.13504645161290324,1.29,BP
GO:0000027,ribosomal large subunit assembly,29,3,0.58,0.02001,1,0.13504645161290324,5.17,BP
GO:0031116,positive regulation of microtubule polym...,29,3,0.58,0.02001,1,0.13504645161290324,5.17,BP
GO:0034629,cellular protein-containing complex loca...,29,3,0.58,0.02001,1,0.13504645161290324,5.17,BP
GO:0051984,positive regulation of chromosome segreg...,29,3,0.58,0.02001,1,0.13504645161290324,5.17,BP
GO:0090169,regulation of spindle assembly,29,3,0.58,0.02001,1,0.13504645161290324,5.17,BP
GO:0120034,positive regulation of plasma membrane b...,106,6,2.13,0.02020,1,0.13613781512605042,2.82,BP
GO:0050768,negative regulation of neurogenesis,339,13,6.81,0.02030,1,0.13662041958041957,1.91,BP
GO:0007019,microtubule depolymerization,52,4,1.05,0.02041,1,0.13697757322175733,3.81,BP
GO:0061014,positive regulation of mRNA catabolic pr...,52,4,1.05,0.02041,1,0.13697757322175733,3.81,BP
GO:0000079,regulation of cyclin-dependent protein s...,78,5,1.57,0.02044,1,0.13698785515320333,3.18,BP
GO:0006323,DNA packaging,168,8,3.38,0.02057,1,0.13766737134909598,2.37,BP
GO:0035295,tube development,1130,33,22.71,0.02064,1,0.13794399999999998,1.45,BP
GO:0043122,regulation of I-kappaB kinase/NF-kappaB ...,169,8,3.4,0.02123,1,0.1414941274238227,2.35,BP
GO:0045931,positive regulation of mitotic cell cycl...,169,8,3.4,0.02123,1,0.1414941274238227,2.35,BP
GO:0040008,regulation of growth,724,23,14.55,0.02132,1,0.14189742738589212,1.58,BP
GO:0031589,cell-substrate adhesion,342,13,6.87,0.02164,1,0.14382828729281769,1.89,BP
GO:0031113,regulation of microtubule polymerization,53,4,1.07,0.02174,1,0.14409487603305784,3.74,BP
GO:0043666,regulation of phosphoprotein phosphatase...,53,4,1.07,0.02174,1,0.14409487603305784,3.74,BP
GO:0009303,rRNA transcription,30,3,0.6,0.02191,1,0.1448226923076923,5,BP
GO:0051569,regulation of histone H3-K4 methylation,30,3,0.6,0.02191,1,0.1448226923076923,5,BP
GO:0050808,synapse organization,455,16,9.15,0.02245,1,0.14818847736625515,1.75,BP
GO:0007043,cell-cell junction assembly,109,6,2.19,0.02282,1,0.15021865937072504,2.74,BP
GO:0034968,histone lysine methylation,109,6,2.19,0.02282,1,0.15021865937072504,2.74,BP
GO:0051254,positive regulation of RNA metabolic pro...,1652,45,33.21,0.02311,1,0.15191983606557377,1.36,BP
GO:0008154,actin polymerization or depolymerization,205,9,4.12,0.02326,1,0.15269729877216914,2.18,BP
GO:0010769,regulation of cell morphogenesis involve...,346,13,6.95,0.02351,1,0.15412822888283378,1.87,BP
GO:0009891,positive regulation of biosynthetic proc...,1960,52,39.4,0.02362,1,0.15455934782608696,1.32,BP
GO:0002088,lens development in camera-type eye,81,5,1.63,0.02364,1,0.15455934782608696,3.07,BP
GO:0030316,osteoclast differentiation,110,6,2.21,0.02374,1,0.1547870794078062,2.71,BP
GO:0032232,negative regulation of actin filament bu...,31,3,0.62,0.02390,1,0.1547870794078062,4.84,BP
GO:0035767,endothelial cell chemotaxis,31,3,0.62,0.02390,1,0.1547870794078062,4.84,BP
GO:0043276,anoikis,31,3,0.62,0.02390,1,0.1547870794078062,4.84,BP
GO:0044818,mitotic G2/M transition checkpoint,31,3,0.62,0.02390,1,0.1547870794078062,4.84,BP
GO:0060795,cell fate commitment involved in formati...,31,3,0.62,0.02390,1,0.1547870794078062,4.84,BP
GO:2000778,positive regulation of interleukin-6 sec...,31,3,0.62,0.02390,1,0.1547870794078062,4.84,BP
GO:0034504,protein localization to nucleus,276,11,5.55,0.02448,1,0.15833032258064514,1.98,BP
GO:0010498,proteasomal protein catabolic process,460,16,9.25,0.02453,1,0.15844075167785235,1.73,BP
GO:1903312,negative regulation of mRNA metabolic pr...,82,5,1.65,0.02477,1,0.1595625702811245,3.03,BP
GO:1904029,regulation of cyclin-dependent protein k...,82,5,1.65,0.02477,1,0.1595625702811245,3.03,BP
GO:0048584,positive regulation of response to stimu...,2187,57,43.96,0.02483,1,0.15973524064171124,1.3,BP
GO:0018193,peptidyl-amino acid modification,1147,33,23.05,0.02490,1,0.1599716955941255,1.43,BP
GO:0021782,glial cell development,112,6,2.25,0.02566,1,0.16397864541832669,2.67,BP
GO:0031570,DNA integrity checkpoint,112,6,2.25,0.02566,1,0.16397864541832669,2.67,BP
GO:0043487,regulation of RNA stability,112,6,2.25,0.02566,1,0.16397864541832669,2.67,BP
GO:0051028,mRNA transport,112,6,2.25,0.02566,1,0.16397864541832669,2.67,BP
GO:0010959,regulation of metal ion transport,425,15,8.54,0.02580,1,0.16455773684210526,1.76,BP
GO:1901888,regulation of cell junction assembly,83,5,1.67,0.02594,1,0.16455773684210526,2.99,BP
GO:1901992,positive regulation of mitotic cell cycl...,83,5,1.67,0.02594,1,0.16455773684210526,2.99,BP
GO:0000462,maturation of SSU-rRNA from tricistronic...,32,3,0.64,0.02599,1,0.16455773684210526,4.69,BP
GO:0008608,attachment of spindle microtubules to ki...,32,3,0.64,0.02599,1,0.16455773684210526,4.69,BP
GO:0031572,G2 DNA damage checkpoint,32,3,0.64,0.02599,1,0.16455773684210526,4.69,BP
GO:0032508,DNA duplex unwinding,32,3,0.64,0.02599,1,0.16455773684210526,4.69,BP
GO:0010721,negative regulation of cell development,388,14,7.8,0.02603,1,0.16459442838370567,1.79,BP
GO:0006281,DNA repair,465,16,9.35,0.02675,1,0.1689251968503937,1.71,BP
GO:0032204,regulation of telomere maintenance,84,5,1.69,0.02714,1,0.1709393717277487,2.96,BP
GO:0034620,cellular response to unfolded protein,84,5,1.69,0.02714,1,0.1709393717277487,2.96,BP
GO:0051091,positive regulation of DNA-binding trans...,246,10,4.94,0.02765,1,0.1734325,2.02,BP
GO:1904951,positive regulation of establishment of ...,467,16,9.39,0.02767,1,0.1734325,1.7,BP
GO:0000187,activation of MAPK activity,114,6,2.29,0.02768,1,0.1734325,2.62,BP
GO:0046822,regulation of nucleocytoplasmic transpor...,114,6,2.29,0.02768,1,0.1734325,2.62,BP
GO:0061061,muscle structure development,704,22,14.15,0.02814,1,0.17513441860465118,1.55,BP
GO:0001706,endoderm formation,33,3,0.66,0.02817,1,0.17513441860465118,4.55,BP
GO:0031112,positive regulation of microtubule polym...,33,3,0.66,0.02817,1,0.17513441860465118,4.55,BP
GO:0032467,positive regulation of cytokinesis,33,3,0.66,0.02817,1,0.17513441860465118,4.55,BP
GO:0061157,mRNA destabilization,33,3,0.66,0.02817,1,0.17513441860465118,4.55,BP
GO:0071709,membrane assembly,33,3,0.66,0.02817,1,0.17513441860465118,4.55,BP
GO:0001935,endothelial cell proliferation,146,7,2.93,0.02838,1,0.17621233548387097,2.39,BP
GO:0043161,proteasome-mediated ubiquitin-dependent ...,393,14,7.9,0.02859,1,0.17728747422680413,1.77,BP
GO:1903050,regulation of proteolysis involved in ce...,213,9,4.28,0.02882,1,0.17848370656370655,2.1,BP
GO:0051310,metaphase plate congression,58,4,1.17,0.02915,1,0.18029537275064267,3.42,BP
GO:0035304,regulation of protein dephosphorylation,86,5,1.73,0.02966,1,0.18274509603072983,2.89,BP
GO:0006914,autophagy,395,14,7.94,0.02966,1,0.18274509603072983,1.76,BP
GO:0061919,process utilizing autophagic mechanism,395,14,7.94,0.02966,1,0.18274509603072983,1.76,BP
GO:0006401,RNA catabolic process,249,10,5,0.02971,1,0.1828190792838875,2,BP
GO:0043414,macromolecule methylation,285,11,5.73,0.02998,1,0.18424490421455939,1.92,BP
GO:0042692,muscle cell differentiation,396,14,7.96,0.03021,1,0.18542158163265307,1.76,BP
GO:0032786,positive regulation of DNA-templated tra...,34,3,0.68,0.03045,1,0.18571026615969582,4.41,BP
GO:1904467,regulation of tumor necrosis factor secr...,34,3,0.68,0.03045,1,0.18571026615969582,4.41,BP
GO:1905898,positive regulation of response to endop...,34,3,0.68,0.03045,1,0.18571026615969582,4.41,BP
GO:2000406,positive regulation of T cell migration,34,3,0.68,0.03045,1,0.18571026615969582,4.41,BP
GO:2000785,regulation of autophagosome assembly,34,3,0.68,0.03045,1,0.18571026615969582,4.41,BP
GO:0032414,positive regulation of ion transmembrane...,117,6,2.35,0.03091,1,0.1882771139240506,2.55,BP
GO:1901879,regulation of protein depolymerization,87,5,1.75,0.03096,1,0.18834326169405816,2.86,BP
GO:0006839,mitochondrial transport,182,8,3.66,0.03119,1,0.1895028787878788,2.19,BP
GO:0048667,cell morphogenesis involved in neuron di...,632,20,12.7,0.03149,1,0.19108433795712482,1.57,BP
GO:0010506,regulation of autophagy,252,10,5.07,0.03187,1,0.19314664987405544,1.97,BP
GO:0072593,reactive oxygen species metabolic proces...,288,11,5.79,0.03199,1,0.19362859296482415,1.9,BP
GO:0002040,sprouting angiogenesis,118,6,2.37,0.03203,1,0.19362859296482415,2.53,BP
GO:0031110,regulation of microtubule polymerization...,88,5,1.77,0.03231,1,0.19483172932330828,2.82,BP
GO:1900076,regulation of cellular response to insul...,88,5,1.77,0.03231,1,0.19483172932330828,2.82,BP
GO:0031124,mRNA 3'-end processing,60,4,1.21,0.03248,1,0.19512329588014982,3.31,BP
GO:0042982,amyloid precursor protein metabolic proc...,60,4,1.21,0.03248,1,0.19512329588014982,3.31,BP
GO:0046847,filopodium assembly,60,4,1.21,0.03248,1,0.19512329588014982,3.31,BP
GO:0010737,protein kinase A signaling,35,3,0.7,0.03282,1,0.19545772277227724,4.29,BP
GO:0016572,histone phosphorylation,35,3,0.7,0.03282,1,0.19545772277227724,4.29,BP
GO:0032228,"regulation of synaptic transmission, GAB...",35,3,0.7,0.03282,1,0.19545772277227724,4.29,BP
GO:0035308,negative regulation of protein dephospho...,35,3,0.7,0.03282,1,0.19545772277227724,4.29,BP
GO:0045686,negative regulation of glial cell differ...,35,3,0.7,0.03282,1,0.19545772277227724,4.29,BP
GO:0050779,RNA destabilization,35,3,0.7,0.03282,1,0.19545772277227724,4.29,BP
GO:1902116,negative regulation of organelle assembl...,35,3,0.7,0.03282,1,0.19545772277227724,4.29,BP
GO:0051961,negative regulation of nervous system de...,363,13,7.3,0.03287,1,0.195513522867738,1.78,BP
GO:2000058,regulation of ubiquitin-dependent protei...,151,7,3.04,0.03321,1,0.19729200000000002,2.3,BP
GO:0043406,positive regulation of MAP kinase activi...,219,9,4.4,0.03355,1,0.1990660912453761,2.05,BP
GO:0051090,regulation of DNA-binding transcription ...,402,14,8.08,0.03365,1,0.19916004914004912,1.73,BP
GO:0007229,integrin-mediated signaling pathway,89,5,1.79,0.03369,1,0.19916004914004912,2.79,BP
GO:0051492,regulation of stress fiber assembly,89,5,1.79,0.03369,1,0.19916004914004912,2.79,BP
GO:1901566,organonitrogen compound biosynthetic pro...,1564,42,31.44,0.03376,1,0.199328981595092,1.34,BP
GO:0071156,regulation of cell cycle arrest,61,4,1.23,0.03423,1,0.2016681517747858,3.25,BP
GO:0014013,regulation of gliogenesis,152,7,3.06,0.03424,1,0.2016681517747858,2.29,BP
GO:0031109,microtubule polymerization or depolymeri...,120,6,2.41,0.03437,1,0.20218635696821516,2.49,BP
GO:2001235,positive regulation of apoptotic signali...,186,8,3.74,0.03481,1,0.20410514423076923,2.14,BP
GO:1903008,organelle disassembly,90,5,1.81,0.03511,1,0.20410514423076923,2.76,BP
GO:0050657,nucleic acid transport,153,7,3.08,0.03529,1,0.20410514423076923,2.27,BP
GO:0050658,RNA transport,153,7,3.08,0.03529,1,0.20410514423076923,2.27,BP
GO:0000184,nuclear-transcribed mRNA catabolic proce...,36,3,0.72,0.03529,1,0.20410514423076923,4.17,BP
GO:0006383,transcription by RNA polymerase III,36,3,0.72,0.03529,1,0.20410514423076923,4.17,BP
GO:0007094,mitotic spindle assembly checkpoint,36,3,0.72,0.03529,1,0.20410514423076923,4.17,BP
GO:0035886,vascular smooth muscle cell differentiat...,36,3,0.72,0.03529,1,0.20410514423076923,4.17,BP
GO:0048009,insulin-like growth factor receptor sign...,36,3,0.72,0.03529,1,0.20410514423076923,4.17,BP
GO:0071173,spindle assembly checkpoint,36,3,0.72,0.03529,1,0.20410514423076923,4.17,BP
GO:0072583,clathrin-dependent endocytosis,36,3,0.72,0.03529,1,0.20410514423076923,4.17,BP
GO:1902991,regulation of amyloid precursor protein ...,36,3,0.72,0.03529,1,0.20410514423076923,4.17,BP
GO:1903427,negative regulation of reactive oxygen s...,36,3,0.72,0.03529,1,0.20410514423076923,4.17,BP
GO:1990774,tumor necrosis factor secretion,36,3,0.72,0.03529,1,0.20410514423076923,4.17,BP
GO:0009056,catabolic process,2279,58,45.81,0.03553,1,0.2051735251798561,1.27,BP
GO:0009416,response to light stimulus,293,11,5.89,0.03556,1,0.2051735251798561,1.87,BP
GO:0071702,organic substance transport,2551,64,51.28,0.03591,1,0.20694481437125747,1.25,BP
GO:0061351,neural precursor cell proliferation,188,8,3.78,0.03672,1,0.2113596172248804,2.12,BP
GO:0032990,cell part morphogenesis,726,22,14.59,0.03757,1,0.215993835125448,1.51,BP
GO:0045601,regulation of endothelial cell different...,37,3,0.74,0.03785,1,0.2173142789034565,4.05,BP
GO:0043388,positive regulation of DNA binding,63,4,1.27,0.03789,1,0.2173142789034565,3.15,BP
GO:0043535,regulation of blood vessel endothelial c...,92,5,1.85,0.03805,1,0.21771296076099883,2.7,BP
GO:1903313,positive regulation of mRNA metabolic pr...,92,5,1.85,0.03805,1,0.21771296076099883,2.7,BP
GO:0051403,stress-activated MAPK cascade,260,10,5.23,0.03816,1,0.2180830403800475,1.91,BP
GO:0090087,regulation of peptide transport,769,23,15.46,0.03852,1,0.21958665088757395,1.49,BP
GO:0034249,negative regulation of cellular amide me...,156,7,3.14,0.03856,1,0.21958665088757395,2.23,BP
GO:0051236,establishment of RNA localization,156,7,3.14,0.03856,1,0.21958665088757395,2.23,BP
GO:0030111,regulation of Wnt signaling pathway,297,11,5.97,0.03861,1,0.2196114893617021,1.84,BP
GO:0032411,positive regulation of transporter activ...,124,6,2.49,0.03936,1,0.22334943396226414,2.41,BP
GO:0060996,dendritic spine development,124,6,2.49,0.03936,1,0.22334943396226414,2.41,BP
GO:0030162,regulation of proteolysis,730,22,14.67,0.03951,1,0.22378630588235296,1.5,BP
GO:0009968,negative regulation of signal transducti...,1192,33,23.96,0.03953,1,0.22378630588235296,1.38,BP
GO:0051304,chromosome separation,93,5,1.87,0.03958,1,0.22380606345475912,2.67,BP
GO:0046328,regulation of JNK cascade,191,8,3.84,0.03972,1,0.22433408450704226,2.08,BP
GO:0061951,establishment of protein localization to...,64,4,1.29,0.03979,1,0.22433487719298245,3.1,BP
GO:0072359,circulatory system development,1150,32,23.12,0.03984,1,0.22433487719298245,1.38,BP
GO:0045665,negative regulation of neuron differenti...,262,10,5.27,0.03986,1,0.22433487719298245,1.9,BP
GO:0006636,unsaturated fatty acid biosynthetic proc...,38,3,0.76,0.04050,1,0.22661162790697675,3.95,BP
GO:0032392,DNA geometric change,38,3,0.76,0.04050,1,0.22661162790697675,3.95,BP
GO:0032506,cytokinetic process,38,3,0.76,0.04050,1,0.22661162790697675,3.95,BP
GO:0071174,mitotic spindle checkpoint,38,3,0.76,0.04050,1,0.22661162790697675,3.95,BP
GO:2000403,positive regulation of lymphocyte migrat...,38,3,0.76,0.04050,1,0.22661162790697675,3.95,BP
GO:0045935,positive regulation of nucleobase-contai...,1852,48,37.23,0.04115,1,0.22998118466898956,1.29,BP
GO:0033627,cell adhesion mediated by integrin,65,4,1.31,0.04176,1,0.23311962877030162,3.05,BP
GO:0034332,adherens junction organization,126,6,2.53,0.04201,1,0.2342434762456547,2.37,BP
GO:0045597,positive regulation of cell differentiat...,1113,31,22.37,0.04216,1,0.2348077777777778,1.39,BP
GO:0032259,methylation,339,12,6.81,0.04234,1,0.23553766473988438,1.76,BP
GO:0045893,"positive regulation of transcription, DN...",1547,41,31.09,0.04249,1,0.236099168591224,1.32,BP
GO:0060828,regulation of canonical Wnt signaling pa...,229,9,4.6,0.04259,1,0.23638186851211074,1.96,BP
GO:0001704,formation of primary germ layer,95,5,1.91,0.04274,1,0.23666844649021865,2.62,BP
GO:0072676,lymphocyte migration,95,5,1.91,0.04274,1,0.23666844649021865,2.62,BP
GO:1901700,response to oxygen-containing compound,1593,42,32.02,0.04324,1,0.23806736842105264,1.31,BP
GO:0010613,positive regulation of cardiac muscle hy...,39,3,0.78,0.04324,1,0.23806736842105264,3.85,BP
GO:0044088,regulation of vacuole organization,39,3,0.78,0.04324,1,0.23806736842105264,3.85,BP
GO:1900087,positive regulation of G1/S transition o...,39,3,0.78,0.04324,1,0.23806736842105264,3.85,BP
GO:1902229,regulation of intrinsic apoptotic signal...,39,3,0.78,0.04324,1,0.23806736842105264,3.85,BP
GO:0030968,endoplasmic reticulum unfolded protein r...,66,4,1.33,0.04377,1,0.2398875170842825,3.01,BP
GO:0034394,protein localization to cell surface,66,4,1.33,0.04377,1,0.2398875170842825,3.01,BP
GO:0034605,cellular response to heat,66,4,1.33,0.04377,1,0.2398875170842825,3.01,BP
GO:0042306,regulation of protein import into nucleu...,66,4,1.33,0.04377,1,0.2398875170842825,3.01,BP
GO:0043010,camera-type eye development,341,12,6.85,0.04393,1,0.24027190909090906,1.75,BP
GO:1903508,positive regulation of nucleic acid-temp...,1551,41,31.18,0.04394,1,0.24027190909090906,1.31,BP
GO:0030155,regulation of cell adhesion,698,21,14.03,0.04421,1,0.24147193657984148,1.5,BP
GO:0023051,regulation of signaling,3409,82,68.52,0.04428,1,0.24147193657984148,1.2,BP
GO:1902680,positive regulation of RNA biosynthetic ...,1552,41,31.2,0.04431,1,0.24147193657984148,1.31,BP
GO:0002793,positive regulation of peptide secretion,342,12,6.87,0.04474,1,0.24353945701357468,1.75,BP
GO:0050807,regulation of synapse organization,268,10,5.39,0.04527,1,0.24614603389830508,1.86,BP
GO:0051147,regulation of muscle cell differentiatio...,162,7,3.26,0.04569,1,0.24814930022573362,2.15,BP
GO:0014742,positive regulation of muscle hypertroph...,40,3,0.8,0.04607,1,0.24908858426966293,3.75,BP
GO:0031577,spindle checkpoint,40,3,0.8,0.04607,1,0.24908858426966293,3.75,BP
GO:0044091,membrane biogenesis,40,3,0.8,0.04607,1,0.24908858426966293,3.75,BP
GO:0046627,negative regulation of insulin receptor ...,40,3,0.8,0.04607,1,0.24908858426966293,3.75,BP
GO:0048858,cell projection morphogenesis,704,21,14.15,0.04762,1,0.25619493895671475,1.48,BP
GO:0051101,regulation of DNA binding,130,6,2.61,0.04766,1,0.25619493895671475,2.3,BP
GO:1901343,negative regulation of vasculature devel...,130,6,2.61,0.04766,1,0.25619493895671475,2.3,BP
GO:2001234,negative regulation of apoptotic signali...,234,9,4.7,0.04768,1,0.25619493895671475,1.91,BP
GO:0006334,nucleosome assembly,98,5,1.97,0.04776,1,0.25619493895671475,2.54,BP
GO:0032760,positive regulation of tumor necrosis fa...,98,5,1.97,0.04776,1,0.25619493895671475,2.54,BP
GO:0006893,Golgi to plasma membrane transport,68,4,1.37,0.04797,1,0.25619493895671475,2.92,BP
GO:0008542,visual learning,68,4,1.37,0.04797,1,0.25619493895671475,2.92,BP
GO:0032387,negative regulation of intracellular tra...,68,4,1.37,0.04797,1,0.25619493895671475,2.92,BP
GO:0042273,ribosomal large subunit biogenesis,68,4,1.37,0.04797,1,0.25619493895671475,2.92,BP
GO:1905515,non-motile cilium assembly,68,4,1.37,0.04797,1,0.25619493895671475,2.92,BP
GO:0001701,in utero embryonic development,542,17,10.89,0.04808,1,0.25649773835920175,1.56,BP
GO:0030307,positive regulation of cell growth,199,8,4,0.04849,1,0.25839853820598,2,BP
GO:0030900,forebrain development,385,13,7.74,0.04861,1,0.25875146017699113,1.68,BP
GO:0032872,regulation of stress-activated MAPK casc...,235,9,4.72,0.04874,1,0.25905481318681317,1.91,BP
GO:0006509,membrane protein ectodomain proteolysis,41,3,0.82,0.04899,1,0.25905481318681317,3.66,BP
GO:0031062,positive regulation of histone methylati...,41,3,0.82,0.04899,1,0.25905481318681317,3.66,BP
GO:0043001,Golgi to plasma membrane protein transpo...,41,3,0.82,0.04899,1,0.25905481318681317,3.66,BP
GO:0048873,homeostasis of number of cells within a ...,41,3,0.82,0.04899,1,0.25905481318681317,3.66,BP
GO:0051154,negative regulation of striated muscle c...,41,3,0.82,0.04899,1,0.25905481318681317,3.66,BP
GO:1903557,positive regulation of tumor necrosis fa...,99,5,1.99,0.04951,1,0.2611550930996714,2.51,BP
GO:2001243,negative regulation of intrinsic apoptot...,99,5,1.99,0.04951,1,0.2611550930996714,2.51,BP
GO:0060041,retina development in camera-type eye,165,7,3.32,0.04955,1,0.2611550930996714,2.11,BP
GO:0016239,positive regulation of macroautophagy,69,4,1.39,0.05015,1,0.2637396721311476,2.88,BP
GO:0048168,regulation of neuronal synaptic plastici...,69,4,1.39,0.05015,1,0.2637396721311476,2.88,BP
GO:0001936,regulation of endothelial cell prolifera...,132,6,2.65,0.05065,1,0.266078384279476,2.26,BP
GO:0007033,vacuole organization,166,7,3.34,0.05088,1,0.2665711860718172,2.1,BP
GO:0070302,regulation of stress-activated protein k...,237,9,4.76,0.05091,1,0.2665711860718172,1.89,BP
GO:0010646,regulation of cell communication,3387,81,68.08,0.05091,1,0.2665711860718172,1.19,BP
GO:0042221,response to chemical,4182,98,84.06,0.05110,1,0.26727521739130433,1.17,BP
GO:0007006,mitochondrial membrane organization,100,5,2.01,0.05129,1,0.2679777198697068,2.49,BP
GO:0006259,DNA metabolic process,920,26,18.49,0.05154,1,0.2689918438177874,1.41,BP
GO:0032103,positive regulation of response to exter...,312,11,6.27,0.05168,1,0.269430292524377,1.75,BP
GO:0048468,cell development,2424,60,48.72,0.05176,1,0.26955532467532467,1.23,BP
GO:2000377,regulation of reactive oxygen species me...,202,8,4.06,0.05208,1,0.2709286054054054,1.97,BP
GO:0001885,endothelial cell development,70,4,1.41,0.05238,1,0.27219498920086393,2.84,BP
GO:0042326,negative regulation of phosphorylation,469,15,9.43,0.05308,1,0.27485316129032256,1.59,BP
GO:0090263,positive regulation of canonical Wnt sig...,101,5,2.03,0.05312,1,0.27485316129032256,2.46,BP
GO:0110020,regulation of actomyosin structure organ...,101,5,2.03,0.05312,1,0.27485316129032256,2.46,BP
GO:0110110,positive regulation of animal organ morp...,101,5,2.03,0.05312,1,0.27485316129032256,2.46,BP
GO:0007492,endoderm development,71,4,1.43,0.05466,1,0.2817653560042508,2.8,BP
GO:0007632,visual behavior,71,4,1.43,0.05466,1,0.2817653560042508,2.8,BP
GO:1904589,regulation of protein import,71,4,1.43,0.05466,1,0.2817653560042508,2.8,BP
GO:0031123,RNA 3'-end processing,102,5,2.05,0.05498,1,0.2817653560042508,2.44,BP
GO:0106027,neuron projection organization,102,5,2.05,0.05498,1,0.2817653560042508,2.44,BP
GO:0008631,intrinsic apoptotic signaling pathway in...,43,3,0.86,0.05510,1,0.2817653560042508,3.49,BP
GO:0030490,maturation of SSU-rRNA,43,3,0.86,0.05510,1,0.2817653560042508,3.49,BP
GO:0031057,negative regulation of histone modificat...,43,3,0.86,0.05510,1,0.2817653560042508,3.49,BP
GO:0031128,developmental induction,43,3,0.86,0.05510,1,0.2817653560042508,3.49,BP
GO:0051293,establishment of spindle localization,43,3,0.86,0.05510,1,0.2817653560042508,3.49,BP
GO:0090224,regulation of spindle organization,43,3,0.86,0.05510,1,0.2817653560042508,3.49,BP
GO:0050803,regulation of synapse structure or activ...,278,10,5.59,0.05535,1,0.28274331210191084,1.79,BP
GO:0007254,JNK cascade,205,8,4.12,0.05584,1,0.28494388123011666,1.94,BP
GO:0007417,central nervous system development,887,25,17.83,0.05686,1,0.28984144067796613,1.4,BP
GO:0017148,negative regulation of translation,136,6,2.73,0.05697,1,0.2900948571428571,2.2,BP
GO:0006909,phagocytosis,206,8,4.14,0.05713,1,0.2906020718816068,1.93,BP
GO:0043393,regulation of protein binding,243,9,4.88,0.05781,1,0.2937504963041183,1.84,BP
GO:0010824,regulation of centrosome duplication,44,3,0.88,0.05828,1,0.29520353684210526,3.41,BP
GO:0098781,ncRNA transcription,44,3,0.88,0.05828,1,0.29520353684210526,3.41,BP
GO:1900077,negative regulation of cellular response...,44,3,0.88,0.05828,1,0.29520353684210526,3.41,BP
GO:0044092,negative regulation of molecular functio...,1018,28,20.46,0.05856,1,0.29630193277310923,1.37,BP
GO:0072331,signal transduction by p53 class mediato...,137,6,2.75,0.05862,1,0.29630193277310923,2.18,BP
GO:0050764,regulation of phagocytosis,104,5,2.09,0.05881,1,0.29695038824763903,2.39,BP
GO:0007369,gastrulation,172,7,3.46,0.05934,1,0.2992509738219895,2.02,BP
GO:0051145,smooth muscle cell differentiation,73,4,1.47,0.05939,1,0.2992509738219895,2.72,BP
GO:0009411,response to UV,138,6,2.77,0.06030,1,0.3015619937694704,2.17,BP
GO:0002755,MyD88-dependent toll-like receptor signa...,20,2,0.4,0.06035,1,0.3015619937694704,5,BP
GO:0010842,retina layer formation,20,2,0.4,0.06035,1,0.3015619937694704,5,BP
GO:0044783,G1 DNA damage checkpoint,20,2,0.4,0.06035,1,0.3015619937694704,5,BP
GO:0044819,mitotic G1/S transition checkpoint,20,2,0.4,0.06035,1,0.3015619937694704,5,BP
GO:0051383,kinetochore organization,20,2,0.4,0.06035,1,0.3015619937694704,5,BP
GO:0061162,establishment of monopolar cell polarity,20,2,0.4,0.06035,1,0.3015619937694704,5,BP
GO:1902993,positive regulation of amyloid precursor...,20,2,0.4,0.06035,1,0.3015619937694704,5,BP
GO:0035967,cellular response to topologically incor...,105,5,2.11,0.06078,1,0.3033803937823834,2.37,BP
GO:0048812,neuron projection morphogenesis,683,20,13.73,0.06084,1,0.3033803937823834,1.46,BP
GO:0010464,regulation of mesenchymal cell prolifera...,45,3,0.9,0.06155,1,0.3062860392967942,3.33,BP
GO:0042987,amyloid precursor protein catabolic proc...,45,3,0.9,0.06155,1,0.3062860392967942,3.33,BP
GO:0050766,positive regulation of phagocytosis,74,4,1.49,0.06183,1,0.30736152892561985,2.68,BP
GO:0060070,canonical Wnt signaling pathway,284,10,5.71,0.06206,1,0.3081865015479876,1.75,BP
GO:0035264,multicellular organism growth,210,8,4.22,0.06248,1,0.30995232989690724,1.9,BP
GO:0030518,intracellular steroid hormone receptor s...,106,5,2.13,0.06279,1,0.3108492592592592,2.35,BP
GO:0051225,spindle assembly,106,5,2.13,0.06279,1,0.3108492592592592,2.35,BP
GO:0051640,organelle localization,604,18,12.14,0.06370,1,0.31503021582733814,1.48,BP
GO:0010507,negative regulation of autophagy,75,4,1.51,0.06433,1,0.3174932923076923,2.65,BP
GO:0045670,regulation of osteoclast differentiation,75,4,1.51,0.06433,1,0.3174932923076923,2.65,BP
GO:0016241,regulation of macroautophagy,107,5,2.15,0.06484,1,0.31796846539618856,2.33,BP
GO:0043266,regulation of potassium ion transport,107,5,2.15,0.06484,1,0.31796846539618856,2.33,BP
GO:0016574,histone ubiquitination,46,3,0.92,0.06490,1,0.31796846539618856,3.26,BP
GO:0032873,negative regulation of stress-activated ...,46,3,0.92,0.06490,1,0.31796846539618856,3.26,BP
GO:0043124,negative regulation of I-kappaB kinase/N...,46,3,0.92,0.06490,1,0.31796846539618856,3.26,BP
GO:0070303,negative regulation of stress-activated ...,46,3,0.92,0.06490,1,0.31796846539618856,3.26,BP
GO:0045732,positive regulation of protein catabolic...,212,8,4.26,0.06527,1,0.31796846539618856,1.88,BP
GO:0050729,positive regulation of inflammatory resp...,141,6,2.83,0.06551,1,0.31796846539618856,2.12,BP
GO:1903532,positive regulation of secretion by cell,484,15,9.73,0.06580,1,0.31796846539618856,1.54,BP
GO:0000413,protein peptidyl-prolyl isomerization,21,2,0.42,0.06584,1,0.31796846539618856,4.76,BP
GO:0031065,positive regulation of histone deacetyla...,21,2,0.42,0.06584,1,0.31796846539618856,4.76,BP
GO:0042535,positive regulation of tumor necrosis fa...,21,2,0.42,0.06584,1,0.31796846539618856,4.76,BP
GO:0046716,muscle cell cellular homeostasis,21,2,0.42,0.06584,1,0.31796846539618856,4.76,BP
GO:0048143,astrocyte activation,21,2,0.42,0.06584,1,0.31796846539618856,4.76,BP
GO:0060457,negative regulation of digestive system ...,21,2,0.42,0.06584,1,0.31796846539618856,4.76,BP
GO:0061339,establishment or maintenance of monopola...,21,2,0.42,0.06584,1,0.31796846539618856,4.76,BP
GO:0090050,positive regulation of cell migration in...,21,2,0.42,0.06584,1,0.31796846539618856,4.76,BP
GO:0098780,response to mitochondrial depolarisation,21,2,0.42,0.06584,1,0.31796846539618856,4.76,BP
GO:1901623,regulation of lymphocyte chemotaxis,21,2,0.42,0.06584,1,0.31796846539618856,4.76,BP
GO:1904666,regulation of ubiquitin protein ligase a...,21,2,0.42,0.06584,1,0.31796846539618856,4.76,BP
GO:2000209,regulation of anoikis,21,2,0.42,0.06584,1,0.31796846539618856,4.76,BP
GO:0051346,negative regulation of hydrolase activit...,404,13,8.12,0.06588,1,0.31796846539618856,1.6,BP
GO:0043270,positive regulation of ion transport,326,11,6.55,0.06629,1,0.3196267334669339,1.68,BP
GO:0070887,cellular response to chemical stimulus,3063,73,61.57,0.06640,1,0.31983663663663664,1.19,BP
GO:0007045,cell-substrate adherens junction assembl...,76,4,1.53,0.06688,1,0.32150505494505494,2.61,BP
GO:0048041,focal adhesion assembly,76,4,1.53,0.06688,1,0.32150505494505494,2.61,BP
GO:0006403,RNA localization,177,7,3.56,0.06702,1,0.3218565269461078,1.97,BP
GO:1901575,organic substance catabolic process,1874,47,37.67,0.06726,1,0.3226870588235294,1.25,BP
GO:0010810,regulation of cell-substrate adhesion,214,8,4.3,0.06813,1,0.3265354183266932,1.86,BP
GO:0001941,postsynaptic membrane organization,47,3,0.94,0.06834,1,0.32689073558648113,3.19,BP
GO:0072604,interleukin-6 secretion,47,3,0.94,0.06834,1,0.32689073558648113,3.19,BP
GO:0071407,cellular response to organic cyclic comp...,487,15,9.79,0.06857,1,0.3273018434093162,1.53,BP
GO:0034612,response to tumor necrosis factor,178,7,3.58,0.06863,1,0.3273018434093162,1.96,BP
GO:0048813,dendrite morphogenesis,178,7,3.58,0.06863,1,0.3273018434093162,1.96,BP
GO:0008344,adult locomotory behavior,109,5,2.19,0.06904,1,0.32860581602373884,2.28,BP
GO:0045185,maintenance of protein location,109,5,2.19,0.06904,1,0.32860581602373884,2.28,BP
GO:0051303,establishment of chromosome localization,77,4,1.55,0.06948,1,0.33037328063241106,2.58,BP
GO:0060627,regulation of vesicle-mediated transport,570,17,11.46,0.06969,1,0.3310446989141165,1.48,BP
GO:0048639,positive regulation of developmental gro...,216,8,4.34,0.07107,1,0.3349658033106134,1.84,BP
GO:0000423,mitophagy,22,2,0.44,0.07149,1,0.3349658033106134,4.55,BP
GO:0022616,DNA strand elongation,22,2,0.44,0.07149,1,0.3349658033106134,4.55,BP
GO:0032331,negative regulation of chondrocyte diffe...,22,2,0.44,0.07149,1,0.3349658033106134,4.55,BP
GO:0046628,positive regulation of insulin receptor ...,22,2,0.44,0.07149,1,0.3349658033106134,4.55,BP
GO:0050857,positive regulation of antigen receptor-...,22,2,0.44,0.07149,1,0.3349658033106134,4.55,BP
GO:0051043,regulation of membrane protein ectodomai...,22,2,0.44,0.07149,1,0.3349658033106134,4.55,BP
GO:0060009,Sertoli cell development,22,2,0.44,0.07149,1,0.3349658033106134,4.55,BP
GO:0070734,histone H3-K27 methylation,22,2,0.44,0.07149,1,0.3349658033106134,4.55,BP
GO:0071870,cellular response to catecholamine stimu...,22,2,0.44,0.07149,1,0.3349658033106134,4.55,BP
GO:1901626,regulation of postsynaptic membrane orga...,22,2,0.44,0.07149,1,0.3349658033106134,4.55,BP
GO:1901889,negative regulation of cell junction ass...,22,2,0.44,0.07149,1,0.3349658033106134,4.55,BP
GO:1902307,positive regulation of sodium ion transm...,22,2,0.44,0.07149,1,0.3349658033106134,4.55,BP
GO:2001026,regulation of endothelial cell chemotaxi...,22,2,0.44,0.07149,1,0.3349658033106134,4.55,BP
GO:0030100,regulation of endocytosis,292,10,5.87,0.07178,1,0.335021511627907,1.7,BP
GO:0016311,dephosphorylation,370,12,7.44,0.07179,1,0.335021511627907,1.61,BP
GO:0045104,intermediate filament cytoskeleton organ...,48,3,0.96,0.07185,1,0.335021511627907,3.12,BP
GO:0051438,regulation of ubiquitin-protein transfer...,48,3,0.96,0.07185,1,0.335021511627907,3.12,BP
GO:0051653,spindle localization,48,3,0.96,0.07185,1,0.335021511627907,3.12,BP
GO:0046785,microtubule polymerization,78,4,1.57,0.07213,1,0.335352231884058,2.55,BP
GO:0050000,chromosome localization,78,4,1.57,0.07213,1,0.335352231884058,2.55,BP
GO:1900182,positive regulation of protein localizat...,78,4,1.57,0.07213,1,0.335352231884058,2.55,BP
GO:0120039,plasma membrane bounded cell projection ...,699,20,14.05,0.07307,1,0.3393946332046332,1.42,BP
GO:0006508,proteolysis,1661,42,33.39,0.07318,1,0.33957778206364514,1.26,BP
GO:0014070,response to organic cyclic compound,742,21,14.91,0.07371,1,0.34170763005780347,1.41,BP
GO:0043405,regulation of MAP kinase activity,294,10,5.91,0.07436,1,0.34438914340712223,1.69,BP
GO:0031099,regeneration,146,6,2.93,0.07476,1,0.3459000576368876,2.05,BP
GO:0070373,negative regulation of ERK1 and ERK2 cas...,79,4,1.59,0.07483,1,0.3459000576368876,2.52,BP
GO:0061136,regulation of proteasomal protein catabo...,182,7,3.66,0.07527,1,0.34709885277246655,1.91,BP
GO:0007520,myoblast fusion,49,3,0.98,0.07545,1,0.34709885277246655,3.06,BP
GO:0045103,intermediate filament-based process,49,3,0.98,0.07545,1,0.34709885277246655,3.06,BP
GO:0050435,amyloid-beta metabolic process,49,3,0.98,0.07545,1,0.34709885277246655,3.06,BP
GO:1903115,regulation of actin filament-based movem...,49,3,0.98,0.07545,1,0.34709885277246655,3.06,BP
GO:0032092,positive regulation of protein binding,112,5,2.25,0.07562,1,0.34754865329512896,2.22,BP
GO:0043009,chordate embryonic development,831,23,16.7,0.07673,1,0.35119875354107644,1.38,BP
GO:0048545,response to steroid hormone,220,8,4.42,0.07718,1,0.35119875354107644,1.81,BP
GO:0032727,positive regulation of interferon-alpha ...,23,2,0.46,0.07729,1,0.35119875354107644,4.35,BP
GO:0036010,protein localization to endosome,23,2,0.46,0.07729,1,0.35119875354107644,4.35,BP
GO:0043687,post-translational protein modification,23,2,0.46,0.07729,1,0.35119875354107644,4.35,BP
GO:0048485,sympathetic nervous system development,23,2,0.46,0.07729,1,0.35119875354107644,4.35,BP
GO:0060390,regulation of SMAD protein signal transd...,23,2,0.46,0.07729,1,0.35119875354107644,4.35,BP
GO:0071868,cellular response to monoamine stimulus,23,2,0.46,0.07729,1,0.35119875354107644,4.35,BP
GO:0071869,response to catecholamine,23,2,0.46,0.07729,1,0.35119875354107644,4.35,BP
GO:0101023,vascular endothelial cell proliferation,23,2,0.46,0.07729,1,0.35119875354107644,4.35,BP
GO:1902914,regulation of protein polyubiquitination,23,2,0.46,0.07729,1,0.35119875354107644,4.35,BP
GO:1905562,regulation of vascular endothelial cell ...,23,2,0.46,0.07729,1,0.35119875354107644,4.35,BP
GO:0050688,regulation of defense response to virus,80,4,1.61,0.07758,1,0.3518519886899152,2.48,BP
GO:2001259,positive regulation of cation channel ac...,80,4,1.61,0.07758,1,0.3518519886899152,2.48,BP
GO:0001952,regulation of cell-matrix adhesion,113,5,2.27,0.07789,1,0.35226191729323314,2.2,BP
GO:0030048,actin filament-based movement,113,5,2.27,0.07789,1,0.35226191729323314,2.2,BP
GO:0043401,steroid hormone mediated signaling pathw...,113,5,2.27,0.07789,1,0.35226191729323314,2.2,BP
GO:0051241,negative regulation of multicellular org...,1357,35,27.28,0.07801,1,0.35247335211267605,1.28,BP
GO:0030856,regulation of epithelial cell differenti...,148,6,2.97,0.07865,1,0.3550317073170732,2.02,BP
GO:0050707,regulation of cytokine secretion,221,8,4.44,0.07876,1,0.35519505154639175,1.8,BP
GO:0010761,fibroblast migration,50,3,1.01,0.07912,1,0.35615101964452756,2.97,BP
GO:0021545,cranial nerve development,50,3,1.01,0.07912,1,0.35615101964452756,2.97,BP
GO:0045785,positive regulation of cell adhesion,417,13,8.38,0.07978,1,0.35878631775700937,1.55,BP
GO:0016525,negative regulation of angiogenesis,114,5,2.29,0.08019,1,0.3599573507462686,2.18,BP
GO:0043123,positive regulation of I-kappaB kinase/N...,114,5,2.29,0.08019,1,0.3599573507462686,2.18,BP
GO:0032479,regulation of type I interferon producti...,81,4,1.63,0.08038,1,0.3604739608574091,2.45,BP
GO:0021953,central nervous system neuron differenti...,223,8,4.48,0.08197,1,0.3672622346368715,1.79,BP
GO:0002831,regulation of response to biotic stimulu...,150,6,3.02,0.08266,1,0.36844780128794846,1.99,BP
GO:0033619,membrane protein proteolysis,51,3,1.03,0.08287,1,0.36844780128794846,2.91,BP
GO:0051353,positive regulation of oxidoreductase ac...,51,3,1.03,0.08287,1,0.36844780128794846,2.91,BP
GO:1902373,negative regulation of mRNA catabolic pr...,51,3,1.03,0.08287,1,0.36844780128794846,2.91,BP
GO:2000649,regulation of sodium ion transmembrane t...,51,3,1.03,0.08287,1,0.36844780128794846,2.91,BP
GO:0010738,regulation of protein kinase A signaling,24,2,0.48,0.08323,1,0.36844780128794846,4.17,BP
GO:0031061,negative regulation of histone methylati...,24,2,0.48,0.08323,1,0.36844780128794846,4.17,BP
GO:0031954,positive regulation of protein autophosp...,24,2,0.48,0.08323,1,0.36844780128794846,4.17,BP
GO:0032770,positive regulation of monooxygenase act...,24,2,0.48,0.08323,1,0.36844780128794846,4.17,BP
GO:0048670,regulation of collateral sprouting,24,2,0.48,0.08323,1,0.36844780128794846,4.17,BP
GO:0062009,secondary palate development,24,2,0.48,0.08323,1,0.36844780128794846,4.17,BP
GO:0071867,response to monoamine,24,2,0.48,0.08323,1,0.36844780128794846,4.17,BP
GO:1903204,negative regulation of oxidative stress-...,24,2,0.48,0.08323,1,0.36844780128794846,4.17,BP
GO:0015931,nucleobase-containing compound transport,187,7,3.76,0.08409,1,0.37191275735294116,1.86,BP
GO:0001933,negative regulation of protein phosphory...,421,13,8.46,0.08441,1,0.3729852341597796,1.54,BP
GO:0032102,negative regulation of response to exter...,341,11,6.85,0.08467,1,0.37379086238532105,1.61,BP
GO:0051261,protein depolymerization,116,5,2.33,0.08491,1,0.3745068010999083,2.15,BP
GO:0030534,adult behavior,188,7,3.78,0.08592,1,0.3786145054945055,1.85,BP
GO:0070542,response to fatty acid,52,3,1.05,0.08669,1,0.3813092138939671,2.86,BP
GO:2000677,regulation of transcription regulatory r...,52,3,1.05,0.08669,1,0.3813092138939671,2.86,BP
GO:0090150,establishment of protein localization to...,226,8,4.54,0.08692,1,0.38197172602739726,1.76,BP
GO:0007420,brain development,632,18,12.7,0.08856,1,0.38882364963503646,1.42,BP
GO:0010640,regulation of platelet-derived growth fa...,25,2,0.5,0.08931,1,0.38962803263825935,4,BP
GO:0021801,cerebral cortex radial glia guided migra...,25,2,0.5,0.08931,1,0.38962803263825935,4,BP
GO:0022030,telencephalon glial cell migration,25,2,0.5,0.08931,1,0.38962803263825935,4,BP
GO:0032469,endoplasmic reticulum calcium ion homeos...,25,2,0.5,0.08931,1,0.38962803263825935,4,BP
GO:0051580,regulation of neurotransmitter uptake,25,2,0.5,0.08931,1,0.38962803263825935,4,BP
GO:1902230,negative regulation of intrinsic apoptot...,25,2,0.5,0.08931,1,0.38962803263825935,4,BP
GO:1903649,regulation of cytoplasmic transport,25,2,0.5,0.08931,1,0.38962803263825935,4,BP
GO:0007283,spermatogenesis,549,16,11.03,0.08950,1,0.3899244162895927,1.45,BP
GO:0046677,response to antibiotic,305,10,6.13,0.08954,1,0.3899244162895927,1.63,BP
GO:2000181,negative regulation of blood vessel morp...,118,5,2.37,0.08976,1,0.39052904159132007,2.11,BP
GO:0014014,negative regulation of gliogenesis,53,3,1.07,0.09059,1,0.3928065945945946,2.8,BP
GO:0051932,"synaptic transmission, GABAergic",53,3,1.07,0.09059,1,0.3928065945945946,2.8,BP
GO:0071242,cellular response to ammonium ion,53,3,1.07,0.09059,1,0.3928065945945946,2.8,BP
GO:0009792,embryo development ending in birth or eg...,848,23,17.04,0.09061,1,0.3928065945945946,1.35,BP
GO:0032606,type I interferon production,85,4,1.71,0.09209,1,0.3985045683453238,2.34,BP
GO:0034502,protein localization to chromosome,85,4,1.71,0.09209,1,0.3985045683453238,2.34,BP
GO:0071478,cellular response to radiation,155,6,3.12,0.09317,1,0.40281584905660384,1.92,BP
GO:0018209,peptidyl-serine modification,348,11,6.99,0.09423,1,0.40600187279151945,1.57,BP
GO:0051496,positive regulation of stress fiber asse...,54,3,1.09,0.09456,1,0.40600187279151945,2.75,BP
GO:0051568,histone H3-K4 methylation,54,3,1.09,0.09456,1,0.40600187279151945,2.75,BP
GO:1901379,regulation of potassium ion transmembran...,86,4,1.73,0.09513,1,0.40600187279151945,2.31,BP
GO:0001654,eye development,389,12,7.82,0.09514,1,0.40600187279151945,1.53,BP
GO:0030178,negative regulation of Wnt signaling pat...,156,6,3.14,0.09536,1,0.40600187279151945,1.91,BP
GO:0000460,maturation of 5.8S rRNA,26,2,0.52,0.09551,1,0.40600187279151945,3.85,BP
GO:0006891,intra-Golgi vesicle-mediated transport,26,2,0.52,0.09551,1,0.40600187279151945,3.85,BP
GO:0032104,regulation of response to extracellular ...,26,2,0.52,0.09551,1,0.40600187279151945,3.85,BP
GO:0032107,regulation of response to nutrient level...,26,2,0.52,0.09551,1,0.40600187279151945,3.85,BP
GO:0045737,positive regulation of cyclin-dependent ...,26,2,0.52,0.09551,1,0.40600187279151945,3.85,BP
GO:0048642,negative regulation of skeletal muscle t...,26,2,0.52,0.09551,1,0.40600187279151945,3.85,BP
GO:0051497,negative regulation of stress fiber asse...,26,2,0.52,0.09551,1,0.40600187279151945,3.85,BP
GO:0051570,regulation of histone H3-K9 methylation,26,2,0.52,0.09551,1,0.40600187279151945,3.85,BP
GO:0072574,hepatocyte proliferation,26,2,0.52,0.09551,1,0.40600187279151945,3.85,BP
GO:0072575,epithelial cell proliferation involved i...,26,2,0.52,0.09551,1,0.40600187279151945,3.85,BP
GO:0099010,modification of postsynaptic structure,26,2,0.52,0.09551,1,0.40600187279151945,3.85,BP
GO:1900078,positive regulation of cellular response...,26,2,0.52,0.09551,1,0.40600187279151945,3.85,BP
GO:1902175,regulation of oxidative stress-induced i...,26,2,0.52,0.09551,1,0.40600187279151945,3.85,BP
GO:0044403,symbiont process,349,11,7.01,0.09565,1,0.4062381288614298,1.57,BP
GO:0051223,regulation of protein transport,725,20,14.57,0.09631,1,0.40868052910052916,1.37,BP
GO:1903409,reactive oxygen species biosynthetic pro...,121,5,2.43,0.09731,1,0.41256010572687224,2.06,BP
GO:0050715,positive regulation of cytokine secretio...,157,6,3.16,0.09757,1,0.4132982746478873,1.9,BP
GO:0050714,positive regulation of protein secretion,311,10,6.25,0.09855,1,0.41583102541630146,1.6,BP
GO:0070372,regulation of ERK1 and ERK2 cascade,311,10,6.25,0.09855,1,0.41583102541630146,1.6,BP
GO:0007528,neuromuscular junction development,55,3,1.11,0.09860,1,0.41583102541630146,2.7,BP
GO:0014009,glial cell proliferation,55,3,1.11,0.09860,1,0.41583102541630146,2.7,BP
GO:0048662,negative regulation of smooth muscle cel...,55,3,1.11,0.09860,1,0.41583102541630146,2.7,BP
GO:0150063,visual system development,392,12,7.88,0.09921,1,0.4180372329246936,1.52,BP
GO:0060322,head development,686,19,13.79,0.10016,1,0.42167097112860896,1.38,BP
GO:0040014,regulation of multicellular organism gro...,88,4,1.77,0.10136,1,0.42535239583333334,2.26,BP
GO:0045861,negative regulation of proteolysis,353,11,7.1,0.10144,1,0.42535239583333334,1.55,BP
GO:0010971,positive regulation of G2/M transition o...,27,2,0.54,0.10183,1,0.42535239583333334,3.7,BP
GO:0032801,receptor catabolic process,27,2,0.54,0.10183,1,0.42535239583333334,3.7,BP
GO:0051560,mitochondrial calcium ion homeostasis,27,2,0.54,0.10183,1,0.42535239583333334,3.7,BP
GO:0060008,Sertoli cell differentiation,27,2,0.54,0.10183,1,0.42535239583333334,3.7,BP
GO:1904353,regulation of telomere capping,27,2,0.54,0.10183,1,0.42535239583333334,3.7,BP
GO:1905144,response to acetylcholine,27,2,0.54,0.10183,1,0.42535239583333334,3.7,BP
GO:1905145,cellular response to acetylcholine,27,2,0.54,0.10183,1,0.42535239583333334,3.7,BP
GO:0003158,endothelium development,123,5,2.47,0.10252,1,0.42749240901213176,2.02,BP
GO:0060759,regulation of response to cytokine stimu...,123,5,2.47,0.10252,1,0.42749240901213176,2.02,BP
GO:0007062,sister chromatid cohesion,56,3,1.13,0.10271,1,0.4275437024221453,2.65,BP
GO:0031641,regulation of myelination,56,3,1.13,0.10271,1,0.4275437024221453,2.65,BP
GO:0048880,sensory system development,395,12,7.94,0.10338,1,0.42975564766839375,1.51,BP
GO:0007266,Rho protein signal transduction,197,7,3.96,0.10342,1,0.42975564766839375,1.77,BP
GO:0043086,negative regulation of catalytic activit...,690,19,13.87,0.10435,1,0.43295555172413797,1.37,BP
GO:0071383,cellular response to steroid hormone sti...,160,6,3.22,0.10437,1,0.43295555172413797,1.86,BP
GO:0008203,cholesterol metabolic process,124,5,2.49,0.10517,1,0.43552327022375215,2.01,BP
GO:0032434,regulation of proteasomal ubiquitin-depe...,124,5,2.49,0.10517,1,0.43552327022375215,2.01,BP
GO:0050727,regulation of inflammatory response,356,11,7.16,0.10592,1,0.4382519690455718,1.54,BP
GO:0033002,muscle cell proliferation,237,8,4.76,0.10655,1,0.43995428571428574,1.68,BP
GO:0002042,cell migration involved in sprouting ang...,57,3,1.15,0.10688,1,0.43995428571428574,2.61,BP
GO:0010463,mesenchymal cell proliferation,57,3,1.15,0.10688,1,0.43995428571428574,2.61,BP
GO:0019080,viral gene expression,57,3,1.15,0.10688,1,0.43995428571428574,2.61,BP
GO:0051893,regulation of focal adhesion assembly,57,3,1.15,0.10688,1,0.43995428571428574,2.61,BP
GO:0090109,regulation of cell-substrate junction as...,57,3,1.15,0.10688,1,0.43995428571428574,2.61,BP
GO:0001759,organ induction,28,2,0.56,0.10826,1,0.4418550636132315,3.57,BP
GO:0002089,lens morphogenesis in camera-type eye,28,2,0.56,0.10826,1,0.4418550636132315,3.57,BP
GO:0010939,regulation of necrotic cell death,28,2,0.56,0.10826,1,0.4418550636132315,3.57,BP
GO:0021952,central nervous system projection neuron...,28,2,0.56,0.10826,1,0.4418550636132315,3.57,BP
GO:0031063,regulation of histone deacetylation,28,2,0.56,0.10826,1,0.4418550636132315,3.57,BP
GO:0032647,regulation of interferon-alpha productio...,28,2,0.56,0.10826,1,0.4418550636132315,3.57,BP
GO:0071168,protein localization to chromatin,28,2,0.56,0.10826,1,0.4418550636132315,3.57,BP
GO:0072576,liver morphogenesis,28,2,0.56,0.10826,1,0.4418550636132315,3.57,BP
GO:0090312,positive regulation of protein deacetyla...,28,2,0.56,0.10826,1,0.4418550636132315,3.57,BP
GO:1904292,regulation of ERAD pathway,28,2,0.56,0.10826,1,0.4418550636132315,3.57,BP
GO:0000723,telomere maintenance,126,5,2.53,0.11058,1,0.45094149152542373,1.98,BP
GO:0008333,endosome to lysosome transport,58,3,1.17,0.11112,1,0.45275989839119385,2.56,BP
GO:0048232,male gamete generation,569,16,11.44,0.11252,1,0.45807634517766493,1.4,BP
GO:0048871,multicellular organismal homeostasis,485,14,9.75,0.11313,1,0.4601703803888419,1.44,BP
GO:0001938,positive regulation of endothelial cell ...,92,4,1.85,0.11437,1,0.46227414225941427,2.16,BP
GO:0045685,regulation of glial cell differentiation,92,4,1.85,0.11437,1,0.46227414225941427,2.16,BP
GO:0070252,actin-mediated cell contraction,92,4,1.85,0.11437,1,0.46227414225941427,2.16,BP
GO:0006376,mRNA splice site selection,29,2,0.58,0.11480,1,0.46227414225941427,3.45,BP
GO:0007007,inner mitochondrial membrane organizatio...,29,2,0.58,0.11480,1,0.46227414225941427,3.45,BP
GO:0034508,centromere complex assembly,29,2,0.58,0.11480,1,0.46227414225941427,3.45,BP
GO:0042026,protein refolding,29,2,0.58,0.11480,1,0.46227414225941427,3.45,BP
GO:0071353,cellular response to interleukin-4,29,2,0.58,0.11480,1,0.46227414225941427,3.45,BP
GO:0071480,cellular response to gamma radiation,29,2,0.58,0.11480,1,0.46227414225941427,3.45,BP
GO:0090181,regulation of cholesterol metabolic proc...,29,2,0.58,0.11480,1,0.46227414225941427,3.45,BP
GO:1902235,regulation of endoplasmic reticulum stre...,29,2,0.58,0.11480,1,0.46227414225941427,3.45,BP
GO:1904031,positive regulation of cyclin-dependent ...,29,2,0.58,0.11480,1,0.46227414225941427,3.45,BP
GO:0007029,endoplasmic reticulum organization,59,3,1.19,0.11543,1,0.4636470450751252,2.52,BP
GO:0070936,protein K48-linked ubiquitination,59,3,1.19,0.11543,1,0.4636470450751252,2.52,BP
GO:1902369,negative regulation of RNA catabolic pro...,59,3,1.19,0.11543,1,0.4636470450751252,2.52,BP
GO:0010811,positive regulation of cell-substrate ad...,128,5,2.57,0.11612,1,0.4656412,1.95,BP
GO:0032200,telomere organization,128,5,2.57,0.11612,1,0.4656412,1.95,BP
GO:0036473,cell death in response to oxidative stre...,93,4,1.87,0.11773,1,0.4717042131557036,2.14,BP
GO:0018105,peptidyl-serine phosphorylation,323,10,6.49,0.11812,1,0.47240730897009964,1.54,BP
GO:0006260,DNA replication,243,8,4.88,0.11820,1,0.47240730897009964,1.64,BP
GO:0006470,protein dephosphorylation,243,8,4.88,0.11820,1,0.47240730897009964,1.64,BP
GO:0007264,small GTPase mediated signal transductio...,489,14,9.83,0.11859,1,0.4735391044776119,1.42,BP
GO:0032680,regulation of tumor necrosis factor prod...,166,6,3.34,0.11868,1,0.4735391044776119,1.8,BP
GO:1902652,secondary alcohol metabolic process,129,5,2.59,0.11894,1,0.47418333057166534,1.93,BP
GO:0008347,glial cell migration,60,3,1.21,0.11979,1,0.4761932947976879,2.48,BP
GO:0033209,tumor necrosis factor-mediated signaling...,60,3,1.21,0.11979,1,0.4761932947976879,2.48,BP
GO:0090307,mitotic spindle assembly,60,3,1.21,0.11979,1,0.4761932947976879,2.48,BP
GO:0007276,gamete generation,704,19,14.15,0.11984,1,0.4761932947976879,1.34,BP
GO:0010648,negative regulation of cell communicatio...,1326,33,26.65,0.12043,1,0.47703614693877555,1.24,BP
GO:0001666,response to hypoxia,205,7,4.12,0.12047,1,0.47703614693877555,1.7,BP
GO:0097061,dendritic spine organization,94,4,1.89,0.12113,1,0.47703614693877555,2.12,BP
GO:0010390,histone monoubiquitination,30,2,0.6,0.12144,1,0.47703614693877555,3.33,BP
GO:0010803,regulation of tumor necrosis factor-medi...,30,2,0.6,0.12144,1,0.47703614693877555,3.33,BP
GO:0031297,replication fork processing,30,2,0.6,0.12144,1,0.47703614693877555,3.33,BP
GO:0032607,interferon-alpha production,30,2,0.6,0.12144,1,0.47703614693877555,3.33,BP
GO:0034260,negative regulation of GTPase activity,30,2,0.6,0.12144,1,0.47703614693877555,3.33,BP
GO:0042533,tumor necrosis factor biosynthetic proce...,30,2,0.6,0.12144,1,0.47703614693877555,3.33,BP
GO:0042534,regulation of tumor necrosis factor bios...,30,2,0.6,0.12144,1,0.47703614693877555,3.33,BP
GO:0061037,negative regulation of cartilage develop...,30,2,0.6,0.12144,1,0.47703614693877555,3.33,BP
GO:0070266,necroptotic process,30,2,0.6,0.12144,1,0.47703614693877555,3.33,BP
GO:1902003,regulation of amyloid-beta formation,30,2,0.6,0.12144,1,0.47703614693877555,3.33,BP
GO:1902751,positive regulation of cell cycle G2/M p...,30,2,0.6,0.12144,1,0.47703614693877555,3.33,BP
GO:0051704,multi-organism process,2245,53,45.12,0.12168,1,0.4775890375203915,1.17,BP
GO:0045944,positive regulation of transcription by ...,1238,31,24.88,0.12232,1,0.47970973105134473,1.25,BP
GO:0016032,viral process,285,9,5.73,0.12242,1,0.47971094462540714,1.57,BP
GO:0051235,maintenance of location,326,10,6.55,0.12332,1,0.4828444589096827,1.53,BP
GO:1903555,regulation of tumor necrosis factor supe...,168,6,3.38,0.12366,1,0.4837820487804878,1.78,BP
GO:0023057,negative regulation of signaling,1330,33,26.73,0.12384,1,0.48409267262388306,1.23,BP
GO:0072665,protein localization to vacuole,61,3,1.23,0.12422,1,0.4843976012965964,2.44,BP
GO:1901016,regulation of potassium ion transmembran...,61,3,1.23,0.12422,1,0.4843976012965964,2.44,BP
GO:1902305,regulation of sodium ion transmembrane t...,61,3,1.23,0.12422,1,0.4843976012965964,2.44,BP
GO:0009790,embryo development,1241,31,24.94,0.12499,1,0.48700557085020246,1.24,BP
GO:0019827,stem cell population maintenance,169,6,3.4,0.12618,1,0.4908473403395311,1.76,BP
GO:0032640,tumor necrosis factor production,169,6,3.4,0.12618,1,0.4908473403395311,1.76,BP
GO:0070848,response to growth factor,623,17,12.52,0.12653,1,0.49181127625201937,1.36,BP
GO:0070371,ERK1 and ERK2 cascade,328,10,6.59,0.12686,1,0.49269598062953995,1.52,BP
GO:0031345,negative regulation of cell projection o...,208,7,4.18,0.12722,1,0.4936956774193549,1.67,BP
GO:0006352,"DNA-templated transcription, initiation",96,4,1.93,0.12807,1,0.493759743795036,2.07,BP
GO:0021602,cranial nerve morphogenesis,31,2,0.62,0.12816,1,0.493759743795036,3.23,BP
GO:0045932,negative regulation of muscle contractio...,31,2,0.62,0.12816,1,0.493759743795036,3.23,BP
GO:0050999,regulation of nitric-oxide synthase acti...,31,2,0.62,0.12816,1,0.493759743795036,3.23,BP
GO:0051491,positive regulation of filopodium assemb...,31,2,0.62,0.12816,1,0.493759743795036,3.23,BP
GO:0070670,response to interleukin-4,31,2,0.62,0.12816,1,0.493759743795036,3.23,BP
GO:0090075,relaxation of muscle,31,2,0.62,0.12816,1,0.493759743795036,3.23,BP
GO:0090162,establishment of epithelial cell polarit...,31,2,0.62,0.12816,1,0.493759743795036,3.23,BP
GO:2001014,regulation of skeletal muscle cell diffe...,31,2,0.62,0.12816,1,0.493759743795036,3.23,BP
GO:0048488,synaptic vesicle endocytosis,62,3,1.25,0.12870,1,0.4942573024740623,2.4,BP
GO:0060038,cardiac muscle cell proliferation,62,3,1.25,0.12870,1,0.4942573024740623,2.4,BP
GO:0140238,presynaptic endocytosis,62,3,1.25,0.12870,1,0.4942573024740623,2.4,BP
GO:1905268,negative regulation of chromatin organiz...,62,3,1.25,0.12870,1,0.4942573024740623,2.4,BP
GO:0051047,positive regulation of secretion,539,15,10.83,0.12906,1,0.4952445933014354,1.39,BP
GO:0045165,cell fate commitment,289,9,5.81,0.13005,1,0.49864589641434265,1.55,BP
GO:0021537,telencephalon development,249,8,5,0.13051,1,0.49929281399046105,1.6,BP
GO:0016125,sterol metabolic process,133,5,2.67,0.13053,1,0.49929281399046105,1.87,BP
GO:0030177,positive regulation of Wnt signaling pat...,133,5,2.67,0.13053,1,0.49929281399046105,1.87,BP
GO:0070201,regulation of establishment of protein l...,757,20,15.22,0.13080,1,0.4999281969817316,1.31,BP
GO:0045807,positive regulation of endocytosis,171,6,3.44,0.13131,1,0.5014791428571429,1.74,BP
GO:0036503,ERAD pathway,97,4,1.95,0.13160,1,0.5021881046788264,2.05,BP
GO:0007626,locomotory behavior,250,8,5.03,0.13262,1,0.5056794294770206,1.59,BP
GO:0030858,positive regulation of epithelial cell d...,63,3,1.27,0.13324,1,0.5072396202531645,2.36,BP
GO:0070059,intrinsic apoptotic signaling pathway in...,63,3,1.27,0.13324,1,0.5072396202531645,2.36,BP
GO:0006633,fatty acid biosynthetic process,134,5,2.69,0.13351,1,0.5078657075098814,1.86,BP
GO:0071706,tumor necrosis factor superfamily cytoki...,172,6,3.46,0.13391,1,0.5082345539906103,1.73,BP
GO:2001257,regulation of cation channel activity,172,6,3.46,0.13391,1,0.5082345539906103,1.73,BP
GO:0002064,epithelial cell development,251,8,5.05,0.13475,1,0.5082345539906103,1.58,BP
GO:0001964,startle response,32,2,0.64,0.13498,1,0.5082345539906103,3.12,BP
GO:0032212,positive regulation of telomere maintena...,32,2,0.64,0.13498,1,0.5082345539906103,3.12,BP
GO:0035329,hippo signaling,32,2,0.64,0.13498,1,0.5082345539906103,3.12,BP
GO:0036475,neuron death in response to oxidative st...,32,2,0.64,0.13498,1,0.5082345539906103,3.12,BP
GO:0050686,negative regulation of mRNA processing,32,2,0.64,0.13498,1,0.5082345539906103,3.12,BP
GO:0051150,regulation of smooth muscle cell differe...,32,2,0.64,0.13498,1,0.5082345539906103,3.12,BP
GO:0060306,regulation of membrane repolarization,32,2,0.64,0.13498,1,0.5082345539906103,3.12,BP
GO:0060977,coronary vasculature morphogenesis,32,2,0.64,0.13498,1,0.5082345539906103,3.12,BP
GO:1900181,negative regulation of protein localizat...,32,2,0.64,0.13498,1,0.5082345539906103,3.12,BP
GO:1903203,regulation of oxidative stress-induced n...,32,2,0.64,0.13498,1,0.5082345539906103,3.12,BP
GO:0070585,protein localization to mitochondrion,98,4,1.97,0.13516,1,0.508514401876466,2.03,BP
GO:0002791,regulation of peptide secretion,544,15,10.93,0.13613,1,0.511307766536965,1.37,BP
GO:0006814,sodium ion transport,212,7,4.26,0.13651,1,0.511307766536965,1.64,BP
GO:2001020,regulation of response to DNA damage sti...,212,7,4.26,0.13651,1,0.511307766536965,1.64,BP
GO:0001837,epithelial to mesenchymal transition,135,5,2.71,0.13651,1,0.511307766536965,1.85,BP
GO:0050905,neuromuscular process,135,5,2.71,0.13651,1,0.511307766536965,1.85,BP
GO:0098727,maintenance of cell number,173,6,3.48,0.13654,1,0.511307766536965,1.72,BP
GO:0007265,Ras protein signal transduction,417,12,8.38,0.13707,1,0.5125858423493045,1.43,BP
GO:0001658,branching involved in ureteric bud morph...,64,3,1.29,0.13784,1,0.5125858423493045,2.33,BP
GO:0007566,embryo implantation,64,3,1.29,0.13784,1,0.5125858423493045,2.33,BP
GO:0009988,cell-cell recognition,64,3,1.29,0.13784,1,0.5125858423493045,2.33,BP
GO:0032233,positive regulation of actin filament bu...,64,3,1.29,0.13784,1,0.5125858423493045,2.33,BP
GO:0043462,regulation of ATPase activity,64,3,1.29,0.13784,1,0.5125858423493045,2.33,BP
GO:0060999,positive regulation of dendritic spine d...,64,3,1.29,0.13784,1,0.5125858423493045,2.33,BP
GO:0090398,cellular senescence,64,3,1.29,0.13784,1,0.5125858423493045,2.33,BP
GO:1903391,regulation of adherens junction organiza...,64,3,1.29,0.13784,1,0.5125858423493045,2.33,BP
GO:0032755,positive regulation of interleukin-6 pro...,99,4,1.99,0.13877,1,0.5156457451737452,2.01,BP
GO:0043624,cellular protein complex disassembly,136,5,2.73,0.13955,1,0.5181439814814814,1.83,BP
GO:0031503,protein-containing complex localization,254,8,5.11,0.14125,1,0.5224718721461187,1.57,BP
GO:0050663,cytokine secretion,254,8,5.11,0.14125,1,0.5224718721461187,1.57,BP
GO:0017038,protein import,214,7,4.3,0.14127,1,0.5224718721461187,1.63,BP
GO:0007097,nuclear migration,33,2,0.66,0.14187,1,0.5224718721461187,3.03,BP
GO:0048841,regulation of axon extension involved in...,33,2,0.66,0.14187,1,0.5224718721461187,3.03,BP
GO:0070897,transcription preinitiation complex asse...,33,2,0.66,0.14187,1,0.5224718721461187,3.03,BP
GO:0099563,modification of synaptic structure,33,2,0.66,0.14187,1,0.5224718721461187,3.03,BP
GO:1901976,regulation of cell cycle checkpoint,33,2,0.66,0.14187,1,0.5224718721461187,3.03,BP
GO:1904646,cellular response to amyloid-beta,33,2,0.66,0.14187,1,0.5224718721461187,3.03,BP
GO:0006913,nucleocytoplasmic transport,295,9,5.93,0.14196,1,0.5224718721461187,1.52,BP
GO:0051169,nuclear transport,295,9,5.93,0.14196,1,0.5224718721461187,1.52,BP
GO:0000381,"regulation of alternative mRNA splicing,...",65,3,1.31,0.14249,1,0.5224718721461187,2.29,BP
GO:0006278,RNA-dependent DNA biosynthetic process,65,3,1.31,0.14249,1,0.5224718721461187,2.29,BP
GO:0007004,telomere maintenance via telomerase,65,3,1.31,0.14249,1,0.5224718721461187,2.29,BP
GO:0071479,cellular response to ionizing radiation,65,3,1.31,0.14249,1,0.5224718721461187,2.29,BP
GO:0099024,plasma membrane invagination,65,3,1.31,0.14249,1,0.5224718721461187,2.29,BP
GO:0009791,post-embryonic development,137,5,2.75,0.14261,1,0.5224718721461187,1.82,BP
GO:0033993,response to lipid,811,21,16.3,0.14267,1,0.5224718721461187,1.29,BP
GO:0050920,regulation of chemotaxis,215,7,4.32,0.14368,1,0.5257704638783269,1.62,BP
GO:0034097,response to cytokine,1037,26,20.84,0.14580,1,0.5330047005307051,1.25,BP
GO:0001578,microtubule bundle formation,101,4,2.03,0.14610,1,0.5330047005307051,1.97,BP
GO:0051651,maintenance of location in cell,101,4,2.03,0.14610,1,0.5330047005307051,1.97,BP
GO:0090174,organelle membrane fusion,101,4,2.03,0.14610,1,0.5330047005307051,1.97,BP
GO:0000422,autophagy of mitochondrion,66,3,1.33,0.14719,1,0.5356850793650794,2.26,BP
GO:0051591,response to cAMP,66,3,1.33,0.14719,1,0.5356850793650794,2.26,BP
GO:0061726,mitochondrion disassembly,66,3,1.33,0.14719,1,0.5356850793650794,2.26,BP
GO:0010977,negative regulation of neuron projection...,177,6,3.56,0.14728,1,0.5356850793650794,1.69,BP
GO:0000186,activation of MAPKK activity,34,2,0.68,0.14883,1,0.5405056301886791,2.94,BP
GO:0018208,peptidyl-proline modification,34,2,0.68,0.14883,1,0.5405056301886791,2.94,BP
GO:0008306,associative learning,102,4,2.05,0.14982,1,0.5428718674698796,1.95,BP
GO:0031532,actin cytoskeleton reorganization,102,4,2.05,0.14982,1,0.5428718674698796,1.95,BP
GO:0098876,vesicle-mediated transport to the plasma...,102,4,2.05,0.14982,1,0.5428718674698796,1.95,BP
GO:0032412,regulation of ion transmembrane transpor...,258,8,5.19,0.15015,1,0.5430220886551465,1.54,BP
GO:0071214,cellular response to abiotic stimulus,299,9,6.01,0.15020,1,0.5430220886551465,1.5,BP
GO:0104004,cellular response to environmental stimu...,299,9,6.01,0.15020,1,0.5430220886551465,1.5,BP
GO:0006801,superoxide metabolic process,67,3,1.35,0.15194,1,0.5486329782445611,2.22,BP
GO:0043484,regulation of RNA splicing,140,5,2.81,0.15198,1,0.5486329782445611,1.78,BP
GO:0048598,embryonic morphogenesis,642,17,12.9,0.15210,1,0.5486545727136432,1.32,BP
GO:0002573,myeloid leukocyte differentiation,219,7,4.4,0.15353,1,0.5523010762331839,1.59,BP
GO:0001708,cell fate specification,103,4,2.07,0.15357,1,0.5523010762331839,1.93,BP
GO:0045778,positive regulation of ossification,103,4,2.07,0.15357,1,0.5523010762331839,1.93,BP
GO:1903426,regulation of reactive oxygen species bi...,103,4,2.07,0.15357,1,0.5523010762331839,1.93,BP
GO:0002082,regulation of oxidative phosphorylation,35,2,0.7,0.15586,1,0.5584499776619508,2.86,BP
GO:0009954,proximal/distal pattern formation,35,2,0.7,0.15586,1,0.5584499776619508,2.86,BP
GO:0038084,vascular endothelial growth factor signa...,35,2,0.7,0.15586,1,0.5584499776619508,2.86,BP
GO:0045940,positive regulation of steroid metabolic...,35,2,0.7,0.15586,1,0.5584499776619508,2.86,BP
GO:0051567,histone H3-K9 methylation,35,2,0.7,0.15586,1,0.5584499776619508,2.86,BP
GO:0043113,receptor clustering,68,3,1.37,0.15674,1,0.5611851785714286,2.19,BP
GO:0048704,embryonic skeletal system morphogenesis,104,4,2.09,0.15736,1,0.5629861115241636,1.91,BP
GO:0010256,endomembrane system organization,387,11,7.78,0.15871,1,0.5673941456166419,1.41,BP
GO:0018205,peptidyl-lysine modification,345,10,6.93,0.15912,1,0.5684375946547885,1.44,BP
GO:0055017,cardiac muscle tissue growth,105,4,2.11,0.16119,1,0.5748736,1.9,BP
GO:0034767,positive regulation of ion transmembrane...,182,6,3.66,0.16122,1,0.5748736,1.64,BP
GO:0034655,nucleobase-containing compound catabolic...,431,12,8.66,0.16128,1,0.5748736,1.39,BP
GO:0060997,dendritic spine morphogenesis,69,3,1.39,0.16158,1,0.5753400887573964,2.16,BP
GO:0051650,establishment of vesicle localization,263,8,5.29,0.16165,1,0.5753400887573964,1.51,BP
GO:0006739,NADP metabolic process,36,2,0.72,0.16295,1,0.5761318148420279,2.78,BP
GO:0021846,cell proliferation in forebrain,36,2,0.72,0.16295,1,0.5761318148420279,2.78,BP
GO:0034205,amyloid-beta formation,36,2,0.72,0.16295,1,0.5761318148420279,2.78,BP
GO:0043114,regulation of vascular permeability,36,2,0.72,0.16295,1,0.5761318148420279,2.78,BP
GO:0051973,positive regulation of telomerase activi...,36,2,0.72,0.16295,1,0.5761318148420279,2.78,BP
GO:0060441,epithelial tube branching involved in lu...,36,2,0.72,0.16295,1,0.5761318148420279,2.78,BP
GO:1904037,positive regulation of epithelial cell a...,36,2,0.72,0.16295,1,0.5761318148420279,2.78,BP
GO:1904358,positive regulation of telomere maintena...,36,2,0.72,0.16295,1,0.5761318148420279,2.78,BP
GO:1905209,positive regulation of cardiocyte differ...,36,2,0.72,0.16295,1,0.5761318148420279,2.78,BP
GO:0046330,positive regulation of JNK cascade,144,5,2.89,0.16486,1,0.5824569162995595,1.73,BP
GO:0071396,cellular response to lipid,607,16,12.2,0.16518,1,0.5831593250183419,1.31,BP
GO:0030324,lung development,224,7,4.5,0.16626,1,0.5859938844184346,1.56,BP
GO:0048641,regulation of skeletal muscle tissue dev...,70,3,1.41,0.16647,1,0.5859938844184346,2.13,BP
GO:1990868,response to chemokine,70,3,1.41,0.16647,1,0.5859938844184346,2.13,BP
GO:1990869,cellular response to chemokine,70,3,1.41,0.16647,1,0.5859938844184346,2.13,BP
GO:0022898,regulation of transmembrane transporter ...,266,8,5.35,0.16874,1,0.592701810282404,1.5,BP
GO:0000956,nuclear-transcribed mRNA catabolic proce...,107,4,2.15,0.16894,1,0.592701810282404,1.86,BP
GO:0002053,positive regulation of mesenchymal cell ...,37,2,0.74,0.17010,1,0.592701810282404,2.7,BP
GO:0006458,'de novo' protein folding,37,2,0.74,0.17010,1,0.592701810282404,2.7,BP
GO:0021799,cerebral cortex radially oriented cell m...,37,2,0.74,0.17010,1,0.592701810282404,2.7,BP
GO:0033144,negative regulation of intracellular ste...,37,2,0.74,0.17010,1,0.592701810282404,2.7,BP
GO:0033146,regulation of intracellular estrogen rec...,37,2,0.74,0.17010,1,0.592701810282404,2.7,BP
GO:0033260,nuclear DNA replication,37,2,0.74,0.17010,1,0.592701810282404,2.7,BP
GO:0048147,negative regulation of fibroblast prolif...,37,2,0.74,0.17010,1,0.592701810282404,2.7,BP
GO:0048846,axon extension involved in axon guidance,37,2,0.74,0.17010,1,0.592701810282404,2.7,BP
GO:0060142,regulation of syncytium formation by pla...,37,2,0.74,0.17010,1,0.592701810282404,2.7,BP
GO:0061756,leukocyte adhesion to vascular endotheli...,37,2,0.74,0.17010,1,0.592701810282404,2.7,BP
GO:1901385,regulation of voltage-gated calcium chan...,37,2,0.74,0.17010,1,0.592701810282404,2.7,BP
GO:1902284,neuron projection extension involved in ...,37,2,0.74,0.17010,1,0.592701810282404,2.7,BP
GO:0016575,histone deacetylation,71,3,1.43,0.17140,1,0.5944276080691643,2.1,BP
GO:0045669,positive regulation of osteoblast differ...,71,3,1.43,0.17140,1,0.5944276080691643,2.1,BP
GO:0060675,ureteric bud morphogenesis,71,3,1.43,0.17140,1,0.5944276080691643,2.1,BP
GO:0070192,chromosome organization involved in meio...,71,3,1.43,0.17140,1,0.5944276080691643,2.1,BP
GO:1901796,regulation of signal transduction by p53...,71,3,1.43,0.17140,1,0.5944276080691643,2.1,BP
GO:2001021,negative regulation of response to DNA d...,71,3,1.43,0.17140,1,0.5944276080691643,2.1,BP
GO:0050680,negative regulation of epithelial cell p...,146,5,2.93,0.17146,1,0.5944276080691643,1.71,BP
GO:0007052,mitotic spindle organization,108,4,2.17,0.17286,1,0.5988497624190066,1.84,BP
GO:0030323,respiratory tube development,227,7,4.56,0.17411,1,0.6027462733812949,1.54,BP
GO:0045667,regulation of osteoblast differentiation,147,5,2.95,0.17480,1,0.604699928109274,1.69,BP
GO:0010324,membrane invagination,72,3,1.45,0.17638,1,0.6085360912981456,2.07,BP
GO:0010611,regulation of cardiac muscle hypertrophy,72,3,1.45,0.17638,1,0.6085360912981456,2.07,BP
GO:0072171,mesonephric tubule morphogenesis,72,3,1.45,0.17638,1,0.6085360912981456,2.07,BP
GO:0007267,cell-cell signaling,1617,38,32.5,0.17724,1,0.6085360912981456,1.17,BP
GO:0006284,base-excision repair,38,2,0.76,0.17730,1,0.6085360912981456,2.63,BP
GO:0010762,regulation of fibroblast migration,38,2,0.76,0.17730,1,0.6085360912981456,2.63,BP
GO:0045005,DNA-dependent DNA replication maintenanc...,38,2,0.76,0.17730,1,0.6085360912981456,2.63,BP
GO:0046329,negative regulation of JNK cascade,38,2,0.76,0.17730,1,0.6085360912981456,2.63,BP
GO:0051647,nucleus localization,38,2,0.76,0.17730,1,0.6085360912981456,2.63,BP
GO:0071158,positive regulation of cell cycle arrest,38,2,0.76,0.17730,1,0.6085360912981456,2.63,BP
GO:0071320,cellular response to cAMP,38,2,0.76,0.17730,1,0.6085360912981456,2.63,BP
GO:1904062,regulation of cation transmembrane trans...,354,10,7.12,0.17769,1,0.609439971489665,1.4,BP
GO:0045927,positive regulation of growth,312,9,6.27,0.17855,1,0.6115178647686833,1.44,BP
GO:0048872,homeostasis of number of cells,312,9,6.27,0.17855,1,0.6115178647686833,1.44,BP
GO:0045446,endothelial cell differentiation,110,4,2.21,0.18080,1,0.618602891566265,1.81,BP
GO:0007422,peripheral nervous system development,73,3,1.47,0.18139,1,0.618602891566265,2.04,BP
GO:0021885,forebrain cell migration,73,3,1.47,0.18139,1,0.618602891566265,2.04,BP
GO:0042733,embryonic digit morphogenesis,73,3,1.47,0.18139,1,0.618602891566265,2.04,BP
GO:0043627,response to estrogen,73,3,1.47,0.18139,1,0.618602891566265,2.04,BP
GO:1990542,mitochondrial transmembrane transport,73,3,1.47,0.18139,1,0.618602891566265,2.04,BP
GO:0044419,interspecies interaction between organis...,399,11,8.02,0.18217,1,0.6208229745042493,1.37,BP
GO:0007257,activation of JUN kinase activity,39,2,0.78,0.18455,1,0.6249504574243491,2.56,BP
GO:0007616,long-term memory,39,2,0.78,0.18455,1,0.6249504574243491,2.56,BP
GO:0016233,telomere capping,39,2,0.78,0.18455,1,0.6249504574243491,2.56,BP
GO:0032781,positive regulation of ATPase activity,39,2,0.78,0.18455,1,0.6249504574243491,2.56,BP
GO:0060236,regulation of mitotic spindle organizati...,39,2,0.78,0.18455,1,0.6249504574243491,2.56,BP
GO:1900026,positive regulation of substrate adhesio...,39,2,0.78,0.18455,1,0.6249504574243491,2.56,BP
GO:1901021,positive regulation of calcium ion trans...,39,2,0.78,0.18455,1,0.6249504574243491,2.56,BP
GO:1904645,response to amyloid-beta,39,2,0.78,0.18455,1,0.6249504574243491,2.56,BP
GO:2001024,negative regulation of response to drug,39,2,0.78,0.18455,1,0.6249504574243491,2.56,BP
GO:0036293,response to decreased oxygen levels,231,7,4.64,0.18483,1,0.6254584810126582,1.51,BP
GO:0051052,regulation of DNA metabolic process,444,12,8.92,0.18557,1,0.6275213211524948,1.35,BP
GO:0030099,myeloid cell differentiation,401,11,8.06,0.18623,1,0.6282557983193278,1.36,BP
GO:0006626,protein targeting to mitochondrion,74,3,1.49,0.18644,1,0.6282557983193278,2.01,BP
GO:0008543,fibroblast growth factor receptor signal...,74,3,1.49,0.18644,1,0.6282557983193278,2.01,BP
GO:0036465,synaptic vesicle recycling,74,3,1.49,0.18644,1,0.6282557983193278,2.01,BP
GO:1903201,regulation of oxidative stress-induced c...,74,3,1.49,0.18644,1,0.6282557983193278,2.01,BP
GO:0006979,response to oxidative stress,402,11,8.08,0.18828,1,0.6340121483554934,1.36,BP
GO:0006939,smooth muscle contraction,112,4,2.25,0.18886,1,0.6350763941299791,1.78,BP
GO:0019079,viral genome replication,112,4,2.25,0.18886,1,0.6350763941299791,1.78,BP
GO:0051146,striated muscle cell differentiation,317,9,6.37,0.19006,1,0.6386653072625699,1.41,BP
GO:0014743,regulation of muscle hypertrophy,75,3,1.51,0.19153,1,0.6406204580152672,1.99,BP
GO:0030433,ubiquitin-dependent ERAD pathway,75,3,1.51,0.19153,1,0.6406204580152672,1.99,BP
GO:0045843,negative regulation of striated muscle t...,75,3,1.51,0.19153,1,0.6406204580152672,1.99,BP
GO:0007099,centriole replication,40,2,0.8,0.19184,1,0.6406204580152672,2.5,BP
GO:0010092,specification of animal organ identity,40,2,0.8,0.19184,1,0.6406204580152672,2.5,BP
GO:0046825,regulation of protein export from nucleu...,40,2,0.8,0.19184,1,0.6406204580152672,2.5,BP
GO:0086004,regulation of cardiac muscle cell contra...,40,2,0.8,0.19184,1,0.6406204580152672,2.5,BP
GO:0090049,regulation of cell migration involved in...,40,2,0.8,0.19184,1,0.6406204580152672,2.5,BP
GO:0110111,negative regulation of animal organ morp...,40,2,0.8,0.19184,1,0.6406204580152672,2.5,BP
GO:0006140,regulation of nucleotide metabolic proce...,113,4,2.27,0.19293,1,0.6438135644937586,1.76,BP
GO:0032409,regulation of transporter activity,276,8,5.55,0.19336,1,0.6448013305613306,1.44,BP
GO:0001824,blastocyst development,153,5,3.08,0.19532,1,0.6504358754325259,1.62,BP
GO:0006606,protein import into nucleus,153,5,3.08,0.19532,1,0.6504358754325259,1.62,BP
GO:0002790,peptide secretion,671,17,13.49,0.19611,1,0.6506163747454176,1.26,BP
GO:0032507,maintenance of protein location in cell,76,3,1.53,0.19666,1,0.6506163747454176,1.96,BP
GO:0048844,artery morphogenesis,76,3,1.53,0.19666,1,0.6506163747454176,1.96,BP
GO:0051193,regulation of cofactor metabolic process,76,3,1.53,0.19666,1,0.6506163747454176,1.96,BP
GO:0097327,response to antineoplastic agent,76,3,1.53,0.19666,1,0.6506163747454176,1.96,BP
GO:0008637,apoptotic mitochondrial changes,114,4,2.29,0.19703,1,0.6506163747454176,1.75,BP
GO:0060419,heart growth,114,4,2.29,0.19703,1,0.6506163747454176,1.75,BP
GO:1904019,epithelial cell apoptotic process,114,4,2.29,0.19703,1,0.6506163747454176,1.75,BP
GO:0009615,response to virus,278,8,5.59,0.19845,1,0.6506163747454176,1.43,BP
GO:0051607,defense response to virus,236,7,4.74,0.19861,1,0.6506163747454176,1.48,BP
GO:0006937,regulation of muscle contraction,154,5,3.1,0.19882,1,0.6506163747454176,1.61,BP
GO:0046661,male sex differentiation,154,5,3.1,0.19882,1,0.6506163747454176,1.61,BP
GO:0002832,negative regulation of response to bioti...,41,2,0.82,0.19916,1,0.6506163747454176,2.44,BP
GO:0014037,Schwann cell differentiation,41,2,0.82,0.19916,1,0.6506163747454176,2.44,BP
GO:0021522,spinal cord motor neuron differentiation,41,2,0.82,0.19916,1,0.6506163747454176,2.44,BP
GO:0021955,central nervous system neuron axonogenes...,41,2,0.82,0.19916,1,0.6506163747454176,2.44,BP
GO:0033628,regulation of cell adhesion mediated by ...,41,2,0.82,0.19916,1,0.6506163747454176,2.44,BP
GO:0035774,positive regulation of insulin secretion...,41,2,0.82,0.19916,1,0.6506163747454176,2.44,BP
GO:0046854,phosphatidylinositol phosphorylation,41,2,0.82,0.19916,1,0.6506163747454176,2.44,BP
GO:0050856,regulation of T cell receptor signaling ...,41,2,0.82,0.19916,1,0.6506163747454176,2.44,BP
GO:0086009,membrane repolarization,41,2,0.82,0.19916,1,0.6506163747454176,2.44,BP
GO:0097300,programmed necrotic cell death,41,2,0.82,0.19916,1,0.6506163747454176,2.44,BP
GO:0098534,centriole assembly,41,2,0.82,0.19916,1,0.6506163747454176,2.44,BP
GO:1900744,regulation of p38MAPK cascade,41,2,0.82,0.19916,1,0.6506163747454176,2.44,BP
GO:1903053,regulation of extracellular matrix organ...,41,2,0.82,0.19916,1,0.6506163747454176,2.44,BP
GO:2000008,regulation of protein localization to ce...,41,2,0.82,0.19916,1,0.6506163747454176,2.44,BP
GO:2000273,positive regulation of signaling recepto...,41,2,0.82,0.19916,1,0.6506163747454176,2.44,BP
GO:2000772,regulation of cellular senescence,41,2,0.82,0.19916,1,0.6506163747454176,2.44,BP
GO:0051209,release of sequestered calcium ion into ...,115,4,2.31,0.20116,1,0.6567041519674356,1.73,BP
GO:0034764,positive regulation of transmembrane tra...,237,7,4.76,0.20141,1,0.6570745220338984,1.47,BP
GO:0048635,negative regulation of muscle organ deve...,77,3,1.55,0.20181,1,0.6579334146341463,1.94,BP
GO:1903046,meiotic cell cycle process,197,6,3.96,0.20618,1,0.6694112903225806,1.52,BP
GO:0062012,regulation of small molecule metabolic p...,367,10,7.38,0.20620,1,0.6694112903225806,1.36,BP
GO:0032768,regulation of monooxygenase activity,42,2,0.84,0.20652,1,0.6694112903225806,2.38,BP
GO:0038083,peptidyl-tyrosine autophosphorylation,42,2,0.84,0.20652,1,0.6694112903225806,2.38,BP
GO:0045197,establishment or maintenance of epitheli...,42,2,0.84,0.20652,1,0.6694112903225806,2.38,BP
GO:0045740,positive regulation of DNA replication,42,2,0.84,0.20652,1,0.6694112903225806,2.38,BP
GO:2000826,regulation of heart morphogenesis,42,2,0.84,0.20652,1,0.6694112903225806,2.38,BP
GO:0006405,RNA export from nucleus,78,3,1.57,0.20700,1,0.6694112903225806,1.91,BP
GO:0034644,cellular response to UV,78,3,1.57,0.20700,1,0.6694112903225806,1.91,BP
GO:0043507,positive regulation of JUN kinase activi...,78,3,1.57,0.20700,1,0.6694112903225806,1.91,BP
GO:0045471,response to ethanol,78,3,1.57,0.20700,1,0.6694112903225806,1.91,BP
GO:1901862,negative regulation of muscle tissue dev...,78,3,1.57,0.20700,1,0.6694112903225806,1.91,BP
GO:0051648,vesicle localization,282,8,5.67,0.20881,1,0.6747428915662651,1.41,BP
GO:0007519,skeletal muscle tissue development,198,6,3.98,0.20933,1,0.6747428915662651,1.51,BP
GO:0008217,regulation of blood pressure,198,6,3.98,0.20933,1,0.6747428915662651,1.51,BP
GO:0051170,import into nucleus,157,5,3.16,0.20945,1,0.6747428915662651,1.58,BP
GO:0003073,regulation of systemic arterial blood pr...,117,4,2.35,0.20949,1,0.6747428915662651,1.7,BP
GO:0051283,negative regulation of sequestering of c...,117,4,2.35,0.20949,1,0.6747428915662651,1.7,BP
GO:0030278,regulation of ossification,240,7,4.82,0.20990,1,0.6751596256684492,1.45,BP
GO:0090257,regulation of muscle system process,240,7,4.82,0.20990,1,0.6751596256684492,1.45,BP
GO:0070588,calcium ion transmembrane transport,283,8,5.69,0.21143,1,0.679590600801068,1.41,BP
GO:0007159,leukocyte cell-cell adhesion,326,9,6.55,0.21156,1,0.679590600801068,1.37,BP
GO:0010833,telomere maintenance via telomere length...,79,3,1.59,0.21222,1,0.6798952330226364,1.89,BP
GO:0032088,negative regulation of NF-kappaB transcr...,79,3,1.59,0.21222,1,0.6798952330226364,1.89,BP
GO:0060976,coronary vasculature development,79,3,1.59,0.21222,1,0.6798952330226364,1.89,BP
GO:0072078,nephron tubule morphogenesis,79,3,1.59,0.21222,1,0.6798952330226364,1.89,BP
GO:0062013,positive regulation of small molecule me...,158,5,3.18,0.21303,1,0.6820361676646707,1.57,BP
GO:0001937,negative regulation of endothelial cell ...,43,2,0.86,0.21391,1,0.6830357796947578,2.33,BP
GO:0007080,mitotic metaphase plate congression,43,2,0.86,0.21391,1,0.6830357796947578,2.33,BP
GO:0048255,mRNA stabilization,43,2,0.86,0.21391,1,0.6830357796947578,2.33,BP
GO:1903573,negative regulation of response to endop...,43,2,0.86,0.21391,1,0.6830357796947578,2.33,BP
GO:0007569,cell aging,159,5,3.2,0.21663,1,0.6912623076923077,1.56,BP
GO:0043154,negative regulation of cysteine-type end...,80,3,1.61,0.21746,1,0.6925331039046988,1.86,BP
GO:0043525,positive regulation of neuron apoptotic ...,80,3,1.61,0.21746,1,0.6925331039046988,1.86,BP
GO:0045682,regulation of epidermis development,80,3,1.61,0.21746,1,0.6925331039046988,1.86,BP
GO:0051282,regulation of sequestering of calcium io...,119,4,2.39,0.21791,1,0.6935072222222222,1.67,BP
GO:0002685,regulation of leukocyte migration,201,6,4.04,0.21887,1,0.6956422985468956,1.49,BP
GO:0019058,viral life cycle,201,6,4.04,0.21887,1,0.6956422985468956,1.49,BP
GO:0042552,myelination,160,5,3.22,0.22026,1,0.6978976671035386,1.55,BP
GO:1903169,regulation of calcium ion transmembrane ...,160,5,3.22,0.22026,1,0.6978976671035386,1.55,BP
GO:0098609,cell-cell adhesion,731,18,14.69,0.22043,1,0.6978976671035386,1.23,BP
GO:0003156,regulation of animal organ formation,44,2,0.88,0.22132,1,0.6978976671035386,2.27,BP
GO:0018023,peptidyl-lysine trimethylation,44,2,0.88,0.22132,1,0.6978976671035386,2.27,BP
GO:0043277,apoptotic cell clearance,44,2,0.88,0.22132,1,0.6978976671035386,2.27,BP
GO:0048854,brain morphogenesis,44,2,0.88,0.22132,1,0.6978976671035386,2.27,BP
GO:0050691,regulation of defense response to virus ...,44,2,0.88,0.22132,1,0.6978976671035386,2.27,BP
GO:0050918,positive chemotaxis,44,2,0.88,0.22132,1,0.6978976671035386,2.27,BP
GO:0051898,negative regulation of protein kinase B ...,44,2,0.88,0.22132,1,0.6978976671035386,2.27,BP
GO:0070849,response to epidermal growth factor,44,2,0.88,0.22132,1,0.6978976671035386,2.27,BP
GO:2000279,negative regulation of DNA biosynthetic ...,44,2,0.88,0.22132,1,0.6978976671035386,2.27,BP
GO:0051208,sequestering of calcium ion,120,4,2.41,0.22216,1,0.7000877013752456,1.66,BP
GO:0033143,regulation of intracellular steroid horm...,81,3,1.63,0.22273,1,0.7005076862745099,1.84,BP
GO:0042147,"retrograde transport, endosome to Golgi",81,3,1.63,0.22273,1,0.7005076862745099,1.84,BP
GO:0072088,nephron epithelium morphogenesis,81,3,1.63,0.22273,1,0.7005076862745099,1.84,BP
GO:0009755,hormone-mediated signaling pathway,161,5,3.24,0.22390,1,0.7032681462140992,1.54,BP
GO:0071356,cellular response to tumor necrosis fact...,161,5,3.24,0.22390,1,0.7032681462140992,1.54,BP
GO:0042542,response to hydrogen peroxide,121,4,2.43,0.22643,1,0.7102875880052151,1.65,BP
GO:1901216,positive regulation of neuron death,121,4,2.43,0.22643,1,0.7102875880052151,1.65,BP
GO:0051291,protein heterooligomerization,162,5,3.26,0.22755,1,0.711535229476406,1.53,BP
GO:0021675,nerve development,82,3,1.65,0.22803,1,0.711535229476406,1.82,BP
GO:0072028,nephron morphogenesis,82,3,1.65,0.22803,1,0.711535229476406,1.82,BP
GO:0001649,osteoblast differentiation,204,6,4.1,0.22856,1,0.711535229476406,1.46,BP
GO:0005978,glycogen biosynthetic process,45,2,0.9,0.22875,1,0.711535229476406,2.22,BP
GO:0006414,translational elongation,45,2,0.9,0.22875,1,0.711535229476406,2.22,BP
GO:0006695,cholesterol biosynthetic process,45,2,0.9,0.22875,1,0.711535229476406,2.22,BP
GO:0009250,glucan biosynthetic process,45,2,0.9,0.22875,1,0.711535229476406,2.22,BP
GO:0035136,forelimb morphogenesis,45,2,0.9,0.22875,1,0.711535229476406,2.22,BP
GO:0050919,negative chemotaxis,45,2,0.9,0.22875,1,0.711535229476406,2.22,BP
GO:0061647,histone H3-K9 modification,45,2,0.9,0.22875,1,0.711535229476406,2.22,BP
GO:0071526,semaphorin-plexin signaling pathway,45,2,0.9,0.22875,1,0.711535229476406,2.22,BP
GO:1901381,positive regulation of potassium ion tra...,45,2,0.9,0.22875,1,0.711535229476406,2.22,BP
GO:0001889,liver development,122,4,2.45,0.23072,1,0.7158121470019343,1.63,BP
GO:0008584,male gonad development,122,4,2.45,0.23072,1,0.7158121470019343,1.63,BP
GO:0090277,positive regulation of peptide hormone s...,122,4,2.45,0.23072,1,0.7158121470019343,1.63,BP
GO:2000278,regulation of DNA biosynthetic process,122,4,2.45,0.23072,1,0.7158121470019343,1.63,BP
GO:0007272,ensheathment of neurons,163,5,3.28,0.23123,1,0.7160094980694981,1.52,BP
GO:0008366,axon ensheathment,163,5,3.28,0.23123,1,0.7160094980694981,1.52,BP
GO:0043901,negative regulation of multi-organism pr...,163,5,3.28,0.23123,1,0.7160094980694981,1.52,BP
GO:0001817,regulation of cytokine production,693,17,13.93,0.23316,1,0.7215214919614148,1.22,BP
GO:1901019,regulation of calcium ion transmembrane ...,83,3,1.67,0.23335,1,0.7216453727506427,1.8,BP
GO:0007005,mitochondrion organization,468,12,9.41,0.23452,1,0.7247978420038537,1.28,BP
GO:0046546,development of primary male sexual chara...,123,4,2.47,0.23502,1,0.7254113149454778,1.62,BP
GO:0048284,organelle fusion,123,4,2.47,0.23502,1,0.7254113149454778,1.62,BP
GO:0021772,olfactory bulb development,46,2,0.92,0.23620,1,0.7271877159309021,2.17,BP
GO:1902653,secondary alcohol biosynthetic process,46,2,0.92,0.23620,1,0.7271877159309021,2.17,BP
GO:1902667,regulation of axon guidance,46,2,0.92,0.23620,1,0.7271877159309021,2.17,BP
GO:1903580,positive regulation of ATP metabolic pro...,46,2,0.92,0.23620,1,0.7271877159309021,2.17,BP
GO:0034470,ncRNA processing,336,9,6.75,0.23652,1,0.7276727923322684,1.33,BP
GO:0044270,cellular nitrogen compound catabolic pro...,469,12,9.43,0.23666,1,0.7276727923322684,1.27,BP
GO:0060538,skeletal muscle organ development,207,6,4.16,0.23838,1,0.7324933333333334,1.44,BP
GO:0014902,myotube differentiation,124,4,2.49,0.23935,1,0.7336001273885351,1.61,BP
GO:0043500,muscle adaptation,124,4,2.49,0.23935,1,0.7336001273885351,1.61,BP
GO:0051153,regulation of striated muscle cell diffe...,124,4,2.49,0.23935,1,0.7336001273885351,1.61,BP
GO:0090090,negative regulation of canonical Wnt sig...,124,4,2.49,0.23935,1,0.7336001273885351,1.61,BP
GO:0097305,response to alcohol,208,6,4.18,0.24168,1,0.7402699936346276,1.44,BP
GO:1904064,positive regulation of cation transmembr...,166,5,3.34,0.24236,1,0.7418806106870229,1.5,BP
GO:0070534,protein K63-linked ubiquitination,47,2,0.94,0.24366,1,0.7442295883470551,2.13,BP
GO:0006665,sphingolipid metabolic process,125,4,2.51,0.24370,1,0.7442295883470551,1.59,BP
GO:0061008,hepaticobiliary system development,125,4,2.51,0.24370,1,0.7442295883470551,1.59,BP
GO:0048524,positive regulation of viral process,85,3,1.71,0.24406,1,0.7442295883470551,1.75,BP
GO:0061333,renal tubule morphogenesis,85,3,1.71,0.24406,1,0.7442295883470551,1.75,BP
GO:1900407,regulation of cellular response to oxida...,85,3,1.71,0.24406,1,0.7442295883470551,1.75,BP
GO:0045862,positive regulation of proteolysis,339,9,6.81,0.24421,1,0.7442295883470551,1.32,BP
GO:0007568,aging,252,7,5.07,0.24514,1,0.7465909367088607,1.38,BP
GO:0046887,positive regulation of hormone secretion,167,5,3.36,0.24610,1,0.7490406072106262,1.49,BP
GO:0060537,muscle tissue development,474,12,9.53,0.24750,1,0.7528255372945638,1.26,BP
GO:0071363,cellular response to growth factor stimu...,610,15,12.26,0.24796,1,0.7535762121212122,1.22,BP
GO:0007631,feeding behavior,126,4,2.53,0.24806,1,0.7535762121212122,1.58,BP
GO:0071559,response to transforming growth factor b...,210,6,4.22,0.24833,1,0.7539204794952681,1.42,BP
GO:0006970,response to osmotic stress,86,3,1.73,0.24944,1,0.7557458161350845,1.73,BP
GO:0051341,regulation of oxidoreductase activity,86,3,1.73,0.24944,1,0.7557458161350845,1.73,BP
GO:0000245,spliceosomal complex assembly,48,2,0.96,0.25113,1,0.7557458161350845,2.08,BP
GO:0001504,neurotransmitter uptake,48,2,0.96,0.25113,1,0.7557458161350845,2.08,BP
GO:0002474,antigen processing and presentation of p...,48,2,0.96,0.25113,1,0.7557458161350845,2.08,BP
GO:0010107,potassium ion import,48,2,0.96,0.25113,1,0.7557458161350845,2.08,BP
GO:0010718,positive regulation of epithelial to mes...,48,2,0.96,0.25113,1,0.7557458161350845,2.08,BP
GO:0021988,olfactory lobe development,48,2,0.96,0.25113,1,0.7557458161350845,2.08,BP
GO:0030857,negative regulation of epithelial cell d...,48,2,0.96,0.25113,1,0.7557458161350845,2.08,BP
GO:0031952,regulation of protein autophosphorylatio...,48,2,0.96,0.25113,1,0.7557458161350845,2.08,BP
GO:0038066,p38MAPK cascade,48,2,0.96,0.25113,1,0.7557458161350845,2.08,BP
GO:0044786,cell cycle DNA replication,48,2,0.96,0.25113,1,0.7557458161350845,2.08,BP
GO:0044848,biological phase,48,2,0.96,0.25113,1,0.7557458161350845,2.08,BP
GO:0090311,regulation of protein deacetylation,48,2,0.96,0.25113,1,0.7557458161350845,2.08,BP
GO:0046700,heterocycle catabolic process,476,12,9.57,0.25188,1,0.75735,1.25,BP
GO:0043087,regulation of GTPase activity,298,8,5.99,0.25218,1,0.75735,1.34,BP
GO:0002761,regulation of myeloid leukocyte differen...,127,4,2.55,0.25245,1,0.75735,1.57,BP
GO:0010212,response to ionizing radiation,127,4,2.55,0.25245,1,0.75735,1.57,BP
GO:0099175,regulation of postsynapse organization,127,4,2.55,0.25245,1,0.75735,1.57,BP
GO:0071897,DNA biosynthetic process,169,5,3.4,0.25362,1,0.7603859439252336,1.47,BP
GO:0048609,multicellular organismal reproductive pr...,843,20,16.94,0.25400,1,0.7610510585305106,1.18,BP
GO:0060541,respiratory system development,255,7,5.13,0.25423,1,0.7612661854387056,1.36,BP
GO:0002690,positive regulation of leukocyte chemota...,87,3,1.75,0.25484,1,0.7616708571428572,1.71,BP
GO:0043648,dicarboxylic acid metabolic process,87,3,1.75,0.25484,1,0.7616708571428572,1.71,BP
GO:2000117,negative regulation of cysteine-type end...,87,3,1.75,0.25484,1,0.7616708571428572,1.71,BP
GO:2000027,regulation of animal organ morphogenesis,212,6,4.26,0.25502,1,0.7617357169459964,1.41,BP
GO:0060401,cytosolic calcium ion transport,170,5,3.42,0.25741,1,0.7683975930521093,1.46,BP
GO:0030520,intracellular estrogen receptor signalin...,49,2,0.98,0.25860,1,0.7690872682323857,2.04,BP
GO:0043489,RNA stabilization,49,2,0.98,0.25860,1,0.7690872682323857,2.04,BP
GO:0048483,autonomic nervous system development,49,2,0.98,0.25860,1,0.7690872682323857,2.04,BP
GO:0061912,selective autophagy,49,2,0.98,0.25860,1,0.7690872682323857,2.04,BP
GO:0090199,regulation of release of cytochrome c fr...,49,2,0.98,0.25860,1,0.7690872682323857,2.04,BP
GO:0090342,regulation of cell aging,49,2,0.98,0.25860,1,0.7690872682323857,2.04,BP
GO:0010717,regulation of epithelial to mesenchymal ...,88,3,1.77,0.26026,1,0.7725916841455892,1.69,BP
GO:0035418,protein localization to synapse,88,3,1.77,0.26026,1,0.7725916841455892,1.69,BP
GO:0044344,cellular response to fibroblast growth f...,88,3,1.77,0.26026,1,0.7725916841455892,1.69,BP
GO:0032874,positive regulation of stress-activated ...,172,5,3.46,0.26502,1,0.7850257265481299,1.45,BP
GO:0035914,skeletal muscle cell differentiation,89,3,1.79,0.26569,1,0.7850257265481299,1.68,BP
GO:1904035,regulation of epithelial cell apoptotic ...,89,3,1.79,0.26569,1,0.7850257265481299,1.68,BP
GO:0006360,transcription by RNA polymerase I,50,2,1.01,0.26608,1,0.7850257265481299,1.98,BP
GO:0032330,regulation of chondrocyte differentiatio...,50,2,1.01,0.26608,1,0.7850257265481299,1.98,BP
GO:0032941,secretion by tissue,50,2,1.01,0.26608,1,0.7850257265481299,1.98,BP
GO:0035088,establishment or maintenance of apical/b...,50,2,1.01,0.26608,1,0.7850257265481299,1.98,BP
GO:0051055,negative regulation of lipid biosyntheti...,50,2,1.01,0.26608,1,0.7850257265481299,1.98,BP
GO:0061245,establishment or maintenance of bipolar ...,50,2,1.01,0.26608,1,0.7850257265481299,1.98,BP
GO:1902930,regulation of alcohol biosynthetic proce...,50,2,1.01,0.26608,1,0.7850257265481299,1.98,BP
GO:0051321,meiotic cell cycle,303,8,6.09,0.26630,1,0.7851933823529411,1.31,BP
GO:0051716,cellular response to stimulus,7732,162,155.41,0.26713,1,0.7871583343539498,1.04,BP
GO:0051259,protein complex oligomerization,620,15,12.46,0.26749,1,0.7877367686658507,1.2,BP
GO:0045637,regulation of myeloid cell differentiati...,216,6,4.34,0.26856,1,0.7904041100917432,1.38,BP
GO:0070304,positive regulation of stress-activated ...,173,5,3.48,0.26884,1,0.7907445476772618,1.44,BP
GO:0006605,protein targeting,260,7,5.23,0.26959,1,0.7919823443223444,1.34,BP
GO:0051056,regulation of small GTPase mediated sign...,260,7,5.23,0.26959,1,0.7919823443223444,1.34,BP
GO:0071774,response to fibroblast growth factor,90,3,1.81,0.27114,1,0.7960498352654057,1.66,BP
GO:0032504,multicellular organism reproduction,854,20,17.17,0.27249,1,0.7973172138098122,1.16,BP
GO:0035107,appendage morphogenesis,174,5,3.5,0.27268,1,0.7973172138098122,1.43,BP
GO:0035108,limb morphogenesis,174,5,3.5,0.27268,1,0.7973172138098122,1.43,BP
GO:1901654,response to ketone,174,5,3.5,0.27268,1,0.7973172138098122,1.43,BP
GO:0016050,vesicle organization,261,7,5.25,0.27270,1,0.7973172138098122,1.33,BP
GO:0010332,response to gamma radiation,51,2,1.03,0.27356,1,0.7973172138098122,1.94,BP
GO:0016126,sterol biosynthetic process,51,2,1.03,0.27356,1,0.7973172138098122,1.94,BP
GO:0031146,SCF-dependent proteasomal ubiquitin-depe...,51,2,1.03,0.27356,1,0.7973172138098122,1.94,BP
GO:0032648,regulation of interferon-beta production,51,2,1.03,0.27356,1,0.7973172138098122,1.94,BP
GO:0048247,lymphocyte chemotaxis,51,2,1.03,0.27356,1,0.7973172138098122,1.94,BP
GO:0051972,regulation of telomerase activity,51,2,1.03,0.27356,1,0.7973172138098122,1.94,BP
GO:0071470,cellular response to osmotic stress,51,2,1.03,0.27356,1,0.7973172138098122,1.94,BP
GO:0043467,regulation of generation of precursor me...,132,4,2.65,0.27458,1,0.7998056658595641,1.51,BP
GO:0006112,energy reserve metabolic process,91,3,1.83,0.27659,1,0.8037144202898551,1.64,BP
GO:0006476,protein deacetylation,91,3,1.83,0.27659,1,0.8037144202898551,1.64,BP
GO:0014015,positive regulation of gliogenesis,91,3,1.83,0.27659,1,0.8037144202898551,1.64,BP
GO:0021954,central nervous system neuron developmen...,91,3,1.83,0.27659,1,0.8037144202898551,1.64,BP
GO:0048762,mesenchymal cell differentiation,219,6,4.4,0.27882,1,0.8073530507462687,1.36,BP
GO:0008037,cell recognition,133,4,2.67,0.27905,1,0.8073530507462687,1.5,BP
GO:1902850,microtubule cytoskeleton organization in...,133,4,2.67,0.27905,1,0.8073530507462687,1.5,BP
GO:0016202,regulation of striated muscle tissue dev...,176,5,3.54,0.28038,1,0.8073530507462687,1.41,BP
GO:0035148,tube formation,176,5,3.54,0.28038,1,0.8073530507462687,1.41,BP
GO:0048592,eye morphogenesis,176,5,3.54,0.28038,1,0.8073530507462687,1.41,BP
GO:0001662,behavioral fear response,52,2,1.05,0.28103,1,0.8073530507462687,1.9,BP
GO:0001895,retina homeostasis,52,2,1.05,0.28103,1,0.8073530507462687,1.9,BP
GO:0001954,positive regulation of cell-matrix adhes...,52,2,1.05,0.28103,1,0.8073530507462687,1.9,BP
GO:0006406,mRNA export from nucleus,52,2,1.05,0.28103,1,0.8073530507462687,1.9,BP
GO:0010712,regulation of collagen metabolic process,52,2,1.05,0.28103,1,0.8073530507462687,1.9,BP
GO:0032481,positive regulation of type I interferon...,52,2,1.05,0.28103,1,0.8073530507462687,1.9,BP
GO:0035924,cellular response to vascular endothelia...,52,2,1.05,0.28103,1,0.8073530507462687,1.9,BP
GO:0044058,regulation of digestive system process,52,2,1.05,0.28103,1,0.8073530507462687,1.9,BP
GO:0045981,positive regulation of nucleotide metabo...,52,2,1.05,0.28103,1,0.8073530507462687,1.9,BP
GO:0048713,regulation of oligodendrocyte differenti...,52,2,1.05,0.28103,1,0.8073530507462687,1.9,BP
GO:0071427,mRNA-containing ribonucleoprotein comple...,52,2,1.05,0.28103,1,0.8073530507462687,1.9,BP
GO:1900544,positive regulation of purine nucleotide...,52,2,1.05,0.28103,1,0.8073530507462687,1.9,BP
GO:1903202,negative regulation of oxidative stress-...,52,2,1.05,0.28103,1,0.8073530507462687,1.9,BP
GO:0009798,axis specification,92,3,1.85,0.28206,1,0.8093456887298748,1.62,BP
GO:0072655,establishment of protein localization to...,92,3,1.85,0.28206,1,0.8093456887298748,1.62,BP
GO:0019439,aromatic compound catabolic process,490,12,9.85,0.28331,1,0.8124479856972587,1.22,BP
GO:0061025,membrane fusion,134,4,2.69,0.28353,1,0.8125946158427636,1.49,BP
GO:0060998,regulation of dendritic spine developmen...,93,3,1.87,0.28754,1,0.821943161634103,1.6,BP
GO:0006261,DNA-dependent DNA replication,135,4,2.71,0.28801,1,0.821943161634103,1.48,BP
GO:0002209,behavioral defense response,53,2,1.07,0.28850,1,0.821943161634103,1.87,BP
GO:0030850,prostate gland development,53,2,1.07,0.28850,1,0.821943161634103,1.87,BP
GO:0032608,interferon-beta production,53,2,1.07,0.28850,1,0.821943161634103,1.87,BP
GO:0042743,hydrogen peroxide metabolic process,53,2,1.07,0.28850,1,0.821943161634103,1.87,BP
GO:0046834,lipid phosphorylation,53,2,1.07,0.28850,1,0.821943161634103,1.87,BP
GO:1900408,negative regulation of cellular response...,53,2,1.07,0.28850,1,0.821943161634103,1.87,BP
GO:1904705,regulation of vascular smooth muscle cel...,53,2,1.07,0.28850,1,0.821943161634103,1.87,BP
GO:1990874,vascular smooth muscle cell proliferatio...,53,2,1.07,0.28850,1,0.821943161634103,1.87,BP
GO:0001816,cytokine production,771,18,15.5,0.29060,1,0.8270891780011829,1.16,BP
GO:0048513,animal organ development,3502,75,70.39,0.29065,1,0.8270891780011829,1.07,BP
GO:0034599,cellular response to oxidative stress,267,7,5.37,0.29150,1,0.8290177304964539,1.3,BP
GO:1901861,regulation of muscle tissue development,179,5,3.6,0.29202,1,0.8299354679223073,1.39,BP
GO:0035023,regulation of Rho protein signal transdu...,136,4,2.73,0.29251,1,0.8299354679223073,1.47,BP
GO:0097553,calcium ion transmembrane import into cy...,136,4,2.73,0.29251,1,0.8299354679223073,1.47,BP
GO:0031348,negative regulation of defense response,223,6,4.48,0.29265,1,0.8299354679223073,1.34,BP
GO:0042116,macrophage activation,94,3,1.89,0.29303,1,0.8299354679223073,1.59,BP
GO:0043506,regulation of JUN kinase activity,94,3,1.89,0.29303,1,0.8299354679223073,1.59,BP
GO:1902882,regulation of response to oxidative stre...,94,3,1.89,0.29303,1,0.8299354679223073,1.59,BP
GO:0048634,regulation of muscle organ development,180,5,3.62,0.29592,1,0.8338078174370976,1.38,BP
GO:0006289,nucleotide-excision repair,54,2,1.09,0.29596,1,0.8338078174370976,1.83,BP
GO:0034113,heterotypic cell-cell adhesion,54,2,1.09,0.29596,1,0.8338078174370976,1.83,BP
GO:0043392,negative regulation of DNA binding,54,2,1.09,0.29596,1,0.8338078174370976,1.83,BP
GO:0045604,regulation of epidermal cell differentia...,54,2,1.09,0.29596,1,0.8338078174370976,1.83,BP
GO:0061900,glial cell activation,54,2,1.09,0.29596,1,0.8338078174370976,1.83,BP
GO:0070265,necrotic cell death,54,2,1.09,0.29596,1,0.8338078174370976,1.83,BP
GO:0098815,modulation of excitatory postsynaptic po...,54,2,1.09,0.29596,1,0.8338078174370976,1.83,BP
GO:0006898,receptor-mediated endocytosis,224,6,4.5,0.29613,1,0.8338078174370976,1.33,BP
GO:0031668,cellular response to extracellular stimu...,224,6,4.5,0.29613,1,0.8338078174370976,1.33,BP
GO:0019953,sexual reproduction,868,20,17.45,0.29671,1,0.8348482710280374,1.15,BP
GO:0048593,camera-type eye morphogenesis,137,4,2.75,0.29702,1,0.8348482710280374,1.45,BP
GO:1903364,positive regulation of cellular protein ...,137,4,2.75,0.29702,1,0.8348482710280374,1.45,BP
GO:0001570,vasculogenesis,95,3,1.91,0.29852,1,0.8371085314685315,1.57,BP
GO:0006906,vesicle fusion,95,3,1.91,0.29852,1,0.8371085314685315,1.57,BP
GO:0060021,roof of mouth development,95,3,1.91,0.29852,1,0.8371085314685315,1.57,BP
GO:1903578,regulation of ATP metabolic process,95,3,1.91,0.29852,1,0.8371085314685315,1.57,BP
GO:0014706,striated muscle tissue development,451,11,9.07,0.29937,1,0.8390031683168317,1.21,BP
GO:0021795,cerebral cortex cell migration,55,2,1.11,0.30341,1,0.8468729234338748,1.8,BP
GO:0030166,proteoglycan biosynthetic process,55,2,1.11,0.30341,1,0.8468729234338748,1.8,BP
GO:0032210,regulation of telomere maintenance via t...,55,2,1.11,0.30341,1,0.8468729234338748,1.8,BP
GO:0035306,positive regulation of dephosphorylation,55,2,1.11,0.30341,1,0.8468729234338748,1.8,BP
GO:0043030,regulation of macrophage activation,55,2,1.11,0.30341,1,0.8468729234338748,1.8,BP
GO:0046902,regulation of mitochondrial membrane per...,55,2,1.11,0.30341,1,0.8468729234338748,1.8,BP
GO:1900024,regulation of substrate adhesion-depende...,55,2,1.11,0.30341,1,0.8468729234338748,1.8,BP
GO:0046683,response to organophosphorus,96,3,1.93,0.30402,1,0.8471014707585408,1.55,BP
GO:0046916,cellular transition metal ion homeostasi...,96,3,1.93,0.30402,1,0.8471014707585408,1.55,BP
GO:0071456,cellular response to hypoxia,96,3,1.93,0.30402,1,0.8471014707585408,1.55,BP
GO:0051051,negative regulation of transport,546,13,10.97,0.30587,1,0.8517629861111111,1.19,BP
GO:0048706,embryonic skeletal system development,139,4,2.79,0.30606,1,0.8517991440138809,1.43,BP
GO:0044703,multi-organism reproductive process,1015,23,20.4,0.30631,1,0.8520021502890174,1.13,BP
GO:0035051,cardiocyte differentiation,183,5,3.68,0.30767,1,0.8552906065857886,1.36,BP
GO:0007173,epidermal growth factor receptor signali...,97,3,1.95,0.30952,1,0.8556991304347826,1.54,BP
GO:0071482,cellular response to light stimulus,97,3,1.95,0.30952,1,0.8556991304347826,1.54,BP
GO:0072080,nephron tubule development,97,3,1.95,0.30952,1,0.8556991304347826,1.54,BP
GO:0120162,positive regulation of cold-induced ther...,97,3,1.95,0.30952,1,0.8556991304347826,1.54,BP
GO:0051924,regulation of calcium ion transport,273,7,5.49,0.31059,1,0.8556991304347826,1.28,BP
GO:0051168,nuclear export,140,4,2.81,0.31059,1,0.8556991304347826,1.42,BP
GO:0002204,somatic recombination of immunoglobulin ...,56,2,1.13,0.31084,1,0.8556991304347826,1.77,BP
GO:0002208,somatic diversification of immunoglobuli...,56,2,1.13,0.31084,1,0.8556991304347826,1.77,BP
GO:0006879,cellular iron ion homeostasis,56,2,1.13,0.31084,1,0.8556991304347826,1.77,BP
GO:0006911,"phagocytosis, engulfment",56,2,1.13,0.31084,1,0.8556991304347826,1.77,BP
GO:0042596,fear response,56,2,1.13,0.31084,1,0.8556991304347826,1.77,BP
GO:0043330,response to exogenous dsRNA,56,2,1.13,0.31084,1,0.8556991304347826,1.77,BP
GO:0045190,isotype switching,56,2,1.13,0.31084,1,0.8556991304347826,1.77,BP
GO:0048538,thymus development,56,2,1.13,0.31084,1,0.8556991304347826,1.77,BP
GO:0060760,positive regulation of response to cytok...,56,2,1.13,0.31084,1,0.8556991304347826,1.77,BP
GO:0099172,presynapse organization,56,2,1.13,0.31084,1,0.8556991304347826,1.77,BP
GO:1902883,negative regulation of response to oxida...,56,2,1.13,0.31084,1,0.8556991304347826,1.77,BP
GO:0050708,regulation of protein secretion,503,12,10.11,0.31351,1,0.8625558147512865,1.19,BP
GO:0043502,regulation of muscle adaptation,98,3,1.97,0.31503,1,0.865528287671233,1.52,BP
GO:0060993,kidney morphogenesis,98,3,1.97,0.31503,1,0.865528287671233,1.52,BP
GO:0050921,positive regulation of chemotaxis,141,4,2.83,0.31513,1,0.865528287671233,1.41,BP
GO:0009161,ribonucleoside monophosphate metabolic p...,275,7,5.53,0.31701,1,0.8696576490630323,1.27,BP
GO:0007423,sensory organ development,598,14,12.02,0.31795,1,0.8696576490630323,1.16,BP
GO:0010823,negative regulation of mitochondrion org...,57,2,1.15,0.31826,1,0.8696576490630323,1.74,BP
GO:0021517,ventral spinal cord development,57,2,1.15,0.31826,1,0.8696576490630323,1.74,BP
GO:0050854,regulation of antigen receptor-mediated ...,57,2,1.15,0.31826,1,0.8696576490630323,1.74,BP
GO:0050879,multicellular organismal movement,57,2,1.15,0.31826,1,0.8696576490630323,1.74,BP
GO:0050881,musculoskeletal movement,57,2,1.15,0.31826,1,0.8696576490630323,1.74,BP
GO:0051196,regulation of coenzyme metabolic process,57,2,1.15,0.31826,1,0.8696576490630323,1.74,BP
GO:0072577,endothelial cell apoptotic process,57,2,1.15,0.31826,1,0.8696576490630323,1.74,BP
GO:0055088,lipid homeostasis,142,4,2.85,0.31968,1,0.8725468859897901,1.4,BP
GO:0072073,kidney epithelium development,142,4,2.85,0.31968,1,0.8725468859897901,1.4,BP
GO:0099072,regulation of postsynaptic membrane neur...,99,3,1.99,0.32053,1,0.8743117733711048,1.51,BP
GO:0097191,extrinsic apoptotic signaling pathway,231,6,4.64,0.32069,1,0.8743117733711048,1.29,BP
GO:0043269,regulation of ion transport,741,17,14.89,0.32271,1,0.8789593208828522,1.14,BP
GO:0051046,regulation of secretion,930,21,18.69,0.32276,1,0.8789593208828522,1.12,BP
GO:0106106,cold-induced thermogenesis,143,4,2.87,0.32423,1,0.8819642509892596,1.39,BP
GO:0120161,regulation of cold-induced thermogenesis,143,4,2.87,0.32423,1,0.8819642509892596,1.39,BP
GO:0061512,protein localization to cilium,58,2,1.17,0.32566,1,0.8846717666483214,1.71,BP
GO:0010771,negative regulation of cell morphogenesi...,100,3,2.01,0.32604,1,0.8846717666483214,1.49,BP
GO:0002687,positive regulation of leukocyte migrati...,144,4,2.89,0.32878,1,0.8846717666483214,1.38,BP
GO:0009267,cellular response to starvation,144,4,2.89,0.32878,1,0.8846717666483214,1.38,BP
GO:0031347,regulation of defense response,650,15,13.07,0.32898,1,0.8846717666483214,1.15,BP
GO:0006119,oxidative phosphorylation,101,3,2.03,0.33155,1,0.8846717666483214,1.48,BP
GO:0033559,unsaturated fatty acid metabolic process,101,3,2.03,0.33155,1,0.8846717666483214,1.48,BP
GO:0060359,response to ammonium ion,101,3,2.03,0.33155,1,0.8846717666483214,1.48,BP
GO:0006954,inflammatory response,699,16,14.05,0.33297,1,0.8846717666483214,1.14,BP
GO:0042775,mitochondrial ATP synthesis coupled elec...,59,2,1.19,0.33303,1,0.8846717666483214,1.68,BP
GO:0043954,cellular component maintenance,59,2,1.19,0.33303,1,0.8846717666483214,1.68,BP
GO:0045806,negative regulation of endocytosis,59,2,1.19,0.33303,1,0.8846717666483214,1.68,BP
GO:1903902,positive regulation of viral life cycle,59,2,1.19,0.33303,1,0.8846717666483214,1.68,BP
GO:0006525,arginine metabolic process,20,1,0.4,0.33388,1,0.8846717666483214,2.5,BP
GO:0019430,removal of superoxide radicals,20,1,0.4,0.33388,1,0.8846717666483214,2.5,BP
GO:0032095,regulation of response to food,20,1,0.4,0.33388,1,0.8846717666483214,2.5,BP
GO:0032148,activation of protein kinase B activity,20,1,0.4,0.33388,1,0.8846717666483214,2.5,BP
GO:0033599,regulation of mammary gland epithelial c...,20,1,0.4,0.33388,1,0.8846717666483214,2.5,BP
GO:0033605,positive regulation of catecholamine sec...,20,1,0.4,0.33388,1,0.8846717666483214,2.5,BP
GO:0033630,positive regulation of cell adhesion med...,20,1,0.4,0.33388,1,0.8846717666483214,2.5,BP
GO:0033962,cytoplasmic mRNA processing body assembl...,20,1,0.4,0.33388,1,0.8846717666483214,2.5,BP
GO:0036344,platelet morphogenesis,20,1,0.4,0.33388,1,0.8846717666483214,2.5,BP
GO:0042451,purine nucleoside biosynthetic process,20,1,0.4,0.33388,1,0.8846717666483214,2.5,BP
GO:0043931,ossification involved in bone maturation,20,1,0.4,0.33388,1,0.8846717666483214,2.5,BP
GO:0045821,positive regulation of glycolytic proces...,20,1,0.4,0.33388,1,0.8846717666483214,2.5,BP
GO:0045986,negative regulation of smooth muscle con...,20,1,0.4,0.33388,1,0.8846717666483214,2.5,BP
GO:0046129,purine ribonucleoside biosynthetic proce...,20,1,0.4,0.33388,1,0.8846717666483214,2.5,BP
GO:0048172,regulation of short-term neuronal synapt...,20,1,0.4,0.33388,1,0.8846717666483214,2.5,BP
GO:0050434,positive regulation of viral transcripti...,20,1,0.4,0.33388,1,0.8846717666483214,2.5,BP
GO:0051481,negative regulation of cytosolic calcium...,20,1,0.4,0.33388,1,0.8846717666483214,2.5,BP
GO:0060123,regulation of growth hormone secretion,20,1,0.4,0.33388,1,0.8846717666483214,2.5,BP
GO:0060252,positive regulation of glial cell prolif...,20,1,0.4,0.33388,1,0.8846717666483214,2.5,BP
GO:0060307,regulation of ventricular cardiac muscle...,20,1,0.4,0.33388,1,0.8846717666483214,2.5,BP
GO:0070828,heterochromatin organization,20,1,0.4,0.33388,1,0.8846717666483214,2.5,BP
GO:0072079,nephron tubule formation,20,1,0.4,0.33388,1,0.8846717666483214,2.5,BP
GO:0072087,renal vesicle development,20,1,0.4,0.33388,1,0.8846717666483214,2.5,BP
GO:0072520,seminiferous tubule development,20,1,0.4,0.33388,1,0.8846717666483214,2.5,BP
GO:0090036,regulation of protein kinase C signaling,20,1,0.4,0.33388,1,0.8846717666483214,2.5,BP
GO:0090502,"RNA phosphodiester bond hydrolysis, endo...",20,1,0.4,0.33388,1,0.8846717666483214,2.5,BP
GO:1900409,positive regulation of cellular response...,20,1,0.4,0.33388,1,0.8846717666483214,2.5,BP
GO:1900451,positive regulation of glutamate recepto...,20,1,0.4,0.33388,1,0.8846717666483214,2.5,BP
GO:1903392,negative regulation of adherens junction...,20,1,0.4,0.33388,1,0.8846717666483214,2.5,BP
GO:1903975,regulation of glial cell migration,20,1,0.4,0.33388,1,0.8846717666483214,2.5,BP
GO:1904385,cellular response to angiotensin,20,1,0.4,0.33388,1,0.8846717666483214,2.5,BP
GO:1904994,regulation of leukocyte adhesion to vasc...,20,1,0.4,0.33388,1,0.8846717666483214,2.5,BP
GO:1990403,embryonic brain development,20,1,0.4,0.33388,1,0.8846717666483214,2.5,BP
GO:2000136,regulation of cell proliferation involve...,20,1,0.4,0.33388,1,0.8846717666483214,2.5,BP
GO:0034660,ncRNA metabolic process,465,11,9.35,0.33405,1,0.8846717666483214,1.18,BP
GO:0071345,cellular response to cytokine stimulus,938,21,18.85,0.33689,1,0.8892175,1.11,BP
GO:0003300,cardiac muscle hypertrophy,102,3,2.05,0.33706,1,0.8892175,1.46,BP
GO:0021510,spinal cord development,102,3,2.05,0.33706,1,0.8892175,1.46,BP
GO:0021549,cerebellum development,102,3,2.05,0.33706,1,0.8892175,1.46,BP
GO:0035601,protein deacylation,102,3,2.05,0.33706,1,0.8892175,1.46,BP
GO:0050886,endocrine process,102,3,2.05,0.33706,1,0.8892175,1.46,BP
GO:0098732,macromolecule deacylation,102,3,2.05,0.33706,1,0.8892175,1.46,BP
GO:0007613,memory,146,4,2.93,0.33790,1,0.8900751395730706,1.37,BP
GO:0072006,nephron development,146,4,2.93,0.33790,1,0.8900751395730706,1.37,BP
GO:0042592,homeostatic process,1899,41,38.17,0.33794,1,0.8900751395730706,1.07,BP
GO:0070482,response to oxygen levels,282,7,5.67,0.33964,1,0.8937378441835645,1.23,BP
GO:0021515,cell differentiation in spinal cord,60,2,1.21,0.34039,1,0.8937378441835645,1.65,BP
GO:0070098,chemokine-mediated signaling pathway,60,2,1.21,0.34039,1,0.8937378441835645,1.65,BP
GO:0090183,regulation of kidney development,60,2,1.21,0.34039,1,0.8937378441835645,1.65,BP
GO:0052547,regulation of peptidase activity,421,10,8.46,0.34066,1,0.8937378441835645,1.18,BP
GO:0019218,regulation of steroid metabolic process,103,3,2.07,0.34256,1,0.8937378441835645,1.45,BP
GO:0048709,oligodendrocyte differentiation,103,3,2.07,0.34256,1,0.8937378441835645,1.45,BP
GO:0061326,renal tubule development,103,3,2.07,0.34256,1,0.8937378441835645,1.45,BP
GO:0050773,regulation of dendrite development,192,5,3.86,0.34325,1,0.8937378441835645,1.3,BP
GO:0009123,nucleoside monophosphate metabolic proce...,284,7,5.71,0.34615,1,0.8937378441835645,1.23,BP
GO:0000466,maturation of 5.8S rRNA from tricistroni...,21,1,0.42,0.34728,1,0.8937378441835645,2.38,BP
GO:0000469,cleavage involved in rRNA processing,21,1,0.42,0.34728,1,0.8937378441835645,2.38,BP
GO:0006120,"mitochondrial electron transport, NADH t...",21,1,0.42,0.34728,1,0.8937378441835645,2.38,BP
GO:0006516,glycoprotein catabolic process,21,1,0.42,0.34728,1,0.8937378441835645,2.38,BP
GO:0006907,pinocytosis,21,1,0.42,0.34728,1,0.8937378441835645,2.38,BP
GO:0010560,positive regulation of glycoprotein bios...,21,1,0.42,0.34728,1,0.8937378441835645,2.38,BP
GO:0017000,antibiotic biosynthetic process,21,1,0.42,0.34728,1,0.8937378441835645,2.38,BP
GO:0022010,central nervous system myelination,21,1,0.42,0.34728,1,0.8937378441835645,2.38,BP
GO:0030813,positive regulation of nucleotide catabo...,21,1,0.42,0.34728,1,0.8937378441835645,2.38,BP
GO:0031290,retinal ganglion cell axon guidance,21,1,0.42,0.34728,1,0.8937378441835645,2.38,BP
GO:0032291,axon ensheathment in central nervous sys...,21,1,0.42,0.34728,1,0.8937378441835645,2.38,BP
GO:0034694,response to prostaglandin,21,1,0.42,0.34728,1,0.8937378441835645,2.38,BP
GO:0036336,dendritic cell migration,21,1,0.42,0.34728,1,0.8937378441835645,2.38,BP
GO:0043369,"CD4-positive or CD8-positive, alpha-beta...",21,1,0.42,0.34728,1,0.8937378441835645,2.38,BP
GO:0043586,tongue development,21,1,0.42,0.34728,1,0.8937378441835645,2.38,BP
GO:0044346,fibroblast apoptotic process,21,1,0.42,0.34728,1,0.8937378441835645,2.38,BP
GO:0046174,polyol catabolic process,21,1,0.42,0.34728,1,0.8937378441835645,2.38,BP
GO:0050908,detection of light stimulus involved in ...,21,1,0.42,0.34728,1,0.8937378441835645,2.38,BP
GO:0050962,detection of light stimulus involved in ...,21,1,0.42,0.34728,1,0.8937378441835645,2.38,BP
GO:0051197,positive regulation of coenzyme metaboli...,21,1,0.42,0.34728,1,0.8937378441835645,2.38,BP
GO:0051770,positive regulation of nitric-oxide synt...,21,1,0.42,0.34728,1,0.8937378441835645,2.38,BP
GO:0061323,cell proliferation involved in heart mor...,21,1,0.42,0.34728,1,0.8937378441835645,2.38,BP
GO:0070633,transepithelial transport,21,1,0.42,0.34728,1,0.8937378441835645,2.38,BP
GO:1900101,regulation of endoplasmic reticulum unfo...,21,1,0.42,0.34728,1,0.8937378441835645,2.38,BP
GO:1900151,regulation of nuclear-transcribed mRNA c...,21,1,0.42,0.34728,1,0.8937378441835645,2.38,BP
GO:1901017,negative regulation of potassium ion tra...,21,1,0.42,0.34728,1,0.8937378441835645,2.38,BP
GO:1990776,response to angiotensin,21,1,0.42,0.34728,1,0.8937378441835645,2.38,BP
GO:2000482,regulation of interleukin-8 secretion,21,1,0.42,0.34728,1,0.8937378441835645,2.38,BP
GO:0006749,glutathione metabolic process,61,2,1.23,0.34771,1,0.8937378441835645,1.63,BP
GO:0016447,somatic recombination of immunoglobulin ...,61,2,1.23,0.34771,1,0.8937378441835645,1.63,BP
GO:0031102,neuron projection regeneration,61,2,1.23,0.34771,1,0.8937378441835645,1.63,BP
GO:1905207,regulation of cardiocyte differentiation,61,2,1.23,0.34771,1,0.8937378441835645,1.63,BP
GO:0001657,ureteric bud development,104,3,2.09,0.34806,1,0.8937378441835645,1.44,BP
GO:0002367,cytokine production involved in immune r...,104,3,2.09,0.34806,1,0.8937378441835645,1.44,BP
GO:0072163,mesonephric epithelium development,104,3,2.09,0.34806,1,0.8937378441835645,1.44,BP
GO:0072164,mesonephric tubule development,104,3,2.09,0.34806,1,0.8937378441835645,1.44,BP
GO:2001022,positive regulation of response to DNA d...,104,3,2.09,0.34806,1,0.8937378441835645,1.44,BP
GO:1903530,regulation of secretion by cell,849,19,17.06,0.34825,1,0.8937487999999999,1.11,BP
GO:0007517,muscle organ development,425,10,8.54,0.35130,1,0.8962754108527131,1.17,BP
GO:0009887,animal organ morphogenesis,1090,24,21.91,0.35188,1,0.8962754108527131,1.1,BP
GO:0032940,secretion by cell,1091,24,21.93,0.35356,1,0.8962754108527131,1.09,BP
GO:0002224,toll-like receptor signaling pathway,105,3,2.11,0.35356,1,0.8962754108527131,1.42,BP
GO:0007009,plasma membrane organization,105,3,2.11,0.35356,1,0.8962754108527131,1.42,BP
GO:0001836,release of cytochrome c from mitochondri...,62,2,1.25,0.35501,1,0.8962754108527131,1.6,BP
GO:0007040,lysosome organization,62,2,1.25,0.35501,1,0.8962754108527131,1.6,BP
GO:0014911,positive regulation of smooth muscle cel...,62,2,1.25,0.35501,1,0.8962754108527131,1.6,BP
GO:0048008,platelet-derived growth factor receptor ...,62,2,1.25,0.35501,1,0.8962754108527131,1.6,BP
GO:0048286,lung alveolus development,62,2,1.25,0.35501,1,0.8962754108527131,1.6,BP
GO:0080171,lytic vacuole organization,62,2,1.25,0.35501,1,0.8962754108527131,1.6,BP
GO:0031669,cellular response to nutrient levels,195,5,3.92,0.35518,1,0.8962754108527131,1.28,BP
GO:1901361,organic cyclic compound catabolic proces...,521,12,10.47,0.35653,1,0.8962754108527131,1.15,BP
GO:0051345,positive regulation of hydrolase activit...,522,12,10.49,0.35895,1,0.8962754108527131,1.14,BP
GO:0014897,striated muscle hypertrophy,106,3,2.13,0.35905,1,0.8962754108527131,1.41,BP
GO:0048024,"regulation of mRNA splicing, via spliceo...",106,3,2.13,0.35905,1,0.8962754108527131,1.41,BP
GO:0000470,maturation of LSU-rRNA,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0002834,regulation of response to tumor cell,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0002837,regulation of immune response to tumor c...,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0003084,positive regulation of systemic arterial...,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0003094,glomerular filtration,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0006837,serotonin transport,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0007130,synaptonemal complex assembly,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0009110,vitamin biosynthetic process,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0016048,detection of temperature stimulus,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0018230,peptidyl-L-cysteine S-palmitoylation,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0018231,peptidyl-S-diacylglycerol-L-cysteine bio...,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0021516,dorsal spinal cord development,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0031643,positive regulation of myelination,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0032098,regulation of appetite,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0032462,regulation of protein homooligomerizatio...,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0032780,negative regulation of ATPase activity,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0032930,positive regulation of superoxide anion ...,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0033008,positive regulation of mast cell activat...,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0036314,response to sterol,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0043306,positive regulation of mast cell degranu...,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0044851,hair cycle phase,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0046597,negative regulation of viral entry into ...,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0046823,negative regulation of nucleocytoplasmic...,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0048486,parasympathetic nervous system developme...,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0051654,establishment of mitochondrion localizat...,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0051797,regulation of hair follicle development,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0060438,trachea development,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0060602,branch elongation of an epithelium,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0060749,mammary gland alveolus development,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0061377,mammary gland lobule development,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0070977,bone maturation,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0071359,cellular response to dsRNA,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0071450,cellular response to oxygen radical,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0071451,cellular response to superoxide,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0071459,"protein localization to chromosome, cent...",22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0071800,podosome assembly,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0072111,cell proliferation involved in kidney de...,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0072215,regulation of metanephros development,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0072273,metanephric nephron morphogenesis,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0090201,negative regulation of release of cytoch...,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0097062,dendritic spine maintenance,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0099625,ventricular cardiac muscle cell membrane...,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:1901673,regulation of mitotic spindle assembly,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:2000353,positive regulation of endothelial cell ...,22,1,0.44,0.36041,1,0.8962754108527131,2.27,BP
GO:0022612,gland morphogenesis,151,4,3.04,0.36072,1,0.8965424264326278,1.32,BP
GO:0040013,negative regulation of locomotion,335,8,6.73,0.36089,1,0.8965424264326278,1.19,BP
GO:0032722,positive regulation of chemokine product...,63,2,1.27,0.36228,1,0.8981408346213291,1.57,BP
GO:0042773,ATP synthesis coupled electron transport,63,2,1.27,0.36228,1,0.8981408346213291,1.57,BP
GO:0043331,response to dsRNA,63,2,1.27,0.36228,1,0.8981408346213291,1.57,BP
GO:2000242,negative regulation of reproductive proc...,63,2,1.27,0.36228,1,0.8981408346213291,1.57,BP
GO:0030308,negative regulation of cell growth,197,5,3.96,0.36315,1,0.899834088568486,1.26,BP
GO:0001823,mesonephros development,107,3,2.15,0.36454,1,0.9005702464065708,1.4,BP
GO:0006275,regulation of DNA replication,107,3,2.15,0.36454,1,0.9005702464065708,1.4,BP
GO:0038127,ERBB signaling pathway,107,3,2.15,0.36454,1,0.9005702464065708,1.4,BP
GO:0060840,artery development,107,3,2.15,0.36454,1,0.9005702464065708,1.4,BP
GO:0035690,cellular response to drug,383,9,7.7,0.36457,1,0.9005702464065708,1.17,BP
GO:0072594,establishment of protein localization to...,383,9,7.7,0.36457,1,0.9005702464065708,1.17,BP
GO:0050728,negative regulation of inflammatory resp...,152,4,3.06,0.36528,1,0.9018611390456645,1.31,BP
GO:0071496,cellular response to external stimulus,290,7,5.83,0.36575,1,0.9021714515318936,1.2,BP
GO:0010830,regulation of myotube differentiation,64,2,1.29,0.36952,1,0.9021714515318936,1.55,BP
GO:0045840,positive regulation of mitotic nuclear d...,64,2,1.29,0.36952,1,0.9021714515318936,1.55,BP
GO:1904356,regulation of telomere maintenance via t...,64,2,1.29,0.36952,1,0.9021714515318936,1.55,BP
GO:0014896,muscle hypertrophy,108,3,2.17,0.37001,1,0.9021714515318936,1.38,BP
GO:0035725,sodium ion transmembrane transport,108,3,2.17,0.37001,1,0.9021714515318936,1.38,BP
GO:0072009,nephron epithelium development,108,3,2.17,0.37001,1,0.9021714515318936,1.38,BP
GO:1904659,glucose transmembrane transport,108,3,2.17,0.37001,1,0.9021714515318936,1.38,BP
GO:0006091,generation of precursor metabolites and ...,385,9,7.74,0.37026,1,0.9021714515318936,1.16,BP
GO:0051260,protein homooligomerization,385,9,7.74,0.37026,1,0.9021714515318936,1.16,BP
GO:0009306,protein secretion,622,14,12.5,0.37099,1,0.9021714515318936,1.12,BP
GO:0048736,appendage development,199,5,4,0.37112,1,0.9021714515318936,1.25,BP
GO:0060173,limb development,199,5,4,0.37112,1,0.9021714515318936,1.25,BP
GO:0006936,muscle contraction,292,7,5.87,0.37231,1,0.9021714515318936,1.19,BP
GO:0002093,auditory receptor cell morphogenesis,23,1,0.46,0.37328,1,0.9021714515318936,2.17,BP
GO:0002719,negative regulation of cytokine producti...,23,1,0.46,0.37328,1,0.9021714515318936,2.17,BP
GO:0006346,methylation-dependent chromatin silencin...,23,1,0.46,0.37328,1,0.9021714515318936,2.17,BP
GO:0010874,regulation of cholesterol efflux,23,1,0.46,0.37328,1,0.9021714515318936,2.17,BP
GO:0014912,negative regulation of smooth muscle cel...,23,1,0.46,0.37328,1,0.9021714515318936,2.17,BP
GO:0022403,cell cycle phase,23,1,0.46,0.37328,1,0.9021714515318936,2.17,BP
GO:0030252,growth hormone secretion,23,1,0.46,0.37328,1,0.9021714515318936,2.17,BP
GO:0030539,male genitalia development,23,1,0.46,0.37328,1,0.9021714515318936,2.17,BP
GO:0032495,response to muramyl dipeptide,23,1,0.46,0.37328,1,0.9021714515318936,2.17,BP
GO:0043501,skeletal muscle adaptation,23,1,0.46,0.37328,1,0.9021714515318936,2.17,BP
GO:0045056,transcytosis,23,1,0.46,0.37328,1,0.9021714515318936,2.17,BP
GO:0045943,positive regulation of transcription by ...,23,1,0.46,0.37328,1,0.9021714515318936,2.17,BP
GO:0048532,anatomical structure arrangement,23,1,0.46,0.37328,1,0.9021714515318936,2.17,BP
GO:0050765,negative regulation of phagocytosis,23,1,0.46,0.37328,1,0.9021714515318936,2.17,BP
GO:0060080,inhibitory postsynaptic potential,23,1,0.46,0.37328,1,0.9021714515318936,2.17,BP
GO:0060972,left/right pattern formation,23,1,0.46,0.37328,1,0.9021714515318936,2.17,BP
GO:0070269,pyroptosis,23,1,0.46,0.37328,1,0.9021714515318936,2.17,BP
GO:0071276,cellular response to cadmium ion,23,1,0.46,0.37328,1,0.9021714515318936,2.17,BP
GO:0071475,cellular hyperosmotic salinity response,23,1,0.46,0.37328,1,0.9021714515318936,2.17,BP
GO:0072202,cell differentiation involved in metanep...,23,1,0.46,0.37328,1,0.9021714515318936,2.17,BP
GO:0097205,renal filtration,23,1,0.46,0.37328,1,0.9021714515318936,2.17,BP
GO:0098869,cellular oxidant detoxification,23,1,0.46,0.37328,1,0.9021714515318936,2.17,BP
GO:0099149,regulation of postsynaptic neurotransmit...,23,1,0.46,0.37328,1,0.9021714515318936,2.17,BP
GO:1902410,mitotic cytokinetic process,23,1,0.46,0.37328,1,0.9021714515318936,2.17,BP
GO:1902884,positive regulation of response to oxida...,23,1,0.46,0.37328,1,0.9021714515318936,2.17,BP
GO:1903020,positive regulation of glycoprotein meta...,23,1,0.46,0.37328,1,0.9021714515318936,2.17,BP
GO:1903055,positive regulation of extracellular mat...,23,1,0.46,0.37328,1,0.9021714515318936,2.17,BP
GO:1903077,negative regulation of protein localizat...,23,1,0.46,0.37328,1,0.9021714515318936,2.17,BP
GO:0008645,hexose transmembrane transport,109,3,2.19,0.37548,1,0.9050270806209314,1.37,BP
GO:0021987,cerebral cortex development,109,3,2.19,0.37548,1,0.9050270806209314,1.37,BP
GO:0048145,regulation of fibroblast proliferation,109,3,2.19,0.37548,1,0.9050270806209314,1.37,BP
GO:1900006,positive regulation of dendrite developm...,109,3,2.19,0.37548,1,0.9050270806209314,1.37,BP
GO:1900542,regulation of purine nucleotide metaboli...,109,3,2.19,0.37548,1,0.9050270806209314,1.37,BP
GO:0007611,learning or memory,293,7,5.89,0.37559,1,0.9050270806209314,1.19,BP
GO:0030330,"DNA damage response, signal transduction...",65,2,1.31,0.37673,1,0.9064123800000001,1.53,BP
GO:0060042,retina morphogenesis in camera-type eye,65,2,1.31,0.37673,1,0.9064123800000001,1.53,BP
GO:0150076,neuroinflammatory response,65,2,1.31,0.37673,1,0.9064123800000001,1.53,BP
GO:0046903,secretion,1250,27,25.13,0.37734,1,0.9074263268365818,1.07,BP
GO:0099003,vesicle-mediated transport in synapse,247,6,4.96,0.37772,1,0.9078864335664336,1.21,BP
GO:0001838,embryonic epithelial tube formation,155,4,3.12,0.37896,1,0.909504,1.28,BP
GO:0032675,regulation of interleukin-6 production,155,4,3.12,0.37896,1,0.909504,1.28,BP
GO:0051053,negative regulation of DNA metabolic pro...,155,4,3.12,0.37896,1,0.909504,1.28,BP
GO:0042035,regulation of cytokine biosynthetic proc...,110,3,2.21,0.38094,1,0.9099615384615385,1.36,BP
GO:0019216,regulation of lipid metabolic process,342,8,6.87,0.38217,1,0.9099615384615385,1.16,BP
GO:0000302,response to reactive oxygen species,202,5,4.06,0.38307,1,0.9099615384615385,1.23,BP
GO:0030522,intracellular receptor signaling pathway,202,5,4.06,0.38307,1,0.9099615384615385,1.23,BP
GO:0003407,neural retina development,66,2,1.33,0.38391,1,0.9099615384615385,1.5,BP
GO:0009064,glutamine family amino acid metabolic pr...,66,2,1.33,0.38391,1,0.9099615384615385,1.5,BP
GO:0043647,inositol phosphate metabolic process,66,2,1.33,0.38391,1,0.9099615384615385,1.5,BP
GO:0060425,lung morphogenesis,66,2,1.33,0.38391,1,0.9099615384615385,1.5,BP
GO:0086003,cardiac muscle cell contraction,66,2,1.33,0.38391,1,0.9099615384615385,1.5,BP
GO:1903845,negative regulation of cellular response...,66,2,1.33,0.38391,1,0.9099615384615385,1.5,BP
GO:1904888,cranial skeletal system development,66,2,1.33,0.38391,1,0.9099615384615385,1.5,BP
GO:0007610,behavior,724,16,14.55,0.38484,1,0.9099615384615385,1.1,BP
GO:0051054,positive regulation of DNA metabolic pro...,249,6,5,0.38489,1,0.9099615384615385,1.2,BP
GO:0002418,immune response to tumor cell,24,1,0.48,0.38589,1,0.9099615384615385,2.08,BP
GO:0006312,mitotic recombination,24,1,0.48,0.38589,1,0.9099615384615385,2.08,BP
GO:0007064,mitotic sister chromatid cohesion,24,1,0.48,0.38589,1,0.9099615384615385,2.08,BP
GO:0007205,protein kinase C-activating G protein-co...,24,1,0.48,0.38589,1,0.9099615384615385,2.08,BP
GO:0009154,purine ribonucleotide catabolic process,24,1,0.48,0.38589,1,0.9099615384615385,2.08,BP
GO:0009261,ribonucleotide catabolic process,24,1,0.48,0.38589,1,0.9099615384615385,2.08,BP
GO:0016578,histone deubiquitination,24,1,0.48,0.38589,1,0.9099615384615385,2.08,BP
GO:0019068,virion assembly,24,1,0.48,0.38589,1,0.9099615384615385,2.08,BP
GO:0021889,olfactory bulb interneuron differentiati...,24,1,0.48,0.38589,1,0.9099615384615385,2.08,BP
GO:0032878,regulation of establishment or maintenan...,24,1,0.48,0.38589,1,0.9099615384615385,2.08,BP
GO:0033233,regulation of protein sumoylation,24,1,0.48,0.38589,1,0.9099615384615385,2.08,BP
GO:0035561,regulation of chromatin binding,24,1,0.48,0.38589,1,0.9099615384615385,2.08,BP
GO:0046685,response to arsenic-containing substance,24,1,0.48,0.38589,1,0.9099615384615385,2.08,BP
GO:0050687,negative regulation of defense response ...,24,1,0.48,0.38589,1,0.9099615384615385,2.08,BP
GO:0070584,mitochondrion morphogenesis,24,1,0.48,0.38589,1,0.9099615384615385,2.08,BP
GO:0099623,regulation of cardiac muscle cell membra...,24,1,0.48,0.38589,1,0.9099615384615385,2.08,BP
GO:1902683,regulation of receptor localization to s...,24,1,0.48,0.38589,1,0.9099615384615385,2.08,BP
GO:0001843,neural tube closure,111,3,2.23,0.38639,1,0.9099615384615385,1.35,BP
GO:0002688,regulation of leukocyte chemotaxis,111,3,2.23,0.38639,1,0.9099615384615385,1.35,BP
GO:0014074,response to purine-containing compound,111,3,2.23,0.38639,1,0.9099615384615385,1.35,BP
GO:0015749,monosaccharide transmembrane transport,111,3,2.23,0.38639,1,0.9099615384615385,1.35,BP
GO:0048144,fibroblast proliferation,111,3,2.23,0.38639,1,0.9099615384615385,1.35,BP
GO:0021543,pallium development,157,4,3.16,0.38807,1,0.9099615384615385,1.27,BP
GO:0045834,positive regulation of lipid metabolic p...,157,4,3.16,0.38807,1,0.9099615384615385,1.27,BP
GO:0051896,regulation of protein kinase B signaling,157,4,3.16,0.38807,1,0.9099615384615385,1.27,BP
GO:0060402,calcium ion transport into cytosol,157,4,3.16,0.38807,1,0.9099615384615385,1.27,BP
GO:0008015,blood circulation,487,11,9.79,0.38993,1,0.9099615384615385,1.12,BP
GO:0002381,immunoglobulin production involved in im...,67,2,1.35,0.39104,1,0.9099615384615385,1.48,BP
GO:0006940,regulation of smooth muscle contraction,67,2,1.35,0.39104,1,0.9099615384615385,1.48,BP
GO:0016445,somatic diversification of immunoglobuli...,67,2,1.35,0.39104,1,0.9099615384615385,1.48,BP
GO:0045739,positive regulation of DNA repair,67,2,1.35,0.39104,1,0.9099615384615385,1.48,BP
GO:0090559,regulation of membrane permeability,67,2,1.35,0.39104,1,0.9099615384615385,1.48,BP
GO:2000179,positive regulation of neural precursor ...,67,2,1.35,0.39104,1,0.9099615384615385,1.48,BP
GO:0009636,response to toxic substance,345,8,6.93,0.39131,1,0.9099615384615385,1.15,BP
GO:0001959,regulation of cytokine-mediated signalin...,112,3,2.25,0.39182,1,0.9099615384615385,1.33,BP
GO:0034219,carbohydrate transmembrane transport,112,3,2.25,0.39182,1,0.9099615384615385,1.33,BP
GO:0060606,tube closure,112,3,2.25,0.39182,1,0.9099615384615385,1.33,BP
GO:0033135,regulation of peptidyl-serine phosphoryl...,158,4,3.18,0.39261,1,0.9099615384615385,1.26,BP
GO:1990845,adaptive thermogenesis,158,4,3.18,0.39261,1,0.9099615384615385,1.26,BP
GO:0043900,regulation of multi-organism process,393,9,7.9,0.39309,1,0.9099615384615385,1.14,BP
GO:0051348,negative regulation of transferase activ...,252,6,5.07,0.39564,1,0.9099615384615385,1.18,BP
GO:0048015,phosphatidylinositol-mediated signaling,159,4,3.2,0.39715,1,0.9099615384615385,1.25,BP
GO:0007589,body fluid secretion,113,3,2.27,0.39725,1,0.9099615384615385,1.32,BP
GO:2000177,regulation of neural precursor cell prol...,113,3,2.27,0.39725,1,0.9099615384615385,1.32,BP
GO:0035082,axoneme assembly,68,2,1.37,0.39814,1,0.9099615384615385,1.46,BP
GO:0045428,regulation of nitric oxide biosynthetic ...,68,2,1.37,0.39814,1,0.9099615384615385,1.46,BP
GO:0048002,antigen processing and presentation of p...,68,2,1.37,0.39814,1,0.9099615384615385,1.46,BP
GO:0048678,response to axon injury,68,2,1.37,0.39814,1,0.9099615384615385,1.46,BP
GO:0050710,negative regulation of cytokine secretio...,68,2,1.37,0.39814,1,0.9099615384615385,1.46,BP
GO:0050771,negative regulation of axonogenesis,68,2,1.37,0.39814,1,0.9099615384615385,1.46,BP
GO:0071426,ribonucleoprotein complex export from nu...,68,2,1.37,0.39814,1,0.9099615384615385,1.46,BP
GO:0000303,response to superoxide,25,1,0.5,0.39825,1,0.9099615384615385,2,BP
GO:0009065,glutamine family amino acid catabolic pr...,25,1,0.5,0.39825,1,0.9099615384615385,2,BP
GO:0010165,response to X-ray,25,1,0.5,0.39825,1,0.9099615384615385,2,BP
GO:0010894,negative regulation of steroid biosynthe...,25,1,0.5,0.39825,1,0.9099615384615385,2,BP
GO:0014821,phasic smooth muscle contraction,25,1,0.5,0.39825,1,0.9099615384615385,2,BP
GO:0032373,positive regulation of sterol transport,25,1,0.5,0.39825,1,0.9099615384615385,2,BP
GO:0032376,positive regulation of cholesterol trans...,25,1,0.5,0.39825,1,0.9099615384615385,2,BP
GO:0032480,negative regulation of type I interferon...,25,1,0.5,0.39825,1,0.9099615384615385,2,BP
GO:0032928,regulation of superoxide anion generatio...,25,1,0.5,0.39825,1,0.9099615384615385,2,BP
GO:0033522,histone H2A ubiquitination,25,1,0.5,0.39825,1,0.9099615384615385,2,BP
GO:0035024,negative regulation of Rho protein signa...,25,1,0.5,0.39825,1,0.9099615384615385,2,BP
GO:0035455,response to interferon-alpha,25,1,0.5,0.39825,1,0.9099615384615385,2,BP
GO:0043567,regulation of insulin-like growth factor...,25,1,0.5,0.39825,1,0.9099615384615385,2,BP
GO:0045648,positive regulation of erythrocyte diffe...,25,1,0.5,0.39825,1,0.9099615384615385,2,BP
GO:0045939,negative regulation of steroid metabolic...,25,1,0.5,0.39825,1,0.9099615384615385,2,BP
GO:0046426,negative regulation of JAK-STAT cascade,25,1,0.5,0.39825,1,0.9099615384615385,2,BP
GO:0048148,behavioral response to cocaine,25,1,0.5,0.39825,1,0.9099615384615385,2,BP
GO:0051443,positive regulation of ubiquitin-protein...,25,1,0.5,0.39825,1,0.9099615384615385,2,BP
GO:0055094,response to lipoprotein particle,25,1,0.5,0.39825,1,0.9099615384615385,2,BP
GO:0060004,reflex,25,1,0.5,0.39825,1,0.9099615384615385,2,BP
GO:0070193,synaptonemal complex organization,25,1,0.5,0.39825,1,0.9099615384615385,2,BP
GO:0071312,cellular response to alkaloid,25,1,0.5,0.39825,1,0.9099615384615385,2,BP
GO:0071711,basement membrane organization,25,1,0.5,0.39825,1,0.9099615384615385,2,BP
GO:0072606,interleukin-8 secretion,25,1,0.5,0.39825,1,0.9099615384615385,2,BP
GO:0085029,extracellular matrix assembly,25,1,0.5,0.39825,1,0.9099615384615385,2,BP
GO:0095500,acetylcholine receptor signaling pathway,25,1,0.5,0.39825,1,0.9099615384615385,2,BP
GO:0098810,neurotransmitter reuptake,25,1,0.5,0.39825,1,0.9099615384615385,2,BP
GO:1901032,negative regulation of response to react...,25,1,0.5,0.39825,1,0.9099615384615385,2,BP
GO:1901798,positive regulation of signal transducti...,25,1,0.5,0.39825,1,0.9099615384615385,2,BP
GO:1903206,negative regulation of hydrogen peroxide...,25,1,0.5,0.39825,1,0.9099615384615385,2,BP
GO:1903747,regulation of establishment of protein l...,25,1,0.5,0.39825,1,0.9099615384615385,2,BP
GO:1903831,signal transduction involved in cellular...,25,1,0.5,0.39825,1,0.9099615384615385,2,BP
GO:1904376,negative regulation of protein localizat...,25,1,0.5,0.39825,1,0.9099615384615385,2,BP
GO:1904738,vascular associated smooth muscle cell m...,25,1,0.5,0.39825,1,0.9099615384615385,2,BP
GO:1904752,regulation of vascular associated smooth...,25,1,0.5,0.39825,1,0.9099615384615385,2,BP
GO:2000637,positive regulation of gene silencing by...,25,1,0.5,0.39825,1,0.9099615384615385,2,BP
GO:2001039,negative regulation of cellular response...,25,1,0.5,0.39825,1,0.9099615384615385,2,BP
GO:0071560,cellular response to transforming growth...,206,5,4.14,0.39900,1,0.9112425249169435,1.21,BP
GO:0060326,cell chemotaxis,301,7,6.05,0.40185,1,0.916881081081081,1.16,BP
GO:0072001,renal system development,301,7,6.05,0.40185,1,0.916881081081081,1.16,BP
GO:0022037,metencephalon development,114,3,2.29,0.40266,1,0.917586295264624,1.31,BP
GO:0032370,positive regulation of lipid transport,69,2,1.39,0.40520,1,0.917586295264624,1.44,BP
GO:0032482,Rab protein signal transduction,69,2,1.39,0.40520,1,0.917586295264624,1.44,BP
GO:0033692,cellular polysaccharide biosynthetic pro...,69,2,1.39,0.40520,1,0.917586295264624,1.44,BP
GO:0050885,neuromuscular process controlling balanc...,69,2,1.39,0.40520,1,0.917586295264624,1.44,BP
GO:0055117,regulation of cardiac muscle contraction,69,2,1.39,0.40520,1,0.917586295264624,1.44,BP
GO:0061035,regulation of cartilage development,69,2,1.39,0.40520,1,0.917586295264624,1.44,BP
GO:0071166,ribonucleoprotein complex localization,69,2,1.39,0.40520,1,0.917586295264624,1.44,BP
GO:0072175,epithelial tube formation,161,4,3.24,0.40622,1,0.917586295264624,1.23,BP
GO:0016197,endosomal transport,208,5,4.18,0.40695,1,0.917586295264624,1.2,BP
GO:0000289,nuclear-transcribed mRNA poly(A) tail sh...,26,1,0.52,0.41036,1,0.917586295264624,1.92,BP
GO:0002478,antigen processing and presentation of e...,26,1,0.52,0.41036,1,0.917586295264624,1.92,BP
GO:0007176,regulation of epidermal growth factor-ac...,26,1,0.52,0.41036,1,0.917586295264624,1.92,BP
GO:0009299,mRNA transcription,26,1,0.52,0.41036,1,0.917586295264624,1.92,BP
GO:0009394,2'-deoxyribonucleotide metabolic process,26,1,0.52,0.41036,1,0.917586295264624,1.92,BP
GO:0018200,peptidyl-glutamic acid modification,26,1,0.52,0.41036,1,0.917586295264624,1.92,BP
GO:0019692,deoxyribose phosphate metabolic process,26,1,0.52,0.41036,1,0.917586295264624,1.92,BP
GO:0021533,cell differentiation in hindbrain,26,1,0.52,0.41036,1,0.917586295264624,1.92,BP
GO:0034114,regulation of heterotypic cell-cell adhe...,26,1,0.52,0.41036,1,0.917586295264624,1.92,BP
GO:0035809,regulation of urine volume,26,1,0.52,0.41036,1,0.917586295264624,1.92,BP
GO:0042044,fluid transport,26,1,0.52,0.41036,1,0.917586295264624,1.92,BP
GO:0043486,histone exchange,26,1,0.52,0.41036,1,0.917586295264624,1.92,BP
GO:0045109,intermediate filament organization,26,1,0.52,0.41036,1,0.917586295264624,1.92,BP
GO:0045761,regulation of adenylate cyclase activity,26,1,0.52,0.41036,1,0.917586295264624,1.92,BP
GO:0048799,animal organ maturation,26,1,0.52,0.41036,1,0.917586295264624,1.92,BP
GO:0050951,sensory perception of temperature stimul...,26,1,0.52,0.41036,1,0.917586295264624,1.92,BP
GO:0060148,positive regulation of posttranscription...,26,1,0.52,0.41036,1,0.917586295264624,1.92,BP
GO:0070168,negative regulation of biomineral tissue...,26,1,0.52,0.41036,1,0.917586295264624,1.92,BP
GO:0070861,regulation of protein exit from endoplas...,26,1,0.52,0.41036,1,0.917586295264624,1.92,BP
GO:0072012,glomerulus vasculature development,26,1,0.52,0.41036,1,0.917586295264624,1.92,BP
GO:0090140,regulation of mitochondrial fission,26,1,0.52,0.41036,1,0.917586295264624,1.92,BP
GO:0090344,negative regulation of cell aging,26,1,0.52,0.41036,1,0.917586295264624,1.92,BP
GO:0098901,regulation of cardiac muscle cell action...,26,1,0.52,0.41036,1,0.917586295264624,1.92,BP
GO:1901071,glucosamine-containing compound metaboli...,26,1,0.52,0.41036,1,0.917586295264624,1.92,BP
GO:1901380,negative regulation of potassium ion tra...,26,1,0.52,0.41036,1,0.917586295264624,1.92,BP
GO:1901739,regulation of myoblast fusion,26,1,0.52,0.41036,1,0.917586295264624,1.92,BP
GO:1902473,regulation of protein localization to sy...,26,1,0.52,0.41036,1,0.917586295264624,1.92,BP
GO:1903671,negative regulation of sprouting angioge...,26,1,0.52,0.41036,1,0.917586295264624,1.92,BP
GO:1904893,negative regulation of STAT cascade,26,1,0.52,0.41036,1,0.917586295264624,1.92,BP
GO:2000050,regulation of non-canonical Wnt signalin...,26,1,0.52,0.41036,1,0.917586295264624,1.92,BP
GO:2000738,positive regulation of stem cell differe...,26,1,0.52,0.41036,1,0.917586295264624,1.92,BP
GO:2000765,regulation of cytoplasmic translation,26,1,0.52,0.41036,1,0.917586295264624,1.92,BP
GO:2000780,negative regulation of double-strand bre...,26,1,0.52,0.41036,1,0.917586295264624,1.92,BP
GO:0007565,female pregnancy,162,4,3.26,0.41074,1,0.917586295264624,1.23,BP
GO:0048017,inositol lipid-mediated signaling,162,4,3.26,0.41074,1,0.917586295264624,1.23,BP
GO:0002562,somatic diversification of immune recept...,70,2,1.41,0.41223,1,0.9196341029207231,1.42,BP
GO:0016444,somatic cell DNA recombination,70,2,1.41,0.41223,1,0.9196341029207231,1.42,BP
GO:0022029,telencephalon cell migration,70,2,1.41,0.41223,1,0.9196341029207231,1.42,BP
GO:0022414,reproductive process,1467,31,29.49,0.41259,1,0.9200106950880446,1.05,BP
GO:0003012,muscle system process,400,9,8.04,0.41311,1,0.9207435479388605,1.12,BP
GO:0010927,cellular component assembly involved in ...,116,3,2.33,0.41344,1,0.9210524444444445,1.29,BP
GO:0000003,reproduction,1468,31,29.51,0.41411,1,0.9221181490050903,1.05,BP
GO:0043281,regulation of cysteine-type endopeptidas...,210,5,4.22,0.41488,1,0.9222526736268725,1.18,BP
GO:0031047,gene silencing by RNA,163,4,3.28,0.41526,1,0.9222526736268725,1.22,BP
GO:0003013,circulatory system process,498,11,10.01,0.41818,1,0.9222526736268725,1.1,BP
GO:0006282,regulation of DNA repair,117,3,2.35,0.41880,1,0.9222526736268725,1.28,BP
GO:0006513,protein monoubiquitination,71,2,1.43,0.41921,1,0.9222526736268725,1.4,BP
GO:0051057,positive regulation of small GTPase medi...,71,2,1.43,0.41921,1,0.9222526736268725,1.4,BP
GO:0032635,interleukin-6 production,164,4,3.3,0.41977,1,0.9222526736268725,1.21,BP
GO:0043433,negative regulation of DNA-binding trans...,164,4,3.3,0.41977,1,0.9222526736268725,1.21,BP
GO:0000305,response to oxygen radical,27,1,0.54,0.42222,1,0.9222526736268725,1.85,BP
GO:0002052,positive regulation of neuroblast prolif...,27,1,0.54,0.42222,1,0.9222526736268725,1.85,BP
GO:0002347,response to tumor cell,27,1,0.54,0.42222,1,0.9222526736268725,1.85,BP
GO:0003071,renal system process involved in regulat...,27,1,0.54,0.42222,1,0.9222526736268725,1.85,BP
GO:0003338,metanephros morphogenesis,27,1,0.54,0.42222,1,0.9222526736268725,1.85,BP
GO:0009163,nucleoside biosynthetic process,27,1,0.54,0.42222,1,0.9222526736268725,1.85,BP
GO:0010893,positive regulation of steroid biosynthe...,27,1,0.54,0.42222,1,0.9222526736268725,1.85,BP
GO:0016556,mRNA modification,27,1,0.54,0.42222,1,0.9222526736268725,1.85,BP
GO:0021697,cerebellar cortex formation,27,1,0.54,0.42222,1,0.9222526736268725,1.85,BP
GO:0021871,forebrain regionalization,27,1,0.54,0.42222,1,0.9222526736268725,1.85,BP
GO:0030970,"retrograde protein transport, ER to cyto...",27,1,0.54,0.42222,1,0.9222526736268725,1.85,BP
GO:0031365,N-terminal protein amino acid modificati...,27,1,0.54,0.42222,1,0.9222526736268725,1.85,BP
GO:0032365,intracellular lipid transport,27,1,0.54,0.42222,1,0.9222526736268725,1.85,BP
GO:0032509,endosome transport via multivesicular bo...,27,1,0.54,0.42222,1,0.9222526736268725,1.85,BP
GO:0035812,renal sodium excretion,27,1,0.54,0.42222,1,0.9222526736268725,1.85,BP
GO:0042455,ribonucleoside biosynthetic process,27,1,0.54,0.42222,1,0.9222526736268725,1.85,BP
GO:0045736,negative regulation of cyclin-dependent ...,27,1,0.54,0.42222,1,0.9222526736268725,1.85,BP
GO:0045738,negative regulation of DNA repair,27,1,0.54,0.42222,1,0.9222526736268725,1.85,BP
GO:0048521,negative regulation of behavior,27,1,0.54,0.42222,1,0.9222526736268725,1.85,BP
GO:0048745,smooth muscle tissue development,27,1,0.54,0.42222,1,0.9222526736268725,1.85,BP
GO:0048843,negative regulation of axon extension in...,27,1,0.54,0.42222,1,0.9222526736268725,1.85,BP
GO:0050901,leukocyte tethering or rolling,27,1,0.54,0.42222,1,0.9222526736268725,1.85,BP
GO:0051125,regulation of actin nucleation,27,1,0.54,0.42222,1,0.9222526736268725,1.85,BP
GO:0051767,nitric-oxide synthase biosynthetic proce...,27,1,0.54,0.42222,1,0.9222526736268725,1.85,BP
GO:0051769,regulation of nitric-oxide synthase bios...,27,1,0.54,0.42222,1,0.9222526736268725,1.85,BP
GO:0061003,positive regulation of dendritic spine m...,27,1,0.54,0.42222,1,0.9222526736268725,1.85,BP
GO:0061437,renal system vasculature development,27,1,0.54,0.42222,1,0.9222526736268725,1.85,BP
GO:0061440,kidney vasculature development,27,1,0.54,0.42222,1,0.9222526736268725,1.85,BP
GO:0071402,cellular response to lipoprotein particl...,27,1,0.54,0.42222,1,0.9222526736268725,1.85,BP
GO:0071474,cellular hyperosmotic response,27,1,0.54,0.42222,1,0.9222526736268725,1.85,BP
GO:1900273,positive regulation of long-term synapti...,27,1,0.54,0.42222,1,0.9222526736268725,1.85,BP
GO:1903010,regulation of bone development,27,1,0.54,0.42222,1,0.9222526736268725,1.85,BP
GO:1903513,endoplasmic reticulum to cytosol transpo...,27,1,0.54,0.42222,1,0.9222526736268725,1.85,BP
GO:2000727,positive regulation of cardiac muscle ce...,27,1,0.54,0.42222,1,0.9222526736268725,1.85,BP
GO:0014020,primary neural tube formation,118,3,2.37,0.42416,1,0.9250072496601722,1.27,BP
GO:0042476,odontogenesis,118,3,2.37,0.42416,1,0.9250072496601722,1.27,BP
GO:0051701,interaction with host,118,3,2.37,0.42416,1,0.9250072496601722,1.27,BP
GO:0072330,monocarboxylic acid biosynthetic process,260,6,5.23,0.42425,1,0.9250072496601722,1.15,BP
GO:0030239,myofibril assembly,72,2,1.45,0.42614,1,0.9282868628338615,1.38,BP
GO:2000779,regulation of double-strand break repair,72,2,1.45,0.42614,1,0.9282868628338615,1.38,BP
GO:0009991,response to extracellular stimulus,405,9,8.14,0.42741,1,0.9299270378619154,1.11,BP
GO:0016458,gene silencing,261,6,5.25,0.42782,1,0.9299270378619154,1.14,BP
GO:0006643,membrane lipid metabolic process,166,4,3.34,0.42876,1,0.9299270378619154,1.2,BP
GO:0048660,regulation of smooth muscle cell prolife...,166,4,3.34,0.42876,1,0.9299270378619154,1.2,BP
GO:0051963,regulation of synapse assembly,119,3,2.39,0.42949,1,0.9299270378619154,1.26,BP
GO:0071346,cellular response to interferon-gamma,119,3,2.39,0.42949,1,0.9299270378619154,1.26,BP
GO:0015980,energy derivation by oxidation of organi...,262,6,5.27,0.43138,1,0.9299270378619154,1.14,BP
GO:0045926,negative regulation of growth,262,6,5.27,0.43138,1,0.9299270378619154,1.14,BP
GO:0021766,hippocampus development,73,2,1.47,0.43304,1,0.9299270378619154,1.36,BP
GO:0097120,receptor localization to synapse,73,2,1.47,0.43304,1,0.9299270378619154,1.36,BP
GO:0044057,regulation of system process,601,13,12.08,0.43338,1,0.9299270378619154,1.08,BP
GO:0002360,T cell lineage commitment,28,1,0.56,0.43385,1,0.9299270378619154,1.79,BP
GO:0006195,purine nucleotide catabolic process,28,1,0.56,0.43385,1,0.9299270378619154,1.79,BP
GO:0010719,negative regulation of epithelial to mes...,28,1,0.56,0.43385,1,0.9299270378619154,1.79,BP
GO:0010954,positive regulation of protein processin...,28,1,0.56,0.43385,1,0.9299270378619154,1.79,BP
GO:0016082,synaptic vesicle priming,28,1,0.56,0.43385,1,0.9299270378619154,1.79,BP
GO:0032891,negative regulation of organic acid tran...,28,1,0.56,0.43385,1,0.9299270378619154,1.79,BP
GO:0036297,interstrand cross-link repair,28,1,0.56,0.43385,1,0.9299270378619154,1.79,BP
GO:0042538,hyperosmotic salinity response,28,1,0.56,0.43385,1,0.9299270378619154,1.79,BP
GO:0044003,modification by symbiont of host morphol...,28,1,0.56,0.43385,1,0.9299270378619154,1.79,BP
GO:0045408,regulation of interleukin-6 biosynthetic...,28,1,0.56,0.43385,1,0.9299270378619154,1.79,BP
GO:0045671,negative regulation of osteoclast differ...,28,1,0.56,0.43385,1,0.9299270378619154,1.79,BP
GO:0048596,embryonic camera-type eye morphogenesis,28,1,0.56,0.43385,1,0.9299270378619154,1.79,BP
GO:0048820,hair follicle maturation,28,1,0.56,0.43385,1,0.9299270378619154,1.79,BP
GO:0050849,negative regulation of calcium-mediated ...,28,1,0.56,0.43385,1,0.9299270378619154,1.79,BP
GO:0051194,positive regulation of cofactor metaboli...,28,1,0.56,0.43385,1,0.9299270378619154,1.79,BP
GO:0060445,branching involved in salivary gland mor...,28,1,0.56,0.43385,1,0.9299270378619154,1.79,BP
GO:0061050,regulation of cell growth involved in ca...,28,1,0.56,0.43385,1,0.9299270378619154,1.79,BP
GO:0061311,cell surface receptor signaling pathway ...,28,1,0.56,0.43385,1,0.9299270378619154,1.79,BP
GO:0070198,"protein localization to chromosome, telo...",28,1,0.56,0.43385,1,0.9299270378619154,1.79,BP
GO:0071108,protein K48-linked deubiquitination,28,1,0.56,0.43385,1,0.9299270378619154,1.79,BP
GO:0086005,ventricular cardiac muscle cell action p...,28,1,0.56,0.43385,1,0.9299270378619154,1.79,BP
GO:0090200,positive regulation of release of cytoch...,28,1,0.56,0.43385,1,0.9299270378619154,1.79,BP
GO:1902668,negative regulation of axon guidance,28,1,0.56,0.43385,1,0.9299270378619154,1.79,BP
GO:1902932,positive regulation of alcohol biosynthe...,28,1,0.56,0.43385,1,0.9299270378619154,1.79,BP
GO:2000310,regulation of NMDA receptor activity,28,1,0.56,0.43385,1,0.9299270378619154,1.79,BP
GO:0002274,myeloid leukocyte activation,215,5,4.32,0.43464,1,0.9307911348464619,1.16,BP
GO:0048515,spermatid differentiation,215,5,4.32,0.43464,1,0.9307911348464619,1.16,BP
GO:0001818,negative regulation of cytokine producti...,263,6,5.29,0.43494,1,0.9310192526690392,1.13,BP
GO:0042594,response to starvation,168,4,3.38,0.43772,1,0.93654352,1.18,BP
GO:0006066,alcohol metabolic process,312,7,6.27,0.43791,1,0.93654352,1.12,BP
GO:0008406,gonad development,216,5,4.34,0.43858,1,0.9375597334517993,1.15,BP
GO:0042108,positive regulation of cytokine biosynth...,74,2,1.49,0.43989,1,0.9391085536823425,1.34,BP
GO:0050810,regulation of steroid biosynthetic proce...,74,2,1.49,0.43989,1,0.9391085536823425,1.34,BP
GO:2000573,positive regulation of DNA biosynthetic ...,74,2,1.49,0.43989,1,0.9391085536823425,1.34,BP
GO:0036294,cellular response to decreased oxygen le...,121,3,2.43,0.44010,1,0.93914022172949,1.23,BP
GO:0030001,metal ion transport,848,18,17.04,0.44037,1,0.9392998404255318,1.06,BP
GO:0050730,regulation of peptidyl-tyrosine phosphor...,265,6,5.33,0.44204,1,0.9394546678321679,1.13,BP
GO:0035265,organ growth,217,5,4.36,0.44251,1,0.9394546678321679,1.15,BP
GO:0002252,immune effector process,752,16,15.12,0.44400,1,0.9394546678321679,1.06,BP
GO:0001919,regulation of receptor recycling,29,1,0.58,0.44525,1,0.9394546678321679,1.72,BP
GO:0003148,outflow tract septum morphogenesis,29,1,0.58,0.44525,1,0.9394546678321679,1.72,BP
GO:0005979,regulation of glycogen biosynthetic proc...,29,1,0.58,0.44525,1,0.9394546678321679,1.72,BP
GO:0006270,DNA replication initiation,29,1,0.58,0.44525,1,0.9394546678321679,1.72,BP
GO:0010800,positive regulation of peptidyl-threonin...,29,1,0.58,0.44525,1,0.9394546678321679,1.72,BP
GO:0010962,regulation of glucan biosynthetic proces...,29,1,0.58,0.44525,1,0.9394546678321679,1.72,BP
GO:0033137,negative regulation of peptidyl-serine p...,29,1,0.58,0.44525,1,0.9394546678321679,1.72,BP
GO:0033273,response to vitamin,29,1,0.58,0.44525,1,0.9394546678321679,1.72,BP
GO:0034390,smooth muscle cell apoptotic process,29,1,0.58,0.44525,1,0.9394546678321679,1.72,BP
GO:0034391,regulation of smooth muscle cell apoptot...,29,1,0.58,0.44525,1,0.9394546678321679,1.72,BP
GO:0042226,interleukin-6 biosynthetic process,29,1,0.58,0.44525,1,0.9394546678321679,1.72,BP
GO:0043032,positive regulation of macrophage activa...,29,1,0.58,0.44525,1,0.9394546678321679,1.72,BP
GO:0045992,negative regulation of embryonic develop...,29,1,0.58,0.44525,1,0.9394546678321679,1.72,BP
GO:0051589,negative regulation of neurotransmitter ...,29,1,0.58,0.44525,1,0.9394546678321679,1.72,BP
GO:0060117,auditory receptor cell development,29,1,0.58,0.44525,1,0.9394546678321679,1.72,BP
GO:0071472,cellular response to salt stress,29,1,0.58,0.44525,1,0.9394546678321679,1.72,BP
GO:0099622,cardiac muscle cell membrane repolarizat...,29,1,0.58,0.44525,1,0.9394546678321679,1.72,BP
GO:1901018,positive regulation of potassium ion tra...,29,1,0.58,0.44525,1,0.9394546678321679,1.72,BP
GO:1902042,negative regulation of extrinsic apoptot...,29,1,0.58,0.44525,1,0.9394546678321679,1.72,BP
GO:1904030,negative regulation of cyclin-dependent ...,29,1,0.58,0.44525,1,0.9394546678321679,1.72,BP
GO:0042089,cytokine biosynthetic process,122,3,2.45,0.44538,1,0.9394546678321679,1.22,BP
GO:0050896,response to stimulus,9311,189,187.15,0.44636,1,0.9394546678321679,1.01,BP
GO:0006302,double-strand break repair,218,5,4.38,0.44643,1,0.9394546678321679,1.14,BP
GO:0070374,positive regulation of ERK1 and ERK2 cas...,218,5,4.38,0.44643,1,0.9394546678321679,1.14,BP
GO:0010952,positive regulation of peptidase activit...,170,4,3.42,0.44663,1,0.9394546678321679,1.17,BP
GO:0008625,extrinsic apoptotic signaling pathway vi...,75,2,1.51,0.44669,1,0.9394546678321679,1.32,BP
GO:0046323,glucose import,75,2,1.51,0.44669,1,0.9394546678321679,1.32,BP
GO:0048645,animal organ formation,75,2,1.51,0.44669,1,0.9394546678321679,1.32,BP
GO:0051705,multi-organism behavior,75,2,1.51,0.44669,1,0.9394546678321679,1.32,BP
GO:0006997,nucleus organization,123,3,2.47,0.45064,1,0.946249426971133,1.21,BP
GO:0007030,Golgi organization,123,3,2.47,0.45064,1,0.946249426971133,1.21,BP
GO:0007612,learning,171,4,3.44,0.45107,1,0.946249426971133,1.16,BP
GO:0046890,regulation of lipid biosynthetic process,171,4,3.44,0.45107,1,0.946249426971133,1.16,BP
GO:0048659,smooth muscle cell proliferation,171,4,3.44,0.45107,1,0.946249426971133,1.16,BP
GO:0002697,regulation of immune effector process,414,9,8.32,0.45309,1,0.946249426971133,1.08,BP
GO:0006809,nitric oxide biosynthetic process,76,2,1.53,0.45345,1,0.946249426971133,1.31,BP
GO:0009060,aerobic respiration,76,2,1.53,0.45345,1,0.946249426971133,1.31,BP
GO:0021879,forebrain neuron differentiation,76,2,1.53,0.45345,1,0.946249426971133,1.31,BP
GO:0032418,lysosome localization,76,2,1.53,0.45345,1,0.946249426971133,1.31,BP
GO:0045137,development of primary sexual characteri...,220,5,4.42,0.45425,1,0.946249426971133,1.13,BP
GO:0043271,negative regulation of ion transport,172,4,3.46,0.45550,1,0.946249426971133,1.16,BP
GO:0006336,DNA replication-independent nucleosome a...,30,1,0.6,0.45641,1,0.946249426971133,1.67,BP
GO:0006536,glutamate metabolic process,30,1,0.6,0.45641,1,0.946249426971133,1.67,BP
GO:0010922,positive regulation of phosphatase activ...,30,1,0.6,0.45641,1,0.946249426971133,1.67,BP
GO:0015012,heparan sulfate proteoglycan biosyntheti...,30,1,0.6,0.45641,1,0.946249426971133,1.67,BP
GO:0022011,myelination in peripheral nervous system,30,1,0.6,0.45641,1,0.946249426971133,1.67,BP
GO:0032292,peripheral nervous system axon ensheathm...,30,1,0.6,0.45641,1,0.946249426971133,1.67,BP
GO:0033005,positive regulation of mast cell activat...,30,1,0.6,0.45641,1,0.946249426971133,1.67,BP
GO:0042168,heme metabolic process,30,1,0.6,0.45641,1,0.946249426971133,1.67,BP
GO:0042481,regulation of odontogenesis,30,1,0.6,0.45641,1,0.946249426971133,1.67,BP
GO:0043951,negative regulation of cAMP-mediated sig...,30,1,0.6,0.45641,1,0.946249426971133,1.67,BP
GO:0044030,regulation of DNA methylation,30,1,0.6,0.45641,1,0.946249426971133,1.67,BP
GO:0048384,retinoic acid receptor signaling pathway,30,1,0.6,0.45641,1,0.946249426971133,1.67,BP
GO:0048643,positive regulation of skeletal muscle t...,30,1,0.6,0.45641,1,0.946249426971133,1.67,BP
GO:0055022,negative regulation of cardiac muscle ti...,30,1,0.6,0.45641,1,0.946249426971133,1.67,BP
GO:0060317,cardiac epithelial to mesenchymal transi...,30,1,0.6,0.45641,1,0.946249426971133,1.67,BP
GO:0060571,morphogenesis of an epithelial fold,30,1,0.6,0.45641,1,0.946249426971133,1.67,BP
GO:0061082,myeloid leukocyte cytokine production,30,1,0.6,0.45641,1,0.946249426971133,1.67,BP
GO:0061117,negative regulation of heart growth,30,1,0.6,0.45641,1,0.946249426971133,1.67,BP
GO:0070306,lens fiber cell differentiation,30,1,0.6,0.45641,1,0.946249426971133,1.67,BP
GO:0070979,protein K11-linked ubiquitination,30,1,0.6,0.45641,1,0.946249426971133,1.67,BP
GO:1903319,positive regulation of protein maturatio...,30,1,0.6,0.45641,1,0.946249426971133,1.67,BP
GO:0032501,multicellular organismal process,8233,167,165.48,0.45795,1,0.9490333333333334,1.01,BP
GO:0002262,myeloid cell homeostasis,173,4,3.48,0.45992,1,0.9515642114310271,1.15,BP
GO:0000271,polysaccharide biosynthetic process,77,2,1.55,0.46016,1,0.9515642114310271,1.29,BP
GO:0002200,somatic diversification of immune recept...,77,2,1.55,0.46016,1,0.9515642114310271,1.29,BP
GO:0055021,regulation of cardiac muscle tissue grow...,77,2,1.55,0.46016,1,0.9515642114310271,1.29,BP
GO:0072332,intrinsic apoptotic signaling pathway by...,77,2,1.55,0.46016,1,0.9515642114310271,1.29,BP
GO:0051271,negative regulation of cellular componen...,319,7,6.41,0.46069,1,0.9517089293271265,1.09,BP
GO:0033138,positive regulation of peptidyl-serine p...,125,3,2.51,0.46110,1,0.9517089293271265,1.2,BP
GO:0009167,purine ribonucleoside monophosphate meta...,271,6,5.45,0.46325,1,0.9517089293271265,1.1,BP
GO:0051100,negative regulation of binding,174,4,3.5,0.46432,1,0.9517089293271265,1.14,BP
GO:0048732,gland development,467,10,9.39,0.46445,1,0.9517089293271265,1.06,BP
GO:0061138,morphogenesis of a branching epithelium,223,5,4.48,0.46593,1,0.9517089293271265,1.12,BP
GO:0006611,protein export from nucleus,126,3,2.53,0.46629,1,0.9517089293271265,1.19,BP
GO:0055076,transition metal ion homeostasis,126,3,2.53,0.46629,1,0.9517089293271265,1.19,BP
GO:0009126,purine nucleoside monophosphate metaboli...,272,6,5.47,0.46677,1,0.9517089293271265,1.1,BP
GO:0030198,extracellular matrix organization,272,6,5.47,0.46677,1,0.9517089293271265,1.1,BP
GO:0001832,blastocyst growth,31,1,0.62,0.46735,1,0.9517089293271265,1.61,BP
GO:0002230,positive regulation of defense response ...,31,1,0.62,0.46735,1,0.9517089293271265,1.61,BP
GO:0006099,tricarboxylic acid cycle,31,1,0.62,0.46735,1,0.9517089293271265,1.61,BP
GO:0006335,DNA replication-dependent nucleosome ass...,31,1,0.62,0.46735,1,0.9517089293271265,1.61,BP
GO:0006767,water-soluble vitamin metabolic process,31,1,0.62,0.46735,1,0.9517089293271265,1.61,BP
GO:0009225,nucleotide-sugar metabolic process,31,1,0.62,0.46735,1,0.9517089293271265,1.61,BP
GO:0009262,deoxyribonucleotide metabolic process,31,1,0.62,0.46735,1,0.9517089293271265,1.61,BP
GO:0009584,detection of visible light,31,1,0.62,0.46735,1,0.9517089293271265,1.61,BP
GO:0022617,extracellular matrix disassembly,31,1,0.62,0.46735,1,0.9517089293271265,1.61,BP
GO:0032967,positive regulation of collagen biosynth...,31,1,0.62,0.46735,1,0.9517089293271265,1.61,BP
GO:0033561,regulation of water loss via skin,31,1,0.62,0.46735,1,0.9517089293271265,1.61,BP
GO:0034723,DNA replication-dependent nucleosome org...,31,1,0.62,0.46735,1,0.9517089293271265,1.61,BP
GO:0034724,DNA replication-independent nucleosome o...,31,1,0.62,0.46735,1,0.9517089293271265,1.61,BP
GO:0042634,regulation of hair cycle,31,1,0.62,0.46735,1,0.9517089293271265,1.61,BP
GO:0043302,positive regulation of leukocyte degranu...,31,1,0.62,0.46735,1,0.9517089293271265,1.61,BP
GO:0051085,chaperone cofactor-dependent protein ref...,31,1,0.62,0.46735,1,0.9517089293271265,1.61,BP
GO:0060914,heart formation,31,1,0.62,0.46735,1,0.9517089293271265,1.61,BP
GO:0070536,protein K63-linked deubiquitination,31,1,0.62,0.46735,1,0.9517089293271265,1.61,BP
GO:0098884,postsynaptic neurotransmitter receptor i...,31,1,0.62,0.46735,1,0.9517089293271265,1.61,BP
GO:0099633,protein localization to postsynaptic spe...,31,1,0.62,0.46735,1,0.9517089293271265,1.61,BP
GO:0099645,neurotransmitter receptor localization t...,31,1,0.62,0.46735,1,0.9517089293271265,1.61,BP
GO:0140239,postsynaptic endocytosis,31,1,0.62,0.46735,1,0.9517089293271265,1.61,BP
GO:1901659,glycosyl compound biosynthetic process,31,1,0.62,0.46735,1,0.9517089293271265,1.61,BP
GO:1905476,negative regulation of protein localizat...,31,1,0.62,0.46735,1,0.9517089293271265,1.61,BP
GO:2000144,positive regulation of DNA-templated tra...,31,1,0.62,0.46735,1,0.9517089293271265,1.61,BP
GO:2000781,positive regulation of double-strand bre...,31,1,0.62,0.46735,1,0.9517089293271265,1.61,BP
GO:0031644,regulation of neurological system proces...,175,4,3.52,0.46872,1,0.9540950253807107,1.14,BP
GO:0099504,synaptic vesicle cycle,224,5,4.5,0.46981,1,0.9559093953488372,1.11,BP
GO:0003208,cardiac ventricle morphogenesis,79,2,1.59,0.47344,1,0.9612629873417723,1.26,BP
GO:0006029,proteoglycan metabolic process,79,2,1.59,0.47344,1,0.9612629873417723,1.26,BP
GO:0048663,neuron fate commitment,79,2,1.59,0.47344,1,0.9612629873417723,1.26,BP
GO:0051279,regulation of release of sequestered cal...,79,2,1.59,0.47344,1,0.9612629873417723,1.26,BP
GO:0051881,regulation of mitochondrial membrane pot...,79,2,1.59,0.47344,1,0.9612629873417723,1.26,BP
GO:0009605,response to external stimulus,2399,49,48.22,0.47513,1,0.9621584943538268,1.02,BP
GO:0010565,regulation of cellular ketone metabolic ...,128,3,2.57,0.47662,1,0.9621584943538268,1.17,BP
GO:0042107,cytokine metabolic process,128,3,2.57,0.47662,1,0.9621584943538268,1.17,BP
GO:0050852,T cell receptor signaling pathway,128,3,2.57,0.47662,1,0.9621584943538268,1.17,BP
GO:0060485,mesenchyme development,275,6,5.53,0.47728,1,0.9621584943538268,1.08,BP
GO:0071241,cellular response to inorganic substance,226,5,4.54,0.47754,1,0.9621584943538268,1.1,BP
GO:0006101,citrate metabolic process,32,1,0.64,0.47808,1,0.9621584943538268,1.56,BP
GO:0010574,regulation of vascular endothelial growt...,32,1,0.64,0.47808,1,0.9621584943538268,1.56,BP
GO:0019884,antigen processing and presentation of e...,32,1,0.64,0.47808,1,0.9621584943538268,1.56,BP
GO:0021680,cerebellar Purkinje cell layer developme...,32,1,0.64,0.47808,1,0.9621584943538268,1.56,BP
GO:0031069,hair follicle morphogenesis,32,1,0.64,0.47808,1,0.9621584943538268,1.56,BP
GO:0032728,positive regulation of interferon-beta p...,32,1,0.64,0.47808,1,0.9621584943538268,1.56,BP
GO:0040036,regulation of fibroblast growth factor r...,32,1,0.64,0.47808,1,0.9621584943538268,1.56,BP
GO:0043457,regulation of cellular respiration,32,1,0.64,0.47808,1,0.9621584943538268,1.56,BP
GO:0045616,regulation of keratinocyte differentiati...,32,1,0.64,0.47808,1,0.9621584943538268,1.56,BP
GO:0048048,embryonic eye morphogenesis,32,1,0.64,0.47808,1,0.9621584943538268,1.56,BP
GO:0060143,positive regulation of syncytium formati...,32,1,0.64,0.47808,1,0.9621584943538268,1.56,BP
GO:0060561,apoptotic process involved in morphogene...,32,1,0.64,0.47808,1,0.9621584943538268,1.56,BP
GO:0070286,axonemal dynein complex assembly,32,1,0.64,0.47808,1,0.9621584943538268,1.56,BP
GO:0071985,multivesicular body sorting pathway,32,1,0.64,0.47808,1,0.9621584943538268,1.56,BP
GO:1902186,regulation of viral release from host ce...,32,1,0.64,0.47808,1,0.9621584943538268,1.56,BP
GO:0030500,regulation of bone mineralization,80,2,1.61,0.48000,1,0.9637450312891113,1.24,BP
GO:0034637,cellular carbohydrate biosynthetic proce...,80,2,1.61,0.48000,1,0.9637450312891113,1.24,BP
GO:0046209,nitric oxide metabolic process,80,2,1.61,0.48000,1,0.9637450312891113,1.24,BP
GO:0051785,positive regulation of nuclear division,80,2,1.61,0.48000,1,0.9637450312891113,1.24,BP
GO:1904427,positive regulation of calcium ion trans...,80,2,1.61,0.48000,1,0.9637450312891113,1.24,BP
GO:0018212,peptidyl-tyrosine modification,325,7,6.53,0.48007,1,0.9637450312891113,1.07,BP
GO:0008277,regulation of G protein-coupled receptor...,129,3,2.59,0.48175,1,0.9667143452877397,1.16,BP
GO:0031667,response to nutrient levels,375,8,7.54,0.48233,1,0.9674747644852021,1.06,BP
GO:0007165,signal transduction,5929,120,119.17,0.48272,1,0.9678535999999999,1.01,BP
GO:0002376,immune system process,2407,49,48.38,0.48504,1,0.9707047729149464,1.01,BP
GO:0001659,temperature homeostasis,179,4,3.6,0.48615,1,0.9707047729149464,1.11,BP
GO:0050890,cognition,327,7,6.57,0.48648,1,0.9707047729149464,1.07,BP
GO:0005977,glycogen metabolic process,81,2,1.63,0.48651,1,0.9707047729149464,1.23,BP
GO:0006073,cellular glucan metabolic process,81,2,1.63,0.48651,1,0.9707047729149464,1.23,BP
GO:0044042,glucan metabolic process,81,2,1.63,0.48651,1,0.9707047729149464,1.23,BP
GO:0016999,antibiotic metabolic process,130,3,2.61,0.48685,1,0.9707047729149464,1.15,BP
GO:0006084,acetyl-CoA metabolic process,33,1,0.66,0.48858,1,0.9707047729149464,1.52,BP
GO:0006623,protein targeting to vacuole,33,1,0.66,0.48858,1,0.9707047729149464,1.52,BP
GO:0014044,Schwann cell development,33,1,0.66,0.48858,1,0.9707047729149464,1.52,BP
GO:0021591,ventricular system development,33,1,0.66,0.48858,1,0.9707047729149464,1.52,BP
GO:0032660,regulation of interleukin-17 production,33,1,0.66,0.48858,1,0.9707047729149464,1.52,BP
GO:0032743,positive regulation of interleukin-2 pro...,33,1,0.66,0.48858,1,0.9707047729149464,1.52,BP
GO:0033598,mammary gland epithelial cell proliferat...,33,1,0.66,0.48858,1,0.9707047729149464,1.52,BP
GO:0045577,regulation of B cell differentiation,33,1,0.66,0.48858,1,0.9707047729149464,1.52,BP
GO:0046596,regulation of viral entry into host cell,33,1,0.66,0.48858,1,0.9707047729149464,1.52,BP
GO:0048013,ephrin receptor signaling pathway,33,1,0.66,0.48858,1,0.9707047729149464,1.52,BP
GO:1901890,positive regulation of cell junction ass...,33,1,0.66,0.48858,1,0.9707047729149464,1.52,BP
GO:1903146,regulation of autophagy of mitochondrion,33,1,0.66,0.48858,1,0.9707047729149464,1.52,BP
GO:1903205,regulation of hydrogen peroxide-induced ...,33,1,0.66,0.48858,1,0.9707047729149464,1.52,BP
GO:1905606,regulation of presynapse assembly,33,1,0.66,0.48858,1,0.9707047729149464,1.52,BP
GO:2001171,positive regulation of ATP biosynthetic ...,33,1,0.66,0.48858,1,0.9707047729149464,1.52,BP
GO:0046578,regulation of Ras protein signal transdu...,229,5,4.6,0.48906,1,0.9712574164259183,1.09,BP
GO:0006816,calcium ion transport,427,9,8.58,0.48984,1,0.9724051485148515,1.05,BP
GO:0034762,regulation of transmembrane transport,576,12,11.58,0.49095,1,0.9742067628865979,1.04,BP
GO:0006637,acyl-CoA metabolic process,82,2,1.65,0.49298,1,0.9760620146222584,1.21,BP
GO:0031646,positive regulation of neurological syst...,82,2,1.65,0.49298,1,0.9760620146222584,1.21,BP
GO:0035383,thioester metabolic process,82,2,1.65,0.49298,1,0.9760620146222584,1.21,BP
GO:0046530,photoreceptor cell differentiation,82,2,1.65,0.49298,1,0.9760620146222584,1.21,BP
GO:1903901,negative regulation of viral life cycle,82,2,1.65,0.49298,1,0.9760620146222584,1.21,BP
GO:0001822,kidney development,280,6,5.63,0.49465,1,0.9760620146222584,1.07,BP
GO:0001501,skeletal system development,528,11,10.61,0.49486,1,0.9760620146222584,1.04,BP
GO:0009855,determination of bilateral symmetry,132,3,2.65,0.49698,1,0.9760620146222584,1.13,BP
GO:0098542,defense response to other organism,529,11,10.63,0.49738,1,0.9760620146222584,1.03,BP
GO:0000002,mitochondrial genome maintenance,34,1,0.68,0.49888,1,0.9760620146222584,1.47,BP
GO:0006356,regulation of transcription by RNA polym...,34,1,0.68,0.49888,1,0.9760620146222584,1.47,BP
GO:0006984,ER-nucleus signaling pathway,34,1,0.68,0.49888,1,0.9760620146222584,1.47,BP
GO:0007617,mating behavior,34,1,0.68,0.49888,1,0.9760620146222584,1.47,BP
GO:0010573,vascular endothelial growth factor produ...,34,1,0.68,0.49888,1,0.9760620146222584,1.47,BP
GO:0010667,negative regulation of cardiac muscle ce...,34,1,0.68,0.49888,1,0.9760620146222584,1.47,BP
GO:0010714,positive regulation of collagen metaboli...,34,1,0.68,0.49888,1,0.9760620146222584,1.47,BP
GO:0010837,regulation of keratinocyte proliferation,34,1,0.68,0.49888,1,0.9760620146222584,1.47,BP
GO:0015804,neutral amino acid transport,34,1,0.68,0.49888,1,0.9760620146222584,1.47,BP
GO:0019076,viral release from host cell,34,1,0.68,0.49888,1,0.9760620146222584,1.47,BP
GO:0035116,embryonic hindlimb morphogenesis,34,1,0.68,0.49888,1,0.9760620146222584,1.47,BP
GO:0035890,exit from host,34,1,0.68,0.49888,1,0.9760620146222584,1.47,BP
GO:0035891,exit from host cell,34,1,0.68,0.49888,1,0.9760620146222584,1.47,BP
GO:0043243,positive regulation of protein complex d...,34,1,0.68,0.49888,1,0.9760620146222584,1.47,BP
GO:0045070,positive regulation of viral genome repl...,34,1,0.68,0.49888,1,0.9760620146222584,1.47,BP
GO:0048194,Golgi vesicle budding,34,1,0.68,0.49888,1,0.9760620146222584,1.47,BP
GO:0052126,movement in host environment,34,1,0.68,0.49888,1,0.9760620146222584,1.47,BP
GO:0052192,movement in environment of other organis...,34,1,0.68,0.49888,1,0.9760620146222584,1.47,BP
GO:0097242,amyloid-beta clearance,34,1,0.68,0.49888,1,0.9760620146222584,1.47,BP
GO:0097366,response to bronchodilator,34,1,0.68,0.49888,1,0.9760620146222584,1.47,BP
GO:0140115,export across plasma membrane,34,1,0.68,0.49888,1,0.9760620146222584,1.47,BP
GO:1902686,mitochondrial outer membrane permeabiliz...,34,1,0.68,0.49888,1,0.9760620146222584,1.47,BP
GO:1990748,cellular detoxification,34,1,0.68,0.49888,1,0.9760620146222584,1.47,BP
GO:0002312,B cell activation involved in immune res...,83,2,1.67,0.49939,1,0.9760620146222584,1.2,BP
GO:0006942,regulation of striated muscle contractio...,83,2,1.67,0.49939,1,0.9760620146222584,1.2,BP
GO:0022904,respiratory electron transport chain,83,2,1.67,0.49939,1,0.9760620146222584,1.2,BP
GO:0032436,positive regulation of proteasomal ubiqu...,83,2,1.67,0.49939,1,0.9760620146222584,1.2,BP
GO:0061178,regulation of insulin secretion involved...,83,2,1.67,0.49939,1,0.9760620146222584,1.2,BP
GO:0009952,anterior/posterior pattern specification,232,5,4.66,0.50049,1,0.9774179707792208,1.07,BP
GO:0090276,regulation of peptide hormone secretion,232,5,4.66,0.50049,1,0.9774179707792208,1.07,BP
GO:0009259,ribonucleotide metabolic process,431,9,8.66,0.50103,1,0.978075602434077,1.04,BP
GO:0030072,peptide hormone secretion,282,6,5.67,0.50155,1,0.9781004952076677,1.06,BP
GO:0001841,neural tube formation,133,3,2.67,0.50201,1,0.9781004952076677,1.12,BP
GO:0002456,T cell mediated immunity,133,3,2.67,0.50201,1,0.9781004952076677,1.12,BP
GO:0009799,specification of symmetry,133,3,2.67,0.50201,1,0.9781004952076677,1.12,BP
GO:0003151,outflow tract morphogenesis,84,2,1.69,0.50574,1,0.9781004952076677,1.18,BP
GO:0006342,chromatin silencing,84,2,1.69,0.50574,1,0.9781004952076677,1.18,BP
GO:0006672,ceramide metabolic process,84,2,1.69,0.50574,1,0.9781004952076677,1.18,BP
GO:0045844,positive regulation of striated muscle t...,84,2,1.69,0.50574,1,0.9781004952076677,1.18,BP
GO:0045913,positive regulation of carbohydrate meta...,84,2,1.69,0.50574,1,0.9781004952076677,1.18,BP
GO:0048636,positive regulation of muscle organ deve...,84,2,1.69,0.50574,1,0.9781004952076677,1.18,BP
GO:0055072,iron ion homeostasis,84,2,1.69,0.50574,1,0.9781004952076677,1.18,BP
GO:0060420,regulation of heart growth,84,2,1.69,0.50574,1,0.9781004952076677,1.18,BP
GO:2001057,reactive nitrogen species metabolic proc...,84,2,1.69,0.50574,1,0.9781004952076677,1.18,BP
GO:0010469,regulation of signaling receptor activit...,134,3,2.69,0.50702,1,0.9781004952076677,1.12,BP
GO:0051928,positive regulation of calcium ion trans...,134,3,2.69,0.50702,1,0.9781004952076677,1.12,BP
GO:0016331,morphogenesis of embryonic epithelium,184,4,3.7,0.50762,1,0.9781004952076677,1.08,BP
GO:0050792,regulation of viral process,184,4,3.7,0.50762,1,0.9781004952076677,1.08,BP
GO:0001539,cilium or flagellum-dependent cell motil...,35,1,0.7,0.50897,1,0.9781004952076677,1.43,BP
GO:0002701,negative regulation of production of mol...,35,1,0.7,0.50897,1,0.9781004952076677,1.43,BP
GO:0002931,response to ischemia,35,1,0.7,0.50897,1,0.9781004952076677,1.43,BP
GO:0007143,female meiotic nuclear division,35,1,0.7,0.50897,1,0.9781004952076677,1.43,BP
GO:0008045,motor neuron axon guidance,35,1,0.7,0.50897,1,0.9781004952076677,1.43,BP
GO:0018345,protein palmitoylation,35,1,0.7,0.50897,1,0.9781004952076677,1.43,BP
GO:0030201,heparan sulfate proteoglycan metabolic p...,35,1,0.7,0.50897,1,0.9781004952076677,1.43,BP
GO:0031338,regulation of vesicle fusion,35,1,0.7,0.50897,1,0.9781004952076677,1.43,BP
GO:0032094,response to food,35,1,0.7,0.50897,1,0.9781004952076677,1.43,BP
GO:0035909,aorta morphogenesis,35,1,0.7,0.50897,1,0.9781004952076677,1.43,BP
GO:0043304,regulation of mast cell degranulation,35,1,0.7,0.50897,1,0.9781004952076677,1.43,BP
GO:0046320,regulation of fatty acid oxidation,35,1,0.7,0.50897,1,0.9781004952076677,1.43,BP
GO:0046686,response to cadmium ion,35,1,0.7,0.50897,1,0.9781004952076677,1.43,BP
GO:0048679,regulation of axon regeneration,35,1,0.7,0.50897,1,0.9781004952076677,1.43,BP
GO:0060285,cilium-dependent cell motility,35,1,0.7,0.50897,1,0.9781004952076677,1.43,BP
GO:0060479,lung cell differentiation,35,1,0.7,0.50897,1,0.9781004952076677,1.43,BP
GO:0090322,regulation of superoxide metabolic proce...,35,1,0.7,0.50897,1,0.9781004952076677,1.43,BP
GO:0097352,autophagosome maturation,35,1,0.7,0.50897,1,0.9781004952076677,1.43,BP
GO:1901068,guanosine-containing compound metabolic ...,35,1,0.7,0.50897,1,0.9781004952076677,1.43,BP
GO:2000036,regulation of stem cell population maint...,35,1,0.7,0.50897,1,0.9781004952076677,1.43,BP
GO:2000171,negative regulation of dendrite developm...,35,1,0.7,0.50897,1,0.9781004952076677,1.43,BP
GO:2001038,regulation of cellular response to drug,35,1,0.7,0.50897,1,0.9781004952076677,1.43,BP
GO:0006952,defense response,1481,30,29.77,0.50996,1,0.9796117844311376,1.01,BP
GO:2000116,regulation of cysteine-type endopeptidas...,235,5,4.72,0.51181,1,0.981667171314741,1.06,BP
GO:0071453,cellular response to oxygen levels,135,3,2.71,0.51199,1,0.981667171314741,1.11,BP
GO:0097306,cellular response to alcohol,135,3,2.71,0.51199,1,0.981667171314741,1.11,BP
GO:1901655,cellular response to ketone,135,3,2.71,0.51199,1,0.981667171314741,1.11,BP
GO:1901863,positive regulation of muscle tissue dev...,85,2,1.71,0.51205,1,0.981667171314741,1.17,BP
GO:0034765,regulation of ion transmembrane transpor...,485,10,9.75,0.51230,1,0.9817553166069295,1.03,BP
GO:0048754,branching morphogenesis of an epithelial...,186,4,3.74,0.51609,1,0.9829551968503938,1.07,BP
GO:1903038,negative regulation of leukocyte cell-ce...,136,3,2.73,0.51694,1,0.9829551968503938,1.1,BP
GO:1903322,positive regulation of protein modificat...,136,3,2.73,0.51694,1,0.9829551968503938,1.1,BP
GO:0001503,ossification,387,8,7.78,0.51789,1,0.9829551968503938,1.03,BP
GO:0010827,regulation of glucose transmembrane tran...,86,2,1.73,0.51830,1,0.9829551968503938,1.16,BP
GO:0014910,regulation of smooth muscle cell migrati...,86,2,1.73,0.51830,1,0.9829551968503938,1.16,BP
GO:0001963,"synaptic transmission, dopaminergic",36,1,0.72,0.51885,1,0.9829551968503938,1.39,BP
GO:0003401,axis elongation,36,1,0.72,0.51885,1,0.9829551968503938,1.39,BP
GO:0006471,protein ADP-ribosylation,36,1,0.72,0.51885,1,0.9829551968503938,1.39,BP
GO:0006972,hyperosmotic response,36,1,0.72,0.51885,1,0.9829551968503938,1.39,BP
GO:0030574,collagen catabolic process,36,1,0.72,0.51885,1,0.9829551968503938,1.39,BP
GO:0032205,negative regulation of telomere maintena...,36,1,0.72,0.51885,1,0.9829551968503938,1.39,BP
GO:0032735,positive regulation of interleukin-12 pr...,36,1,0.72,0.51885,1,0.9829551968503938,1.39,BP
GO:0033006,regulation of mast cell activation invol...,36,1,0.72,0.51885,1,0.9829551968503938,1.39,BP
GO:0033238,regulation of cellular amine metabolic p...,36,1,0.72,0.51885,1,0.9829551968503938,1.39,BP
GO:0033363,secretory granule organization,36,1,0.72,0.51885,1,0.9829551968503938,1.39,BP
GO:0035115,embryonic forelimb morphogenesis,36,1,0.72,0.51885,1,0.9829551968503938,1.39,BP
GO:0040020,regulation of meiotic nuclear division,36,1,0.72,0.51885,1,0.9829551968503938,1.39,BP
GO:0042311,vasodilation,36,1,0.72,0.51885,1,0.9829551968503938,1.39,BP
GO:0043516,"regulation of DNA damage response, signa...",36,1,0.72,0.51885,1,0.9829551968503938,1.39,BP
GO:0045815,"positive regulation of gene expression, ...",36,1,0.72,0.51885,1,0.9829551968503938,1.39,BP
GO:0048710,regulation of astrocyte differentiation,36,1,0.72,0.51885,1,0.9829551968503938,1.39,BP
GO:0051084,'de novo' posttranslational protein fold...,36,1,0.72,0.51885,1,0.9829551968503938,1.39,BP
GO:0051953,negative regulation of amine transport,36,1,0.72,0.51885,1,0.9829551968503938,1.39,BP
GO:0070873,regulation of glycogen metabolic process,36,1,0.72,0.51885,1,0.9829551968503938,1.39,BP
GO:0097106,postsynaptic density organization,36,1,0.72,0.51885,1,0.9829551968503938,1.39,BP
GO:1903959,regulation of anion transmembrane transp...,36,1,0.72,0.51885,1,0.9829551968503938,1.39,BP
GO:1990089,response to nerve growth factor,36,1,0.72,0.51885,1,0.9829551968503938,1.39,BP
GO:1990090,cellular response to nerve growth factor...,36,1,0.72,0.51885,1,0.9829551968503938,1.39,BP
GO:0006813,potassium ion transport,237,5,4.76,0.51931,1,0.9834394805194806,1.05,BP
GO:0001764,neuron migration,187,4,3.76,0.52030,1,0.9849266719118804,1.06,BP
GO:0040029,"regulation of gene expression, epigeneti...",288,6,5.79,0.52204,1,0.9878318836020448,1.04,BP
GO:0022900,electron transport chain,87,2,1.75,0.52450,1,0.9907808648227503,1.14,BP
GO:0042475,odontogenesis of dentin-containing tooth,87,2,1.75,0.52450,1,0.9907808648227503,1.14,BP
GO:0060079,excitatory postsynaptic potential,87,2,1.75,0.52450,1,0.9907808648227503,1.14,BP
GO:0070509,calcium ion import,87,2,1.75,0.52450,1,0.9907808648227503,1.14,BP
GO:0016441,posttranscriptional gene silencing,138,3,2.77,0.52676,1,0.9907808648227503,1.08,BP
GO:0001702,gastrulation with mouth forming second,37,1,0.74,0.52854,1,0.9907808648227503,1.35,BP
GO:0010664,negative regulation of striated muscle c...,37,1,0.74,0.52854,1,0.9907808648227503,1.35,BP
GO:0014003,oligodendrocyte development,37,1,0.74,0.52854,1,0.9907808648227503,1.35,BP
GO:0021884,forebrain neuron development,37,1,0.74,0.52854,1,0.9907808648227503,1.35,BP
GO:0031279,regulation of cyclase activity,37,1,0.74,0.52854,1,0.9907808648227503,1.35,BP
GO:0032733,positive regulation of interleukin-10 pr...,37,1,0.74,0.52854,1,0.9907808648227503,1.35,BP
GO:0035794,positive regulation of mitochondrial mem...,37,1,0.74,0.52854,1,0.9907808648227503,1.35,BP
GO:0035850,epithelial cell differentiation involved...,37,1,0.74,0.52854,1,0.9907808648227503,1.35,BP
GO:0036474,cell death in response to hydrogen perox...,37,1,0.74,0.52854,1,0.9907808648227503,1.35,BP
GO:0043628,ncRNA 3'-end processing,37,1,0.74,0.52854,1,0.9907808648227503,1.35,BP
GO:0048665,neuron fate specification,37,1,0.74,0.52854,1,0.9907808648227503,1.35,BP
GO:0048730,epidermis morphogenesis,37,1,0.74,0.52854,1,0.9907808648227503,1.35,BP
GO:0051693,actin filament capping,37,1,0.74,0.52854,1,0.9907808648227503,1.35,BP
GO:0071398,cellular response to fatty acid,37,1,0.74,0.52854,1,0.9907808648227503,1.35,BP
GO:0072348,sulfur compound transport,37,1,0.74,0.52854,1,0.9907808648227503,1.35,BP
GO:0072350,tricarboxylic acid metabolic process,37,1,0.74,0.52854,1,0.9907808648227503,1.35,BP
GO:0099174,regulation of presynapse organization,37,1,0.74,0.52854,1,0.9907808648227503,1.35,BP
GO:1903432,regulation of TORC1 signaling,37,1,0.74,0.52854,1,0.9907808648227503,1.35,BP
GO:1903792,negative regulation of anion transport,37,1,0.74,0.52854,1,0.9907808648227503,1.35,BP
GO:0007548,sex differentiation,290,6,5.83,0.52880,1,0.9908822429906543,1.03,BP
GO:0019217,regulation of fatty acid metabolic proce...,88,2,1.77,0.53065,1,0.9935750194552528,1.13,BP
GO:0032024,positive regulation of insulin secretion,88,2,1.77,0.53065,1,0.9935750194552528,1.13,BP
GO:0034101,erythrocyte homeostasis,139,3,2.79,0.53163,1,0.9950227771295217,1.08,BP
GO:0007162,negative regulation of cell adhesion,291,6,5.85,0.53216,1,0.9956274961119751,1.03,BP
GO:0043491,protein kinase B signaling,190,4,3.82,0.53283,1,0.9964935717061796,1.05,BP
GO:0019221,cytokine-mediated signaling pathway,342,7,6.87,0.53379,1,0.9975135844660195,1.02,BP
GO:0050900,leukocyte migration,342,7,6.87,0.53379,1,0.9975135844660195,1.02,BP
GO:0045444,fat cell differentiation,241,5,4.84,0.53415,1,0.997688,1.03,BP
GO:0002221,pattern recognition receptor signaling p...,140,3,2.81,0.53647,1,0.997688,1.07,BP
GO:0021872,forebrain generation of neurons,89,2,1.79,0.53674,1,0.997688,1.12,BP
GO:0033077,T cell differentiation in thymus,89,2,1.79,0.53674,1,0.997688,1.12,BP
GO:0001763,morphogenesis of a branching structure,242,5,4.86,0.53783,1,0.997688,1.03,BP
GO:0000578,embryonic axis specification,38,1,0.76,0.53803,1,0.997688,1.32,BP
GO:0001953,negative regulation of cell-matrix adhes...,38,1,0.76,0.53803,1,0.997688,1.32,BP
GO:0006778,porphyrin-containing compound metabolic ...,38,1,0.76,0.53803,1,0.997688,1.32,BP
GO:0007435,salivary gland morphogenesis,38,1,0.76,0.53803,1,0.997688,1.32,BP
GO:0016601,Rac protein signal transduction,38,1,0.76,0.53803,1,0.997688,1.32,BP
GO:0032885,regulation of polysaccharide biosyntheti...,38,1,0.76,0.53803,1,0.997688,1.32,BP
GO:0040019,positive regulation of embryonic develop...,38,1,0.76,0.53803,1,0.997688,1.32,BP
GO:0042149,cellular response to glucose starvation,38,1,0.76,0.53803,1,0.997688,1.32,BP
GO:0042554,superoxide anion generation,38,1,0.76,0.53803,1,0.997688,1.32,BP
GO:0043267,negative regulation of potassium ion tra...,38,1,0.76,0.53803,1,0.997688,1.32,BP
GO:0043368,positive T cell selection,38,1,0.76,0.53803,1,0.997688,1.32,BP
GO:0071391,cellular response to estrogen stimulus,38,1,0.76,0.53803,1,0.997688,1.32,BP
GO:0072210,metanephric nephron development,38,1,0.76,0.53803,1,0.997688,1.32,BP
GO:2000463,positive regulation of excitatory postsy...,38,1,0.76,0.53803,1,0.997688,1.32,BP
GO:2001025,positive regulation of response to drug,38,1,0.76,0.53803,1,0.997688,1.32,BP
GO:0042493,response to drug,898,18,18.05,0.53912,1,0.9993241294298922,1,BP
GO:0042110,T cell activation,496,10,9.97,0.54093,1,1,1,BP
GO:0044706,multi-multicellular organism process,192,4,3.86,0.54109,1,1,1.04,BP
GO:0034341,response to interferon-gamma,141,3,2.83,0.54128,1,1,1.06,BP
GO:0046165,alcohol biosynthetic process,141,3,2.83,0.54128,1,1,1.06,BP
GO:0010466,negative regulation of peptidase activit...,243,5,4.88,0.54149,1,1,1.02,BP
GO:1903037,regulation of leukocyte cell-cell adhesi...,294,6,5.91,0.54219,1,1,1.02,BP
GO:0032642,regulation of chemokine production,90,2,1.81,0.54277,1,1,1.1,BP
GO:0045814,"negative regulation of gene expression, ...",90,2,1.81,0.54277,1,1,1.1,BP
GO:0045833,negative regulation of lipid metabolic p...,90,2,1.81,0.54277,1,1,1.1,BP
GO:0072091,regulation of stem cell proliferation,90,2,1.81,0.54277,1,1,1.1,BP
GO:1904063,negative regulation of cation transmembr...,90,2,1.81,0.54277,1,1,1.1,BP
GO:1905954,positive regulation of lipid localizatio...,90,2,1.81,0.54277,1,1,1.1,BP
GO:0001655,urogenital system development,345,7,6.93,0.54305,1,1,1.01,BP
GO:0021915,neural tube development,193,4,3.88,0.54520,1,1,1.03,BP
GO:0022408,negative regulation of cell-cell adhesio...,193,4,3.88,0.54520,1,1,1.03,BP
GO:0002758,innate immune response-activating signal...,142,3,2.85,0.54607,1,1,1.05,BP
GO:0006826,iron ion transport,39,1,0.78,0.54734,1,1,1.28,BP
GO:0030521,androgen receptor signaling pathway,39,1,0.78,0.54734,1,1,1.28,BP
GO:0030810,positive regulation of nucleotide biosyn...,39,1,0.78,0.54734,1,1,1.28,BP
GO:0031076,embryonic camera-type eye development,39,1,0.78,0.54734,1,1,1.28,BP
GO:0060251,regulation of glial cell proliferation,39,1,0.78,0.54734,1,1,1.28,BP
GO:0061462,protein localization to lysosome,39,1,0.78,0.54734,1,1,1.28,BP
GO:0070528,protein kinase C signaling,39,1,0.78,0.54734,1,1,1.28,BP
GO:0070570,regulation of neuron projection regenera...,39,1,0.78,0.54734,1,1,1.28,BP
GO:0072595,maintenance of protein localization in o...,39,1,0.78,0.54734,1,1,1.28,BP
GO:1900373,positive regulation of purine nucleotide...,39,1,0.78,0.54734,1,1,1.28,BP
GO:1901998,toxin transport,39,1,0.78,0.54734,1,1,1.28,BP
GO:1902692,regulation of neuroblast proliferation,39,1,0.78,0.54734,1,1,1.28,BP
GO:1905710,positive regulation of membrane permeabi...,39,1,0.78,0.54734,1,1,1.28,BP
GO:2000142,regulation of DNA-templated transcriptio...,39,1,0.78,0.54734,1,1,1.28,BP
GO:0019693,ribose phosphate metabolic process,448,9,9,0.54773,1,1,1,BP
GO:0006497,protein lipidation,91,2,1.83,0.54876,1,1,1.09,BP
GO:0035773,insulin secretion involved in cellular r...,91,2,1.83,0.54876,1,1,1.09,BP
GO:0052548,regulation of endopeptidase activity,347,7,6.97,0.54919,1,1,1,BP
GO:0071804,cellular potassium ion transport,194,4,3.9,0.54928,1,1,1.03,BP
GO:0071805,potassium ion transmembrane transport,194,4,3.9,0.54928,1,1,1.03,BP
GO:0022409,positive regulation of cell-cell adhesio...,246,5,4.94,0.55240,1,1,1.01,BP
GO:0046034,ATP metabolic process,246,5,4.94,0.55240,1,1,1.01,BP
GO:0001676,long-chain fatty acid metabolic process,92,2,1.85,0.55468,1,1,1.08,BP
GO:0042770,signal transduction in response to DNA d...,92,2,1.85,0.55468,1,1,1.08,BP
GO:0031333,negative regulation of protein complex a...,144,3,2.89,0.55554,1,1,1.04,BP
GO:0001835,blastocyst hatching,40,1,0.8,0.55645,1,1,1.25,BP
GO:0001881,receptor recycling,40,1,0.8,0.55645,1,1,1.25,BP
GO:0002369,T cell cytokine production,40,1,0.8,0.55645,1,1,1.25,BP
GO:0002686,negative regulation of leukocyte migrati...,40,1,0.8,0.55645,1,1,1.25,BP
GO:0010661,positive regulation of muscle cell apopt...,40,1,0.8,0.55645,1,1,1.25,BP
GO:0021696,cerebellar cortex morphogenesis,40,1,0.8,0.55645,1,1,1.25,BP
GO:0030225,macrophage differentiation,40,1,0.8,0.55645,1,1,1.25,BP
GO:0032008,positive regulation of TOR signaling,40,1,0.8,0.55645,1,1,1.25,BP
GO:0032620,interleukin-17 production,40,1,0.8,0.55645,1,1,1.25,BP
GO:0035188,hatching,40,1,0.8,0.55645,1,1,1.25,BP
GO:0035307,positive regulation of protein dephospho...,40,1,0.8,0.55645,1,1,1.25,BP
GO:0045191,regulation of isotype switching,40,1,0.8,0.55645,1,1,1.25,BP
GO:0051339,regulation of lyase activity,40,1,0.8,0.55645,1,1,1.25,BP
GO:0060325,face morphogenesis,40,1,0.8,0.55645,1,1,1.25,BP
GO:0071542,dopaminergic neuron differentiation,40,1,0.8,0.55645,1,1,1.25,BP
GO:0071684,organism emergence from protective struc...,40,1,0.8,0.55645,1,1,1.25,BP
GO:0072523,purine-containing compound catabolic pro...,40,1,0.8,0.55645,1,1,1.25,BP
GO:0099590,neurotransmitter receptor internalizatio...,40,1,0.8,0.55645,1,1,1.25,BP
GO:1905332,positive regulation of morphogenesis of ...,40,1,0.8,0.55645,1,1,1.25,BP
GO:0048771,tissue remodeling,196,4,3.94,0.55739,1,1,1.02,BP
GO:0050731,positive regulation of peptidyl-tyrosine...,196,4,3.94,0.55739,1,1,1.02,BP
GO:0006935,chemotaxis,604,12,12.14,0.55753,1,1,0.99,BP
GO:0007411,axon guidance,248,5,4.98,0.55961,1,1,1,BP
GO:0030326,embryonic limb morphogenesis,145,3,2.91,0.56024,1,1,1.03,BP
GO:0035113,embryonic appendage morphogenesis,145,3,2.91,0.56024,1,1,1.03,BP
GO:0014909,smooth muscle cell migration,93,2,1.87,0.56055,1,1,1.07,BP
GO:0046889,positive regulation of lipid biosyntheti...,93,2,1.87,0.56055,1,1,1.07,BP
GO:0060395,SMAD protein signal transduction,93,2,1.87,0.56055,1,1,1.07,BP
GO:0008202,steroid metabolic process,300,6,6.03,0.56196,1,1,1,BP
GO:0009117,nucleotide metabolic process,556,11,11.18,0.56413,1,1,0.98,BP
GO:0042330,taxis,607,12,12.2,0.56448,1,1,0.98,BP
GO:1903900,regulation of viral life cycle,146,3,2.93,0.56490,1,1,1.02,BP
GO:0002227,innate immune response in mucosa,41,1,0.82,0.56538,1,1,1.22,BP
GO:0002888,positive regulation of myeloid leukocyte...,41,1,0.82,0.56538,1,1,1.22,BP
GO:0003298,physiological muscle hypertrophy,41,1,0.82,0.56538,1,1,1.22,BP
GO:0003301,physiological cardiac muscle hypertrophy,41,1,0.82,0.56538,1,1,1.22,BP
GO:0009409,response to cold,41,1,0.82,0.56538,1,1,1.22,BP
GO:0009651,response to salt stress,41,1,0.82,0.56538,1,1,1.22,BP
GO:0010470,regulation of gastrulation,41,1,0.82,0.56538,1,1,1.22,BP
GO:0030501,positive regulation of bone mineralizati...,41,1,0.82,0.56538,1,1,1.22,BP
GO:0033344,cholesterol efflux,41,1,0.82,0.56538,1,1,1.22,BP
GO:0034105,positive regulation of tissue remodeling,41,1,0.82,0.56538,1,1,1.22,BP
GO:0044764,multi-organism cellular process,41,1,0.82,0.56538,1,1,1.22,BP
GO:0045494,photoreceptor cell maintenance,41,1,0.82,0.56538,1,1,1.22,BP
GO:0046164,alcohol catabolic process,41,1,0.82,0.56538,1,1,1.22,BP
GO:0046326,positive regulation of glucose import,41,1,0.82,0.56538,1,1,1.22,BP
GO:0046782,regulation of viral transcription,41,1,0.82,0.56538,1,1,1.22,BP
GO:0051281,positive regulation of release of seques...,41,1,0.82,0.56538,1,1,1.22,BP
GO:0055026,negative regulation of cardiac muscle ti...,41,1,0.82,0.56538,1,1,1.22,BP
GO:0061049,cell growth involved in cardiac muscle c...,41,1,0.82,0.56538,1,1,1.22,BP
GO:0070884,regulation of calcineurin-NFAT signaling...,41,1,0.82,0.56538,1,1,1.22,BP
GO:0071364,cellular response to epidermal growth fa...,41,1,0.82,0.56538,1,1,1.22,BP
GO:0098801,regulation of renal system process,41,1,0.82,0.56538,1,1,1.22,BP
GO:0106056,regulation of calcineurin-mediated signa...,41,1,0.82,0.56538,1,1,1.22,BP
GO:1903170,negative regulation of calcium ion trans...,41,1,0.82,0.56538,1,1,1.22,BP
GO:0007215,glutamate receptor signaling pathway,94,2,1.89,0.56637,1,1,1.06,BP
GO:0032602,chemokine production,94,2,1.89,0.56637,1,1,1.06,BP
GO:0070555,response to interleukin-1,94,2,1.89,0.56637,1,1,1.06,BP
GO:2000060,positive regulation of ubiquitin-depende...,94,2,1.89,0.56637,1,1,1.06,BP
GO:0097485,neuron projection guidance,250,5,5.03,0.56675,1,1,0.99,BP
GO:0090596,sensory organ morphogenesis,302,6,6.07,0.56847,1,1,0.99,BP
GO:0043903,"regulation of symbiosis, encompassing mu...",199,4,4,0.56941,1,1,1,BP
GO:0022407,regulation of cell-cell adhesion,405,8,8.14,0.56956,1,1,0.98,BP
GO:0000266,mitochondrial fission,42,1,0.84,0.57414,1,1,1.19,BP
GO:0001709,cell fate determination,42,1,0.84,0.57414,1,1,1.19,BP
GO:0006687,glycosphingolipid metabolic process,42,1,0.84,0.57414,1,1,1.19,BP
GO:0007431,salivary gland development,42,1,0.84,0.57414,1,1,1.19,BP
GO:0010559,regulation of glycoprotein biosynthetic ...,42,1,0.84,0.57414,1,1,1.19,BP
GO:0030835,negative regulation of actin filament de...,42,1,0.84,0.57414,1,1,1.19,BP
GO:0032459,regulation of protein oligomerization,42,1,0.84,0.57414,1,1,1.19,BP
GO:0033059,cellular pigmentation,42,1,0.84,0.57414,1,1,1.19,BP
GO:0034198,cellular response to amino acid starvati...,42,1,0.84,0.57414,1,1,1.19,BP
GO:0042220,response to cocaine,42,1,0.84,0.57414,1,1,1.19,BP
GO:0045923,positive regulation of fatty acid metabo...,42,1,0.84,0.57414,1,1,1.19,BP
GO:0050685,positive regulation of mRNA processing,42,1,0.84,0.57414,1,1,1.19,BP
GO:0055023,positive regulation of cardiac muscle ti...,42,1,0.84,0.57414,1,1,1.19,BP
GO:0060122,inner ear receptor cell stereocilium org...,42,1,0.84,0.57414,1,1,1.19,BP
GO:0099084,postsynaptic specialization organization,42,1,0.84,0.57414,1,1,1.19,BP
GO:1900015,regulation of cytokine production involv...,42,1,0.84,0.57414,1,1,1.19,BP
GO:1902742,apoptotic process involved in developmen...,42,1,0.84,0.57414,1,1,1.19,BP
GO:0008643,carbohydrate transport,148,3,2.97,0.57414,1,1,1.01,BP
GO:0042133,neurotransmitter metabolic process,148,3,2.97,0.57414,1,1,1.01,BP
GO:0045321,leukocyte activation,866,17,17.41,0.57498,1,1,0.98,BP
GO:0015672,monovalent inorganic cation transport,459,9,9.23,0.57703,1,1,0.98,BP
GO:0042158,lipoprotein biosynthetic process,96,2,1.93,0.57783,1,1,1.04,BP
GO:0034614,cellular response to reactive oxygen spe...,149,3,2.99,0.57872,1,1,1,BP
GO:0001819,positive regulation of cytokine producti...,460,9,9.25,0.57965,1,1,0.97,BP
GO:0006040,amino sugar metabolic process,43,1,0.86,0.58271,1,1,1.16,BP
GO:0010907,positive regulation of glucose metabolic...,43,1,0.86,0.58271,1,1,1.16,BP
GO:0031670,cellular response to nutrient,43,1,0.86,0.58271,1,1,1.16,BP
GO:0032371,regulation of sterol transport,43,1,0.86,0.58271,1,1,1.16,BP
GO:0032374,regulation of cholesterol transport,43,1,0.86,0.58271,1,1,1.16,BP
GO:0032958,inositol phosphate biosynthetic process,43,1,0.86,0.58271,1,1,1.16,BP
GO:0038202,TORC1 signaling,43,1,0.86,0.58271,1,1,1.16,BP
GO:0040018,positive regulation of multicellular org...,43,1,0.86,0.58271,1,1,1.16,BP
GO:0042771,intrinsic apoptotic signaling pathway in...,43,1,0.86,0.58271,1,1,1.16,BP
GO:0043403,skeletal muscle tissue regeneration,43,1,0.86,0.58271,1,1,1.16,BP
GO:0044743,protein transmembrane import into intrac...,43,1,0.86,0.58271,1,1,1.16,BP
GO:0046621,negative regulation of organ growth,43,1,0.86,0.58271,1,1,1.16,BP
GO:0086002,cardiac muscle cell action potential inv...,43,1,0.86,0.58271,1,1,1.16,BP
GO:0090317,negative regulation of intracellular pro...,43,1,0.86,0.58271,1,1,1.16,BP
GO:1901031,regulation of response to reactive oxyge...,43,1,0.86,0.58271,1,1,1.16,BP
GO:0006753,nucleoside phosphate metabolic process,564,11,11.34,0.58324,1,1,0.97,BP
GO:0021761,limbic system development,97,2,1.95,0.58348,1,1,1.03,BP
GO:0045638,negative regulation of myeloid cell diff...,97,2,1.95,0.58348,1,1,1.03,BP
GO:0048525,negative regulation of viral process,97,2,1.95,0.58348,1,1,1.03,BP
GO:0070167,regulation of biomineral tissue developm...,97,2,1.95,0.58348,1,1,1.03,BP
GO:0099565,"chemical synaptic transmission, postsyna...",97,2,1.95,0.58348,1,1,1.03,BP
GO:0003018,vascular process in circulatory system,204,4,4.1,0.58903,1,1,0.98,BP
GO:2001237,negative regulation of extrinsic apoptot...,98,2,1.97,0.58908,1,1,1.02,BP
GO:0001569,branching involved in blood vessel morph...,44,1,0.88,0.59112,1,1,1.14,BP
GO:0006890,"retrograde vesicle-mediated transport, G...",44,1,0.88,0.59112,1,1,1.14,BP
GO:0016925,protein sumoylation,44,1,0.88,0.59112,1,1,1.14,BP
GO:0019083,viral transcription,44,1,0.88,0.59112,1,1,1.14,BP
GO:0032527,protein exit from endoplasmic reticulum,44,1,0.88,0.59112,1,1,1.14,BP
GO:0060964,regulation of gene silencing by miRNA,44,1,0.88,0.59112,1,1,1.14,BP
GO:1903039,positive regulation of leukocyte cell-ce...,205,4,4.12,0.59289,1,1,0.97,BP
GO:0009135,purine nucleoside diphosphate metabolic ...,99,2,1.99,0.59461,1,1,1.01,BP
GO:0009179,purine ribonucleoside diphosphate metabo...,99,2,1.99,0.59461,1,1,1.01,BP
GO:0033865,nucleoside bisphosphate metabolic proces...,99,2,1.99,0.59461,1,1,1.01,BP
GO:0033875,ribonucleoside bisphosphate metabolic pr...,99,2,1.99,0.59461,1,1,1.01,BP
GO:0034032,purine nucleoside bisphosphate metabolic...,99,2,1.99,0.59461,1,1,1.01,BP
GO:0043473,pigmentation,99,2,1.99,0.59461,1,1,1.01,BP
GO:0098662,inorganic cation transmembrane transport,621,12,12.48,0.59633,1,1,0.96,BP
GO:0007286,spermatid development,206,4,4.14,0.59673,1,1,0.97,BP
GO:0050804,modulation of chemical synaptic transmis...,673,13,13.53,0.59773,1,1,0.96,BP
GO:0048705,skeletal system morphogenesis,259,5,5.21,0.59816,1,1,0.96,BP
GO:0002063,chondrocyte development,45,1,0.9,0.59935,1,1,1.11,BP
GO:0002534,cytokine production involved in inflamma...,45,1,0.9,0.59935,1,1,1.11,BP
GO:0007628,adult walking behavior,45,1,0.9,0.59935,1,1,1.11,BP
GO:0014046,dopamine secretion,45,1,0.9,0.59935,1,1,1.11,BP
GO:0014059,regulation of dopamine secretion,45,1,0.9,0.59935,1,1,1.11,BP
GO:0032881,regulation of polysaccharide metabolic p...,45,1,0.9,0.59935,1,1,1.11,BP
GO:0032965,regulation of collagen biosynthetic proc...,45,1,0.9,0.59935,1,1,1.11,BP
GO:0043616,keratinocyte proliferation,45,1,0.9,0.59935,1,1,1.11,BP
GO:0051646,mitochondrion localization,45,1,0.9,0.59935,1,1,1.11,BP
GO:0060421,positive regulation of heart growth,45,1,0.9,0.59935,1,1,1.11,BP
GO:0090184,positive regulation of kidney developmen...,45,1,0.9,0.59935,1,1,1.11,BP
GO:0099177,regulation of trans-synaptic signaling,674,13,13.55,0.59988,1,1,0.96,BP
GO:0010660,regulation of muscle cell apoptotic proc...,100,2,2.01,0.60009,1,1,1,BP
GO:0043112,receptor metabolic process,207,4,4.16,0.60055,1,1,0.96,BP
GO:0048738,cardiac muscle tissue development,261,5,5.25,0.60496,1,1,0.95,BP
GO:0007389,pattern specification process,470,9,9.45,0.60546,1,1,0.95,BP
GO:0007584,response to nutrient,101,2,2.03,0.60552,1,1,0.99,BP
GO:0032006,regulation of TOR signaling,101,2,2.03,0.60552,1,1,0.99,BP
GO:0046939,nucleotide phosphorylation,101,2,2.03,0.60552,1,1,0.99,BP
GO:0055024,regulation of cardiac muscle tissue deve...,101,2,2.03,0.60552,1,1,0.99,BP
GO:0001774,microglial cell activation,46,1,0.92,0.60742,1,1,1.09,BP
GO:0001990,regulation of systemic arterial blood pr...,46,1,0.92,0.60742,1,1,1.09,BP
GO:0002269,leukocyte activation involved in inflamm...,46,1,0.92,0.60742,1,1,1.09,BP
GO:0010799,regulation of peptidyl-threonine phospho...,46,1,0.92,0.60742,1,1,1.09,BP
GO:0018198,peptidyl-cysteine modification,46,1,0.92,0.60742,1,1,1.09,BP
GO:0032007,negative regulation of TOR signaling,46,1,0.92,0.60742,1,1,1.09,BP
GO:0033013,tetrapyrrole metabolic process,46,1,0.92,0.60742,1,1,1.09,BP
GO:0042073,intraciliary transport,46,1,0.92,0.60742,1,1,1.09,BP
GO:0060323,head morphogenesis,46,1,0.92,0.60742,1,1,1.09,BP
GO:0072666,establishment of protein localization to...,46,1,0.92,0.60742,1,1,1.09,BP
GO:0098754,detoxification,46,1,0.92,0.60742,1,1,1.09,BP
GO:1990928,response to amino acid starvation,46,1,0.92,0.60742,1,1,1.09,BP
GO:0046496,nicotinamide nucleotide metabolic proces...,156,3,3.14,0.60985,1,1,0.96,BP
GO:0071248,cellular response to metal ion,156,3,3.14,0.60985,1,1,0.96,BP
GO:0010522,regulation of calcium ion transport into...,102,2,2.05,0.61089,1,1,0.98,BP
GO:0033555,multicellular organismal response to str...,102,2,2.05,0.61089,1,1,0.98,BP
GO:0050848,regulation of calcium-mediated signaling,102,2,2.05,0.61089,1,1,0.98,BP
GO:0048878,chemical homeostasis,1192,23,23.96,0.61114,1,1,0.96,BP
GO:0051216,cartilage development,210,4,4.22,0.61187,1,1,0.95,BP
GO:0043062,extracellular structure organization,316,6,6.35,0.61261,1,1,0.94,BP
GO:0009150,purine ribonucleotide metabolic process,421,8,8.46,0.61333,1,1,0.95,BP
GO:0046879,hormone secretion,369,7,7.42,0.61412,1,1,0.94,BP
GO:0006110,regulation of glycolytic process,47,1,0.94,0.61533,1,1,1.06,BP
GO:0019098,reproductive behavior,47,1,0.94,0.61533,1,1,1.06,BP
GO:0030517,negative regulation of axon extension,47,1,0.94,0.61533,1,1,1.06,BP
GO:0030811,regulation of nucleotide catabolic proce...,47,1,0.94,0.61533,1,1,1.06,BP
GO:0035137,hindlimb morphogenesis,47,1,0.94,0.61533,1,1,1.06,BP
GO:0035196,production of miRNAs involved in gene si...,47,1,0.94,0.61533,1,1,1.06,BP
GO:0045429,positive regulation of nitric oxide bios...,47,1,0.94,0.61533,1,1,1.06,BP
GO:0060147,regulation of posttranscriptional gene s...,47,1,0.94,0.61533,1,1,1.06,BP
GO:0060966,regulation of gene silencing by RNA,47,1,0.94,0.61533,1,1,1.06,BP
GO:0071300,cellular response to retinoic acid,47,1,0.94,0.61533,1,1,1.06,BP
GO:0090279,regulation of calcium ion import,47,1,0.94,0.61533,1,1,1.06,BP
GO:0090659,walking behavior,47,1,0.94,0.61533,1,1,1.06,BP
GO:0120163,negative regulation of cold-induced ther...,47,1,0.94,0.61533,1,1,1.06,BP
GO:1902041,regulation of extrinsic apoptotic signal...,47,1,0.94,0.61533,1,1,1.06,BP
GO:1903018,regulation of glycoprotein metabolic pro...,47,1,0.94,0.61533,1,1,1.06,BP
GO:0007623,circadian rhythm,211,4,4.24,0.61560,1,1,0.94,BP
GO:0009185,ribonucleoside diphosphate metabolic pro...,103,2,2.07,0.61620,1,1,0.97,BP
GO:0034446,substrate adhesion-dependent cell spread...,103,2,2.07,0.61620,1,1,0.97,BP
GO:0051897,positive regulation of protein kinase B ...,103,2,2.07,0.61620,1,1,0.97,BP
GO:1902106,negative regulation of leukocyte differe...,103,2,2.07,0.61620,1,1,0.97,BP
GO:0019362,pyridine nucleotide metabolic process,158,3,3.18,0.61846,1,1,0.94,BP
GO:0022412,cellular process involved in reproductio...,423,8,8.5,0.61863,1,1,0.94,BP
GO:0048562,embryonic organ morphogenesis,318,6,6.39,0.61870,1,1,0.94,BP
GO:0002682,regulation of immune system process,1351,26,27.16,0.62032,1,1,0.96,BP
GO:0006874,cellular calcium ion homeostasis,476,9,9.57,0.62057,1,1,0.94,BP
GO:0009953,dorsal/ventral pattern formation,104,2,2.09,0.62146,1,1,0.96,BP
GO:0042136,neurotransmitter biosynthetic process,104,2,2.09,0.62146,1,1,0.96,BP
GO:0051289,protein homotetramerization,104,2,2.09,0.62146,1,1,0.96,BP
GO:0031349,positive regulation of defense response,372,7,7.48,0.62258,1,1,0.94,BP
GO:1903707,negative regulation of hemopoiesis,159,3,3.2,0.62271,1,1,0.94,BP
GO:0070838,divalent metal ion transport,477,9,9.59,0.62305,1,1,0.94,BP
GO:0002762,negative regulation of myeloid leukocyte...,48,1,0.96,0.62308,1,1,1.04,BP
GO:0003382,epithelial cell morphogenesis,48,1,0.96,0.62308,1,1,1.04,BP
GO:0032456,endocytic recycling,48,1,0.96,0.62308,1,1,1.04,BP
GO:0043303,mast cell degranulation,48,1,0.96,0.62308,1,1,1.04,BP
GO:0045581,negative regulation of T cell differenti...,48,1,0.96,0.62308,1,1,1.04,BP
GO:0045646,regulation of erythrocyte differentiatio...,48,1,0.96,0.62308,1,1,1.04,BP
GO:0048010,vascular endothelial growth factor recep...,48,1,0.96,0.62308,1,1,1.04,BP
GO:0048599,oocyte development,48,1,0.96,0.62308,1,1,1.04,BP
GO:0048701,embryonic cranial skeleton morphogenesis,48,1,0.96,0.62308,1,1,1.04,BP
GO:0050850,positive regulation of calcium-mediated ...,48,1,0.96,0.62308,1,1,1.04,BP
GO:0061005,cell differentiation involved in kidney ...,48,1,0.96,0.62308,1,1,1.04,BP
GO:1904407,positive regulation of nitric oxide meta...,48,1,0.96,0.62308,1,1,1.04,BP
GO:2000725,regulation of cardiac muscle cell differ...,48,1,0.96,0.62308,1,1,1.04,BP
GO:0051048,negative regulation of secretion,267,5,5.37,0.62497,1,1,0.93,BP
GO:0000018,regulation of DNA recombination,105,2,2.11,0.62666,1,1,0.95,BP
GO:0010657,muscle cell apoptotic process,105,2,2.11,0.62666,1,1,0.95,BP
GO:0046849,bone remodeling,105,2,2.11,0.62666,1,1,0.95,BP
GO:1901800,positive regulation of proteasomal prote...,105,2,2.11,0.62666,1,1,0.95,BP
GO:0002757,immune response-activating signal transd...,321,6,6.45,0.62775,1,1,0.93,BP
GO:0060047,heart contraction,215,4,4.32,0.63030,1,1,0.93,BP
GO:0072511,divalent inorganic cation transport,480,9,9.65,0.63047,1,1,0.93,BP
GO:0001961,positive regulation of cytokine-mediated...,49,1,0.98,0.63067,1,1,1.02,BP
GO:0002279,mast cell activation involved in immune ...,49,1,0.98,0.63067,1,1,1.02,BP
GO:0002448,mast cell mediated immunity,49,1,0.98,0.63067,1,1,1.02,BP
GO:0010862,positive regulation of pathway-restricte...,49,1,0.98,0.63067,1,1,1.02,BP
GO:0014888,striated muscle adaptation,49,1,0.98,0.63067,1,1,1.02,BP
GO:0031050,dsRNA processing,49,1,0.98,0.63067,1,1,1.02,BP
GO:0043300,regulation of leukocyte degranulation,49,1,0.98,0.63067,1,1,1.02,BP
GO:0050873,brown fat cell differentiation,49,1,0.98,0.63067,1,1,1.02,BP
GO:0070169,positive regulation of biomineral tissue...,49,1,0.98,0.63067,1,1,1.02,BP
GO:0070918,production of small RNA involved in gene...,49,1,0.98,0.63067,1,1,1.02,BP
GO:0099054,presynapse assembly,49,1,0.98,0.63067,1,1,1.02,BP
GO:1904036,negative regulation of epithelial cell a...,49,1,0.98,0.63067,1,1,1.02,BP
GO:0018108,peptidyl-tyrosine phosphorylation,322,6,6.47,0.63074,1,1,0.93,BP
GO:0006631,fatty acid metabolic process,375,7,7.54,0.63093,1,1,0.93,BP
GO:0010950,positive regulation of endopeptidase act...,161,3,3.24,0.63113,1,1,0.93,BP
GO:0030217,T cell differentiation,269,5,5.41,0.63151,1,1,0.92,BP
GO:0006875,cellular metal ion homeostasis,585,11,11.76,0.63158,1,1,0.94,BP
GO:0032091,negative regulation of protein binding,106,2,2.13,0.63181,1,1,0.94,BP
GO:0034766,negative regulation of ion transmembrane...,106,2,2.13,0.63181,1,1,0.94,BP
GO:1903844,regulation of cellular response to trans...,106,2,2.13,0.63181,1,1,0.94,BP
GO:0030855,epithelial cell differentiation,638,12,12.82,0.63356,1,1,0.94,BP
GO:0003002,regionalization,376,7,7.56,0.63369,1,1,0.93,BP
GO:0042593,glucose homeostasis,270,5,5.43,0.63475,1,1,0.92,BP
GO:2001236,regulation of extrinsic apoptotic signal...,162,3,3.26,0.63529,1,1,0.92,BP
GO:0009914,hormone transport,377,7,7.58,0.63645,1,1,0.92,BP
GO:0014812,muscle cell migration,107,2,2.15,0.63690,1,1,0.93,BP
GO:0044264,cellular polysaccharide metabolic proces...,107,2,2.15,0.63690,1,1,0.93,BP
GO:0055006,cardiac cell development,107,2,2.15,0.63690,1,1,0.93,BP
GO:0009205,purine ribonucleoside triphosphate metab...,271,5,5.45,0.63797,1,1,0.92,BP
GO:0030336,negative regulation of cell migration,271,5,5.45,0.63797,1,1,0.92,BP
GO:0033500,carbohydrate homeostasis,271,5,5.45,0.63797,1,1,0.92,BP
GO:0010828,positive regulation of glucose transmemb...,50,1,1.01,0.63811,1,1,0.99,BP
GO:0033003,regulation of mast cell activation,50,1,1.01,0.63811,1,1,0.99,BP
GO:0033173,calcineurin-NFAT signaling cascade,50,1,1.01,0.63811,1,1,0.99,BP
GO:0042491,inner ear auditory receptor cell differe...,50,1,1.01,0.63811,1,1,0.99,BP
GO:0050891,multicellular organismal water homeostas...,50,1,1.01,0.63811,1,1,0.99,BP
GO:0051955,regulation of amino acid transport,50,1,1.01,0.63811,1,1,0.99,BP
GO:0060043,regulation of cardiac muscle cell prolif...,50,1,1.01,0.63811,1,1,0.99,BP
GO:0090329,regulation of DNA-dependent DNA replicat...,50,1,1.01,0.63811,1,1,0.99,BP
GO:0001505,regulation of neurotransmitter levels,378,7,7.6,0.63918,1,1,0.92,BP
GO:0050851,antigen receptor-mediated signaling path...,163,3,3.28,0.63941,1,1,0.91,BP
GO:0072524,pyridine-containing compound metabolic p...,163,3,3.28,0.63941,1,1,0.91,BP
GO:0002440,production of molecular mediator of immu...,218,4,4.38,0.64108,1,1,0.91,BP
GO:0003014,renal system process,108,2,2.17,0.64193,1,1,0.92,BP
GO:0015844,monoamine transport,108,2,2.17,0.64193,1,1,0.92,BP
GO:0022600,digestive system process,108,2,2.17,0.64193,1,1,0.92,BP
GO:0071222,cellular response to lipopolysaccharide,273,5,5.49,0.64437,1,1,0.91,BP
GO:0033673,negative regulation of kinase activity,219,4,4.4,0.64463,1,1,0.91,BP
GO:0006812,cation transport,1110,21,22.31,0.64463,1,1,0.94,BP
GO:0001974,blood vessel remodeling,51,1,1.03,0.64541,1,1,0.97,BP
GO:0007032,endosome organization,51,1,1.03,0.64541,1,1,0.97,BP
GO:0007129,synapsis,51,1,1.03,0.64541,1,1,0.97,BP
GO:0008038,neuron recognition,51,1,1.03,0.64541,1,1,0.97,BP
GO:0021587,cerebellum morphogenesis,51,1,1.03,0.64541,1,1,0.97,BP
GO:0030834,regulation of actin filament depolymeriz...,51,1,1.03,0.64541,1,1,0.97,BP
GO:0032355,response to estradiol,51,1,1.03,0.64541,1,1,0.97,BP
GO:0043550,regulation of lipid kinase activity,51,1,1.03,0.64541,1,1,0.97,BP
GO:0048806,genitalia development,51,1,1.03,0.64541,1,1,0.97,BP
GO:0051954,positive regulation of amine transport,51,1,1.03,0.64541,1,1,0.97,BP
GO:0061001,regulation of dendritic spine morphogene...,51,1,1.03,0.64541,1,1,0.97,BP
GO:0072132,mesenchyme morphogenesis,51,1,1.03,0.64541,1,1,0.97,BP
GO:0001942,hair follicle development,109,2,2.19,0.64691,1,1,0.91,BP
GO:0019882,antigen processing and presentation,109,2,2.19,0.64691,1,1,0.91,BP
GO:0032963,collagen metabolic process,109,2,2.19,0.64691,1,1,0.91,BP
GO:0048259,regulation of receptor-mediated endocyto...,109,2,2.19,0.64691,1,1,0.91,BP
GO:0060562,epithelial tube morphogenesis,381,7,7.66,0.64733,1,1,0.91,BP
GO:0010038,response to metal ion,274,5,5.51,0.64754,1,1,0.91,BP
GO:0090287,regulation of cellular response to growt...,274,5,5.51,0.64754,1,1,0.91,BP
GO:0002792,negative regulation of peptide secretion,165,3,3.32,0.64756,1,1,0.9,BP
GO:0098655,cation transmembrane transport,698,13,14.03,0.64983,1,1,0.93,BP
GO:0044283,small molecule biosynthetic process,646,12,12.98,0.65045,1,1,0.92,BP
GO:0009199,ribonucleoside triphosphate metabolic pr...,275,5,5.53,0.65069,1,1,0.9,BP
GO:0030258,lipid modification,221,4,4.44,0.65165,1,1,0.9,BP
GO:2000379,positive regulation of reactive oxygen s...,110,2,2.21,0.65184,1,1,0.9,BP
GO:0000288,nuclear-transcribed mRNA catabolic proce...,52,1,1.05,0.65255,1,1,0.95,BP
GO:0009994,oocyte differentiation,52,1,1.05,0.65255,1,1,0.95,BP
GO:0030901,midbrain development,52,1,1.05,0.65255,1,1,0.95,BP
GO:0031103,axon regeneration,52,1,1.05,0.65255,1,1,0.95,BP
GO:0061614,pri-miRNA transcription by RNA polymeras...,52,1,1.05,0.65255,1,1,0.95,BP
GO:2001222,regulation of neuron migration,52,1,1.05,0.65255,1,1,0.95,BP
GO:0002263,cell activation involved in immune respo...,276,5,5.55,0.65382,1,1,0.9,BP
GO:0006790,sulfur compound metabolic process,276,5,5.55,0.65382,1,1,0.9,BP
GO:0006732,coenzyme metabolic process,330,6,6.63,0.65413,1,1,0.9,BP
GO:0002218,activation of innate immune response,167,3,3.36,0.65559,1,1,0.89,BP
GO:0034404,nucleobase-containing small molecule bio...,167,3,3.36,0.65559,1,1,0.89,BP
GO:0022404,molting cycle process,111,2,2.23,0.65671,1,1,0.9,BP
GO:0022405,hair cycle process,111,2,2.23,0.65671,1,1,0.9,BP
GO:0098773,skin epidermis development,111,2,2.23,0.65671,1,1,0.9,BP
GO:0055074,calcium ion homeostasis,492,9,9.89,0.65933,1,1,0.91,BP
GO:0045333,cellular respiration,168,3,3.38,0.65955,1,1,0.89,BP
GO:0009583,detection of light stimulus,53,1,1.07,0.65955,1,1,0.93,BP
GO:0035176,social behavior,53,1,1.07,0.65955,1,1,0.93,BP
GO:0045214,sarcomere organization,53,1,1.07,0.65955,1,1,0.93,BP
GO:0045777,positive regulation of blood pressure,53,1,1.07,0.65955,1,1,0.93,BP
GO:0051703,intraspecies interaction between organis...,53,1,1.07,0.65955,1,1,0.93,BP
GO:0055010,ventricular cardiac muscle tissue morpho...,53,1,1.07,0.65955,1,1,0.93,BP
GO:0061077,chaperone-mediated protein folding,53,1,1.07,0.65955,1,1,0.93,BP
GO:0097720,calcineurin-mediated signaling,53,1,1.07,0.65955,1,1,0.93,BP
GO:0009144,purine nucleoside triphosphate metabolic...,279,5,5.61,0.66312,1,1,0.89,BP
GO:0097237,cellular response to toxic substance,169,3,3.4,0.66348,1,1,0.88,BP
GO:0003015,heart process,225,4,4.52,0.66543,1,1,0.88,BP
GO:0002764,immune response-regulating signaling pat...,334,6,6.71,0.66548,1,1,0.89,BP
GO:0050830,defense response to Gram-positive bacter...,113,2,2.27,0.66629,1,1,0.88,BP
GO:0060078,regulation of postsynaptic membrane pote...,113,2,2.27,0.66629,1,1,0.88,BP
GO:0002385,mucosal immune response,54,1,1.09,0.66641,1,1,0.92,BP
GO:0003044,regulation of systemic arterial blood pr...,54,1,1.09,0.66641,1,1,0.92,BP
GO:0007618,mating,54,1,1.09,0.66641,1,1,0.92,BP
GO:0009948,anterior/posterior axis specification,54,1,1.09,0.66641,1,1,0.92,BP
GO:0010517,regulation of phospholipase activity,54,1,1.09,0.66641,1,1,0.92,BP
GO:0032731,positive regulation of interleukin-1 bet...,54,1,1.09,0.66641,1,1,0.92,BP
GO:0032964,collagen biosynthetic process,54,1,1.09,0.66641,1,1,0.92,BP
GO:0035065,regulation of histone acetylation,54,1,1.09,0.66641,1,1,0.92,BP
GO:0048546,digestive tract morphogenesis,54,1,1.09,0.66641,1,1,0.92,BP
GO:0055025,positive regulation of cardiac muscle ti...,54,1,1.09,0.66641,1,1,0.92,BP
GO:0055078,sodium ion homeostasis,54,1,1.09,0.66641,1,1,0.92,BP
GO:0086001,cardiac muscle cell action potential,54,1,1.09,0.66641,1,1,0.92,BP
GO:1900271,regulation of long-term synaptic potenti...,54,1,1.09,0.66641,1,1,0.92,BP
GO:1903533,regulation of protein targeting,54,1,1.09,0.66641,1,1,0.92,BP
GO:2000351,regulation of endothelial cell apoptotic...,54,1,1.09,0.66641,1,1,0.92,BP
GO:2000241,regulation of reproductive process,170,3,3.42,0.66737,1,1,0.88,BP
GO:0071219,cellular response to molecule of bacteri...,281,5,5.65,0.66923,1,1,0.88,BP
GO:0006090,pyruvate metabolic process,114,2,2.29,0.67100,1,1,0.87,BP
GO:0031398,positive regulation of protein ubiquitin...,114,2,2.29,0.67100,1,1,0.87,BP
GO:0007154,cell communication,6556,128,131.78,0.67276,1,1,0.97,BP
GO:0006900,vesicle budding from membrane,55,1,1.11,0.67313,1,1,0.9,BP
GO:0019369,arachidonic acid metabolic process,55,1,1.11,0.67313,1,1,0.9,BP
GO:0021575,hindbrain morphogenesis,55,1,1.11,0.67313,1,1,0.9,BP
GO:0030042,actin filament depolymerization,55,1,1.11,0.67313,1,1,0.9,BP
GO:0032655,regulation of interleukin-12 production,55,1,1.11,0.67313,1,1,0.9,BP
GO:0035272,exocrine system development,55,1,1.11,0.67313,1,1,0.9,BP
GO:0035315,hair cell differentiation,55,1,1.11,0.67313,1,1,0.9,BP
GO:0045058,T cell selection,55,1,1.11,0.67313,1,1,0.9,BP
GO:0045599,negative regulation of fat cell differen...,55,1,1.11,0.67313,1,1,0.9,BP
GO:0045687,positive regulation of glial cell differ...,55,1,1.11,0.67313,1,1,0.9,BP
GO:0046580,negative regulation of Ras protein signa...,55,1,1.11,0.67313,1,1,0.9,BP
GO:0046718,viral entry into host cell,55,1,1.11,0.67313,1,1,0.9,BP
GO:0050732,negative regulation of peptidyl-tyrosine...,55,1,1.11,0.67313,1,1,0.9,BP
GO:0050775,positive regulation of dendrite morphoge...,55,1,1.11,0.67313,1,1,0.9,BP
GO:0050922,negative regulation of chemotaxis,55,1,1.11,0.67313,1,1,0.9,BP
GO:0010035,response to inorganic substance,498,9,10.01,0.67326,1,1,0.9,BP
GO:0009607,response to biotic stimulus,1076,20,21.63,0.67329,1,1,0.92,BP
GO:0007268,chemical synaptic transmission,868,16,17.45,0.67445,1,1,0.92,BP
GO:0098916,anterograde trans-synaptic signaling,868,16,17.45,0.67445,1,1,0.92,BP
GO:0001775,cell activation,973,18,19.56,0.67524,1,1,0.92,BP
GO:0032368,regulation of lipid transport,115,2,2.31,0.67565,1,1,0.87,BP
GO:0071901,negative regulation of protein serine/th...,115,2,2.31,0.67565,1,1,0.87,BP
GO:1905330,regulation of morphogenesis of an epithe...,115,2,2.31,0.67565,1,1,0.87,BP
GO:0006163,purine nucleotide metabolic process,446,8,8.96,0.67676,1,1,0.89,BP
GO:0061448,connective tissue development,284,5,5.71,0.67825,1,1,0.88,BP
GO:2000146,negative regulation of cell motility,284,5,5.71,0.67825,1,1,0.88,BP
GO:0002251,organ or tissue specific immune response,56,1,1.13,0.67972,1,1,0.88,BP
GO:0002833,positive regulation of response to bioti...,56,1,1.13,0.67972,1,1,0.88,BP
GO:0019731,antibacterial humoral response,56,1,1.13,0.67972,1,1,0.88,BP
GO:0030104,water homeostasis,56,1,1.13,0.67972,1,1,0.88,BP
GO:0035019,somatic stem cell population maintenance,56,1,1.13,0.67972,1,1,0.88,BP
GO:0043620,regulation of DNA-templated transcriptio...,56,1,1.13,0.67972,1,1,0.88,BP
GO:0046513,ceramide biosynthetic process,56,1,1.13,0.67972,1,1,0.88,BP
GO:0060761,negative regulation of response to cytok...,56,1,1.13,0.67972,1,1,0.88,BP
GO:2000648,positive regulation of stem cell prolife...,56,1,1.13,0.67972,1,1,0.88,BP
GO:0072503,cellular divalent inorganic cation homeo...,501,9,10.07,0.68010,1,1,0.89,BP
GO:2001023,regulation of response to drug,116,2,2.33,0.68025,1,1,0.86,BP
GO:0046649,lymphocyte activation,714,13,14.35,0.68123,1,1,0.91,BP
GO:0009132,nucleoside diphosphate metabolic process,117,2,2.35,0.68480,1,1,0.85,BP
GO:0030282,bone mineralization,117,2,2.35,0.68480,1,1,0.85,BP
GO:0090305,nucleic acid phosphodiester bond hydroly...,117,2,2.35,0.68480,1,1,0.85,BP
GO:0007588,excretion,57,1,1.15,0.68618,1,1,0.87,BP
GO:0010665,regulation of cardiac muscle cell apopto...,57,1,1.15,0.68618,1,1,0.87,BP
GO:0032653,regulation of interleukin-10 production,57,1,1.15,0.68618,1,1,0.87,BP
GO:0042551,neuron maturation,57,1,1.15,0.68618,1,1,0.87,BP
GO:0043470,regulation of carbohydrate catabolic pro...,57,1,1.15,0.68618,1,1,0.87,BP
GO:0045620,negative regulation of lymphocyte differ...,57,1,1.15,0.68618,1,1,0.87,BP
GO:0046622,positive regulation of organ growth,57,1,1.15,0.68618,1,1,0.87,BP
GO:0051445,regulation of meiotic cell cycle,57,1,1.15,0.68618,1,1,0.87,BP
GO:0072347,response to anesthetic,57,1,1.15,0.68618,1,1,0.87,BP
GO:1903539,protein localization to postsynaptic mem...,57,1,1.15,0.68618,1,1,0.87,BP
GO:0006733,oxidoreduction coenzyme metabolic proces...,175,3,3.52,0.68635,1,1,0.85,BP
GO:0098660,inorganic ion transmembrane transport,664,12,13.35,0.68690,1,1,0.9,BP
GO:0005976,polysaccharide metabolic process,118,2,2.37,0.68929,1,1,0.84,BP
GO:0019751,polyol metabolic process,118,2,2.37,0.68929,1,1,0.84,BP
GO:1903052,positive regulation of proteolysis invol...,118,2,2.37,0.68929,1,1,0.84,BP
GO:0099537,trans-synaptic signaling,877,16,17.63,0.69007,1,1,0.91,BP
GO:0051186,cofactor metabolic process,506,9,10.17,0.69131,1,1,0.88,BP
GO:0001754,eye photoreceptor cell differentiation,58,1,1.17,0.69250,1,1,0.85,BP
GO:0032615,interleukin-12 production,58,1,1.17,0.69250,1,1,0.85,BP
GO:0048016,inositol phosphate-mediated signaling,58,1,1.17,0.69250,1,1,0.85,BP
GO:0065002,intracellular protein transmembrane tran...,58,1,1.17,0.69250,1,1,0.85,BP
GO:0070972,protein localization to endoplasmic reti...,58,1,1.17,0.69250,1,1,0.85,BP
GO:0098900,regulation of action potential,58,1,1.17,0.69250,1,1,0.85,BP
GO:1900449,regulation of glutamate receptor signali...,58,1,1.17,0.69250,1,1,0.85,BP
GO:0055065,metal ion homeostasis,667,12,13.41,0.69275,1,1,0.89,BP
GO:0008016,regulation of heart contraction,177,3,3.56,0.69372,1,1,0.84,BP
GO:0043902,positive regulation of multi-organism pr...,177,3,3.56,0.69372,1,1,0.84,BP
GO:0002062,chondrocyte differentiation,119,2,2.39,0.69373,1,1,0.84,BP
GO:0051952,regulation of amine transport,119,2,2.39,0.69373,1,1,0.84,BP
GO:0050878,regulation of body fluid levels,345,6,6.93,0.69547,1,1,0.87,BP
GO:0048608,reproductive structure development,454,8,9.13,0.69566,1,1,0.88,BP
GO:0048489,synaptic vesicle transport,178,3,3.58,0.69735,1,1,0.84,BP
GO:0097480,establishment of synaptic vesicle locali...,178,3,3.58,0.69735,1,1,0.84,BP
GO:1901136,carbohydrate derivative catabolic proces...,120,2,2.41,0.69812,1,1,0.83,BP
GO:0045089,positive regulation of innate immune res...,235,4,4.72,0.69822,1,1,0.85,BP
GO:0001755,neural crest cell migration,59,1,1.19,0.69870,1,1,0.84,BP
GO:0010524,positive regulation of calcium ion trans...,59,1,1.19,0.69870,1,1,0.84,BP
GO:0010656,negative regulation of muscle cell apopt...,59,1,1.19,0.69870,1,1,0.84,BP
GO:0015872,dopamine transport,59,1,1.19,0.69870,1,1,0.84,BP
GO:0030260,entry into host cell,59,1,1.19,0.69870,1,1,0.84,BP
GO:0032663,regulation of interleukin-2 production,59,1,1.19,0.69870,1,1,0.84,BP
GO:0032835,glomerulus development,59,1,1.19,0.69870,1,1,0.84,BP
GO:0035567,non-canonical Wnt signaling pathway,59,1,1.19,0.69870,1,1,0.84,BP
GO:0044409,entry into host,59,1,1.19,0.69870,1,1,0.84,BP
GO:0046128,purine ribonucleoside metabolic process,59,1,1.19,0.69870,1,1,0.84,BP
GO:0051806,entry into cell of other organism involv...,59,1,1.19,0.69870,1,1,0.84,BP
GO:0051828,entry into other organism involved in sy...,59,1,1.19,0.69870,1,1,0.84,BP
GO:0071806,protein transmembrane transport,59,1,1.19,0.69870,1,1,0.84,BP
GO:1901616,organic hydroxy compound catabolic proce...,59,1,1.19,0.69870,1,1,0.84,BP
GO:0023052,signaling,6490,126,130.45,0.69871,1,1,0.97,BP
GO:0051707,response to other organism,1040,19,20.9,0.69890,1,1,0.91,BP
GO:0006575,cellular modified amino acid metabolic p...,179,3,3.6,0.70095,1,1,0.83,BP
GO:0007219,Notch signaling pathway,179,3,3.6,0.70095,1,1,0.83,BP
GO:0010951,negative regulation of endopeptidase act...,179,3,3.6,0.70095,1,1,0.83,BP
GO:0140013,meiotic nuclear division,179,3,3.6,0.70095,1,1,0.83,BP
GO:0043207,response to external biotic stimulus,1042,19,20.94,0.70201,1,1,0.91,BP
GO:0031929,TOR signaling,121,2,2.43,0.70246,1,1,0.82,BP
GO:0046620,regulation of organ growth,121,2,2.43,0.70246,1,1,0.82,BP
GO:0007416,synapse assembly,180,3,3.62,0.70452,1,1,0.83,BP
GO:0001825,blastocyst formation,60,1,1.21,0.70477,1,1,0.83,BP
GO:0007595,lactation,60,1,1.21,0.70477,1,1,0.83,BP
GO:0010662,regulation of striated muscle cell apopt...,60,1,1.21,0.70477,1,1,0.83,BP
GO:0060119,inner ear receptor cell development,60,1,1.21,0.70477,1,1,0.83,BP
GO:0060324,face development,60,1,1.21,0.70477,1,1,0.83,BP
GO:0060986,endocrine hormone secretion,60,1,1.21,0.70477,1,1,0.83,BP
GO:2001238,positive regulation of extrinsic apoptot...,60,1,1.21,0.70477,1,1,0.83,BP
GO:0061458,reproductive system development,458,8,9.21,0.70484,1,1,0.87,BP
GO:0099536,synaptic signaling,886,16,17.81,0.70526,1,1,0.9,BP
GO:0006888,ER to Golgi vesicle-mediated transport,122,2,2.45,0.70674,1,1,0.82,BP
GO:0010906,regulation of glucose metabolic process,122,2,2.45,0.70674,1,1,0.82,BP
GO:0009141,nucleoside triphosphate metabolic proces...,295,5,5.93,0.70993,1,1,0.84,BP
GO:0015850,organic hydroxy compound transport,239,4,4.8,0.71068,1,1,0.83,BP
GO:0002712,regulation of B cell mediated immunity,61,1,1.23,0.71072,1,1,0.81,BP
GO:0002886,regulation of myeloid leukocyte mediated...,61,1,1.23,0.71072,1,1,0.81,BP
GO:0002889,regulation of immunoglobulin mediated im...,61,1,1.23,0.71072,1,1,0.81,BP
GO:0006446,regulation of translational initiation,61,1,1.23,0.71072,1,1,0.81,BP
GO:0006493,protein O-linked glycosylation,61,1,1.23,0.71072,1,1,0.81,BP
GO:0010659,cardiac muscle cell apoptotic process,61,1,1.23,0.71072,1,1,0.81,BP
GO:0021695,cerebellar cortex development,61,1,1.23,0.71072,1,1,0.81,BP
GO:0030837,negative regulation of actin filament po...,61,1,1.23,0.71072,1,1,0.81,BP
GO:0032613,interleukin-10 production,61,1,1.23,0.71072,1,1,0.81,BP
GO:0042058,regulation of epidermal growth factor re...,61,1,1.23,0.71072,1,1,0.81,BP
GO:0051058,negative regulation of small GTPase medi...,61,1,1.23,0.71072,1,1,0.81,BP
GO:1903428,positive regulation of reactive oxygen s...,61,1,1.23,0.71072,1,1,0.81,BP
GO:0002377,immunoglobulin production,123,2,2.47,0.71097,1,1,0.81,BP
GO:0007368,determination of left/right symmetry,123,2,2.47,0.71097,1,1,0.81,BP
GO:0015837,amine transport,123,2,2.47,0.71097,1,1,0.81,BP
GO:0050868,negative regulation of T cell activation,123,2,2.47,0.71097,1,1,0.81,BP
GO:0002521,leukocyte differentiation,570,10,11.46,0.71276,1,1,0.87,BP
GO:0007586,digestion,124,2,2.49,0.71516,1,1,0.8,BP
GO:0042157,lipoprotein metabolic process,124,2,2.49,0.71516,1,1,0.8,BP
GO:0003229,ventricular cardiac muscle tissue develo...,62,1,1.25,0.71655,1,1,0.8,BP
GO:0010171,body morphogenesis,62,1,1.25,0.71655,1,1,0.8,BP
GO:0010812,negative regulation of cell-substrate ad...,62,1,1.25,0.71655,1,1,0.8,BP
GO:0032732,positive regulation of interleukin-1 pro...,62,1,1.25,0.71655,1,1,0.8,BP
GO:0042461,photoreceptor cell development,62,1,1.25,0.71655,1,1,0.8,BP
GO:0045143,homologous chromosome segregation,62,1,1.25,0.71655,1,1,0.8,BP
GO:0090501,RNA phosphodiester bond hydrolysis,62,1,1.25,0.71655,1,1,0.8,BP
GO:1902105,regulation of leukocyte differentiation,298,5,5.99,0.71818,1,1,0.83,BP
GO:0051262,protein tetramerization,184,3,3.7,0.71846,1,1,0.81,BP
GO:1903706,regulation of hemopoiesis,410,7,8.24,0.72028,1,1,0.85,BP
GO:0051588,regulation of neurotransmitter transport,185,3,3.72,0.72187,1,1,0.81,BP
GO:0032677,regulation of interleukin-8 production,63,1,1.27,0.72227,1,1,0.79,BP
GO:0042246,tissue regeneration,63,1,1.27,0.72227,1,1,0.79,BP
GO:0043949,regulation of cAMP-mediated signaling,63,1,1.27,0.72227,1,1,0.79,BP
GO:0045661,regulation of myoblast differentiation,63,1,1.27,0.72227,1,1,0.79,BP
GO:0060393,regulation of pathway-restricted SMAD pr...,63,1,1.27,0.72227,1,1,0.79,BP
GO:1903307,positive regulation of regulated secreto...,63,1,1.27,0.72227,1,1,0.79,BP
GO:2000756,regulation of peptidyl-lysine acetylatio...,63,1,1.27,0.72227,1,1,0.79,BP
GO:0016064,immunoglobulin mediated immune response,126,2,2.53,0.72337,1,1,0.79,BP
GO:0055086,nucleobase-containing small molecule met...,631,11,12.68,0.72636,1,1,0.87,BP
GO:0043280,positive regulation of cysteine-type end...,127,2,2.55,0.72740,1,1,0.78,BP
GO:0060048,cardiac muscle contraction,127,2,2.55,0.72740,1,1,0.78,BP
GO:0001510,RNA methylation,64,1,1.29,0.72787,1,1,0.78,BP
GO:0009880,embryonic pattern specification,64,1,1.29,0.72787,1,1,0.78,BP
GO:0010658,striated muscle cell apoptotic process,64,1,1.29,0.72787,1,1,0.78,BP
GO:0010676,positive regulation of cellular carbohyd...,64,1,1.29,0.72787,1,1,0.78,BP
GO:0030512,negative regulation of transforming grow...,64,1,1.29,0.72787,1,1,0.78,BP
GO:0032720,negative regulation of tumor necrosis fa...,64,1,1.29,0.72787,1,1,0.78,BP
GO:0035904,aorta development,64,1,1.29,0.72787,1,1,0.78,BP
GO:0042278,purine nucleoside metabolic process,64,1,1.29,0.72787,1,1,0.78,BP
GO:0046579,positive regulation of Ras protein signa...,64,1,1.29,0.72787,1,1,0.78,BP
GO:0046394,carboxylic acid biosynthetic process,359,6,7.22,0.73097,1,1,0.83,BP
GO:0009582,detection of abiotic stimulus,128,2,2.57,0.73138,1,1,0.78,BP
GO:0030218,erythrocyte differentiation,128,2,2.57,0.73138,1,1,0.78,BP
GO:0031623,receptor internalization,128,2,2.57,0.73138,1,1,0.78,BP
GO:0042303,molting cycle,128,2,2.57,0.73138,1,1,0.78,BP
GO:0042633,hair cycle,128,2,2.57,0.73138,1,1,0.78,BP
GO:0072507,divalent inorganic cation homeostasis,525,9,10.55,0.73162,1,1,0.85,BP
GO:0006109,regulation of carbohydrate metabolic pro...,188,3,3.78,0.73189,1,1,0.79,BP
GO:0007507,heart development,634,11,12.74,0.73196,1,1,0.86,BP
GO:0001707,mesoderm formation,65,1,1.31,0.73335,1,1,0.76,BP
GO:0030032,lamellipodium assembly,65,1,1.31,0.73335,1,1,0.76,BP
GO:0048278,vesicle docking,65,1,1.31,0.73335,1,1,0.76,BP
GO:0051926,negative regulation of calcium ion trans...,65,1,1.31,0.73335,1,1,0.76,BP
GO:0099601,regulation of neurotransmitter receptor ...,65,1,1.31,0.73335,1,1,0.76,BP
GO:1901264,carbohydrate derivative transport,65,1,1.31,0.73335,1,1,0.76,BP
GO:1903556,negative regulation of tumor necrosis fa...,65,1,1.31,0.73335,1,1,0.76,BP
GO:2000736,regulation of stem cell differentiation,65,1,1.31,0.73335,1,1,0.76,BP
GO:2001169,regulation of ATP biosynthetic process,65,1,1.31,0.73335,1,1,0.76,BP
GO:0016053,organic acid biosynthetic process,360,6,7.24,0.73339,1,1,0.83,BP
GO:0071216,cellular response to biotic stimulus,304,5,6.11,0.73417,1,1,0.82,BP
GO:0050870,positive regulation of T cell activation,189,3,3.8,0.73517,1,1,0.79,BP
GO:0097479,synaptic vesicle localization,189,3,3.8,0.73517,1,1,0.79,BP
GO:0003279,cardiac septum development,129,2,2.59,0.73531,1,1,0.77,BP
GO:0009581,detection of external stimulus,129,2,2.59,0.73531,1,1,0.77,BP
GO:0014065,phosphatidylinositol 3-kinase signaling,129,2,2.59,0.73531,1,1,0.77,BP
GO:0035195,gene silencing by miRNA,129,2,2.59,0.73531,1,1,0.77,BP
GO:0048640,negative regulation of developmental gro...,129,2,2.59,0.73531,1,1,0.77,BP
GO:0051592,response to calcium ion,129,2,2.59,0.73531,1,1,0.77,BP
GO:0050806,positive regulation of synaptic transmis...,362,6,7.28,0.73819,1,1,0.82,BP
GO:0042440,pigment metabolic process,66,1,1.33,0.73873,1,1,0.75,BP
GO:0045123,cellular extravasation,66,1,1.33,0.73873,1,1,0.75,BP
GO:0046324,regulation of glucose import,66,1,1.33,0.73873,1,1,0.75,BP
GO:0060389,pathway-restricted SMAD protein phosphor...,66,1,1.33,0.73873,1,1,0.75,BP
GO:0071260,cellular response to mechanical stimulus,66,1,1.33,0.73873,1,1,0.75,BP
GO:1901184,regulation of ERBB signaling pathway,66,1,1.33,0.73873,1,1,0.75,BP
GO:0019724,B cell mediated immunity,130,2,2.61,0.73919,1,1,0.77,BP
GO:0046883,regulation of hormone secretion,307,5,6.17,0.74192,1,1,0.81,BP
GO:0015696,ammonium transport,131,2,2.63,0.74303,1,1,0.76,BP
GO:0045995,regulation of embryonic development,131,2,2.63,0.74303,1,1,0.76,BP
GO:0023061,signal release,531,9,10.67,0.74360,1,1,0.84,BP
GO:0032623,interleukin-2 production,67,1,1.35,0.74400,1,1,0.74,BP
GO:0060688,regulation of morphogenesis of a branchi...,67,1,1.35,0.74400,1,1,0.74,BP
GO:0071695,anatomical structure maturation,192,3,3.86,0.74481,1,1,0.78,BP
GO:0009166,nucleotide catabolic process,132,2,2.65,0.74681,1,1,0.75,BP
GO:0050863,regulation of T cell activation,309,5,6.21,0.74699,1,1,0.81,BP
GO:0055002,striated muscle cell development,193,3,3.88,0.74797,1,1,0.77,BP
GO:0002711,positive regulation of T cell mediated i...,68,1,1.37,0.74916,1,1,0.73,BP
GO:0006305,DNA alkylation,68,1,1.37,0.74916,1,1,0.73,BP
GO:0006306,DNA methylation,68,1,1.37,0.74916,1,1,0.73,BP
GO:0032922,circadian regulation of gene expression,68,1,1.37,0.74916,1,1,0.73,BP
GO:0090278,negative regulation of peptide hormone s...,68,1,1.37,0.74916,1,1,0.73,BP
GO:0046488,phosphatidylinositol metabolic process,133,2,2.67,0.75055,1,1,0.75,BP
GO:0050906,detection of stimulus involved in sensor...,133,2,2.67,0.75055,1,1,0.75,BP
GO:0002429,immune response-activating cell surface ...,194,3,3.9,0.75109,1,1,0.77,BP
GO:0009888,tissue development,1970,36,39.6,0.75144,1,1,0.91,BP
GO:0030003,cellular cation homeostasis,645,11,12.96,0.75183,1,1,0.85,BP
GO:0001541,ovarian follicle development,69,1,1.39,0.75422,1,1,0.72,BP
GO:0006766,vitamin metabolic process,69,1,1.39,0.75422,1,1,0.72,BP
GO:0007405,neuroblast proliferation,69,1,1.39,0.75422,1,1,0.72,BP
GO:0032637,interleukin-8 production,69,1,1.39,0.75422,1,1,0.72,BP
GO:0043299,leukocyte degranulation,69,1,1.39,0.75422,1,1,0.72,BP
GO:0043407,negative regulation of MAP kinase activi...,69,1,1.39,0.75422,1,1,0.72,BP
GO:0045576,mast cell activation,69,1,1.39,0.75422,1,1,0.72,BP
GO:0048146,positive regulation of fibroblast prolif...,69,1,1.39,0.75422,1,1,0.72,BP
GO:0048332,mesoderm morphogenesis,69,1,1.39,0.75422,1,1,0.72,BP
GO:0002698,negative regulation of immune effector p...,134,2,2.69,0.75424,1,1,0.74,BP
GO:0034763,negative regulation of transmembrane tra...,134,2,2.69,0.75424,1,1,0.74,BP
GO:0048167,regulation of synaptic plasticity,369,6,7.42,0.75448,1,1,0.81,BP
GO:0003205,cardiac chamber development,196,3,3.94,0.75723,1,1,0.76,BP
GO:0042180,cellular ketone metabolic process,196,3,3.94,0.75723,1,1,0.76,BP
GO:0035194,posttranscriptional gene silencing by RN...,135,2,2.71,0.75788,1,1,0.74,BP
GO:0002090,regulation of receptor internalization,70,1,1.41,0.75917,1,1,0.71,BP
GO:0003341,cilium movement,70,1,1.41,0.75917,1,1,0.71,BP
GO:0050864,regulation of B cell activation,136,2,2.73,0.76148,1,1,0.73,BP
GO:0006469,negative regulation of protein kinase ac...,198,3,3.98,0.76326,1,1,0.75,BP
GO:0001913,T cell mediated cytotoxicity,71,1,1.43,0.76403,1,1,0.7,BP
GO:0009119,ribonucleoside metabolic process,71,1,1.43,0.76403,1,1,0.7,BP
GO:0032413,negative regulation of ion transmembrane...,71,1,1.43,0.76403,1,1,0.7,BP
GO:0046173,polyol biosynthetic process,71,1,1.43,0.76403,1,1,0.7,BP
GO:0050433,regulation of catecholamine secretion,71,1,1.43,0.76403,1,1,0.7,BP
GO:0050801,ion homeostasis,816,14,16.4,0.76455,1,1,0.85,BP
GO:0045055,regulated exocytosis,258,4,5.19,0.76471,1,1,0.77,BP
GO:0071236,cellular response to antibiotic,199,3,4,0.76623,1,1,0.75,BP
GO:0042509,regulation of tyrosine phosphorylation o...,72,1,1.45,0.76879,1,1,0.69,BP
GO:0097755,positive regulation of blood vessel diam...,72,1,1.45,0.76879,1,1,0.69,BP
GO:0045087,innate immune response,710,12,14.27,0.76922,1,1,0.84,BP
GO:0048469,cell maturation,201,3,4.04,0.77207,1,1,0.74,BP
GO:0006887,exocytosis,377,6,7.58,0.77219,1,1,0.79,BP
GO:0009611,response to wounding,491,8,9.87,0.77362,1,1,0.81,BP
GO:0016079,synaptic vesicle exocytosis,140,2,2.81,0.77540,1,1,0.71,BP
GO:0016573,histone acetylation,140,2,2.81,0.77540,1,1,0.71,BP
GO:0072521,purine-containing compound metabolic pro...,492,8,9.89,0.77551,1,1,0.81,BP
GO:0008610,lipid biosynthetic process,548,9,11.01,0.77552,1,1,0.82,BP
GO:0006873,cellular ion homeostasis,659,11,13.25,0.77565,1,1,0.83,BP
GO:0002066,columnar/cuboidal epithelial cell develo...,74,1,1.49,0.77802,1,1,0.67,BP
GO:0002532,production of molecular mediator involve...,74,1,1.49,0.77802,1,1,0.67,BP
GO:0007193,adenylate cyclase-inhibiting G protein-c...,74,1,1.49,0.77802,1,1,0.67,BP
GO:0042130,negative regulation of T cell proliferat...,74,1,1.49,0.77802,1,1,0.67,BP
GO:0050432,catecholamine secretion,74,1,1.49,0.77802,1,1,0.67,BP
GO:0051155,positive regulation of striated muscle c...,74,1,1.49,0.77802,1,1,0.67,BP
GO:0060191,regulation of lipase activity,74,1,1.49,0.77802,1,1,0.67,BP
GO:1901983,regulation of protein acetylation,74,1,1.49,0.77802,1,1,0.67,BP
GO:1903036,positive regulation of response to wound...,74,1,1.49,0.77802,1,1,0.67,BP
GO:0010821,regulation of mitochondrion organization,141,2,2.83,0.77877,1,1,0.71,BP
GO:0048568,embryonic organ development,495,8,9.95,0.78111,1,1,0.8,BP
GO:0007292,female gamete generation,142,2,2.85,0.78209,1,1,0.7,BP
GO:0002637,regulation of immunoglobulin production,75,1,1.51,0.78250,1,1,0.66,BP
GO:0003333,amino acid transmembrane transport,75,1,1.51,0.78250,1,1,0.66,BP
GO:0060563,neuroepithelial cell differentiation,75,1,1.51,0.78250,1,1,0.66,BP
GO:0061097,regulation of protein tyrosine kinase ac...,75,1,1.51,0.78250,1,1,0.66,BP
GO:0072089,stem cell proliferation,143,2,2.87,0.78538,1,1,0.7,BP
GO:1901292,nucleoside phosphate catabolic process,143,2,2.87,0.78538,1,1,0.7,BP
GO:0002768,immune response-regulating cell surface ...,206,3,4.14,0.78616,1,1,0.72,BP
GO:0007260,tyrosine phosphorylation of STAT protein,76,1,1.53,0.78689,1,1,0.65,BP
GO:0010822,positive regulation of mitochondrion org...,76,1,1.53,0.78689,1,1,0.65,BP
GO:0032272,negative regulation of protein polymeriz...,76,1,1.53,0.78689,1,1,0.65,BP
GO:0045453,bone resorption,76,1,1.53,0.78689,1,1,0.65,BP
GO:0055008,cardiac muscle tissue morphogenesis,76,1,1.53,0.78689,1,1,0.65,BP
GO:0007281,germ cell development,326,5,6.55,0.78714,1,1,0.76,BP
GO:0002009,morphogenesis of an epithelium,555,9,11.16,0.78780,1,1,0.81,BP
GO:0042391,regulation of membrane potential,442,7,8.88,0.78810,1,1,0.79,BP
GO:0055007,cardiac muscle cell differentiation,144,2,2.89,0.78861,1,1,0.69,BP
GO:0071333,cellular response to glucose stimulus,144,2,2.89,0.78861,1,1,0.69,BP
GO:0090288,negative regulation of cellular response...,144,2,2.89,0.78861,1,1,0.69,BP
GO:2001056,positive regulation of cysteine-type end...,144,2,2.89,0.78861,1,1,0.69,BP
GO:0051224,negative regulation of protein transport,207,3,4.16,0.78889,1,1,0.72,BP
GO:0055001,muscle cell development,207,3,4.16,0.78889,1,1,0.72,BP
GO:0001756,somitogenesis,77,1,1.55,0.79119,1,1,0.65,BP
GO:0015918,sterol transport,77,1,1.55,0.79119,1,1,0.65,BP
GO:0030301,cholesterol transport,77,1,1.55,0.79119,1,1,0.65,BP
GO:0051965,positive regulation of synapse assembly,77,1,1.55,0.79119,1,1,0.65,BP
GO:0140056,organelle localization by membrane tethe...,77,1,1.55,0.79119,1,1,0.65,BP
GO:0007204,positive regulation of cytosolic calcium...,328,5,6.59,0.79153,1,1,0.76,BP
GO:0018393,internal peptidyl-lysine acetylation,145,2,2.91,0.79181,1,1,0.69,BP
GO:0008544,epidermis development,329,5,6.61,0.79369,1,1,0.76,BP
GO:0007224,smoothened signaling pathway,146,2,2.93,0.79496,1,1,0.68,BP
GO:1905952,regulation of lipid localization,146,2,2.93,0.79496,1,1,0.68,BP
GO:0030148,sphingolipid biosynthetic process,78,1,1.57,0.79540,1,1,0.64,BP
GO:0032729,positive regulation of interferon-gamma ...,78,1,1.57,0.79540,1,1,0.64,BP
GO:0061180,mammary gland epithelium development,78,1,1.57,0.79540,1,1,0.64,BP
GO:0061515,myeloid cell development,78,1,1.57,0.79540,1,1,0.64,BP
GO:1901606,alpha-amino acid catabolic process,78,1,1.57,0.79540,1,1,0.64,BP
GO:1901135,carbohydrate derivative metabolic proces...,1003,17,20.16,0.79804,1,1,0.84,BP
GO:0003006,developmental process involved in reprod...,784,13,15.76,0.79805,1,1,0.82,BP
GO:0071331,cellular response to hexose stimulus,147,2,2.95,0.79807,1,1,0.68,BP
GO:0019722,calcium-mediated signaling,211,3,4.24,0.79952,1,1,0.71,BP
GO:0042098,T cell proliferation,211,3,4.24,0.79952,1,1,0.71,BP
GO:0030808,regulation of nucleotide biosynthetic pr...,79,1,1.59,0.79953,1,1,0.63,BP
GO:0061844,antimicrobial humoral immune response me...,79,1,1.59,0.79953,1,1,0.63,BP
GO:0071277,cellular response to calcium ion,79,1,1.59,0.79953,1,1,0.63,BP
GO:1900371,regulation of purine nucleotide biosynth...,79,1,1.59,0.79953,1,1,0.63,BP
GO:0003206,cardiac chamber morphogenesis,148,2,2.97,0.80113,1,1,0.67,BP
GO:0006475,internal protein amino acid acetylation,148,2,2.97,0.80113,1,1,0.67,BP
GO:0071326,cellular response to monosaccharide stim...,148,2,2.97,0.80113,1,1,0.67,BP
GO:0030595,leukocyte chemotaxis,212,3,4.26,0.80211,1,1,0.7,BP
GO:1904950,negative regulation of establishment of ...,212,3,4.26,0.80211,1,1,0.7,BP
GO:0032787,monocarboxylic acid metabolic process,564,9,11.34,0.80287,1,1,0.79,BP
GO:0006919,activation of cysteine-type endopeptidas...,80,1,1.61,0.80357,1,1,0.62,BP
GO:0032410,negative regulation of transporter activ...,80,1,1.61,0.80357,1,1,0.62,BP
GO:0032890,regulation of organic acid transport,80,1,1.61,0.80357,1,1,0.62,BP
GO:0003231,cardiac ventricle development,149,2,2.99,0.80416,1,1,0.67,BP
GO:0002700,regulation of production of molecular me...,150,2,3.02,0.80715,1,1,0.66,BP
GO:0006664,glycolipid metabolic process,81,1,1.63,0.80753,1,1,0.61,BP
GO:0038034,signal transduction in absence of ligand,81,1,1.63,0.80753,1,1,0.61,BP
GO:0043279,response to alkaloid,81,1,1.63,0.80753,1,1,0.61,BP
GO:0051702,interaction with symbiont,81,1,1.63,0.80753,1,1,0.61,BP
GO:0060113,inner ear receptor cell differentiation,81,1,1.63,0.80753,1,1,0.61,BP
GO:0070613,regulation of protein processing,81,1,1.63,0.80753,1,1,0.61,BP
GO:0097192,extrinsic apoptotic signaling pathway in...,81,1,1.63,0.80753,1,1,0.61,BP
GO:2000243,positive regulation of reproductive proc...,81,1,1.63,0.80753,1,1,0.61,BP
GO:0055080,cation homeostasis,736,12,14.79,0.80855,1,1,0.81,BP
GO:0019637,organophosphate metabolic process,957,16,19.24,0.80884,1,1,0.83,BP
GO:0006865,amino acid transport,151,2,3.04,0.81009,1,1,0.66,BP
GO:0002253,activation of immune response,396,6,7.96,0.81041,1,1,0.75,BP
GO:0001738,morphogenesis of a polarized epithelium,82,1,1.65,0.81142,1,1,0.61,BP
GO:0002718,regulation of cytokine production involv...,82,1,1.65,0.81142,1,1,0.61,BP
GO:0022406,membrane docking,82,1,1.65,0.81142,1,1,0.61,BP
GO:0032651,regulation of interleukin-1 beta product...,82,1,1.65,0.81142,1,1,0.61,BP
GO:0044106,cellular amine metabolic process,82,1,1.65,0.81142,1,1,0.61,BP
GO:1903509,liposaccharide metabolic process,82,1,1.65,0.81142,1,1,0.61,BP
GO:0009913,epidermal cell differentiation,216,3,4.34,0.81217,1,1,0.69,BP
GO:0042113,B cell activation,278,4,5.59,0.81275,1,1,0.72,BP
GO:0035050,embryonic heart tube development,83,1,1.67,0.81522,1,1,0.6,BP
GO:1903317,regulation of protein maturation,83,1,1.67,0.81522,1,1,0.6,BP
GO:0003007,heart morphogenesis,280,4,5.63,0.81709,1,1,0.71,BP
GO:0009100,glycoprotein metabolic process,341,5,6.85,0.81831,1,1,0.73,BP
GO:0010675,regulation of cellular carbohydrate meta...,154,2,3.1,0.81869,1,1,0.65,BP
GO:0044728,DNA methylation or demethylation,84,1,1.69,0.81895,1,1,0.59,BP
GO:0009101,glycoprotein biosynthetic process,281,4,5.65,0.81922,1,1,0.71,BP
GO:0042742,defense response to bacterium,281,4,5.65,0.81922,1,1,0.71,BP
GO:0043547,positive regulation of GTPase activity,219,3,4.4,0.81944,1,1,0.68,BP
GO:0006310,DNA recombination,282,4,5.67,0.82134,1,1,0.71,BP
GO:0050709,negative regulation of protein secretion,155,2,3.12,0.82147,1,1,0.64,BP
GO:0071322,cellular response to carbohydrate stimul...,155,2,3.12,0.82147,1,1,0.64,BP
GO:0014032,neural crest cell development,85,1,1.71,0.82260,1,1,0.58,BP
GO:0032526,response to retinoic acid,85,1,1.71,0.82260,1,1,0.58,BP
GO:0097581,lamellipodium organization,85,1,1.71,0.82260,1,1,0.58,BP
GO:0006694,steroid biosynthetic process,156,2,3.14,0.82422,1,1,0.64,BP
GO:0018394,peptidyl-lysine acetylation,156,2,3.14,0.82422,1,1,0.64,BP
GO:0002275,myeloid cell activation involved in immu...,86,1,1.73,0.82618,1,1,0.58,BP
GO:0006096,glycolytic process,86,1,1.73,0.82618,1,1,0.58,BP
GO:0034103,regulation of tissue remodeling,86,1,1.73,0.82618,1,1,0.58,BP
GO:0042632,cholesterol homeostasis,86,1,1.73,0.82618,1,1,0.58,BP
GO:0060411,cardiac septum morphogenesis,86,1,1.73,0.82618,1,1,0.58,BP
GO:0051250,negative regulation of lymphocyte activa...,157,2,3.16,0.82693,1,1,0.63,BP
GO:0098771,inorganic ion homeostasis,750,12,15.08,0.82759,1,1,0.8,BP
GO:0009156,ribonucleoside monophosphate biosyntheti...,158,2,3.18,0.82960,1,1,0.63,BP
GO:0006757,ATP generation from ADP,87,1,1.75,0.82969,1,1,0.57,BP
GO:0009593,detection of chemical stimulus,87,1,1.75,0.82969,1,1,0.57,BP
GO:0042490,mechanoreceptor differentiation,87,1,1.75,0.82969,1,1,0.57,BP
GO:0051384,response to glucocorticoid,87,1,1.75,0.82969,1,1,0.57,BP
GO:0055092,sterol homeostasis,87,1,1.75,0.82969,1,1,0.57,BP
GO:0002520,immune system development,1030,17,20.7,0.83025,1,1,0.82,BP
GO:0002449,lymphocyte mediated immunity,287,4,5.77,0.83161,1,1,0.69,BP
GO:0032945,negative regulation of mononuclear cell ...,88,1,1.77,0.83313,1,1,0.56,BP
GO:0050672,negative regulation of lymphocyte prolif...,88,1,1.77,0.83313,1,1,0.56,BP
GO:0030097,hemopoiesis,922,15,18.53,0.83317,1,1,0.81,BP
GO:0030073,insulin secretion,225,3,4.52,0.83325,1,1,0.66,BP
GO:0032496,response to lipopolysaccharide,349,5,7.01,0.83338,1,1,0.71,BP
GO:0044262,cellular carbohydrate metabolic process,288,4,5.79,0.83360,1,1,0.69,BP
GO:0002694,regulation of leukocyte activation,528,8,10.61,0.83606,1,1,0.75,BP
GO:0001656,metanephros development,89,1,1.79,0.83650,1,1,0.56,BP
GO:0051149,positive regulation of muscle cell diffe...,89,1,1.79,0.83650,1,1,0.56,BP
GO:0051937,catecholamine transport,89,1,1.79,0.83650,1,1,0.56,BP
GO:0060415,muscle tissue morphogenesis,89,1,1.79,0.83650,1,1,0.56,BP
GO:0070301,cellular response to hydrogen peroxide,89,1,1.79,0.83650,1,1,0.56,BP
GO:0006941,striated muscle contraction,161,2,3.24,0.83740,1,1,0.62,BP
GO:0031214,biomineral tissue development,161,2,3.24,0.83740,1,1,0.62,BP
GO:0071466,cellular response to xenobiotic stimulus,161,2,3.24,0.83740,1,1,0.62,BP
GO:0009116,nucleoside metabolic process,90,1,1.81,0.83980,1,1,0.55,BP
GO:0014031,mesenchymal cell development,90,1,1.81,0.83980,1,1,0.55,BP
GO:0031016,pancreas development,90,1,1.81,0.83980,1,1,0.55,BP
GO:0042866,pyruvate biosynthetic process,90,1,1.81,0.83980,1,1,0.55,BP
GO:0009260,ribonucleotide biosynthetic process,228,3,4.58,0.83982,1,1,0.66,BP
GO:0006650,glycerophospholipid metabolic process,229,3,4.6,0.84195,1,1,0.65,BP
GO:0030879,mammary gland development,163,2,3.28,0.84242,1,1,0.61,BP
GO:0000041,transition metal ion transport,91,1,1.83,0.84303,1,1,0.55,BP
GO:0002709,regulation of T cell mediated immunity,91,1,1.83,0.84303,1,1,0.55,BP
GO:0019226,transmission of nerve impulse,91,1,1.83,0.84303,1,1,0.55,BP
GO:0031960,response to corticosteroid,91,1,1.83,0.84303,1,1,0.55,BP
GO:0048864,stem cell development,91,1,1.83,0.84303,1,1,0.55,BP
GO:0043588,skin development,293,4,5.89,0.84328,1,1,0.68,BP
GO:0055082,cellular chemical homeostasis,819,13,16.46,0.84344,1,1,0.79,BP
GO:1901617,organic hydroxy compound biosynthetic pr...,230,3,4.62,0.84406,1,1,0.65,BP
GO:0001678,cellular glucose homeostasis,164,2,3.3,0.84487,1,1,0.61,BP
GO:0009124,nucleoside monophosphate biosynthetic pr...,164,2,3.3,0.84487,1,1,0.61,BP
GO:0051606,detection of stimulus,231,3,4.64,0.84615,1,1,0.65,BP
GO:0009063,cellular amino acid catabolic process,92,1,1.85,0.84620,1,1,0.54,BP
GO:0009308,amine metabolic process,92,1,1.85,0.84620,1,1,0.54,BP
GO:0014033,neural crest cell differentiation,92,1,1.85,0.84620,1,1,0.54,BP
GO:0060348,bone development,232,3,4.66,0.84822,1,1,0.64,BP
GO:0002683,negative regulation of immune system pro...,478,7,9.61,0.84880,1,1,0.73,BP
GO:0048511,rhythmic process,296,4,5.95,0.84885,1,1,0.67,BP
GO:0045445,myoblast differentiation,93,1,1.87,0.84931,1,1,0.53,BP
GO:0070664,negative regulation of leukocyte prolife...,93,1,1.87,0.84931,1,1,0.53,BP
GO:0007179,transforming growth factor beta receptor...,166,2,3.34,0.84968,1,1,0.6,BP
GO:0043543,protein acylation,233,3,4.68,0.85026,1,1,0.64,BP
GO:0045088,regulation of innate immune response,297,4,5.97,0.85067,1,1,0.67,BP
GO:0032611,interleukin-1 beta production,94,1,1.89,0.85235,1,1,0.53,BP
GO:0046031,ADP metabolic process,94,1,1.89,0.85235,1,1,0.53,BP
GO:0048477,oogenesis,94,1,1.89,0.85235,1,1,0.53,BP
GO:0050829,defense response to Gram-negative bacter...,94,1,1.89,0.85235,1,1,0.53,BP
GO:0019725,cellular homeostasis,940,15,18.89,0.85315,1,1,0.79,BP
GO:0046390,ribose phosphate biosynthetic process,235,3,4.72,0.85426,1,1,0.64,BP
GO:1901615,organic hydroxy compound metabolic proce...,482,7,9.69,0.85459,1,1,0.72,BP
GO:0002444,myeloid leukocyte mediated immunity,95,1,1.91,0.85533,1,1,0.52,BP
GO:0045069,regulation of viral genome replication,95,1,1.91,0.85533,1,1,0.52,BP
GO:0045582,positive regulation of T cell differenti...,95,1,1.91,0.85533,1,1,0.52,BP
GO:0050795,regulation of behavior,95,1,1.91,0.85533,1,1,0.52,BP
GO:0051817,modification of morphology or physiology...,95,1,1.91,0.85533,1,1,0.52,BP
GO:0060968,regulation of gene silencing,95,1,1.91,0.85533,1,1,0.52,BP
GO:0002705,positive regulation of leukocyte mediate...,169,2,3.4,0.85664,1,1,0.59,BP
GO:1903531,negative regulation of secretion by cell,237,3,4.76,0.85818,1,1,0.63,BP
GO:0061053,somite development,96,1,1.93,0.85825,1,1,0.52,BP
GO:0001101,response to acid chemical,364,5,7.32,0.85888,1,1,0.68,BP
GO:0007178,transmembrane receptor protein serine/th...,364,5,7.32,0.85888,1,1,0.68,BP
GO:0006304,DNA modification,97,1,1.95,0.86111,1,1,0.51,BP
GO:0014066,regulation of phosphatidylinositol 3-kin...,97,1,1.95,0.86111,1,1,0.51,BP
GO:0019395,fatty acid oxidation,97,1,1.95,0.86111,1,1,0.51,BP
GO:0046888,negative regulation of hormone secretion,97,1,1.95,0.86111,1,1,0.51,BP
GO:0048644,muscle organ morphogenesis,97,1,1.95,0.86111,1,1,0.51,BP
GO:0140029,exocytic process,97,1,1.95,0.86111,1,1,0.51,BP
GO:0006836,neurotransmitter transport,303,4,6.09,0.86122,1,1,0.66,BP
GO:1903522,regulation of blood circulation,239,3,4.8,0.86200,1,1,0.62,BP
GO:0002237,response to molecule of bacterial origin,367,5,7.38,0.86357,1,1,0.68,BP
GO:0019730,antimicrobial humoral response,98,1,1.97,0.86392,1,1,0.51,BP
GO:0045132,meiotic chromosome segregation,98,1,1.97,0.86392,1,1,0.51,BP
GO:0002460,adaptive immune response based on somati...,305,4,6.13,0.86459,1,1,0.65,BP
GO:0035296,regulation of tube diameter,173,2,3.48,0.86546,1,1,0.57,BP
GO:0050880,regulation of blood vessel size,173,2,3.48,0.86546,1,1,0.57,BP
GO:0097746,regulation of blood vessel diameter,173,2,3.48,0.86546,1,1,0.57,BP
GO:0051249,regulation of lymphocyte activation,430,6,8.64,0.86608,1,1,0.69,BP
GO:0006165,nucleoside diphosphate phosphorylation,99,1,1.99,0.86666,1,1,0.5,BP
GO:0006641,triglyceride metabolic process,99,1,1.99,0.86666,1,1,0.5,BP
GO:0030279,negative regulation of ossification,99,1,1.99,0.86666,1,1,0.5,BP
GO:0034440,lipid oxidation,99,1,1.99,0.86666,1,1,0.5,BP
GO:0045639,positive regulation of myeloid cell diff...,99,1,1.99,0.86666,1,1,0.5,BP
GO:0035150,regulation of tube size,174,2,3.5,0.86758,1,1,0.57,BP
GO:0032652,regulation of interleukin-1 production,100,1,2.01,0.86936,1,1,0.5,BP
GO:0002703,regulation of leukocyte mediated immunit...,243,3,4.88,0.86937,1,1,0.61,BP
GO:0002443,leukocyte mediated immunity,372,5,7.48,0.87110,1,1,0.67,BP
GO:0060429,epithelium development,1182,19,23.76,0.87113,1,1,0.8,BP
GO:0042129,regulation of T cell proliferation,176,2,3.54,0.87174,1,1,0.56,BP
GO:0045921,positive regulation of exocytosis,101,1,2.03,0.87200,1,1,0.49,BP
GO:0055013,cardiac muscle cell development,101,1,2.03,0.87200,1,1,0.49,BP
GO:0062014,negative regulation of small molecule me...,102,1,2.05,0.87458,1,1,0.49,BP
GO:0051480,regulation of cytosolic calcium ion conc...,375,5,7.54,0.87545,1,1,0.66,BP
GO:0017156,calcium ion regulated exocytosis,178,2,3.58,0.87578,1,1,0.56,BP
GO:0017157,regulation of exocytosis,247,3,4.96,0.87640,1,1,0.6,BP
GO:0019359,nicotinamide nucleotide biosynthetic pro...,103,1,2.07,0.87711,1,1,0.48,BP
GO:0046651,lymphocyte proliferation,313,4,6.29,0.87738,1,1,0.64,BP
GO:0048729,tissue morphogenesis,679,10,13.65,0.87937,1,1,0.73,BP
GO:0017015,regulation of transforming growth factor...,104,1,2.09,0.87960,1,1,0.48,BP
GO:0030317,flagellated sperm motility,104,1,2.09,0.87960,1,1,0.48,BP
GO:0043255,regulation of carbohydrate biosynthetic ...,104,1,2.09,0.87960,1,1,0.48,BP
GO:2000300,regulation of synaptic vesicle exocytosi...,104,1,2.09,0.87960,1,1,0.48,BP
GO:0051188,cofactor biosynthetic process,249,3,5,0.87978,1,1,0.6,BP
GO:0032943,mononuclear cell proliferation,315,4,6.33,0.88041,1,1,0.63,BP
GO:0097722,sperm motility,105,1,2.11,0.88203,1,1,0.47,BP
GO:1903825,organic acid transmembrane transport,105,1,2.11,0.88203,1,1,0.47,BP
GO:1905039,carboxylic acid transmembrane transport,105,1,2.11,0.88203,1,1,0.47,BP
GO:1903034,regulation of response to wounding,182,2,3.66,0.88351,1,1,0.55,BP
GO:0048534,hematopoietic or lymphoid organ developm...,972,15,19.54,0.88409,1,1,0.77,BP
GO:0019363,pyridine nucleotide biosynthetic process,106,1,2.13,0.88441,1,1,0.47,BP
GO:0035282,segmentation,106,1,2.13,0.88441,1,1,0.47,BP
GO:0002696,positive regulation of leukocyte activat...,318,4,6.39,0.88483,1,1,0.63,BP
GO:0002699,positive regulation of immune effector p...,253,3,5.09,0.88631,1,1,0.59,BP
GO:0002822,regulation of adaptive immune response b...,185,2,3.72,0.88902,1,1,0.54,BP
GO:0009749,response to glucose,185,2,3.72,0.88902,1,1,0.54,BP
GO:0006612,protein targeting to membrane,108,1,2.17,0.88903,1,1,0.46,BP
GO:0021700,developmental maturation,321,4,6.45,0.88911,1,1,0.62,BP
GO:0050865,regulation of cell activation,570,8,11.46,0.88965,1,1,0.7,BP
GO:0009566,fertilization,186,2,3.74,0.89080,1,1,0.53,BP
GO:0006690,icosanoid metabolic process,109,1,2.19,0.89128,1,1,0.46,BP
GO:0045621,positive regulation of lymphocyte differ...,109,1,2.19,0.89128,1,1,0.46,BP
GO:1902803,regulation of synaptic vesicle transport,109,1,2.19,0.89128,1,1,0.46,BP
GO:0002695,negative regulation of leukocyte activat...,187,2,3.76,0.89255,1,1,0.53,BP
GO:0002706,regulation of lymphocyte mediated immuni...,187,2,3.76,0.89255,1,1,0.53,BP
GO:0050796,regulation of insulin secretion,187,2,3.76,0.89255,1,1,0.53,BP
GO:0032649,regulation of interferon-gamma productio...,110,1,2.21,0.89347,1,1,0.45,BP
GO:0072525,pyridine-containing compound biosyntheti...,110,1,2.21,0.89347,1,1,0.45,BP
GO:0006629,lipid metabolic process,1266,20,25.45,0.89366,1,1,0.79,BP
GO:0006473,protein acetylation,188,2,3.78,0.89428,1,1,0.53,BP
GO:0007156,homophilic cell adhesion via plasma memb...,111,1,2.23,0.89562,1,1,0.45,BP
GO:0046632,alpha-beta T cell differentiation,111,1,2.23,0.89562,1,1,0.45,BP
GO:0007269,neurotransmitter secretion,189,2,3.8,0.89598,1,1,0.53,BP
GO:0009746,response to hexose,189,2,3.8,0.89598,1,1,0.53,BP
GO:1903305,regulation of regulated secretory pathwa...,189,2,3.8,0.89598,1,1,0.53,BP
GO:0034284,response to monosaccharide,190,2,3.82,0.89766,1,1,0.52,BP
GO:0099643,signal release from synapse,190,2,3.82,0.89766,1,1,0.52,BP
GO:0007127,meiosis I,112,1,2.25,0.89773,1,1,0.44,BP
GO:0042100,B cell proliferation,112,1,2.25,0.89773,1,1,0.44,BP
GO:0090100,positive regulation of transmembrane rec...,112,1,2.25,0.89773,1,1,0.44,BP
GO:1901657,glycosyl compound metabolic process,112,1,2.25,0.89773,1,1,0.44,BP
GO:0008585,female gonad development,113,1,2.27,0.89980,1,1,0.44,BP
GO:0032612,interleukin-1 production,113,1,2.27,0.89980,1,1,0.44,BP
GO:0090101,negative regulation of transmembrane rec...,113,1,2.27,0.89980,1,1,0.44,BP
GO:0006955,immune response,1387,22,27.88,0.90010,1,1,0.79,BP
GO:0009108,coenzyme biosynthetic process,192,2,3.86,0.90093,1,1,0.52,BP
GO:0046486,glycerolipid metabolic process,330,4,6.63,0.90112,1,1,0.6,BP
GO:0055114,oxidation-reduction process,878,13,17.65,0.90179,1,1,0.74,BP
GO:0048814,regulation of dendrite morphogenesis,114,1,2.29,0.90182,1,1,0.44,BP
GO:0044255,cellular lipid metabolic process,936,14,18.81,0.90186,1,1,0.74,BP
GO:0030098,lymphocyte differentiation,396,5,7.96,0.90251,1,1,0.63,BP
GO:0006869,lipid transport,332,4,6.67,0.90363,1,1,0.6,BP
GO:0042472,inner ear morphogenesis,115,1,2.31,0.90381,1,1,0.43,BP
GO:0046467,membrane lipid biosynthetic process,115,1,2.31,0.90381,1,1,0.43,BP
GO:0051251,positive regulation of lymphocyte activa...,265,3,5.33,0.90402,1,1,0.56,BP
GO:0002285,lymphocyte activation involved in immune...,195,2,3.92,0.90567,1,1,0.51,BP
GO:0046545,development of primary female sexual cha...,116,1,2.33,0.90575,1,1,0.43,BP
GO:0050867,positive regulation of cell activation,334,4,6.71,0.90609,1,1,0.6,BP
GO:0002684,positive regulation of immune system pro...,942,14,18.93,0.90650,1,1,0.74,BP
GO:0006006,glucose metabolic process,196,2,3.94,0.90720,1,1,0.51,BP
GO:0016051,carbohydrate biosynthetic process,196,2,3.94,0.90720,1,1,0.51,BP
GO:0061982,meiosis I cell cycle process,117,1,2.35,0.90766,1,1,0.43,BP
GO:0009617,response to bacterium,769,11,15.46,0.90850,1,1,0.71,BP
GO:0034220,ion transmembrane transport,887,13,17.83,0.90889,1,1,0.73,BP
GO:1901605,alpha-amino acid metabolic process,198,2,3.98,0.91019,1,1,0.5,BP
GO:0007498,mesoderm development,119,1,2.39,0.91135,1,1,0.42,BP
GO:0070661,leukocyte proliferation,339,4,6.81,0.91198,1,1,0.59,BP
GO:0002366,leukocyte activation involved in immune ...,272,3,5.47,0.91317,1,1,0.55,BP
GO:0002819,regulation of adaptive immune response,201,2,4.04,0.91451,1,1,0.5,BP
GO:0044070,regulation of anion transport,121,1,2.43,0.91490,1,1,0.41,BP
GO:0048565,digestive tract development,122,1,2.45,0.91662,1,1,0.41,BP
GO:0009743,response to carbohydrate,203,2,4.08,0.91728,1,1,0.49,BP
GO:0006639,acylglycerol metabolic process,123,1,2.47,0.91831,1,1,0.4,BP
GO:0032609,interferon-gamma production,123,1,2.47,0.91831,1,1,0.4,BP
GO:0042752,regulation of circadian rhythm,124,1,2.49,0.91996,1,1,0.4,BP
GO:0046434,organophosphate catabolic process,205,2,4.12,0.91996,1,1,0.49,BP
GO:0098742,cell-cell adhesion via plasma-membrane a...,205,2,4.12,0.91996,1,1,0.49,BP
GO:0006638,neutral lipid metabolic process,125,1,2.51,0.92158,1,1,0.4,BP
GO:0017144,drug metabolic process,727,10,14.61,0.92233,1,1,0.68,BP
GO:0000724,double-strand break repair via homologou...,126,1,2.53,0.92316,1,1,0.4,BP
GO:0000725,recombinational repair,126,1,2.53,0.92316,1,1,0.4,BP
GO:0050866,negative regulation of cell activation,208,2,4.18,0.92384,1,1,0.48,BP
GO:0005975,carbohydrate metabolic process,545,7,10.95,0.92424,1,1,0.64,BP
GO:0071229,cellular response to acid chemical,282,3,5.67,0.92487,1,1,0.53,BP
GO:1903708,positive regulation of hemopoiesis,209,2,4.2,0.92509,1,1,0.48,BP
GO:0009165,nucleotide biosynthetic process,284,3,5.71,0.92703,1,1,0.53,BP
GO:0048839,inner ear development,211,2,4.24,0.92753,1,1,0.47,BP
GO:0050778,positive regulation of immune response,617,8,12.4,0.93150,1,1,0.65,BP
GO:0001508,action potential,132,1,2.65,0.93203,1,1,0.38,BP
GO:1901568,fatty acid derivative metabolic process,132,1,2.65,0.93203,1,1,0.38,BP
GO:1901293,nucleoside phosphate biosynthetic proces...,290,3,5.83,0.93317,1,1,0.51,BP
GO:0006754,ATP biosynthetic process,133,1,2.67,0.93340,1,1,0.37,BP
GO:0001909,leukocyte mediated cytotoxicity,135,1,2.71,0.93607,1,1,0.37,BP
GO:0055123,digestive system development,135,1,2.71,0.93607,1,1,0.37,BP
GO:0009152,purine ribonucleotide biosynthetic proce...,219,2,4.4,0.93658,1,1,0.45,BP
GO:0010817,regulation of hormone levels,562,7,11.3,0.93716,1,1,0.62,BP
GO:0002708,positive regulation of lymphocyte mediat...,136,1,2.73,0.93736,1,1,0.37,BP
GO:0002824,positive regulation of adaptive immune r...,136,1,2.73,0.93736,1,1,0.37,BP
GO:0042060,wound healing,365,4,7.34,0.93762,1,1,0.54,BP
GO:0042471,ear morphogenesis,137,1,2.75,0.93863,1,1,0.36,BP
GO:0045598,regulation of fat cell differentiation,137,1,2.75,0.93863,1,1,0.36,BP
GO:0046928,regulation of neurotransmitter secretion,137,1,2.75,0.93863,1,1,0.36,BP
GO:0009451,RNA modification,138,1,2.77,0.93987,1,1,0.36,BP
GO:0017158,regulation of calcium ion-dependent exoc...,139,1,2.79,0.94109,1,1,0.36,BP
GO:0002250,adaptive immune response,439,5,8.82,0.94243,1,1,0.57,BP
GO:0043436,oxoacid metabolic process,940,13,18.89,0.94257,1,1,0.69,BP
GO:0019318,hexose metabolic process,225,2,4.52,0.94266,1,1,0.44,BP
GO:0007338,single fertilization,141,1,2.83,0.94345,1,1,0.35,BP
GO:0016052,carbohydrate catabolic process,141,1,2.83,0.94345,1,1,0.35,BP
GO:0010876,lipid localization,373,4,7.5,0.94403,1,1,0.53,BP
GO:0030216,keratinocyte differentiation,142,1,2.85,0.94459,1,1,0.35,BP
GO:0002821,positive regulation of adaptive immune r...,143,1,2.87,0.94571,1,1,0.35,BP
GO:0009206,purine ribonucleoside triphosphate biosy...,143,1,2.87,0.94571,1,1,0.35,BP
GO:0035637,multicellular organismal signaling,143,1,2.87,0.94571,1,1,0.35,BP
GO:0061041,regulation of wound healing,143,1,2.87,0.94571,1,1,0.35,BP
GO:0009145,purine nucleoside triphosphate biosynthe...,144,1,2.89,0.94681,1,1,0.35,BP
GO:0019233,sensory perception of pain,144,1,2.89,0.94681,1,1,0.35,BP
GO:0048863,stem cell differentiation,230,2,4.62,0.94729,1,1,0.43,BP
GO:0050670,regulation of lymphocyte proliferation,230,2,4.62,0.94729,1,1,0.43,BP
GO:0002065,columnar/cuboidal epithelial cell differ...,146,1,2.93,0.94894,1,1,0.34,BP
GO:0009201,ribonucleoside triphosphate biosynthetic...,146,1,2.93,0.94894,1,1,0.34,BP
GO:0032944,regulation of mononuclear cell prolifera...,232,2,4.66,0.94905,1,1,0.43,BP
GO:0035821,modification of morphology or physiology...,147,1,2.95,0.94998,1,1,0.34,BP
GO:0046660,female sex differentiation,147,1,2.95,0.94998,1,1,0.34,BP
GO:0098693,regulation of synaptic vesicle cycle,147,1,2.95,0.94998,1,1,0.34,BP
GO:0007187,G protein-coupled receptor signaling pat...,234,2,4.7,0.95074,1,1,0.43,BP
GO:0090092,regulation of transmembrane receptor pro...,235,2,4.72,0.95157,1,1,0.42,BP
GO:0009410,response to xenobiotic stimulus,236,2,4.74,0.95239,1,1,0.42,BP
GO:0050776,regulation of immune response,777,10,15.62,0.95251,1,1,0.64,BP
GO:0019752,carboxylic acid metabolic process,901,12,18.11,0.95292,1,1,0.66,BP
GO:0030183,B cell differentiation,150,1,3.02,0.95295,1,1,0.33,BP
GO:0055067,monovalent inorganic cation homeostasis,150,1,3.02,0.95295,1,1,0.33,BP
GO:0045580,regulation of T cell differentiation,151,1,3.04,0.95390,1,1,0.33,BP
GO:0006164,purine nucleotide biosynthetic process,238,2,4.78,0.95398,1,1,0.42,BP
GO:0016485,protein processing,238,2,4.78,0.95398,1,1,0.42,BP
GO:0006082,organic acid metabolic process,968,13,19.46,0.95559,1,1,0.67,BP
GO:0043583,ear development,241,2,4.84,0.95627,1,1,0.41,BP
GO:0009127,purine nucleoside monophosphate biosynth...,154,1,3.1,0.95665,1,1,0.32,BP
GO:0009168,purine ribonucleoside monophosphate bios...,154,1,3.1,0.95665,1,1,0.32,BP
GO:0072522,purine-containing compound biosynthetic ...,243,2,4.88,0.95774,1,1,0.41,BP
GO:0009142,nucleoside triphosphate biosynthetic pro...,156,1,3.14,0.95839,1,1,0.32,BP
GO:0070663,regulation of leukocyte proliferation,245,2,4.92,0.95915,1,1,0.41,BP
GO:0046631,alpha-beta T cell activation,157,1,3.16,0.95923,1,1,0.32,BP
GO:1901137,carbohydrate derivative biosynthetic pro...,600,7,12.06,0.95926,1,1,0.58,BP
GO:0002244,hematopoietic progenitor cell differenti...,158,1,3.18,0.96005,1,1,0.31,BP
GO:0050777,negative regulation of immune response,159,1,3.2,0.96086,1,1,0.31,BP
GO:0007601,visual perception,162,1,3.26,0.96319,1,1,0.31,BP
GO:0060291,long-term synaptic potentiation,253,2,5.09,0.96439,1,1,0.39,BP
GO:0005996,monosaccharide metabolic process,254,2,5.11,0.96500,1,1,0.39,BP
GO:0046425,regulation of JAK-STAT cascade,166,1,3.34,0.96609,1,1,0.3,BP
GO:0050953,sensory perception of light stimulus,166,1,3.34,0.96609,1,1,0.3,BP
GO:0030509,BMP signaling pathway,170,1,3.42,0.96875,1,1,0.29,BP
GO:1902107,positive regulation of leukocyte differe...,170,1,3.42,0.96875,1,1,0.29,BP
GO:1904892,regulation of STAT cascade,171,1,3.44,0.96938,1,1,0.29,BP
GO:0001906,cell killing,172,1,3.46,0.97001,1,1,0.29,BP
GO:0006520,cellular amino acid metabolic process,266,2,5.35,0.97155,1,1,0.37,BP
GO:0006644,phospholipid metabolic process,352,3,7.08,0.97394,1,1,0.42,BP
GO:0019933,cAMP-mediated signaling,181,1,3.64,0.97505,1,1,0.27,BP
GO:0071772,response to BMP,181,1,3.64,0.97505,1,1,0.27,BP
GO:0071773,cellular response to BMP stimulus,181,1,3.64,0.97505,1,1,0.27,BP
GO:0098656,anion transmembrane transport,182,1,3.66,0.97556,1,1,0.27,BP
GO:0019932,second-messenger-mediated signaling,432,4,8.68,0.97558,1,1,0.46,BP
GO:0009612,response to mechanical stimulus,183,1,3.68,0.97605,1,1,0.27,BP
GO:0045619,regulation of lymphocyte differentiation,184,1,3.7,0.97654,1,1,0.27,BP
GO:0055085,transmembrane transport,1281,17,25.75,0.97682,1,1,0.66,BP
GO:0044281,small molecule metabolic process,1760,25,35.38,0.97756,1,1,0.71,BP
GO:0007259,JAK-STAT cascade,190,1,3.82,0.97925,1,1,0.26,BP
GO:0097696,STAT cascade,195,1,3.92,0.98127,1,1,0.26,BP
GO:0006486,protein glycosylation,199,1,4,0.98275,1,1,0.25,BP
GO:0043413,macromolecule glycosylation,199,1,4,0.98275,1,1,0.25,BP
GO:0044242,cellular lipid catabolic process,199,1,4,0.98275,1,1,0.25,BP
GO:0051604,protein maturation,300,2,6.03,0.98432,1,1,0.33,BP
GO:0006959,humoral immune response,204,1,4.1,0.98443,1,1,0.24,BP
GO:0007188,adenylate cyclase-modulating G protein-c...,205,1,4.12,0.98475,1,1,0.24,BP
GO:0046942,carboxylic acid transport,303,2,6.09,0.98513,1,1,0.33,BP
GO:0015849,organic acid transport,304,2,6.11,0.98539,1,1,0.33,BP
GO:0015893,drug transport,209,1,4.2,0.98595,1,1,0.24,BP
GO:0006811,ion transport,1581,21,31.78,0.98633,1,1,0.66,BP
GO:0019935,cyclic-nucleotide-mediated signaling,213,1,4.28,0.98705,1,1,0.23,BP
GO:0070085,glycosylation,213,1,4.28,0.98705,1,1,0.23,BP
GO:0016054,organic acid catabolic process,215,1,4.32,0.98757,1,1,0.23,BP
GO:0046395,carboxylic acid catabolic process,215,1,4.32,0.98757,1,1,0.23,BP
GO:0044282,small molecule catabolic process,314,2,6.31,0.98777,1,1,0.32,BP
GO:1990823,response to leukemia inhibitory factor,328,2,6.59,0.99047,1,1,0.3,BP
GO:1990830,cellular response to leukemia inhibitory...,328,2,6.59,0.99047,1,1,0.3,BP
GO:0090407,organophosphate biosynthetic process,505,4,10.15,0.99178,1,1,0.39,BP
GO:0007605,sensory perception of sound,268,1,5.39,0.99582,1,1,0.19,BP
GO:0050954,sensory perception of mechanical stimulu...,299,1,6.01,0.99779,1,1,0.17,BP
GO:0016042,lipid catabolic process,307,1,6.17,0.99813,1,1,0.16,BP
GO:0015711,organic anion transport,420,2,8.44,0.99822,1,1,0.24,BP
GO:0006820,anion transport,555,2,11.16,0.99986,1,1,0.18,BP
GO:0003008,system process,2937,30,59.03,1.00000,1,1,0.51,BP
GO:0050877,nervous system process,2290,15,46.03,1.00000,1,1,0.33,BP
GO:0007186,G protein-coupled receptor signaling pat...,1902,8,38.23,1.00000,1,1,0.21,BP
GO:0007600,sensory perception,1781,3,35.8,1.00000,1,1,0.08,BP
GO:0008150,biological_process,21194,426,426,1.00000,1,1,1,BP
GO:0000038,very long-chain fatty acid metabolic pro...,30,0,0.6,1.00000,1,1,0,BP
GO:0000096,sulfur amino acid metabolic process,38,0,0.76,1.00000,1,1,0,BP
GO:0000132,establishment of mitotic spindle orienta...,30,0,0.6,1.00000,1,1,0,BP
GO:0000154,rRNA modification,25,0,0.5,1.00000,1,1,0,BP
GO:0000272,polysaccharide catabolic process,25,0,0.5,1.00000,1,1,0,BP
GO:0000387,spliceosomal snRNP assembly,31,0,0.62,1.00000,1,1,0,BP
GO:0000726,non-recombinational repair,57,0,1.15,1.00000,1,1,0,BP
GO:0000731,DNA synthesis involved in DNA repair,28,0,0.56,1.00000,1,1,0,BP
GO:0000737,"DNA catabolic process, endonucleolytic",26,0,0.52,1.00000,1,1,0,BP
GO:0000959,mitochondrial RNA metabolic process,42,0,0.84,1.00000,1,1,0,BP
GO:0001516,prostaglandin biosynthetic process,25,0,0.5,1.00000,1,1,0,BP
GO:0001523,retinoid metabolic process,55,0,1.11,1.00000,1,1,0,BP
GO:0001556,oocyte maturation,30,0,0.6,1.00000,1,1,0,BP
GO:0001562,response to protozoan,37,0,0.74,1.00000,1,1,0,BP
GO:0001573,ganglioside metabolic process,20,0,0.4,1.00000,1,1,0,BP
GO:0001580,detection of chemical stimulus involved ...,48,0,0.96,1.00000,1,1,0,BP
GO:0001696,gastric acid secretion,20,0,0.4,1.00000,1,1,0,BP
GO:0001736,establishment of planar polarity,61,0,1.23,1.00000,1,1,0,BP
GO:0001773,myeloid dendritic cell activation,33,0,0.66,1.00000,1,1,0,BP
GO:0001776,leukocyte homeostasis,110,0,2.21,1.00000,1,1,0,BP
GO:0001779,natural killer cell differentiation,31,0,0.62,1.00000,1,1,0,BP
GO:0001780,neutrophil homeostasis,22,0,0.44,1.00000,1,1,0,BP
GO:0001782,B cell homeostasis,37,0,0.74,1.00000,1,1,0,BP
GO:0001783,B cell apoptotic process,41,0,0.82,1.00000,1,1,0,BP
GO:0001829,trophectodermal cell differentiation,25,0,0.5,1.00000,1,1,0,BP
GO:0001890,placenta development,173,0,3.48,1.00000,1,1,0,BP
GO:0001892,embryonic placenta development,114,0,2.29,1.00000,1,1,0,BP
GO:0001893,maternal placenta development,32,0,0.64,1.00000,1,1,0,BP
GO:0001910,regulation of leukocyte mediated cytotox...,103,0,2.07,1.00000,1,1,0,BP
GO:0001911,negative regulation of leukocyte mediate...,23,0,0.46,1.00000,1,1,0,BP
GO:0001912,positive regulation of leukocyte mediate...,80,0,1.61,1.00000,1,1,0,BP
GO:0001914,regulation of T cell mediated cytotoxici...,51,0,1.03,1.00000,1,1,0,BP
GO:0001916,positive regulation of T cell mediated c...,46,0,0.92,1.00000,1,1,0,BP
GO:0001945,lymph vessel development,29,0,0.58,1.00000,1,1,0,BP
GO:0001946,lymphangiogenesis,21,0,0.42,1.00000,1,1,0,BP
GO:0001947,heart looping,60,0,1.21,1.00000,1,1,0,BP
GO:0001956,positive regulation of neurotransmitter ...,26,0,0.52,1.00000,1,1,0,BP
GO:0001958,endochondral ossification,30,0,0.6,1.00000,1,1,0,BP
GO:0001960,negative regulation of cytokine-mediated...,52,0,1.05,1.00000,1,1,0,BP
GO:0001976,neurological system process involved in ...,21,0,0.42,1.00000,1,1,0,BP
GO:0002011,morphogenesis of an epithelial sheet,59,0,1.19,1.00000,1,1,0,BP
GO:0002021,response to dietary excess,34,0,0.68,1.00000,1,1,0,BP
GO:0002026,regulation of the force of heart contrac...,31,0,0.62,1.00000,1,1,0,BP
GO:0002027,regulation of heart rate,93,0,1.87,1.00000,1,1,0,BP
GO:0002029,desensitization of G protein-coupled rec...,28,0,0.56,1.00000,1,1,0,BP
GO:0002067,glandular epithelial cell differentiatio...,59,0,1.19,1.00000,1,1,0,BP
GO:0002068,glandular epithelial cell development,28,0,0.56,1.00000,1,1,0,BP
GO:0002076,osteoblast development,20,0,0.4,1.00000,1,1,0,BP
GO:0002092,positive regulation of receptor internal...,29,0,0.58,1.00000,1,1,0,BP
GO:0002097,tRNA wobble base modification,21,0,0.42,1.00000,1,1,0,BP
GO:0002115,store-operated calcium entry,22,0,0.44,1.00000,1,1,0,BP
GO:0002228,natural killer cell mediated immunity,63,0,1.27,1.00000,1,1,0,BP
GO:0002260,lymphocyte homeostasis,78,0,1.57,1.00000,1,1,0,BP
GO:0002286,T cell activation involved in immune res...,113,0,2.27,1.00000,1,1,0,BP
GO:0002287,alpha-beta T cell activation involved in...,66,0,1.33,1.00000,1,1,0,BP
GO:0002292,T cell differentiation involved in immun...,71,0,1.43,1.00000,1,1,0,BP
GO:0002293,alpha-beta T cell differentiation involv...,65,0,1.31,1.00000,1,1,0,BP
GO:0002294,"CD4-positive, alpha-beta T cell differen...",64,0,1.29,1.00000,1,1,0,BP
GO:0002313,mature B cell differentiation involved i...,20,0,0.4,1.00000,1,1,0,BP
GO:0002320,lymphoid progenitor cell differentiation,23,0,0.46,1.00000,1,1,0,BP
GO:0002323,natural killer cell activation involved ...,39,0,0.78,1.00000,1,1,0,BP
GO:0002335,mature B cell differentiation,27,0,0.54,1.00000,1,1,0,BP
GO:0002374,cytokine secretion involved in immune re...,24,0,0.48,1.00000,1,1,0,BP
GO:0002428,antigen processing and presentation of p...,31,0,0.62,1.00000,1,1,0,BP
GO:0002437,inflammatory response to antigenic stimu...,58,0,1.17,1.00000,1,1,0,BP
GO:0002438,acute inflammatory response to antigenic...,25,0,0.5,1.00000,1,1,0,BP
GO:0002446,neutrophil mediated immunity,34,0,0.68,1.00000,1,1,0,BP
GO:0002455,humoral immune response mediated by circ...,44,0,0.88,1.00000,1,1,0,BP
GO:0002475,antigen processing and presentation via ...,35,0,0.7,1.00000,1,1,0,BP
GO:0002476,antigen processing and presentation of e...,30,0,0.6,1.00000,1,1,0,BP
GO:0002483,antigen processing and presentation of e...,37,0,0.74,1.00000,1,1,0,BP
GO:0002484,antigen processing and presentation of e...,30,0,0.6,1.00000,1,1,0,BP
GO:0002486,antigen processing and presentation of e...,29,0,0.58,1.00000,1,1,0,BP
GO:0002495,antigen processing and presentation of p...,21,0,0.42,1.00000,1,1,0,BP
GO:0002504,antigen processing and presentation of p...,22,0,0.44,1.00000,1,1,0,BP
GO:0002507,tolerance induction,28,0,0.56,1.00000,1,1,0,BP
GO:0002523,leukocyte migration involved in inflamma...,20,0,0.4,1.00000,1,1,0,BP
GO:0002526,acute inflammatory response,119,0,2.39,1.00000,1,1,0,BP
GO:0002548,monocyte chemotaxis,54,0,1.09,1.00000,1,1,0,BP
GO:0002577,regulation of antigen processing and pre...,21,0,0.42,1.00000,1,1,0,BP
GO:0002639,positive regulation of immunoglobulin pr...,50,0,1.01,1.00000,1,1,0,BP
GO:0002673,regulation of acute inflammatory respons...,63,0,1.27,1.00000,1,1,0,BP
GO:0002675,positive regulation of acute inflammator...,32,0,0.64,1.00000,1,1,0,BP
GO:0002691,regulation of cellular extravasation,32,0,0.64,1.00000,1,1,0,BP
GO:0002693,positive regulation of cellular extravas...,23,0,0.46,1.00000,1,1,0,BP
GO:0002702,positive regulation of production of mol...,103,0,2.07,1.00000,1,1,0,BP
GO:0002704,negative regulation of leukocyte mediate...,56,0,1.13,1.00000,1,1,0,BP
GO:0002707,negative regulation of lymphocyte mediat...,46,0,0.92,1.00000,1,1,0,BP
GO:0002714,positive regulation of B cell mediated i...,46,0,0.92,1.00000,1,1,0,BP
GO:0002715,regulation of natural killer cell mediat...,51,0,1.03,1.00000,1,1,0,BP
GO:0002716,negative regulation of natural killer ce...,20,0,0.4,1.00000,1,1,0,BP
GO:0002717,positive regulation of natural killer ce...,34,0,0.68,1.00000,1,1,0,BP
GO:0002720,positive regulation of cytokine producti...,53,0,1.07,1.00000,1,1,0,BP
GO:0002724,regulation of T cell cytokine production,30,0,0.6,1.00000,1,1,0,BP
GO:0002753,cytoplasmic pattern recognition receptor...,38,0,0.76,1.00000,1,1,0,BP
GO:0002763,positive regulation of myeloid leukocyte...,65,0,1.31,1.00000,1,1,0,BP
GO:0002820,negative regulation of adaptive immune r...,47,0,0.94,1.00000,1,1,0,BP
GO:0002823,negative regulation of adaptive immune r...,42,0,0.84,1.00000,1,1,0,BP
GO:0002825,regulation of T-helper 1 type immune res...,31,0,0.62,1.00000,1,1,0,BP
GO:0002827,positive regulation of T-helper 1 type i...,24,0,0.48,1.00000,1,1,0,BP
GO:0002828,regulation of type 2 immune response,32,0,0.64,1.00000,1,1,0,BP
GO:0002861,regulation of inflammatory response to a...,32,0,0.64,1.00000,1,1,0,BP
GO:0002891,positive regulation of immunoglobulin me...,46,0,0.92,1.00000,1,1,0,BP
GO:0002902,regulation of B cell apoptotic process,30,0,0.6,1.00000,1,1,0,BP
GO:0002903,negative regulation of B cell apoptotic ...,23,0,0.46,1.00000,1,1,0,BP
GO:0002920,regulation of humoral immune response,36,0,0.72,1.00000,1,1,0,BP
GO:0003009,skeletal muscle contraction,40,0,0.8,1.00000,1,1,0,BP
GO:0003016,respiratory system process,33,0,0.66,1.00000,1,1,0,BP
GO:0003081,regulation of systemic arterial blood pr...,32,0,0.64,1.00000,1,1,0,BP
GO:0003085,negative regulation of systemic arterial...,27,0,0.54,1.00000,1,1,0,BP
GO:0003143,embryonic heart tube morphogenesis,67,0,1.35,1.00000,1,1,0,BP
GO:0003170,heart valve development,58,0,1.17,1.00000,1,1,0,BP
GO:0003171,atrioventricular valve development,27,0,0.54,1.00000,1,1,0,BP
GO:0003176,aortic valve development,23,0,0.46,1.00000,1,1,0,BP
GO:0003177,pulmonary valve development,21,0,0.42,1.00000,1,1,0,BP
GO:0003179,heart valve morphogenesis,47,0,0.94,1.00000,1,1,0,BP
GO:0003181,atrioventricular valve morphogenesis,24,0,0.48,1.00000,1,1,0,BP
GO:0003197,endocardial cushion development,47,0,0.94,1.00000,1,1,0,BP
GO:0003203,endocardial cushion morphogenesis,34,0,0.68,1.00000,1,1,0,BP
GO:0003209,cardiac atrium morphogenesis,34,0,0.68,1.00000,1,1,0,BP
GO:0003230,cardiac atrium development,38,0,0.76,1.00000,1,1,0,BP
GO:0003254,regulation of membrane depolarization,45,0,0.9,1.00000,1,1,0,BP
GO:0003272,endocardial cushion formation,24,0,0.48,1.00000,1,1,0,BP
GO:0003281,ventricular septum development,87,0,1.75,1.00000,1,1,0,BP
GO:0003283,atrial septum development,21,0,0.42,1.00000,1,1,0,BP
GO:0003299,muscle hypertrophy in response to stress,26,0,0.52,1.00000,1,1,0,BP
GO:0003309,type B pancreatic cell differentiation,31,0,0.62,1.00000,1,1,0,BP
GO:0003323,type B pancreatic cell development,22,0,0.44,1.00000,1,1,0,BP
GO:0003351,epithelial cilium movement,25,0,0.5,1.00000,1,1,0,BP
GO:0003413,chondrocyte differentiation involved in ...,29,0,0.58,1.00000,1,1,0,BP
GO:0003416,endochondral bone growth,43,0,0.86,1.00000,1,1,0,BP
GO:0003417,growth plate cartilage development,36,0,0.72,1.00000,1,1,0,BP
GO:0003418,growth plate cartilage chondrocyte diffe...,22,0,0.44,1.00000,1,1,0,BP
GO:0003433,chondrocyte development involved in endo...,22,0,0.44,1.00000,1,1,0,BP
GO:0005980,glycogen catabolic process,20,0,0.4,1.00000,1,1,0,BP
GO:0006022,aminoglycan metabolic process,101,0,2.03,1.00000,1,1,0,BP
GO:0006023,aminoglycan biosynthetic process,53,0,1.07,1.00000,1,1,0,BP
GO:0006024,glycosaminoglycan biosynthetic process,43,0,0.86,1.00000,1,1,0,BP
GO:0006026,aminoglycan catabolic process,26,0,0.52,1.00000,1,1,0,BP
GO:0006081,cellular aldehyde metabolic process,70,0,1.41,1.00000,1,1,0,BP
GO:0006089,lactate metabolic process,21,0,0.42,1.00000,1,1,0,BP
GO:0006094,gluconeogenesis,73,0,1.47,1.00000,1,1,0,BP
GO:0006111,regulation of gluconeogenesis,51,0,1.03,1.00000,1,1,0,BP
GO:0006144,purine nucleobase metabolic process,23,0,0.46,1.00000,1,1,0,BP
GO:0006213,pyrimidine nucleoside metabolic process,26,0,0.52,1.00000,1,1,0,BP
GO:0006220,pyrimidine nucleotide metabolic process,32,0,0.64,1.00000,1,1,0,BP
GO:0006221,pyrimidine nucleotide biosynthetic proce...,24,0,0.48,1.00000,1,1,0,BP
GO:0006298,mismatch repair,26,0,0.52,1.00000,1,1,0,BP
GO:0006301,postreplication repair,23,0,0.46,1.00000,1,1,0,BP
GO:0006303,double-strand break repair via nonhomolo...,50,0,1.01,1.00000,1,1,0,BP
GO:0006308,DNA catabolic process,33,0,0.66,1.00000,1,1,0,BP
GO:0006349,regulation of gene expression by genetic...,21,0,0.42,1.00000,1,1,0,BP
GO:0006367,transcription initiation from RNA polyme...,62,0,1.25,1.00000,1,1,0,BP
GO:0006379,mRNA cleavage,20,0,0.4,1.00000,1,1,0,BP
GO:0006399,tRNA metabolic process,169,0,3.4,1.00000,1,1,0,BP
GO:0006400,tRNA modification,72,0,1.45,1.00000,1,1,0,BP
GO:0006418,tRNA aminoacylation for protein translat...,41,0,0.82,1.00000,1,1,0,BP
GO:0006482,protein demethylation,31,0,0.62,1.00000,1,1,0,BP
GO:0006487,protein N-linked glycosylation,67,0,1.35,1.00000,1,1,0,BP
GO:0006505,GPI anchor metabolic process,32,0,0.64,1.00000,1,1,0,BP
GO:0006506,GPI anchor biosynthetic process,31,0,0.62,1.00000,1,1,0,BP
GO:0006515,protein quality control for misfolded or...,27,0,0.54,1.00000,1,1,0,BP
GO:0006541,glutamine metabolic process,21,0,0.42,1.00000,1,1,0,BP
GO:0006576,cellular biogenic amine metabolic proces...,46,0,0.92,1.00000,1,1,0,BP
GO:0006582,melanin metabolic process,24,0,0.48,1.00000,1,1,0,BP
GO:0006584,catecholamine metabolic process,57,0,1.15,1.00000,1,1,0,BP
GO:0006625,protein targeting to peroxisome,20,0,0.4,1.00000,1,1,0,BP
GO:0006635,fatty acid beta-oxidation,67,0,1.35,1.00000,1,1,0,BP
GO:0006661,phosphatidylinositol biosynthetic proces...,59,0,1.19,1.00000,1,1,0,BP
GO:0006688,glycosphingolipid biosynthetic process,20,0,0.4,1.00000,1,1,0,BP
GO:0006692,prostanoid metabolic process,41,0,0.82,1.00000,1,1,0,BP
GO:0006693,prostaglandin metabolic process,41,0,0.82,1.00000,1,1,0,BP
GO:0006699,bile acid biosynthetic process,20,0,0.4,1.00000,1,1,0,BP
GO:0006706,steroid catabolic process,24,0,0.48,1.00000,1,1,0,BP
GO:0006720,isoprenoid metabolic process,81,0,1.63,1.00000,1,1,0,BP
GO:0006721,terpenoid metabolic process,62,0,1.25,1.00000,1,1,0,BP
GO:0006730,one-carbon metabolic process,27,0,0.54,1.00000,1,1,0,BP
GO:0006734,NADH metabolic process,29,0,0.58,1.00000,1,1,0,BP
GO:0006760,folic acid-containing compound metabolic...,25,0,0.5,1.00000,1,1,0,BP
GO:0006775,fat-soluble vitamin metabolic process,33,0,0.66,1.00000,1,1,0,BP
GO:0006779,porphyrin-containing compound biosynthet...,26,0,0.52,1.00000,1,1,0,BP
GO:0006783,heme biosynthetic process,21,0,0.42,1.00000,1,1,0,BP
GO:0006805,xenobiotic metabolic process,113,0,2.27,1.00000,1,1,0,BP
GO:0006817,phosphate ion transport,26,0,0.52,1.00000,1,1,0,BP
GO:0006821,chloride transport,100,0,2.01,1.00000,1,1,0,BP
GO:0006829,zinc ion transport,32,0,0.64,1.00000,1,1,0,BP
GO:0006835,dicarboxylic acid transport,79,0,1.59,1.00000,1,1,0,BP
GO:0006855,drug transmembrane transport,70,0,1.41,1.00000,1,1,0,BP
GO:0006882,cellular zinc ion homeostasis,26,0,0.52,1.00000,1,1,0,BP
GO:0006884,cell volume homeostasis,31,0,0.62,1.00000,1,1,0,BP
GO:0006885,regulation of pH,93,0,1.87,1.00000,1,1,0,BP
GO:0006903,vesicle targeting,38,0,0.76,1.00000,1,1,0,BP
GO:0006904,vesicle docking involved in exocytosis,46,0,0.92,1.00000,1,1,0,BP
GO:0006921,cellular component disassembly involved ...,30,0,0.6,1.00000,1,1,0,BP
GO:0006925,inflammatory cell apoptotic process,25,0,0.5,1.00000,1,1,0,BP
GO:0006929,substrate-dependent cell migration,28,0,0.56,1.00000,1,1,0,BP
GO:0006953,acute-phase response,41,0,0.82,1.00000,1,1,0,BP
GO:0006956,complement activation,52,0,1.05,1.00000,1,1,0,BP
GO:0006958,"complement activation, classical pathway",30,0,0.6,1.00000,1,1,0,BP
GO:0006998,nuclear envelope organization,39,0,0.78,1.00000,1,1,0,BP
GO:0007020,microtubule nucleation,23,0,0.46,1.00000,1,1,0,BP
GO:0007031,peroxisome organization,35,0,0.7,1.00000,1,1,0,BP
GO:0007035,vacuolar acidification,20,0,0.4,1.00000,1,1,0,BP
GO:0007131,reciprocal meiotic recombination,48,0,0.96,1.00000,1,1,0,BP
GO:0007140,male meiotic nuclear division,51,0,1.03,1.00000,1,1,0,BP
GO:0007141,male meiosis I,22,0,0.44,1.00000,1,1,0,BP
GO:0007157,heterophilic cell-cell adhesion via plas...,48,0,0.96,1.00000,1,1,0,BP
GO:0007164,establishment of tissue polarity,62,0,1.25,1.00000,1,1,0,BP
GO:0007189,adenylate cyclase-activating G protein-c...,131,0,2.63,1.00000,1,1,0,BP
GO:0007190,activation of adenylate cyclase activity,21,0,0.42,1.00000,1,1,0,BP
GO:0007200,phospholipase C-activating G protein-cou...,97,0,1.95,1.00000,1,1,0,BP
GO:0007212,dopamine receptor signaling pathway,43,0,0.86,1.00000,1,1,0,BP
GO:0007214,gamma-aminobutyric acid signaling pathwa...,27,0,0.54,1.00000,1,1,0,BP
GO:0007218,neuropeptide signaling pathway,81,0,1.63,1.00000,1,1,0,BP
GO:0007263,nitric oxide mediated signal transductio...,27,0,0.54,1.00000,1,1,0,BP
GO:0007271,"synaptic transmission, cholinergic",34,0,0.68,1.00000,1,1,0,BP
GO:0007274,neuromuscular synaptic transmission,34,0,0.68,1.00000,1,1,0,BP
GO:0007289,spermatid nucleus differentiation,26,0,0.52,1.00000,1,1,0,BP
GO:0007339,binding of sperm to zona pellucida,40,0,0.8,1.00000,1,1,0,BP
GO:0007340,acrosome reaction,39,0,0.78,1.00000,1,1,0,BP
GO:0007413,axonal fasciculation,26,0,0.52,1.00000,1,1,0,BP
GO:0007530,sex determination,29,0,0.58,1.00000,1,1,0,BP
GO:0007549,dosage compensation,27,0,0.54,1.00000,1,1,0,BP
GO:0007585,respiratory gaseous exchange,56,0,1.13,1.00000,1,1,0,BP
GO:0007596,blood coagulation,158,0,3.18,1.00000,1,1,0,BP
GO:0007599,hemostasis,160,0,3.22,1.00000,1,1,0,BP
GO:0007602,phototransduction,31,0,0.62,1.00000,1,1,0,BP
GO:0007606,sensory perception of chemical stimulus,1218,0,24.48,1.00000,1,1,0,BP
GO:0007608,sensory perception of smell,1120,0,22.51,1.00000,1,1,0,BP
GO:0007620,copulation,26,0,0.52,1.00000,1,1,0,BP
GO:0007622,rhythmic behavior,64,0,1.29,1.00000,1,1,0,BP
GO:0007625,grooming behavior,21,0,0.42,1.00000,1,1,0,BP
GO:0007635,chemosensory behavior,22,0,0.44,1.00000,1,1,0,BP
GO:0008033,tRNA processing,115,0,2.31,1.00000,1,1,0,BP
GO:0008053,mitochondrial fusion,21,0,0.42,1.00000,1,1,0,BP
GO:0008156,negative regulation of DNA replication,35,0,0.7,1.00000,1,1,0,BP
GO:0008206,bile acid metabolic process,29,0,0.58,1.00000,1,1,0,BP
GO:0008207,C21-steroid hormone metabolic process,39,0,0.78,1.00000,1,1,0,BP
GO:0008210,estrogen metabolic process,21,0,0.42,1.00000,1,1,0,BP
GO:0008211,glucocorticoid metabolic process,23,0,0.46,1.00000,1,1,0,BP
GO:0008214,protein dealkylation,31,0,0.62,1.00000,1,1,0,BP
GO:0008299,isoprenoid biosynthetic process,30,0,0.6,1.00000,1,1,0,BP
GO:0008340,determination of adult lifespan,28,0,0.56,1.00000,1,1,0,BP
GO:0008356,asymmetric cell division,21,0,0.42,1.00000,1,1,0,BP
GO:0008535,respiratory chain complex IV assembly,23,0,0.46,1.00000,1,1,0,BP
GO:0008589,regulation of smoothened signaling pathw...,85,0,1.71,1.00000,1,1,0,BP
GO:0008593,regulation of Notch signaling pathway,87,0,1.75,1.00000,1,1,0,BP
GO:0008652,cellular amino acid biosynthetic process,64,0,1.29,1.00000,1,1,0,BP
GO:0008654,phospholipid biosynthetic process,160,0,3.22,1.00000,1,1,0,BP
GO:0009048,dosage compensation by inactivation of X...,25,0,0.5,1.00000,1,1,0,BP
GO:0009062,fatty acid catabolic process,93,0,1.87,1.00000,1,1,0,BP
GO:0009066,aspartate family amino acid metabolic pr...,42,0,0.84,1.00000,1,1,0,BP
GO:0009067,aspartate family amino acid biosynthetic...,22,0,0.44,1.00000,1,1,0,BP
GO:0009069,serine family amino acid metabolic proce...,40,0,0.8,1.00000,1,1,0,BP
GO:0009072,aromatic amino acid family metabolic pro...,34,0,0.68,1.00000,1,1,0,BP
GO:0009112,nucleobase metabolic process,36,0,0.72,1.00000,1,1,0,BP
GO:0009187,cyclic nucleotide metabolic process,35,0,0.7,1.00000,1,1,0,BP
GO:0009190,cyclic nucleotide biosynthetic process,24,0,0.48,1.00000,1,1,0,BP
GO:0009247,glycolipid biosynthetic process,57,0,1.15,1.00000,1,1,0,BP
GO:0009251,glucan catabolic process,20,0,0.4,1.00000,1,1,0,BP
GO:0009268,response to pH,40,0,0.8,1.00000,1,1,0,BP
GO:0009311,oligosaccharide metabolic process,35,0,0.7,1.00000,1,1,0,BP
GO:0009395,phospholipid catabolic process,43,0,0.86,1.00000,1,1,0,BP
GO:0009404,toxin metabolic process,22,0,0.44,1.00000,1,1,0,BP
GO:0009595,detection of biotic stimulus,26,0,0.52,1.00000,1,1,0,BP
GO:0009620,response to fungus,39,0,0.78,1.00000,1,1,0,BP
GO:0009648,photoperiodism,24,0,0.48,1.00000,1,1,0,BP
GO:0009649,entrainment of circadian clock,26,0,0.52,1.00000,1,1,0,BP
GO:0009712,catechol-containing compound metabolic p...,57,0,1.15,1.00000,1,1,0,BP
GO:0009713,catechol-containing compound biosyntheti...,26,0,0.52,1.00000,1,1,0,BP
GO:0010039,response to iron ion,20,0,0.4,1.00000,1,1,0,BP
GO:0010043,response to zinc ion,31,0,0.62,1.00000,1,1,0,BP
GO:0010155,regulation of proton transport,26,0,0.52,1.00000,1,1,0,BP
GO:0010257,NADH dehydrogenase complex assembly,45,0,0.9,1.00000,1,1,0,BP
GO:0010259,multicellular organism aging,46,0,0.92,1.00000,1,1,0,BP
GO:0010453,regulation of cell fate commitment,32,0,0.64,1.00000,1,1,0,BP
GO:0010458,exit from mitosis,28,0,0.56,1.00000,1,1,0,BP
GO:0010460,positive regulation of heart rate,27,0,0.54,1.00000,1,1,0,BP
GO:0010499,proteasomal ubiquitin-independent protei...,23,0,0.46,1.00000,1,1,0,BP
GO:0010518,positive regulation of phospholipase act...,43,0,0.86,1.00000,1,1,0,BP
GO:0010543,regulation of platelet activation,34,0,0.68,1.00000,1,1,0,BP
GO:0010569,regulation of double-strand break repair...,43,0,0.86,1.00000,1,1,0,BP
GO:0010575,positive regulation of vascular endothel...,25,0,0.5,1.00000,1,1,0,BP
GO:0010586,miRNA metabolic process,29,0,0.58,1.00000,1,1,0,BP
GO:0010591,regulation of lamellipodium assembly,32,0,0.64,1.00000,1,1,0,BP
GO:0010592,positive regulation of lamellipodium ass...,23,0,0.46,1.00000,1,1,0,BP
GO:0010596,negative regulation of endothelial cell ...,51,0,1.03,1.00000,1,1,0,BP
GO:0010614,negative regulation of cardiac muscle hy...,32,0,0.64,1.00000,1,1,0,BP
GO:0010623,programmed cell death involved in cell d...,20,0,0.4,1.00000,1,1,0,BP
GO:0010633,negative regulation of epithelial cell m...,70,0,1.41,1.00000,1,1,0,BP
GO:0010663,positive regulation of striated muscle c...,24,0,0.48,1.00000,1,1,0,BP
GO:0010666,positive regulation of cardiac muscle ce...,23,0,0.46,1.00000,1,1,0,BP
GO:0010669,epithelial structure maintenance,25,0,0.5,1.00000,1,1,0,BP
GO:0010677,negative regulation of cellular carbohyd...,47,0,0.94,1.00000,1,1,0,BP
GO:0010742,macrophage derived foam cell differentia...,25,0,0.5,1.00000,1,1,0,BP
GO:0010743,regulation of macrophage derived foam ce...,21,0,0.42,1.00000,1,1,0,BP
GO:0010758,regulation of macrophage chemotaxis,31,0,0.62,1.00000,1,1,0,BP
GO:0010759,positive regulation of macrophage chemot...,21,0,0.42,1.00000,1,1,0,BP
GO:0010829,negative regulation of glucose transmemb...,26,0,0.52,1.00000,1,1,0,BP
GO:0010831,positive regulation of myotube different...,39,0,0.78,1.00000,1,1,0,BP
GO:0010863,positive regulation of phospholipase C a...,26,0,0.52,1.00000,1,1,0,BP
GO:0010866,regulation of triglyceride biosynthetic ...,21,0,0.42,1.00000,1,1,0,BP
GO:0010869,regulation of receptor biosynthetic proc...,20,0,0.4,1.00000,1,1,0,BP
GO:0010883,regulation of lipid storage,43,0,0.86,1.00000,1,1,0,BP
GO:0010884,positive regulation of lipid storage,23,0,0.46,1.00000,1,1,0,BP
GO:0010955,negative regulation of protein processin...,37,0,0.74,1.00000,1,1,0,BP
GO:0010996,response to auditory stimulus,23,0,0.46,1.00000,1,1,0,BP
GO:0014047,glutamate secretion,34,0,0.68,1.00000,1,1,0,BP
GO:0014048,regulation of glutamate secretion,25,0,0.5,1.00000,1,1,0,BP
GO:0014068,positive regulation of phosphatidylinosi...,72,0,1.45,1.00000,1,1,0,BP
GO:0014075,response to amine,20,0,0.4,1.00000,1,1,0,BP
GO:0014741,negative regulation of muscle hypertroph...,34,0,0.68,1.00000,1,1,0,BP
GO:0014808,release of sequestered calcium ion into ...,21,0,0.42,1.00000,1,1,0,BP
GO:0014823,response to activity,34,0,0.68,1.00000,1,1,0,BP
GO:0014829,vascular smooth muscle contraction,27,0,0.54,1.00000,1,1,0,BP
GO:0014850,response to muscle activity,21,0,0.42,1.00000,1,1,0,BP
GO:0014887,cardiac muscle adaptation,27,0,0.54,1.00000,1,1,0,BP
GO:0014898,cardiac muscle hypertrophy in response t...,26,0,0.52,1.00000,1,1,0,BP
GO:0014904,myotube cell development,43,0,0.86,1.00000,1,1,0,BP
GO:0015695,organic cation transport,37,0,0.74,1.00000,1,1,0,BP
GO:0015698,inorganic anion transport,141,0,2.83,1.00000,1,1,0,BP
GO:0015718,monocarboxylic acid transport,151,0,3.04,1.00000,1,1,0,BP
GO:0015721,bile acid and bile salt transport,23,0,0.46,1.00000,1,1,0,BP
GO:0015732,prostaglandin transport,21,0,0.42,1.00000,1,1,0,BP
GO:0015748,organophosphate ester transport,85,0,1.71,1.00000,1,1,0,BP
GO:0015800,acidic amino acid transport,63,0,1.27,1.00000,1,1,0,BP
GO:0015807,L-amino acid transport,60,0,1.21,1.00000,1,1,0,BP
GO:0015813,L-glutamate transmembrane transport,22,0,0.44,1.00000,1,1,0,BP
GO:0015874,norepinephrine transport,22,0,0.44,1.00000,1,1,0,BP
GO:0015908,fatty acid transport,86,0,1.73,1.00000,1,1,0,BP
GO:0015909,long-chain fatty acid transport,58,0,1.17,1.00000,1,1,0,BP
GO:0015914,phospholipid transport,65,0,1.31,1.00000,1,1,0,BP
GO:0015985,"energy coupled proton transport, down el...",22,0,0.44,1.00000,1,1,0,BP
GO:0015986,ATP synthesis coupled proton transport,22,0,0.44,1.00000,1,1,0,BP
GO:0016073,snRNA metabolic process,42,0,0.84,1.00000,1,1,0,BP
GO:0016075,rRNA catabolic process,24,0,0.48,1.00000,1,1,0,BP
GO:0016101,diterpenoid metabolic process,57,0,1.15,1.00000,1,1,0,BP
GO:0016180,snRNA processing,25,0,0.5,1.00000,1,1,0,BP
GO:0016339,calcium-dependent cell-cell adhesion via...,39,0,0.78,1.00000,1,1,0,BP
GO:0016577,histone demethylation,28,0,0.56,1.00000,1,1,0,BP
GO:0016973,poly(A)+ mRNA export from nucleus,20,0,0.4,1.00000,1,1,0,BP
GO:0017001,antibiotic catabolic process,46,0,0.92,1.00000,1,1,0,BP
GO:0017004,cytochrome complex assembly,33,0,0.66,1.00000,1,1,0,BP
GO:0017145,stem cell division,52,0,1.05,1.00000,1,1,0,BP
GO:0018126,protein hydroxylation,25,0,0.5,1.00000,1,1,0,BP
GO:0018149,peptide cross-linking,62,0,1.25,1.00000,1,1,0,BP
GO:0018195,peptidyl-arginine modification,27,0,0.54,1.00000,1,1,0,BP
GO:0018196,peptidyl-asparagine modification,21,0,0.42,1.00000,1,1,0,BP
GO:0018279,protein N-linked glycosylation via aspar...,20,0,0.4,1.00000,1,1,0,BP
GO:0018958,phenol-containing compound metabolic pro...,111,0,2.23,1.00000,1,1,0,BP
GO:0019048,modulation by virus of host morphology o...,24,0,0.48,1.00000,1,1,0,BP
GO:0019228,neuronal action potential,45,0,0.9,1.00000,1,1,0,BP
GO:0019229,regulation of vasoconstriction,76,0,1.53,1.00000,1,1,0,BP
GO:0019236,response to pheromone,105,0,2.11,1.00000,1,1,0,BP
GO:0019319,hexose biosynthetic process,76,0,1.53,1.00000,1,1,0,BP
GO:0019320,hexose catabolic process,26,0,0.52,1.00000,1,1,0,BP
GO:0019373,epoxygenase P450 pathway,31,0,0.62,1.00000,1,1,0,BP
GO:0019400,alditol metabolic process,22,0,0.44,1.00000,1,1,0,BP
GO:0019432,triglyceride biosynthetic process,35,0,0.7,1.00000,1,1,0,BP
GO:0019433,triglyceride catabolic process,26,0,0.52,1.00000,1,1,0,BP
GO:0019674,NAD metabolic process,47,0,0.94,1.00000,1,1,0,BP
GO:0019748,secondary metabolic process,66,0,1.33,1.00000,1,1,0,BP
GO:0019835,cytolysis,35,0,0.7,1.00000,1,1,0,BP
GO:0019883,antigen processing and presentation of e...,40,0,0.8,1.00000,1,1,0,BP
GO:0019885,antigen processing and presentation of e...,37,0,0.74,1.00000,1,1,0,BP
GO:0019915,lipid storage,71,0,1.43,1.00000,1,1,0,BP
GO:0019934,cGMP-mediated signaling,39,0,0.78,1.00000,1,1,0,BP
GO:0021511,spinal cord patterning,28,0,0.56,1.00000,1,1,0,BP
GO:0021513,spinal cord dorsal/ventral patterning,26,0,0.52,1.00000,1,1,0,BP
GO:0021532,neural tube patterning,47,0,0.94,1.00000,1,1,0,BP
GO:0021536,diencephalon development,69,0,1.39,1.00000,1,1,0,BP
GO:0021544,subpallium development,24,0,0.48,1.00000,1,1,0,BP
GO:0021895,cerebral cortex neuron differentiation,25,0,0.5,1.00000,1,1,0,BP
GO:0021904,dorsal/ventral neural tube patterning,30,0,0.6,1.00000,1,1,0,BP
GO:0021983,pituitary gland development,39,0,0.78,1.00000,1,1,0,BP
GO:0022401,negative adaptation of signaling pathway,28,0,0.56,1.00000,1,1,0,BP
GO:0022410,circadian sleep/wake cycle process,32,0,0.64,1.00000,1,1,0,BP
GO:0022602,ovulation cycle process,48,0,0.96,1.00000,1,1,0,BP
GO:0023019,signal transduction involved in regulati...,23,0,0.46,1.00000,1,1,0,BP
GO:0023058,adaptation of signaling pathway,30,0,0.6,1.00000,1,1,0,BP
GO:0030004,cellular monovalent inorganic cation hom...,97,0,1.95,1.00000,1,1,0,BP
GO:0030101,natural killer cell activation,100,0,2.01,1.00000,1,1,0,BP
GO:0030149,sphingolipid catabolic process,29,0,0.58,1.00000,1,1,0,BP
GO:0030168,platelet activation,79,0,1.59,1.00000,1,1,0,BP
GO:0030193,regulation of blood coagulation,78,0,1.57,1.00000,1,1,0,BP
GO:0030194,positive regulation of blood coagulation,26,0,0.52,1.00000,1,1,0,BP
GO:0030195,negative regulation of blood coagulation,49,0,0.98,1.00000,1,1,0,BP
GO:0030199,collagen fibril organization,54,0,1.09,1.00000,1,1,0,BP
GO:0030203,glycosaminoglycan metabolic process,83,0,1.67,1.00000,1,1,0,BP
GO:0030204,chondroitin sulfate metabolic process,22,0,0.44,1.00000,1,1,0,BP
GO:0030212,hyaluronan metabolic process,27,0,0.54,1.00000,1,1,0,BP
GO:0030219,megakaryocyte differentiation,53,0,1.07,1.00000,1,1,0,BP
GO:0030224,monocyte differentiation,29,0,0.58,1.00000,1,1,0,BP
GO:0030261,chromosome condensation,45,0,0.9,1.00000,1,1,0,BP
GO:0030262,apoptotic nuclear changes,29,0,0.58,1.00000,1,1,0,BP
GO:0030318,melanocyte differentiation,29,0,0.58,1.00000,1,1,0,BP
GO:0030325,adrenal gland development,24,0,0.48,1.00000,1,1,0,BP
GO:0030431,sleep,39,0,0.78,1.00000,1,1,0,BP
GO:0030488,tRNA methylation,29,0,0.58,1.00000,1,1,0,BP
GO:0030510,regulation of BMP signaling pathway,97,0,1.95,1.00000,1,1,0,BP
GO:0030511,positive regulation of transforming grow...,29,0,0.58,1.00000,1,1,0,BP
GO:0030513,positive regulation of BMP signaling pat...,38,0,0.76,1.00000,1,1,0,BP
GO:0030514,negative regulation of BMP signaling pat...,53,0,1.07,1.00000,1,1,0,BP
GO:0030593,neutrophil chemotaxis,101,0,2.03,1.00000,1,1,0,BP
GO:0030641,regulation of cellular pH,76,0,1.53,1.00000,1,1,0,BP
GO:0030728,ovulation,23,0,0.46,1.00000,1,1,0,BP
GO:0030851,granulocyte differentiation,38,0,0.76,1.00000,1,1,0,BP
GO:0030878,thyroid gland development,28,0,0.56,1.00000,1,1,0,BP
GO:0030888,regulation of B cell proliferation,69,0,1.39,1.00000,1,1,0,BP
GO:0030889,negative regulation of B cell proliferat...,20,0,0.4,1.00000,1,1,0,BP
GO:0030890,positive regulation of B cell proliferat...,44,0,0.88,1.00000,1,1,0,BP
GO:0030903,notochord development,24,0,0.48,1.00000,1,1,0,BP
GO:0030947,regulation of vascular endothelial growt...,33,0,0.66,1.00000,1,1,0,BP
GO:0031018,endocrine pancreas development,52,0,1.05,1.00000,1,1,0,BP
GO:0031294,lymphocyte costimulation,32,0,0.64,1.00000,1,1,0,BP
GO:0031295,T cell costimulation,30,0,0.6,1.00000,1,1,0,BP
GO:0031341,regulation of cell killing,125,0,2.51,1.00000,1,1,0,BP
GO:0031342,negative regulation of cell killing,27,0,0.54,1.00000,1,1,0,BP
GO:0031343,positive regulation of cell killing,94,0,1.89,1.00000,1,1,0,BP
GO:0031424,keratinization,35,0,0.7,1.00000,1,1,0,BP
GO:0031529,ruffle organization,53,0,1.07,1.00000,1,1,0,BP
GO:0031629,synaptic vesicle fusion to presynaptic a...,25,0,0.5,1.00000,1,1,0,BP
GO:0031638,zymogen activation,64,0,1.29,1.00000,1,1,0,BP
GO:0031639,plasminogen activation,25,0,0.5,1.00000,1,1,0,BP
GO:0031640,killing of cells of other organism,40,0,0.8,1.00000,1,1,0,BP
GO:0031645,negative regulation of neurological syst...,30,0,0.6,1.00000,1,1,0,BP
GO:0031648,protein destabilization,48,0,0.96,1.00000,1,1,0,BP
GO:0031649,heat generation,22,0,0.44,1.00000,1,1,0,BP
GO:0031663,lipopolysaccharide-mediated signaling pa...,51,0,1.03,1.00000,1,1,0,BP
GO:0031935,regulation of chromatin silencing,38,0,0.76,1.00000,1,1,0,BP
GO:0032042,mitochondrial DNA metabolic process,22,0,0.44,1.00000,1,1,0,BP
GO:0032069,regulation of nuclease activity,27,0,0.54,1.00000,1,1,0,BP
GO:0032196,transposition,22,0,0.44,1.00000,1,1,0,BP
GO:0032211,negative regulation of telomere maintena...,20,0,0.4,1.00000,1,1,0,BP
GO:0032288,myelin assembly,20,0,0.4,1.00000,1,1,0,BP
GO:0032303,regulation of icosanoid secretion,22,0,0.44,1.00000,1,1,0,BP
GO:0032309,icosanoid secretion,47,0,0.94,1.00000,1,1,0,BP
GO:0032332,positive regulation of chondrocyte diffe...,21,0,0.42,1.00000,1,1,0,BP
GO:0032350,regulation of hormone metabolic process,54,0,1.09,1.00000,1,1,0,BP
GO:0032352,positive regulation of hormone metabolic...,24,0,0.48,1.00000,1,1,0,BP
GO:0032366,intracellular sterol transport,22,0,0.44,1.00000,1,1,0,BP
GO:0032367,intracellular cholesterol transport,22,0,0.44,1.00000,1,1,0,BP
GO:0032369,negative regulation of lipid transport,28,0,0.56,1.00000,1,1,0,BP
GO:0032400,melanosome localization,22,0,0.44,1.00000,1,1,0,BP
GO:0032461,positive regulation of protein oligomeri...,24,0,0.48,1.00000,1,1,0,BP
GO:0032528,microvillus organization,26,0,0.52,1.00000,1,1,0,BP
GO:0032543,mitochondrial translation,76,0,1.53,1.00000,1,1,0,BP
GO:0032616,interleukin-13 production,22,0,0.44,1.00000,1,1,0,BP
GO:0032633,interleukin-4 production,38,0,0.76,1.00000,1,1,0,BP
GO:0032673,regulation of interleukin-4 production,31,0,0.62,1.00000,1,1,0,BP
GO:0032682,negative regulation of chemokine product...,22,0,0.44,1.00000,1,1,0,BP
GO:0032689,negative regulation of interferon-gamma ...,32,0,0.64,1.00000,1,1,0,BP
GO:0032691,negative regulation of interleukin-1 bet...,24,0,0.48,1.00000,1,1,0,BP
GO:0032692,negative regulation of interleukin-1 pro...,33,0,0.66,1.00000,1,1,0,BP
GO:0032693,negative regulation of interleukin-10 pr...,21,0,0.42,1.00000,1,1,0,BP
GO:0032703,negative regulation of interleukin-2 pro...,25,0,0.5,1.00000,1,1,0,BP
GO:0032715,negative regulation of interleukin-6 pro...,51,0,1.03,1.00000,1,1,0,BP
GO:0032753,positive regulation of interleukin-4 pro...,25,0,0.5,1.00000,1,1,0,BP
GO:0032757,positive regulation of interleukin-8 pro...,46,0,0.92,1.00000,1,1,0,BP
GO:0032800,receptor biosynthetic process,25,0,0.5,1.00000,1,1,0,BP
GO:0032814,regulation of natural killer cell activa...,44,0,0.88,1.00000,1,1,0,BP
GO:0032816,positive regulation of natural killer ce...,31,0,0.62,1.00000,1,1,0,BP
GO:0032892,positive regulation of organic acid tran...,48,0,0.96,1.00000,1,1,0,BP
GO:0032897,negative regulation of viral transcripti...,22,0,0.44,1.00000,1,1,0,BP
GO:0032924,activin receptor signaling pathway,44,0,0.88,1.00000,1,1,0,BP
GO:0032925,regulation of activin receptor signaling...,28,0,0.56,1.00000,1,1,0,BP
GO:0032946,positive regulation of mononuclear cell ...,139,0,2.79,1.00000,1,1,0,BP
GO:0032957,inositol trisphosphate metabolic process,27,0,0.54,1.00000,1,1,0,BP
GO:0032959,inositol trisphosphate biosynthetic proc...,23,0,0.46,1.00000,1,1,0,BP
GO:0032981,mitochondrial respiratory chain complex ...,45,0,0.9,1.00000,1,1,0,BP
GO:0033014,tetrapyrrole biosynthetic process,27,0,0.54,1.00000,1,1,0,BP
GO:0033028,myeloid cell apoptotic process,37,0,0.74,1.00000,1,1,0,BP
GO:0033032,regulation of myeloid cell apoptotic pro...,34,0,0.68,1.00000,1,1,0,BP
GO:0033033,negative regulation of myeloid cell apop...,20,0,0.4,1.00000,1,1,0,BP
GO:0033081,regulation of T cell differentiation in ...,31,0,0.62,1.00000,1,1,0,BP
GO:0033108,mitochondrial respiratory chain complex ...,78,0,1.57,1.00000,1,1,0,BP
GO:0033119,negative regulation of RNA splicing,29,0,0.58,1.00000,1,1,0,BP
GO:0033120,positive regulation of RNA splicing,47,0,0.94,1.00000,1,1,0,BP
GO:0033139,regulation of peptidyl-serine phosphoryl...,31,0,0.62,1.00000,1,1,0,BP
GO:0033141,positive regulation of peptidyl-serine p...,29,0,0.58,1.00000,1,1,0,BP
GO:0033145,positive regulation of intracellular ste...,23,0,0.46,1.00000,1,1,0,BP
GO:0033198,response to ATP,28,0,0.56,1.00000,1,1,0,BP
GO:0033617,mitochondrial respiratory chain complex ...,20,0,0.4,1.00000,1,1,0,BP
GO:0033622,integrin activation,24,0,0.48,1.00000,1,1,0,BP
GO:0033687,osteoblast proliferation,30,0,0.6,1.00000,1,1,0,BP
GO:0033688,regulation of osteoblast proliferation,27,0,0.54,1.00000,1,1,0,BP
GO:0033866,nucleoside bisphosphate biosynthetic pro...,35,0,0.7,1.00000,1,1,0,BP
GO:0034030,ribonucleoside bisphosphate biosynthetic...,35,0,0.7,1.00000,1,1,0,BP
GO:0034033,purine nucleoside bisphosphate biosynthe...,35,0,0.7,1.00000,1,1,0,BP
GO:0034067,protein localization to Golgi apparatus,27,0,0.54,1.00000,1,1,0,BP
GO:0034104,negative regulation of tissue remodeling,24,0,0.48,1.00000,1,1,0,BP
GO:0034109,homotypic cell-cell adhesion,68,0,1.37,1.00000,1,1,0,BP
GO:0034110,regulation of homotypic cell-cell adhesi...,31,0,0.62,1.00000,1,1,0,BP
GO:0034121,regulation of toll-like receptor signali...,64,0,1.29,1.00000,1,1,0,BP
GO:0034122,negative regulation of toll-like recepto...,35,0,0.7,1.00000,1,1,0,BP
GO:0034123,positive regulation of toll-like recepto...,26,0,0.52,1.00000,1,1,0,BP
GO:0034142,toll-like receptor 4 signaling pathway,33,0,0.66,1.00000,1,1,0,BP
GO:0034143,regulation of toll-like receptor 4 signa...,20,0,0.4,1.00000,1,1,0,BP
GO:0034204,lipid translocation,29,0,0.58,1.00000,1,1,0,BP
GO:0034308,primary alcohol metabolic process,62,0,1.25,1.00000,1,1,0,BP
GO:0034311,diol metabolic process,23,0,0.46,1.00000,1,1,0,BP
GO:0034340,response to type I interferon,44,0,0.88,1.00000,1,1,0,BP
GO:0034367,protein-containing complex remodeling,21,0,0.42,1.00000,1,1,0,BP
GO:0034368,protein-lipid complex remodeling,20,0,0.4,1.00000,1,1,0,BP
GO:0034369,plasma lipoprotein particle remodeling,20,0,0.4,1.00000,1,1,0,BP
GO:0034377,plasma lipoprotein particle assembly,20,0,0.4,1.00000,1,1,0,BP
GO:0034381,plasma lipoprotein particle clearance,36,0,0.72,1.00000,1,1,0,BP
GO:0034383,low-density lipoprotein particle clearan...,24,0,0.48,1.00000,1,1,0,BP
GO:0034405,response to fluid shear stress,22,0,0.44,1.00000,1,1,0,BP
GO:0034453,microtubule anchoring,27,0,0.54,1.00000,1,1,0,BP
GO:0034505,tooth mineralization,24,0,0.48,1.00000,1,1,0,BP
GO:0034661,ncRNA catabolic process,37,0,0.74,1.00000,1,1,0,BP
GO:0034754,cellular hormone metabolic process,106,0,2.13,1.00000,1,1,0,BP
GO:0035025,positive regulation of Rho protein signa...,33,0,0.66,1.00000,1,1,0,BP
GO:0035036,sperm-egg recognition,46,0,0.92,1.00000,1,1,0,BP
GO:0035066,positive regulation of histone acetylati...,30,0,0.6,1.00000,1,1,0,BP
GO:0035094,response to nicotine,33,0,0.66,1.00000,1,1,0,BP
GO:0035162,embryonic hemopoiesis,28,0,0.56,1.00000,1,1,0,BP
GO:0035249,"synaptic transmission, glutamatergic",106,0,2.13,1.00000,1,1,0,BP
GO:0035268,protein mannosylation,22,0,0.44,1.00000,1,1,0,BP
GO:0035270,endocrine system development,137,0,2.75,1.00000,1,1,0,BP
GO:0035335,peptidyl-tyrosine dephosphorylation,28,0,0.56,1.00000,1,1,0,BP
GO:0035357,peroxisome proliferator activated recept...,21,0,0.42,1.00000,1,1,0,BP
GO:0035384,thioester biosynthetic process,25,0,0.5,1.00000,1,1,0,BP
GO:0035456,response to interferon-beta,66,0,1.33,1.00000,1,1,0,BP
GO:0035458,cellular response to interferon-beta,56,0,1.13,1.00000,1,1,0,BP
GO:0035493,SNARE complex assembly,23,0,0.46,1.00000,1,1,0,BP
GO:0035510,DNA dealkylation,23,0,0.46,1.00000,1,1,0,BP
GO:0035584,calcium-mediated signaling using intrace...,20,0,0.4,1.00000,1,1,0,BP
GO:0035634,response to stilbenoid,22,0,0.44,1.00000,1,1,0,BP
GO:0035640,exploration behavior,30,0,0.6,1.00000,1,1,0,BP
GO:0035710,"CD4-positive, alpha-beta T cell activati...",100,0,2.01,1.00000,1,1,0,BP
GO:0035743,"CD4-positive, alpha-beta T cell cytokine...",23,0,0.46,1.00000,1,1,0,BP
GO:0035813,regulation of renal sodium excretion,25,0,0.5,1.00000,1,1,0,BP
GO:0035825,homologous recombination,49,0,0.98,1.00000,1,1,0,BP
GO:0035855,megakaryocyte development,20,0,0.4,1.00000,1,1,0,BP
GO:0035883,enteroendocrine cell differentiation,34,0,0.68,1.00000,1,1,0,BP
GO:0035929,steroid hormone secretion,26,0,0.52,1.00000,1,1,0,BP
GO:0036003,positive regulation of transcription fro...,27,0,0.54,1.00000,1,1,0,BP
GO:0036037,"CD8-positive, alpha-beta T cell activati...",27,0,0.54,1.00000,1,1,0,BP
GO:0036075,replacement ossification,30,0,0.6,1.00000,1,1,0,BP
GO:0036230,granulocyte activation,35,0,0.7,1.00000,1,1,0,BP
GO:0036303,lymph vessel morphogenesis,22,0,0.44,1.00000,1,1,0,BP
GO:0036342,post-anal tail morphogenesis,26,0,0.52,1.00000,1,1,0,BP
GO:0038179,neurotrophin signaling pathway,41,0,0.82,1.00000,1,1,0,BP
GO:0039528,cytoplasmic pattern recognition receptor...,24,0,0.48,1.00000,1,1,0,BP
GO:0040001,establishment of mitotic spindle localiz...,33,0,0.66,1.00000,1,1,0,BP
GO:0042036,negative regulation of cytokine biosynth...,32,0,0.64,1.00000,1,1,0,BP
GO:0042053,regulation of dopamine metabolic process,21,0,0.42,1.00000,1,1,0,BP
GO:0042059,negative regulation of epidermal growth ...,25,0,0.5,1.00000,1,1,0,BP
GO:0042069,regulation of catecholamine metabolic pr...,22,0,0.44,1.00000,1,1,0,BP
GO:0042088,T-helper 1 type immune response,49,0,0.98,1.00000,1,1,0,BP
GO:0042092,type 2 immune response,38,0,0.76,1.00000,1,1,0,BP
GO:0042093,T-helper cell differentiation,63,0,1.27,1.00000,1,1,0,BP
GO:0042094,interleukin-2 biosynthetic process,22,0,0.44,1.00000,1,1,0,BP
GO:0042102,positive regulation of T cell proliferat...,100,0,2.01,1.00000,1,1,0,BP
GO:0042104,positive regulation of activated T cell ...,27,0,0.54,1.00000,1,1,0,BP
GO:0042119,neutrophil activation,29,0,0.58,1.00000,1,1,0,BP
GO:0042178,xenobiotic catabolic process,22,0,0.44,1.00000,1,1,0,BP
GO:0042181,ketone biosynthetic process,44,0,0.88,1.00000,1,1,0,BP
GO:0042267,natural killer cell mediated cytotoxicit...,61,0,1.23,1.00000,1,1,0,BP
GO:0042269,regulation of natural killer cell mediat...,50,0,1.01,1.00000,1,1,0,BP
GO:0042304,regulation of fatty acid biosynthetic pr...,41,0,0.82,1.00000,1,1,0,BP
GO:0042310,vasoconstriction,101,0,2.03,1.00000,1,1,0,BP
GO:0042398,cellular modified amino acid biosyntheti...,42,0,0.84,1.00000,1,1,0,BP
GO:0042403,thyroid hormone metabolic process,25,0,0.5,1.00000,1,1,0,BP
GO:0042417,dopamine metabolic process,42,0,0.84,1.00000,1,1,0,BP
GO:0042423,catecholamine biosynthetic process,26,0,0.52,1.00000,1,1,0,BP
GO:0042430,indole-containing compound metabolic pro...,25,0,0.5,1.00000,1,1,0,BP
GO:0042438,melanin biosynthetic process,22,0,0.44,1.00000,1,1,0,BP
GO:0042445,hormone metabolic process,219,0,4.4,1.00000,1,1,0,BP
GO:0042446,hormone biosynthetic process,75,0,1.51,1.00000,1,1,0,BP
GO:0042462,eye photoreceptor cell development,44,0,0.88,1.00000,1,1,0,BP
GO:0042474,middle ear morphogenesis,24,0,0.48,1.00000,1,1,0,BP
GO:0042501,serine phosphorylation of STAT protein,36,0,0.72,1.00000,1,1,0,BP
GO:0042531,positive regulation of tyrosine phosphor...,56,0,1.13,1.00000,1,1,0,BP
GO:0042537,benzene-containing compound metabolic pr...,22,0,0.44,1.00000,1,1,0,BP
GO:0042558,pteridine-containing compound metabolic ...,31,0,0.62,1.00000,1,1,0,BP
GO:0042572,retinol metabolic process,24,0,0.48,1.00000,1,1,0,BP
GO:0042573,retinoic acid metabolic process,25,0,0.5,1.00000,1,1,0,BP
GO:0042698,ovulation cycle,61,0,1.23,1.00000,1,1,0,BP
GO:0042730,fibrinolysis,20,0,0.4,1.00000,1,1,0,BP
GO:0042737,drug catabolic process,150,0,3.02,1.00000,1,1,0,BP
GO:0042738,exogenous drug catabolic process,53,0,1.07,1.00000,1,1,0,BP
GO:0042744,hydrogen peroxide catabolic process,27,0,0.54,1.00000,1,1,0,BP
GO:0042745,circadian sleep/wake cycle,35,0,0.7,1.00000,1,1,0,BP
GO:0042749,regulation of circadian sleep/wake cycle,31,0,0.62,1.00000,1,1,0,BP
GO:0042753,positive regulation of circadian rhythm,27,0,0.54,1.00000,1,1,0,BP
GO:0042755,eating behavior,48,0,0.96,1.00000,1,1,0,BP
GO:0042832,defense response to protozoan,34,0,0.68,1.00000,1,1,0,BP
GO:0043011,myeloid dendritic cell differentiation,20,0,0.4,1.00000,1,1,0,BP
GO:0043029,T cell homeostasis,46,0,0.92,1.00000,1,1,0,BP
GO:0043038,amino acid activation,45,0,0.9,1.00000,1,1,0,BP
GO:0043039,tRNA aminoacylation,44,0,0.88,1.00000,1,1,0,BP
GO:0043090,amino acid import,31,0,0.62,1.00000,1,1,0,BP
GO:0043153,entrainment of circadian clock by photop...,23,0,0.46,1.00000,1,1,0,BP
GO:0043171,peptide catabolic process,26,0,0.52,1.00000,1,1,0,BP
GO:0043200,response to amino acid,188,0,3.78,1.00000,1,1,0,BP
GO:0043367,"CD4-positive, alpha-beta T cell differen...",81,0,1.63,1.00000,1,1,0,BP
GO:0043370,"regulation of CD4-positive, alpha-beta T...",50,0,1.01,1.00000,1,1,0,BP
GO:0043371,"negative regulation of CD4-positive, alp...",23,0,0.46,1.00000,1,1,0,BP
GO:0043372,"positive regulation of CD4-positive, alp...",30,0,0.6,1.00000,1,1,0,BP
GO:0043496,regulation of protein homodimerization a...,24,0,0.48,1.00000,1,1,0,BP
GO:0043537,negative regulation of blood vessel endo...,32,0,0.64,1.00000,1,1,0,BP
GO:0043551,regulation of phosphatidylinositol 3-kin...,41,0,0.82,1.00000,1,1,0,BP
GO:0043552,positive regulation of phosphatidylinosi...,29,0,0.58,1.00000,1,1,0,BP
GO:0043574,peroxisomal transport,20,0,0.4,1.00000,1,1,0,BP
GO:0043576,regulation of respiratory gaseous exchan...,23,0,0.46,1.00000,1,1,0,BP
GO:0043618,regulation of transcription from RNA pol...,51,0,1.03,1.00000,1,1,0,BP
GO:0043921,modulation by host of viral transcriptio...,24,0,0.48,1.00000,1,1,0,BP
GO:0043950,positive regulation of cAMP-mediated sig...,33,0,0.66,1.00000,1,1,0,BP
GO:0043966,histone H3 acetylation,63,0,1.27,1.00000,1,1,0,BP
GO:0043967,histone H4 acetylation,63,0,1.27,1.00000,1,1,0,BP
GO:0043984,histone H4-K16 acetylation,21,0,0.42,1.00000,1,1,0,BP
GO:0044060,regulation of endocrine process,55,0,1.11,1.00000,1,1,0,BP
GO:0044062,regulation of excretion,31,0,0.62,1.00000,1,1,0,BP
GO:0044247,cellular polysaccharide catabolic proces...,22,0,0.44,1.00000,1,1,0,BP
GO:0044272,sulfur compound biosynthetic process,80,0,1.61,1.00000,1,1,0,BP
GO:0044273,sulfur compound catabolic process,21,0,0.42,1.00000,1,1,0,BP
GO:0044275,cellular carbohydrate catabolic process,36,0,0.72,1.00000,1,1,0,BP
GO:0044319,"wound healing, spreading of cells",31,0,0.62,1.00000,1,1,0,BP
GO:0044331,cell-cell adhesion mediated by cadherin,40,0,0.8,1.00000,1,1,0,BP
GO:0044342,type B pancreatic cell proliferation,28,0,0.56,1.00000,1,1,0,BP
GO:0044364,disruption of cells of other organism,40,0,0.8,1.00000,1,1,0,BP
GO:0044458,motile cilium assembly,30,0,0.6,1.00000,1,1,0,BP
GO:0044550,secondary metabolite biosynthetic proces...,28,0,0.56,1.00000,1,1,0,BP
GO:0044788,modulation by host of viral process,28,0,0.56,1.00000,1,1,0,BP
GO:0045017,glycerolipid biosynthetic process,142,0,2.85,1.00000,1,1,0,BP
GO:0045047,protein targeting to ER,32,0,0.64,1.00000,1,1,0,BP
GO:0045061,thymic T cell selection,28,0,0.56,1.00000,1,1,0,BP
GO:0045063,T-helper 1 cell differentiation,22,0,0.44,1.00000,1,1,0,BP
GO:0045066,regulatory T cell differentiation,33,0,0.66,1.00000,1,1,0,BP
GO:0045071,negative regulation of viral genome repl...,57,0,1.15,1.00000,1,1,0,BP
GO:0045076,regulation of interleukin-2 biosynthetic...,20,0,0.4,1.00000,1,1,0,BP
GO:0045117,azole transport,26,0,0.52,1.00000,1,1,0,BP
GO:0045124,regulation of bone resorption,52,0,1.05,1.00000,1,1,0,BP
GO:0045187,regulation of circadian sleep/wake cycle...,28,0,0.56,1.00000,1,1,0,BP
GO:0045292,"mRNA cis splicing, via spliceosome",29,0,0.58,1.00000,1,1,0,BP
GO:0045332,phospholipid translocation,28,0,0.56,1.00000,1,1,0,BP
GO:0045454,cell redox homeostasis,63,0,1.27,1.00000,1,1,0,BP
GO:0045475,locomotor rhythm,21,0,0.42,1.00000,1,1,0,BP
GO:0045589,regulation of regulatory T cell differen...,30,0,0.6,1.00000,1,1,0,BP
GO:0045600,positive regulation of fat cell differen...,62,0,1.25,1.00000,1,1,0,BP
GO:0045606,positive regulation of epidermal cell di...,22,0,0.44,1.00000,1,1,0,BP
GO:0045622,regulation of T-helper cell differentiat...,38,0,0.76,1.00000,1,1,0,BP
GO:0045623,negative regulation of T-helper cell dif...,20,0,0.4,1.00000,1,1,0,BP
GO:0045624,positive regulation of T-helper cell dif...,22,0,0.44,1.00000,1,1,0,BP
GO:0045649,regulation of macrophage differentiation,20,0,0.4,1.00000,1,1,0,BP
GO:0045652,regulation of megakaryocyte differentiat...,31,0,0.62,1.00000,1,1,0,BP
GO:0045662,negative regulation of myoblast differen...,31,0,0.62,1.00000,1,1,0,BP
GO:0045663,positive regulation of myoblast differen...,28,0,0.56,1.00000,1,1,0,BP
GO:0045668,negative regulation of osteoblast differ...,65,0,1.31,1.00000,1,1,0,BP
GO:0045672,positive regulation of osteoclast differ...,33,0,0.66,1.00000,1,1,0,BP
GO:0045683,negative regulation of epidermis develop...,22,0,0.44,1.00000,1,1,0,BP
GO:0045684,positive regulation of epidermis develop...,37,0,0.74,1.00000,1,1,0,BP
GO:0045723,positive regulation of fatty acid biosyn...,24,0,0.48,1.00000,1,1,0,BP
GO:0045730,respiratory burst,27,0,0.54,1.00000,1,1,0,BP
GO:0045742,positive regulation of epidermal growth ...,26,0,0.52,1.00000,1,1,0,BP
GO:0045744,negative regulation of G protein-coupled...,59,0,1.19,1.00000,1,1,0,BP
GO:0045745,positive regulation of G protein-coupled...,36,0,0.72,1.00000,1,1,0,BP
GO:0045746,negative regulation of Notch signaling p...,38,0,0.76,1.00000,1,1,0,BP
GO:0045747,positive regulation of Notch signaling p...,40,0,0.8,1.00000,1,1,0,BP
GO:0045776,negative regulation of blood pressure,60,0,1.21,1.00000,1,1,0,BP
GO:0045780,positive regulation of bone resorption,28,0,0.56,1.00000,1,1,0,BP
GO:0045822,negative regulation of heart contraction,28,0,0.56,1.00000,1,1,0,BP
GO:0045823,positive regulation of heart contraction,43,0,0.86,1.00000,1,1,0,BP
GO:0045824,negative regulation of innate immune res...,60,0,1.21,1.00000,1,1,0,BP
GO:0045830,positive regulation of isotype switching,30,0,0.6,1.00000,1,1,0,BP
GO:0045838,positive regulation of membrane potentia...,20,0,0.4,1.00000,1,1,0,BP
GO:0045851,pH reduction,40,0,0.8,1.00000,1,1,0,BP
GO:0045879,negative regulation of smoothened signal...,33,0,0.66,1.00000,1,1,0,BP
GO:0045880,positive regulation of smoothened signal...,38,0,0.76,1.00000,1,1,0,BP
GO:0045907,positive regulation of vasoconstriction,47,0,0.94,1.00000,1,1,0,BP
GO:0045910,negative regulation of DNA recombination,48,0,0.96,1.00000,1,1,0,BP
GO:0045911,positive regulation of DNA recombination,43,0,0.86,1.00000,1,1,0,BP
GO:0045912,negative regulation of carbohydrate meta...,52,0,1.05,1.00000,1,1,0,BP
GO:0045920,negative regulation of exocytosis,31,0,0.62,1.00000,1,1,0,BP
GO:0045922,negative regulation of fatty acid metabo...,24,0,0.48,1.00000,1,1,0,BP
GO:0045933,positive regulation of muscle contractio...,53,0,1.07,1.00000,1,1,0,BP
GO:0045948,positive regulation of translational ini...,21,0,0.42,1.00000,1,1,0,BP
GO:0045954,positive regulation of natural killer ce...,34,0,0.68,1.00000,1,1,0,BP
GO:0045956,positive regulation of calcium ion-depen...,28,0,0.56,1.00000,1,1,0,BP
GO:0045980,negative regulation of nucleotide metabo...,31,0,0.62,1.00000,1,1,0,BP
GO:0045987,positive regulation of smooth muscle con...,36,0,0.72,1.00000,1,1,0,BP
GO:0046006,regulation of activated T cell prolifera...,39,0,0.78,1.00000,1,1,0,BP
GO:0046039,GTP metabolic process,29,0,0.58,1.00000,1,1,0,BP
GO:0046131,pyrimidine ribonucleoside metabolic proc...,20,0,0.4,1.00000,1,1,0,BP
GO:0046148,pigment biosynthetic process,53,0,1.07,1.00000,1,1,0,BP
GO:0046189,phenol-containing compound biosynthetic ...,51,0,1.03,1.00000,1,1,0,BP
GO:0046325,negative regulation of glucose import,21,0,0.42,1.00000,1,1,0,BP
GO:0046339,diacylglycerol metabolic process,22,0,0.44,1.00000,1,1,0,BP
GO:0046364,monosaccharide biosynthetic process,82,0,1.65,1.00000,1,1,0,BP
GO:0046365,monosaccharide catabolic process,30,0,0.6,1.00000,1,1,0,BP
GO:0046427,positive regulation of JAK-STAT cascade,103,0,2.07,1.00000,1,1,0,BP
GO:0046456,icosanoid biosynthetic process,39,0,0.78,1.00000,1,1,0,BP
GO:0046457,prostanoid biosynthetic process,25,0,0.5,1.00000,1,1,0,BP
GO:0046460,neutral lipid biosynthetic process,38,0,0.76,1.00000,1,1,0,BP
GO:0046461,neutral lipid catabolic process,35,0,0.7,1.00000,1,1,0,BP
GO:0046463,acylglycerol biosynthetic process,38,0,0.76,1.00000,1,1,0,BP
GO:0046464,acylglycerol catabolic process,35,0,0.7,1.00000,1,1,0,BP
GO:0046466,membrane lipid catabolic process,32,0,0.64,1.00000,1,1,0,BP
GO:0046470,phosphatidylcholine metabolic process,37,0,0.74,1.00000,1,1,0,BP
GO:0046474,glycerophospholipid biosynthetic process,107,0,2.15,1.00000,1,1,0,BP
GO:0046475,glycerophospholipid catabolic process,23,0,0.46,1.00000,1,1,0,BP
GO:0046503,glycerolipid catabolic process,54,0,1.09,1.00000,1,1,0,BP
GO:0046514,ceramide catabolic process,20,0,0.4,1.00000,1,1,0,BP
GO:0046599,regulation of centriole replication,23,0,0.46,1.00000,1,1,0,BP
GO:0046633,alpha-beta T cell proliferation,41,0,0.82,1.00000,1,1,0,BP
GO:0046634,regulation of alpha-beta T cell activati...,104,0,2.09,1.00000,1,1,0,BP
GO:0046635,positive regulation of alpha-beta T cell...,70,0,1.41,1.00000,1,1,0,BP
GO:0046636,negative regulation of alpha-beta T cell...,42,0,0.84,1.00000,1,1,0,BP
GO:0046637,regulation of alpha-beta T cell differen...,67,0,1.35,1.00000,1,1,0,BP
GO:0046638,positive regulation of alpha-beta T cell...,49,0,0.98,1.00000,1,1,0,BP
GO:0046639,negative regulation of alpha-beta T cell...,27,0,0.54,1.00000,1,1,0,BP
GO:0046640,regulation of alpha-beta T cell prolifer...,38,0,0.76,1.00000,1,1,0,BP
GO:0046641,positive regulation of alpha-beta T cell...,23,0,0.46,1.00000,1,1,0,BP
GO:0046653,tetrahydrofolate metabolic process,20,0,0.4,1.00000,1,1,0,BP
GO:0046676,negative regulation of insulin secretion,57,0,1.15,1.00000,1,1,0,BP
GO:0046697,decidualization,21,0,0.42,1.00000,1,1,0,BP
GO:0046717,acid secretion,122,0,2.45,1.00000,1,1,0,BP
GO:0046839,phospholipid dephosphorylation,36,0,0.72,1.00000,1,1,0,BP
GO:0046850,regulation of bone remodeling,62,0,1.25,1.00000,1,1,0,BP
GO:0046852,positive regulation of bone remodeling,28,0,0.56,1.00000,1,1,0,BP
GO:0046856,phosphatidylinositol dephosphorylation,24,0,0.48,1.00000,1,1,0,BP
GO:0046885,regulation of hormone biosynthetic proce...,39,0,0.78,1.00000,1,1,0,BP
GO:0046931,pore complex assembly,23,0,0.46,1.00000,1,1,0,BP
GO:0048011,neurotrophin TRK receptor signaling path...,32,0,0.64,1.00000,1,1,0,BP
GO:0048025,"negative regulation of mRNA splicing, vi...",24,0,0.48,1.00000,1,1,0,BP
GO:0048026,"positive regulation of mRNA splicing, vi...",30,0,0.6,1.00000,1,1,0,BP
GO:0048066,developmental pigmentation,52,0,1.05,1.00000,1,1,0,BP
GO:0048103,somatic stem cell division,28,0,0.56,1.00000,1,1,0,BP
GO:0048199,"vesicle targeting, to, from or within Go...",20,0,0.4,1.00000,1,1,0,BP
GO:0048240,sperm capacitation,34,0,0.68,1.00000,1,1,0,BP
GO:0048245,eosinophil chemotaxis,20,0,0.4,1.00000,1,1,0,BP
GO:0048246,macrophage chemotaxis,43,0,0.86,1.00000,1,1,0,BP
GO:0048260,positive regulation of receptor-mediated...,57,0,1.15,1.00000,1,1,0,BP
GO:0048261,negative regulation of receptor-mediated...,20,0,0.4,1.00000,1,1,0,BP
GO:0048265,response to pain,40,0,0.8,1.00000,1,1,0,BP
GO:0048266,behavioral response to pain,25,0,0.5,1.00000,1,1,0,BP
GO:0048305,immunoglobulin secretion,27,0,0.54,1.00000,1,1,0,BP
GO:0048333,mesodermal cell differentiation,23,0,0.46,1.00000,1,1,0,BP
GO:0048339,paraxial mesoderm development,22,0,0.44,1.00000,1,1,0,BP
GO:0048490,anterograde synaptic vesicle transport,20,0,0.4,1.00000,1,1,0,BP
GO:0048512,circadian behavior,61,0,1.23,1.00000,1,1,0,BP
GO:0048520,positive regulation of behavior,40,0,0.8,1.00000,1,1,0,BP
GO:0048535,lymph node development,31,0,0.62,1.00000,1,1,0,BP
GO:0048536,spleen development,45,0,0.9,1.00000,1,1,0,BP
GO:0048557,embryonic digestive tract morphogenesis,20,0,0.4,1.00000,1,1,0,BP
GO:0048566,embryonic digestive tract development,33,0,0.66,1.00000,1,1,0,BP
GO:0048569,post-embryonic animal organ development,21,0,0.42,1.00000,1,1,0,BP
GO:0048661,positive regulation of smooth muscle cel...,107,0,2.15,1.00000,1,1,0,BP
GO:0048714,positive regulation of oligodendrocyte d...,30,0,0.6,1.00000,1,1,0,BP
GO:0048741,skeletal muscle fiber development,39,0,0.78,1.00000,1,1,0,BP
GO:0048747,muscle fiber development,81,0,1.63,1.00000,1,1,0,BP
GO:0048821,erythrocyte development,39,0,0.78,1.00000,1,1,0,BP
GO:0048857,neural nucleus development,22,0,0.44,1.00000,1,1,0,BP
GO:0050482,arachidonic acid secretion,31,0,0.62,1.00000,1,1,0,BP
GO:0050654,chondroitin sulfate proteoglycan metabol...,30,0,0.6,1.00000,1,1,0,BP
GO:0050671,positive regulation of lymphocyte prolif...,137,0,2.75,1.00000,1,1,0,BP
GO:0050701,interleukin-1 secretion,62,0,1.25,1.00000,1,1,0,BP
GO:0050702,interleukin-1 beta secretion,53,0,1.07,1.00000,1,1,0,BP
GO:0050704,regulation of interleukin-1 secretion,54,0,1.09,1.00000,1,1,0,BP
GO:0050706,regulation of interleukin-1 beta secreti...,46,0,0.92,1.00000,1,1,0,BP
GO:0050716,positive regulation of interleukin-1 sec...,40,0,0.8,1.00000,1,1,0,BP
GO:0050718,positive regulation of interleukin-1 bet...,37,0,0.74,1.00000,1,1,0,BP
GO:0050798,activated T cell proliferation,47,0,0.94,1.00000,1,1,0,BP
GO:0050802,"circadian sleep/wake cycle, sleep",29,0,0.58,1.00000,1,1,0,BP
GO:0050805,negative regulation of synaptic transmis...,81,0,1.63,1.00000,1,1,0,BP
GO:0050817,coagulation,161,0,3.24,1.00000,1,1,0,BP
GO:0050818,regulation of coagulation,82,0,1.65,1.00000,1,1,0,BP
GO:0050819,negative regulation of coagulation,51,0,1.03,1.00000,1,1,0,BP
GO:0050820,positive regulation of coagulation,29,0,0.58,1.00000,1,1,0,BP
GO:0050832,defense response to fungus,25,0,0.5,1.00000,1,1,0,BP
GO:0050853,B cell receptor signaling pathway,48,0,0.96,1.00000,1,1,0,BP
GO:0050858,negative regulation of antigen receptor-...,26,0,0.52,1.00000,1,1,0,BP
GO:0050869,negative regulation of B cell activation,36,0,0.72,1.00000,1,1,0,BP
GO:0050871,positive regulation of B cell activation,85,0,1.71,1.00000,1,1,0,BP
GO:0050892,intestinal absorption,38,0,0.76,1.00000,1,1,0,BP
GO:0050907,detection of chemical stimulus involved ...,59,0,1.19,1.00000,1,1,0,BP
GO:0050909,sensory perception of taste,70,0,1.41,1.00000,1,1,0,BP
GO:0050910,detection of mechanical stimulus involve...,20,0,0.4,1.00000,1,1,0,BP
GO:0050912,detection of chemical stimulus involved ...,52,0,1.05,1.00000,1,1,0,BP
GO:0050913,sensory perception of bitter taste,51,0,1.03,1.00000,1,1,0,BP
GO:0050926,regulation of positive chemotaxis,27,0,0.54,1.00000,1,1,0,BP
GO:0050927,positive regulation of positive chemotax...,26,0,0.52,1.00000,1,1,0,BP
GO:0050931,pigment cell differentiation,39,0,0.78,1.00000,1,1,0,BP
GO:0050966,detection of mechanical stimulus involve...,20,0,0.4,1.00000,1,1,0,BP
GO:0050974,detection of mechanical stimulus involve...,45,0,0.9,1.00000,1,1,0,BP
GO:0050982,detection of mechanical stimulus,60,0,1.21,1.00000,1,1,0,BP
GO:0050994,regulation of lipid catabolic process,57,0,1.15,1.00000,1,1,0,BP
GO:0050995,negative regulation of lipid catabolic p...,24,0,0.48,1.00000,1,1,0,BP
GO:0050996,positive regulation of lipid catabolic p...,27,0,0.54,1.00000,1,1,0,BP
GO:0051016,barbed-end actin filament capping,21,0,0.42,1.00000,1,1,0,BP
GO:0051023,regulation of immunoglobulin secretion,21,0,0.42,1.00000,1,1,0,BP
GO:0051123,RNA polymerase II preinitiation complex ...,26,0,0.52,1.00000,1,1,0,BP
GO:0051180,vitamin transport,32,0,0.64,1.00000,1,1,0,BP
GO:0051181,cofactor transport,36,0,0.72,1.00000,1,1,0,BP
GO:0051187,cofactor catabolic process,55,0,1.11,1.00000,1,1,0,BP
GO:0051195,negative regulation of cofactor metaboli...,21,0,0.42,1.00000,1,1,0,BP
GO:0051205,protein insertion into membrane,25,0,0.5,1.00000,1,1,0,BP
GO:0051290,protein heterotetramerization,54,0,1.09,1.00000,1,1,0,BP
GO:0051294,establishment of spindle orientation,36,0,0.72,1.00000,1,1,0,BP
GO:0051307,meiotic chromosome separation,28,0,0.56,1.00000,1,1,0,BP
GO:0051349,positive regulation of lyase activity,20,0,0.4,1.00000,1,1,0,BP
GO:0051354,negative regulation of oxidoreductase ac...,28,0,0.56,1.00000,1,1,0,BP
GO:0051446,positive regulation of meiotic cell cycl...,28,0,0.56,1.00000,1,1,0,BP
GO:0051447,negative regulation of meiotic cell cycl...,20,0,0.4,1.00000,1,1,0,BP
GO:0051450,myoblast proliferation,21,0,0.42,1.00000,1,1,0,BP
GO:0051452,intracellular pH reduction,35,0,0.7,1.00000,1,1,0,BP
GO:0051453,regulation of intracellular pH,69,0,1.39,1.00000,1,1,0,BP
GO:0051457,maintenance of protein location in nucle...,24,0,0.48,1.00000,1,1,0,BP
GO:0051482,positive regulation of cytosolic calcium...,37,0,0.74,1.00000,1,1,0,BP
GO:0051590,positive regulation of neurotransmitter ...,51,0,1.03,1.00000,1,1,0,BP
GO:0051602,response to electrical stimulus,24,0,0.48,1.00000,1,1,0,BP
GO:0051673,membrane disruption in other organism,28,0,0.56,1.00000,1,1,0,BP
GO:0051788,response to misfolded protein,25,0,0.5,1.00000,1,1,0,BP
GO:0051818,disruption of cells of other organism in...,21,0,0.42,1.00000,1,1,0,BP
GO:0051851,modification by host of symbiont morphol...,75,0,1.51,1.00000,1,1,0,BP
GO:0051865,protein autoubiquitination,76,0,1.53,1.00000,1,1,0,BP
GO:0051875,pigment granule localization,23,0,0.46,1.00000,1,1,0,BP
GO:0051882,mitochondrial depolarization,24,0,0.48,1.00000,1,1,0,BP
GO:0051883,killing of cells in other organism invol...,21,0,0.42,1.00000,1,1,0,BP
GO:0051894,positive regulation of focal adhesion as...,25,0,0.5,1.00000,1,1,0,BP
GO:0051899,membrane depolarization,82,0,1.65,1.00000,1,1,0,BP
GO:0051900,regulation of mitochondrial depolarizati...,21,0,0.42,1.00000,1,1,0,BP
GO:0051905,establishment of pigment granule localiz...,20,0,0.4,1.00000,1,1,0,BP
GO:0051930,regulation of sensory perception of pain,54,0,1.09,1.00000,1,1,0,BP
GO:0051931,regulation of sensory perception,55,0,1.11,1.00000,1,1,0,BP
GO:0051957,positive regulation of amino acid transp...,28,0,0.56,1.00000,1,1,0,BP
GO:0051966,"regulation of synaptic transmission, glu...",78,0,1.57,1.00000,1,1,0,BP
GO:0051968,positive regulation of synaptic transmis...,40,0,0.8,1.00000,1,1,0,BP
GO:0051969,regulation of transmission of nerve impu...,23,0,0.46,1.00000,1,1,0,BP
GO:0052312,modulation of transcription in other org...,24,0,0.48,1.00000,1,1,0,BP
GO:0052472,modulation by host of symbiont transcrip...,24,0,0.48,1.00000,1,1,0,BP
GO:0052652,cyclic purine nucleotide metabolic proce...,24,0,0.48,1.00000,1,1,0,BP
GO:0055003,cardiac myofibril assembly,26,0,0.52,1.00000,1,1,0,BP
GO:0055064,chloride ion homeostasis,20,0,0.4,1.00000,1,1,0,BP
GO:0055069,zinc ion homeostasis,27,0,0.54,1.00000,1,1,0,BP
GO:0055075,potassium ion homeostasis,31,0,0.62,1.00000,1,1,0,BP
GO:0055081,anion homeostasis,68,0,1.37,1.00000,1,1,0,BP
GO:0055083,monovalent inorganic anion homeostasis,35,0,0.7,1.00000,1,1,0,BP
GO:0055090,acylglycerol homeostasis,35,0,0.7,1.00000,1,1,0,BP
GO:0060037,pharyngeal system development,28,0,0.56,1.00000,1,1,0,BP
GO:0060039,pericardium development,29,0,0.58,1.00000,1,1,0,BP
GO:0060045,positive regulation of cardiac muscle ce...,27,0,0.54,1.00000,1,1,0,BP
GO:0060065,uterus development,26,0,0.52,1.00000,1,1,0,BP
GO:0060071,"Wnt signaling pathway, planar cell polar...",40,0,0.8,1.00000,1,1,0,BP
GO:0060074,synapse maturation,31,0,0.62,1.00000,1,1,0,BP
GO:0060099,"regulation of phagocytosis, engulfment",20,0,0.4,1.00000,1,1,0,BP
GO:0060135,maternal process involved in female preg...,47,0,0.94,1.00000,1,1,0,BP
GO:0060193,positive regulation of lipase activity,55,0,1.11,1.00000,1,1,0,BP
GO:0060216,definitive hemopoiesis,24,0,0.48,1.00000,1,1,0,BP
GO:0060218,hematopoietic stem cell differentiation,30,0,0.6,1.00000,1,1,0,BP
GO:0060219,camera-type eye photoreceptor cell diffe...,28,0,0.56,1.00000,1,1,0,BP
GO:0060259,regulation of feeding behavior,38,0,0.76,1.00000,1,1,0,BP
GO:0060260,regulation of transcription initiation f...,29,0,0.58,1.00000,1,1,0,BP
GO:0060261,positive regulation of transcription ini...,23,0,0.46,1.00000,1,1,0,BP
GO:0060292,long-term synaptic depression,35,0,0.7,1.00000,1,1,0,BP
GO:0060294,cilium movement involved in cell motilit...,20,0,0.4,1.00000,1,1,0,BP
GO:0060333,interferon-gamma-mediated signaling path...,23,0,0.46,1.00000,1,1,0,BP
GO:0060337,type I interferon signaling pathway,39,0,0.78,1.00000,1,1,0,BP
GO:0060338,regulation of type I interferon-mediated...,25,0,0.5,1.00000,1,1,0,BP
GO:0060343,trabecula formation,27,0,0.54,1.00000,1,1,0,BP
GO:0060349,bone morphogenesis,117,0,2.35,1.00000,1,1,0,BP
GO:0060350,endochondral bone morphogenesis,75,0,1.51,1.00000,1,1,0,BP
GO:0060351,cartilage development involved in endoch...,52,0,1.05,1.00000,1,1,0,BP
GO:0060384,innervation,29,0,0.58,1.00000,1,1,0,BP
GO:0060412,ventricular septum morphogenesis,51,0,1.03,1.00000,1,1,0,BP
GO:0060428,lung epithelium development,52,0,1.05,1.00000,1,1,0,BP
GO:0060443,mammary gland morphogenesis,58,0,1.17,1.00000,1,1,0,BP
GO:0060444,branching involved in mammary gland duct...,28,0,0.56,1.00000,1,1,0,BP
GO:0060456,positive regulation of digestive system ...,20,0,0.4,1.00000,1,1,0,BP
GO:0060487,lung epithelial cell differentiation,34,0,0.68,1.00000,1,1,0,BP
GO:0060512,prostate gland morphogenesis,34,0,0.68,1.00000,1,1,0,BP
GO:0060536,cartilage morphogenesis,27,0,0.54,1.00000,1,1,0,BP
GO:0060575,intestinal epithelial cell differentiati...,22,0,0.44,1.00000,1,1,0,BP
GO:0060603,mammary gland duct morphogenesis,40,0,0.8,1.00000,1,1,0,BP
GO:0060612,adipose tissue development,50,0,1.01,1.00000,1,1,0,BP
GO:0060632,regulation of microtubule-based movement,31,0,0.62,1.00000,1,1,0,BP
GO:0060669,embryonic placenta morphogenesis,32,0,0.64,1.00000,1,1,0,BP
GO:0060674,placenta blood vessel development,37,0,0.74,1.00000,1,1,0,BP
GO:0060706,cell differentiation involved in embryon...,33,0,0.66,1.00000,1,1,0,BP
GO:0060711,labyrinthine layer development,59,0,1.19,1.00000,1,1,0,BP
GO:0060713,labyrinthine layer morphogenesis,27,0,0.54,1.00000,1,1,0,BP
GO:0060716,labyrinthine layer blood vessel developm...,26,0,0.52,1.00000,1,1,0,BP
GO:0060740,prostate gland epithelium morphogenesis,33,0,0.66,1.00000,1,1,0,BP
GO:0060765,regulation of androgen receptor signalin...,28,0,0.56,1.00000,1,1,0,BP
GO:0060969,negative regulation of gene silencing,36,0,0.72,1.00000,1,1,0,BP
GO:0061036,positive regulation of cartilage develop...,31,0,0.62,1.00000,1,1,0,BP
GO:0061045,negative regulation of wound healing,71,0,1.43,1.00000,1,1,0,BP
GO:0061098,positive regulation of protein tyrosine ...,44,0,0.88,1.00000,1,1,0,BP
GO:0061099,negative regulation of protein tyrosine ...,27,0,0.54,1.00000,1,1,0,BP
GO:0061213,positive regulation of mesonephros devel...,25,0,0.5,1.00000,1,1,0,BP
GO:0061217,regulation of mesonephros development,28,0,0.56,1.00000,1,1,0,BP
GO:0061298,retina vasculature development in camera...,27,0,0.54,1.00000,1,1,0,BP
GO:0061337,cardiac conduction,58,0,1.17,1.00000,1,1,0,BP
GO:0061371,determination of heart left/right asymme...,67,0,1.35,1.00000,1,1,0,BP
GO:0061383,trabecula morphogenesis,53,0,1.07,1.00000,1,1,0,BP
GO:0061384,heart trabecula morphogenesis,36,0,0.72,1.00000,1,1,0,BP
GO:0061436,establishment of skin barrier,26,0,0.52,1.00000,1,1,0,BP
GO:0061478,response to platelet aggregation inhibit...,66,0,1.33,1.00000,1,1,0,BP
GO:0065005,protein-lipid complex assembly,24,0,0.48,1.00000,1,1,0,BP
GO:0070050,neuron cellular homeostasis,25,0,0.5,1.00000,1,1,0,BP
GO:0070076,histone lysine demethylation,28,0,0.56,1.00000,1,1,0,BP
GO:0070129,regulation of mitochondrial translation,27,0,0.54,1.00000,1,1,0,BP
GO:0070199,establishment of protein localization to...,24,0,0.48,1.00000,1,1,0,BP
GO:0070206,protein trimerization,62,0,1.25,1.00000,1,1,0,BP
GO:0070207,protein homotrimerization,40,0,0.8,1.00000,1,1,0,BP
GO:0070227,lymphocyte apoptotic process,98,0,1.97,1.00000,1,1,0,BP
GO:0070228,regulation of lymphocyte apoptotic proce...,76,0,1.53,1.00000,1,1,0,BP
GO:0070229,negative regulation of lymphocyte apopto...,49,0,0.98,1.00000,1,1,0,BP
GO:0070230,positive regulation of lymphocyte apopto...,21,0,0.42,1.00000,1,1,0,BP
GO:0070231,T cell apoptotic process,58,0,1.17,1.00000,1,1,0,BP
GO:0070232,regulation of T cell apoptotic process,43,0,0.86,1.00000,1,1,0,BP
GO:0070233,negative regulation of T cell apoptotic ...,26,0,0.52,1.00000,1,1,0,BP
GO:0070242,thymocyte apoptotic process,22,0,0.44,1.00000,1,1,0,BP
GO:0070296,sarcoplasmic reticulum calcium ion trans...,29,0,0.58,1.00000,1,1,0,BP
GO:0070328,triglyceride homeostasis,35,0,0.7,1.00000,1,1,0,BP
GO:0070498,interleukin-1-mediated signaling pathway,20,0,0.4,1.00000,1,1,0,BP
GO:0070527,platelet aggregation,45,0,0.9,1.00000,1,1,0,BP
GO:0070665,positive regulation of leukocyte prolife...,146,0,2.93,1.00000,1,1,0,BP
GO:0070741,response to interleukin-6,32,0,0.64,1.00000,1,1,0,BP
GO:0070841,inclusion body assembly,22,0,0.44,1.00000,1,1,0,BP
GO:0070920,regulation of production of small RNA in...,21,0,0.42,1.00000,1,1,0,BP
GO:0070988,demethylation,64,0,1.29,1.00000,1,1,0,BP
GO:0071218,cellular response to misfolded protein,23,0,0.46,1.00000,1,1,0,BP
GO:0071230,cellular response to amino acid stimulus,175,0,3.52,1.00000,1,1,0,BP
GO:0071234,cellular response to phenylalanine,25,0,0.5,1.00000,1,1,0,BP
GO:0071347,cellular response to interleukin-1,76,0,1.53,1.00000,1,1,0,BP
GO:0071354,cellular response to interleukin-6,30,0,0.6,1.00000,1,1,0,BP
GO:0071357,cellular response to type I interferon,39,0,0.78,1.00000,1,1,0,BP
GO:0071361,cellular response to ethanol,27,0,0.54,1.00000,1,1,0,BP
GO:0071384,cellular response to corticosteroid stim...,48,0,0.96,1.00000,1,1,0,BP
GO:0071385,cellular response to glucocorticoid stim...,46,0,0.92,1.00000,1,1,0,BP
GO:0071392,cellular response to estradiol stimulus,24,0,0.48,1.00000,1,1,0,BP
GO:0071425,hematopoietic stem cell proliferation,26,0,0.52,1.00000,1,1,0,BP
GO:0071467,cellular response to pH,23,0,0.46,1.00000,1,1,0,BP
GO:0071514,genetic imprinting,38,0,0.76,1.00000,1,1,0,BP
GO:0071548,response to dexamethasone,31,0,0.62,1.00000,1,1,0,BP
GO:0071549,cellular response to dexamethasone stimu...,28,0,0.56,1.00000,1,1,0,BP
GO:0071577,zinc ion transmembrane transport,23,0,0.46,1.00000,1,1,0,BP
GO:0071604,transforming growth factor beta producti...,36,0,0.72,1.00000,1,1,0,BP
GO:0071605,monocyte chemotactic protein-1 productio...,20,0,0.4,1.00000,1,1,0,BP
GO:0071616,acyl-CoA biosynthetic process,25,0,0.5,1.00000,1,1,0,BP
GO:0071621,granulocyte chemotaxis,124,0,2.49,1.00000,1,1,0,BP
GO:0071622,regulation of granulocyte chemotaxis,50,0,1.01,1.00000,1,1,0,BP
GO:0071624,positive regulation of granulocyte chemo...,27,0,0.54,1.00000,1,1,0,BP
GO:0071634,regulation of transforming growth factor...,34,0,0.68,1.00000,1,1,0,BP
GO:0071637,regulation of monocyte chemotactic prote...,20,0,0.4,1.00000,1,1,0,BP
GO:0071674,mononuclear cell migration,82,0,1.65,1.00000,1,1,0,BP
GO:0071675,regulation of mononuclear cell migration,50,0,1.01,1.00000,1,1,0,BP
GO:0071677,positive regulation of mononuclear cell ...,25,0,0.5,1.00000,1,1,0,BP
GO:0071715,icosanoid transport,53,0,1.07,1.00000,1,1,0,BP
GO:0071825,protein-lipid complex subunit organizati...,37,0,0.74,1.00000,1,1,0,BP
GO:0071827,plasma lipoprotein particle organization,33,0,0.66,1.00000,1,1,0,BP
GO:0071875,adrenergic receptor signaling pathway,31,0,0.62,1.00000,1,1,0,BP
GO:0071880,adenylate cyclase-activating adrenergic ...,29,0,0.58,1.00000,1,1,0,BP
GO:0071887,leukocyte apoptotic process,132,0,2.65,1.00000,1,1,0,BP
GO:0072170,metanephric tubule development,21,0,0.42,1.00000,1,1,0,BP
GO:0072207,metanephric epithelium development,24,0,0.48,1.00000,1,1,0,BP
GO:0072243,metanephric nephron epithelium developme...,20,0,0.4,1.00000,1,1,0,BP
GO:0072329,monocarboxylic acid catabolic process,112,0,2.25,1.00000,1,1,0,BP
GO:0072337,modified amino acid transport,23,0,0.46,1.00000,1,1,0,BP
GO:0072376,protein activation cascade,64,0,1.29,1.00000,1,1,0,BP
GO:0072395,signal transduction involved in cell cyc...,29,0,0.58,1.00000,1,1,0,BP
GO:0072401,signal transduction involved in DNA inte...,29,0,0.58,1.00000,1,1,0,BP
GO:0072422,signal transduction involved in DNA dama...,29,0,0.58,1.00000,1,1,0,BP
GO:0072527,pyrimidine-containing compound metabolic...,51,0,1.03,1.00000,1,1,0,BP
GO:0072528,pyrimidine-containing compound biosynthe...,27,0,0.54,1.00000,1,1,0,BP
GO:0072538,T-helper 17 type immune response,32,0,0.64,1.00000,1,1,0,BP
GO:0072539,T-helper 17 cell differentiation,28,0,0.56,1.00000,1,1,0,BP
GO:0072599,establishment of protein localization to...,36,0,0.72,1.00000,1,1,0,BP
GO:0072643,interferon-gamma secretion,24,0,0.48,1.00000,1,1,0,BP
GO:0072662,protein localization to peroxisome,20,0,0.4,1.00000,1,1,0,BP
GO:0072663,establishment of protein localization to...,20,0,0.4,1.00000,1,1,0,BP
GO:0072677,eosinophil migration,24,0,0.48,1.00000,1,1,0,BP
GO:0080053,response to phenylalanine,25,0,0.5,1.00000,1,1,0,BP
GO:0080111,DNA demethylation,21,0,0.42,1.00000,1,1,0,BP
GO:0080154,regulation of fertilization,28,0,0.56,1.00000,1,1,0,BP
GO:0086010,membrane depolarization during action po...,31,0,0.62,1.00000,1,1,0,BP
GO:0086019,cell-cell signaling involved in cardiac ...,25,0,0.5,1.00000,1,1,0,BP
GO:0086065,cell communication involved in cardiac c...,37,0,0.74,1.00000,1,1,0,BP
GO:0086091,regulation of heart rate by cardiac cond...,33,0,0.66,1.00000,1,1,0,BP
GO:0089718,amino acid import across plasma membrane,28,0,0.56,1.00000,1,1,0,BP
GO:0090022,regulation of neutrophil chemotaxis,31,0,0.62,1.00000,1,1,0,BP
GO:0090023,positive regulation of neutrophil chemot...,25,0,0.5,1.00000,1,1,0,BP
GO:0090025,regulation of monocyte chemotaxis,26,0,0.52,1.00000,1,1,0,BP
GO:0090077,foam cell differentiation,26,0,0.52,1.00000,1,1,0,BP
GO:0090102,cochlea development,49,0,0.98,1.00000,1,1,0,BP
GO:0090103,cochlea morphogenesis,28,0,0.56,1.00000,1,1,0,BP
GO:0090114,COPII-coated vesicle budding,25,0,0.5,1.00000,1,1,0,BP
GO:0090175,regulation of establishment of planar po...,42,0,0.84,1.00000,1,1,0,BP
GO:0090189,regulation of branching involved in uret...,26,0,0.52,1.00000,1,1,0,BP
GO:0090190,positive regulation of branching involve...,23,0,0.46,1.00000,1,1,0,BP
GO:0090207,regulation of triglyceride metabolic pro...,45,0,0.9,1.00000,1,1,0,BP
GO:0090208,positive regulation of triglyceride meta...,26,0,0.52,1.00000,1,1,0,BP
GO:0090218,positive regulation of lipid kinase acti...,33,0,0.66,1.00000,1,1,0,BP
GO:0090280,positive regulation of calcium ion impor...,25,0,0.5,1.00000,1,1,0,BP
GO:0090303,positive regulation of wound healing,57,0,1.15,1.00000,1,1,0,BP
GO:0090313,regulation of protein targeting to membr...,34,0,0.68,1.00000,1,1,0,BP
GO:0090314,positive regulation of protein targeting...,28,0,0.56,1.00000,1,1,0,BP
GO:0090330,regulation of platelet aggregation,22,0,0.44,1.00000,1,1,0,BP
GO:0090382,phagosome maturation,22,0,0.44,1.00000,1,1,0,BP
GO:0090504,epiboly,32,0,0.64,1.00000,1,1,0,BP
GO:0090505,epiboly involved in wound healing,31,0,0.62,1.00000,1,1,0,BP
GO:0090630,activation of GTPase activity,83,0,1.67,1.00000,1,1,0,BP
GO:0097006,regulation of plasma lipoprotein particl...,62,0,1.25,1.00000,1,1,0,BP
GO:0097009,energy homeostasis,39,0,0.78,1.00000,1,1,0,BP
GO:0097028,dendritic cell differentiation,38,0,0.76,1.00000,1,1,0,BP
GO:0097035,regulation of membrane lipid distributio...,53,0,1.07,1.00000,1,1,0,BP
GO:0097107,postsynaptic density assembly,22,0,0.44,1.00000,1,1,0,BP
GO:0097150,neuronal stem cell population maintenanc...,24,0,0.48,1.00000,1,1,0,BP
GO:0097164,ammonium ion metabolic process,170,0,3.42,1.00000,1,1,0,BP
GO:0097178,ruffle assembly,42,0,0.84,1.00000,1,1,0,BP
GO:0097186,amelogenesis,24,0,0.48,1.00000,1,1,0,BP
GO:0097194,execution phase of apoptosis,67,0,1.35,1.00000,1,1,0,BP
GO:0097320,plasma membrane tubulation,20,0,0.4,1.00000,1,1,0,BP
GO:0097345,mitochondrial outer membrane permeabiliz...,29,0,0.58,1.00000,1,1,0,BP
GO:0097484,dendrite extension,43,0,0.86,1.00000,1,1,0,BP
GO:0097502,mannosylation,23,0,0.46,1.00000,1,1,0,BP
GO:0097529,myeloid leukocyte migration,208,0,4.18,1.00000,1,1,0,BP
GO:0097530,granulocyte migration,146,0,2.93,1.00000,1,1,0,BP
GO:0097734,extracellular exosome biogenesis,21,0,0.42,1.00000,1,1,0,BP
GO:0097756,negative regulation of blood vessel diam...,107,0,2.15,1.00000,1,1,0,BP
GO:0098581,detection of external biotic stimulus,23,0,0.46,1.00000,1,1,0,BP
GO:0098586,cellular response to virus,50,0,1.01,1.00000,1,1,0,BP
GO:0098659,inorganic cation import across plasma me...,86,0,1.73,1.00000,1,1,0,BP
GO:0098661,inorganic anion transmembrane transport,59,0,1.19,1.00000,1,1,0,BP
GO:0098698,postsynaptic specialization assembly,29,0,0.58,1.00000,1,1,0,BP
GO:0098739,import across plasma membrane,119,0,2.39,1.00000,1,1,0,BP
GO:0098743,cell aggregation,20,0,0.4,1.00000,1,1,0,BP
GO:0098751,bone cell development,37,0,0.74,1.00000,1,1,0,BP
GO:0098868,bone growth,46,0,0.92,1.00000,1,1,0,BP
GO:0098877,neurotransmitter receptor transport to p...,22,0,0.44,1.00000,1,1,0,BP
GO:0098969,neurotransmitter receptor transport to p...,21,0,0.42,1.00000,1,1,0,BP
GO:0099068,postsynapse assembly,34,0,0.68,1.00000,1,1,0,BP
GO:0099170,postsynaptic modulation of chemical syna...,22,0,0.44,1.00000,1,1,0,BP
GO:0099500,vesicle fusion to plasma membrane,26,0,0.52,1.00000,1,1,0,BP
GO:0099514,synaptic vesicle cytoskeletal transport,20,0,0.4,1.00000,1,1,0,BP
GO:0099517,synaptic vesicle transport along microtu...,20,0,0.4,1.00000,1,1,0,BP
GO:0099560,synaptic membrane adhesion,31,0,0.62,1.00000,1,1,0,BP
GO:0099587,inorganic ion import across plasma membr...,86,0,1.73,1.00000,1,1,0,BP
GO:0099632,protein transport within plasma membrane,31,0,0.62,1.00000,1,1,0,BP
GO:0099637,neurotransmitter receptor transport,31,0,0.62,1.00000,1,1,0,BP
GO:0106030,neuron projection fasciculation,26,0,0.52,1.00000,1,1,0,BP
GO:0120033,negative regulation of plasma membrane b...,25,0,0.5,1.00000,1,1,0,BP
GO:0140053,mitochondrial gene expression,103,0,2.07,1.00000,1,1,0,BP
GO:0140058,neuron projection arborization,21,0,0.42,1.00000,1,1,0,BP
GO:0140112,extracellular vesicle biogenesis,23,0,0.46,1.00000,1,1,0,BP
GO:0150077,regulation of neuroinflammatory response,25,0,0.5,1.00000,1,1,0,BP
GO:1900017,positive regulation of cytokine producti...,21,0,0.42,1.00000,1,1,0,BP
GO:1900027,regulation of ruffle assembly,29,0,0.58,1.00000,1,1,0,BP
GO:1900046,regulation of hemostasis,79,0,1.59,1.00000,1,1,0,BP
GO:1900047,negative regulation of hemostasis,50,0,1.01,1.00000,1,1,0,BP
GO:1900048,positive regulation of hemostasis,26,0,0.52,1.00000,1,1,0,BP
GO:1900117,regulation of execution phase of apoptos...,30,0,0.6,1.00000,1,1,0,BP
GO:1900120,regulation of receptor binding,24,0,0.48,1.00000,1,1,0,BP
GO:1900242,regulation of synaptic vesicle endocytos...,23,0,0.46,1.00000,1,1,0,BP
GO:1900274,regulation of phospholipase C activity,30,0,0.6,1.00000,1,1,0,BP
GO:1900543,negative regulation of purine nucleotide...,30,0,0.6,1.00000,1,1,0,BP
GO:1900745,positive regulation of p38MAPK cascade,28,0,0.56,1.00000,1,1,0,BP
GO:1901020,negative regulation of calcium ion trans...,31,0,0.62,1.00000,1,1,0,BP
GO:1901028,regulation of mitochondrial outer membra...,20,0,0.4,1.00000,1,1,0,BP
GO:1901099,negative regulation of signal transducti...,33,0,0.66,1.00000,1,1,0,BP
GO:1901185,negative regulation of ERBB signaling pa...,27,0,0.54,1.00000,1,1,0,BP
GO:1901186,positive regulation of ERBB signaling pa...,28,0,0.56,1.00000,1,1,0,BP
GO:1901522,positive regulation of transcription fro...,21,0,0.42,1.00000,1,1,0,BP
GO:1901532,regulation of hematopoietic progenitor c...,27,0,0.54,1.00000,1,1,0,BP
GO:1901570,fatty acid derivative biosynthetic proce...,51,0,1.03,1.00000,1,1,0,BP
GO:1901571,fatty acid derivative transport,53,0,1.07,1.00000,1,1,0,BP
GO:1901607,alpha-amino acid biosynthetic process,61,0,1.23,1.00000,1,1,0,BP
GO:1901658,glycosyl compound catabolic process,25,0,0.5,1.00000,1,1,0,BP
GO:1901661,quinone metabolic process,31,0,0.62,1.00000,1,1,0,BP
GO:1901741,positive regulation of myoblast fusion,23,0,0.46,1.00000,1,1,0,BP
GO:1901797,negative regulation of signal transducti...,32,0,0.64,1.00000,1,1,0,BP
GO:1901984,negative regulation of protein acetylati...,24,0,0.48,1.00000,1,1,0,BP
GO:1901985,positive regulation of protein acetylati...,43,0,0.86,1.00000,1,1,0,BP
GO:1902108,regulation of mitochondrial membrane per...,40,0,0.8,1.00000,1,1,0,BP
GO:1902110,positive regulation of mitochondrial mem...,32,0,0.64,1.00000,1,1,0,BP
GO:1902253,regulation of intrinsic apoptotic signal...,30,0,0.6,1.00000,1,1,0,BP
GO:1902254,negative regulation of intrinsic apoptot...,20,0,0.4,1.00000,1,1,0,BP
GO:1902475,L-alpha-amino acid transmembrane transpo...,39,0,0.78,1.00000,1,1,0,BP
GO:1902476,chloride transmembrane transport,39,0,0.78,1.00000,1,1,0,BP
GO:1902600,proton transmembrane transport,90,0,1.81,1.00000,1,1,0,BP
GO:1902622,regulation of neutrophil migration,41,0,0.82,1.00000,1,1,0,BP
GO:1902624,positive regulation of neutrophil migrat...,33,0,0.66,1.00000,1,1,0,BP
GO:1902743,regulation of lamellipodium organization,44,0,0.88,1.00000,1,1,0,BP
GO:1902745,positive regulation of lamellipodium org...,31,0,0.62,1.00000,1,1,0,BP
GO:1902893,regulation of pri-miRNA transcription by...,45,0,0.9,1.00000,1,1,0,BP
GO:1902895,positive regulation of pri-miRNA transcr...,35,0,0.7,1.00000,1,1,0,BP
GO:1903035,negative regulation of response to wound...,89,0,1.79,1.00000,1,1,0,BP
GO:1903131,mononuclear cell differentiation,29,0,0.58,1.00000,1,1,0,BP
GO:1903306,negative regulation of regulated secreto...,23,0,0.46,1.00000,1,1,0,BP
GO:1903318,negative regulation of protein maturatio...,37,0,0.74,1.00000,1,1,0,BP
GO:1903393,positive regulation of adherens junction...,31,0,0.62,1.00000,1,1,0,BP
GO:1903421,regulation of synaptic vesicle recycling,31,0,0.62,1.00000,1,1,0,BP
GO:1903429,regulation of cell maturation,33,0,0.66,1.00000,1,1,0,BP
GO:1903487,regulation of lactation,29,0,0.58,1.00000,1,1,0,BP
GO:1903489,positive regulation of lactation,27,0,0.54,1.00000,1,1,0,BP
GO:1903510,mucopolysaccharide metabolic process,58,0,1.17,1.00000,1,1,0,BP
GO:1903514,release of sequestered calcium ion into ...,22,0,0.44,1.00000,1,1,0,BP
GO:1903523,negative regulation of blood circulation,42,0,0.84,1.00000,1,1,0,BP
GO:1903524,positive regulation of blood circulation,90,0,1.81,1.00000,1,1,0,BP
GO:1903540,establishment of protein localization to...,23,0,0.46,1.00000,1,1,0,BP
GO:1903579,negative regulation of ATP metabolic pro...,29,0,0.58,1.00000,1,1,0,BP
GO:1903725,regulation of phospholipid metabolic pro...,72,0,1.45,1.00000,1,1,0,BP
GO:1903727,positive regulation of phospholipid meta...,46,0,0.92,1.00000,1,1,0,BP
GO:1903793,positive regulation of anion transport,65,0,1.31,1.00000,1,1,0,BP
GO:1903798,regulation of production of miRNAs invol...,20,0,0.4,1.00000,1,1,0,BP
GO:1903846,positive regulation of cellular response...,29,0,0.58,1.00000,1,1,0,BP
GO:1903859,regulation of dendrite extension,32,0,0.64,1.00000,1,1,0,BP
GO:1903861,positive regulation of dendrite extensio...,29,0,0.58,1.00000,1,1,0,BP
GO:1903963,arachidonate transport,31,0,0.62,1.00000,1,1,0,BP
GO:1904321,response to forskolin,65,0,1.31,1.00000,1,1,0,BP
GO:1904322,cellular response to forskolin,65,0,1.31,1.00000,1,1,0,BP
GO:1904357,negative regulation of telomere maintena...,26,0,0.52,1.00000,1,1,0,BP
GO:1904707,positive regulation of vascular smooth m...,35,0,0.7,1.00000,1,1,0,BP
GO:1904861,excitatory synapse assembly,29,0,0.58,1.00000,1,1,0,BP
GO:1904894,positive regulation of STAT cascade,107,0,2.15,1.00000,1,1,0,BP
GO:1905153,regulation of membrane invagination,21,0,0.42,1.00000,1,1,0,BP
GO:1905208,negative regulation of cardiocyte differ...,24,0,0.48,1.00000,1,1,0,BP
GO:1905314,semi-lunar valve development,31,0,0.62,1.00000,1,1,0,BP
GO:1905517,macrophage migration,57,0,1.15,1.00000,1,1,0,BP
GO:1905521,regulation of macrophage migration,42,0,0.84,1.00000,1,1,0,BP
GO:1905523,positive regulation of macrophage migrat...,27,0,0.54,1.00000,1,1,0,BP
GO:1905809,negative regulation of synapse organizat...,25,0,0.5,1.00000,1,1,0,BP
GO:1905939,regulation of gonad development,25,0,0.5,1.00000,1,1,0,BP
GO:1905953,negative regulation of lipid localizatio...,41,0,0.82,1.00000,1,1,0,BP
GO:1990126,"retrograde transport, endosome to plasma...",29,0,0.58,1.00000,1,1,0,BP
GO:1990182,exosomal secretion,20,0,0.4,1.00000,1,1,0,BP
GO:1990266,neutrophil migration,119,0,2.39,1.00000,1,1,0,BP
GO:1990573,potassium ion import across plasma membr...,43,0,0.86,1.00000,1,1,0,BP
GO:2000010,positive regulation of protein localizat...,22,0,0.44,1.00000,1,1,0,BP
GO:2000106,regulation of leukocyte apoptotic proces...,108,0,2.17,1.00000,1,1,0,BP
GO:2000107,negative regulation of leukocyte apoptot...,69,0,1.39,1.00000,1,1,0,BP
GO:2000108,positive regulation of leukocyte apoptot...,33,0,0.66,1.00000,1,1,0,BP
GO:2000178,negative regulation of neural precursor ...,28,0,0.56,1.00000,1,1,0,BP
GO:2000191,regulation of fatty acid transport,32,0,0.64,1.00000,1,1,0,BP
GO:2000193,positive regulation of fatty acid transp...,21,0,0.42,1.00000,1,1,0,BP
GO:2000249,regulation of actin cytoskeleton reorgan...,35,0,0.7,1.00000,1,1,0,BP
GO:2000272,negative regulation of signaling recepto...,27,0,0.54,1.00000,1,1,0,BP
GO:2000311,regulation of AMPA receptor activity,28,0,0.56,1.00000,1,1,0,BP
GO:2000316,regulation of T-helper 17 type immune re...,23,0,0.46,1.00000,1,1,0,BP
GO:2000352,negative regulation of endothelial cell ...,31,0,0.62,1.00000,1,1,0,BP
GO:2000514,"regulation of CD4-positive, alpha-beta T...",64,0,1.29,1.00000,1,1,0,BP
GO:2000515,"negative regulation of CD4-positive, alp...",31,0,0.62,1.00000,1,1,0,BP
GO:2000516,"positive regulation of CD4-positive, alp...",36,0,0.72,1.00000,1,1,0,BP
GO:2000678,negative regulation of transcription reg...,20,0,0.4,1.00000,1,1,0,BP
GO:2000726,negative regulation of cardiac muscle ce...,20,0,0.4,1.00000,1,1,0,BP
GO:2000737,negative regulation of stem cell differe...,26,0,0.52,1.00000,1,1,0,BP
GO:2000757,negative regulation of peptidyl-lysine a...,22,0,0.44,1.00000,1,1,0,BP
GO:2000758,positive regulation of peptidyl-lysine a...,34,0,0.68,1.00000,1,1,0,BP
GO:2000831,regulation of steroid hormone secretion,23,0,0.46,1.00000,1,1,0,BP
GO:2001032,regulation of double-strand break repair...,21,0,0.42,1.00000,1,1,0,BP
GO:2001224,positive regulation of neuron migration,21,0,0.42,1.00000,1,1,0,BP
GO:2001239,regulation of extrinsic apoptotic signal...,48,0,0.96,1.00000,1,1,0,BP
GO:2001240,negative regulation of extrinsic apoptot...,33,0,0.66,1.00000,1,1,0,BP
GO:2001258,negative regulation of cation channel ac...,41,0,0.82,1.00000,1,1,0,BP
GO:0005488,binding,13259,360,269.16,3.0e-23,2.4870000000000002e-20,2.4870000000000002e-20,1.34,MF
GO:0005515,protein binding,8941,281,181.51,6.3e-23,5.2227e-20,2.61135e-20,1.55,MF
GO:0019899,enzyme binding,2351,102,47.73,4.9e-14,4.0621e-11,1.3540333333333333e-11,2.14,MF
GO:1901363,heterocyclic compound binding,5061,160,102.74,2.8e-10,2.3212000000000002e-7,5.8030000000000004e-8,1.56,MF
GO:0003723,RNA binding,1068,54,21.68,6.1e-10,5.056899999999999e-7,8.053142857142858e-8,2.49,MF
GO:0008092,cytoskeletal protein binding,976,51,19.81,6.2e-10,5.139800000000001e-7,8.053142857142858e-8,2.57,MF
GO:0097159,organic cyclic compound binding,5162,161,104.79,6.8e-10,5.6372e-7,8.053142857142858e-8,1.54,MF
GO:0003676,nucleic acid binding,3105,108,63.03,6.0e-09,4.974e-6,6.2175e-7,1.71,MF
GO:0003774,motor activity,133,16,2.7,1.3e-08,1.0777e-5,1.1974444444444446e-6,5.93,MF
GO:0044877,protein-containing complex binding,1256,56,25.5,2.5e-08,2.0725e-5,2.0725e-6,2.2,MF
GO:0003735,structural constituent of ribosome,151,16,3.07,7.9e-08,6.5491e-5,5.953727272727273e-6,5.21,MF
GO:0003777,microtubule motor activity,84,12,1.71,1.3e-07,1.0776999999999999e-4,8.980833333333332e-6,7.02,MF
GO:0003729,mRNA binding,270,20,5.48,7.3e-07,6.0517e-4,4.655153846153846e-5,3.65,MF
GO:0003779,actin binding,429,26,8.71,8.1e-07,6.7149e-4,4.796357142857143e-5,2.99,MF
GO:0005198,structural molecule activity,610,31,12.38,3.0e-06,0.002487,1.658e-4,2.5,MF
GO:0016462,pyrophosphatase activity,883,39,17.93,4.9e-06,0.0040621,2.399736842105263e-4,2.18,MF
GO:0016817,"hydrolase activity, acting on acid anhyd...",886,39,17.99,5.3e-06,0.0043937,2.399736842105263e-4,2.17,MF
GO:0016818,"hydrolase activity, acting on acid anhyd...",886,39,17.99,5.3e-06,0.0043937,2.399736842105263e-4,2.17,MF
GO:0019900,kinase binding,821,37,16.67,5.5e-06,0.0045595,2.399736842105263e-4,2.22,MF
GO:0017111,nucleoside-triphosphatase activity,830,37,16.85,7.0e-06,0.005803,2.9015000000000003e-4,2.2,MF
GO:0042393,histone binding,218,16,4.43,1.1e-05,0.009119,4.3423809523809523e-4,3.61,MF
GO:0035639,purine ribonucleoside triphosphate bindi...,1756,62,35.65,1.3e-05,0.010777,4.898636363636363e-4,1.74,MF
GO:0017076,purine nucleotide binding,1843,64,37.41,1.5e-05,0.012435,5.406521739130434e-4,1.71,MF
GO:0015631,tubulin binding,339,20,6.88,2.2e-05,0.018238,7.599166666666666e-4,2.91,MF
GO:0032555,purine ribonucleotide binding,1831,63,37.17,2.4e-05,0.019896,7.958399999999999e-4,1.69,MF
GO:0043167,ion binding,5533,150,112.32,2.9e-05,0.024041,9.246538461538461e-4,1.34,MF
GO:0032553,ribonucleotide binding,1848,63,37.52,3.1e-05,0.025699,9.518148148148148e-4,1.68,MF
GO:0019901,protein kinase binding,740,32,15.02,5.3e-05,0.043937000000000004,0.0015691785714285714,2.13,MF
GO:0005524,ATP binding,1429,51,29.01,6.2e-05,0.051398,0.0017132666666666667,1.76,MF
GO:0030554,adenyl nucleotide binding,1505,53,30.55,6.2e-05,0.051398,0.0017132666666666667,1.73,MF
GO:0000166,nucleotide binding,2075,67,42.12,9.0e-05,0.07461000000000001,0.0023315625000000003,1.59,MF
GO:1901265,nucleoside phosphate binding,2075,67,42.12,9.0e-05,0.07461000000000001,0.0023315625000000003,1.59,MF
GO:0019843,rRNA binding,71,8,1.44,9.4e-05,0.077926,0.002361393939393939,5.56,MF
GO:0032559,adenyl ribonucleotide binding,1494,52,30.33,9.8e-05,0.081242,0.002389470588235294,1.71,MF
GO:0000993,RNA polymerase II complex binding,38,6,0.77,0.00011,0.09119000000000001,0.0026054285714285715,7.79,MF
GO:0044389,ubiquitin-like protein ligase binding,326,18,6.62,0.00013,0.10776999999999999,0.002993611111111111,2.72,MF
GO:0008017,microtubule binding,242,15,4.91,0.00014,0.11606,0.0031367567567567567,3.05,MF
GO:0019902,phosphatase binding,217,14,4.41,0.00015,0.12434999999999999,0.003272368421052631,3.17,MF
GO:0003682,chromatin binding,589,26,11.96,0.00019,0.15751,0.004038717948717949,2.17,MF
GO:0031625,ubiquitin protein ligase binding,307,17,6.23,0.00020,0.1658,0.004145,2.73,MF
GO:0043175,RNA polymerase core enzyme binding,43,6,0.87,0.00022,0.18238000000000001,0.004448292682926829,6.9,MF
GO:0043168,anion binding,2733,81,55.48,0.00026,0.21553999999999998,0.005131904761904761,1.46,MF
GO:0097367,carbohydrate derivative binding,2158,67,43.81,0.00028,0.23212,0.00539813953488372,1.53,MF
GO:0005178,integrin binding,128,10,2.6,0.00029,0.24041,0.0054638636363636365,3.85,MF
GO:0016301,kinase activity,778,31,15.79,0.00030,0.24869999999999998,0.005526666666666666,1.96,MF
GO:0016887,ATPase activity,386,19,7.84,0.00038,0.31502,0.006848260869565218,2.42,MF
GO:0050839,cell adhesion molecule binding,245,14,4.97,0.00052,0.43107999999999996,0.009171914893617022,2.82,MF
GO:0070064,proline-rich region binding,20,4,0.41,0.00063,0.52227,0.010880625,9.76,MF
GO:0019903,protein phosphatase binding,170,11,3.45,0.00073,0.60517,0.012350408163265306,3.19,MF
GO:0051015,actin filament binding,200,12,4.06,0.00083,0.68807,0.013761399999999998,2.96,MF
GO:0036094,small molecule binding,2460,72,49.94,0.00087,0.72123,0.014141764705882352,1.44,MF
GO:0001098,basal transcription machinery binding,58,6,1.18,0.00112,0.92848,0.017194074074074073,5.08,MF
GO:0001099,basal RNA polymerase II transcription ma...,58,6,1.18,0.00112,0.92848,0.017194074074074073,5.08,MF
GO:0070063,RNA polymerase binding,58,6,1.18,0.00112,0.92848,0.017194074074074073,5.08,MF
GO:0016772,"transferase activity, transferring phosp...",921,33,18.7,0.00120,0.9947999999999999,0.01776428571428571,1.76,MF
GO:0042802,identical protein binding,1906,58,38.69,0.00120,0.9947999999999999,0.01776428571428571,1.5,MF
GO:0003712,transcription coregulator activity,460,20,9.34,0.00125,1,0.018179824561403508,2.14,MF
GO:0004386,helicase activity,156,10,3.17,0.00135,1,0.019295689655172414,3.15,MF
GO:0008144,drug binding,1685,52,34.21,0.00162,1,0.022762372881355932,1.52,MF
GO:0003714,transcription corepressor activity,190,11,3.86,0.00180,1,0.02487,2.85,MF
GO:0008574,ATP-dependent microtubule motor activity...,28,4,0.57,0.00233,1,0.031154354838709677,7.02,MF
GO:0043325,"phosphatidylinositol-3,4-bisphosphate bi...",28,4,0.57,0.00233,1,0.031154354838709677,7.02,MF
GO:0140096,"catalytic activity, acting on a protein",2187,63,44.4,0.00276,1,0.03631809523809523,1.42,MF
GO:1990939,ATP-dependent microtubule motor activity,49,5,0.99,0.00308,1,0.039895625,5.05,MF
GO:0032182,ubiquitin-like protein binding,95,7,1.93,0.00323,1,0.04095507462686567,3.63,MF
GO:0002020,protease binding,148,9,3,0.00330,1,0.04095507462686567,3,MF
GO:0016773,"phosphotransferase activity, alcohol gro...",717,26,14.56,0.00331,1,0.04095507462686567,1.79,MF
GO:0043236,laminin binding,31,4,0.63,0.00341,1,0.04096942028985507,6.35,MF
GO:0002039,p53 binding,72,6,1.46,0.00341,1,0.04096942028985507,4.11,MF
GO:0051082,unfolded protein binding,97,7,1.97,0.00363,1,0.04298957142857143,3.55,MF
GO:0004672,protein kinase activity,616,23,12.51,0.00393,1,0.04588690140845071,1.84,MF
GO:0008270,zinc ion binding,691,25,14.03,0.00405,1,0.04663125,1.78,MF
GO:0046872,metal ion binding,3533,93,71.72,0.00411,1,0.046673835616438356,1.3,MF
GO:1990841,promoter-specific chromatin binding,53,5,1.08,0.00434,1,0.048619729729729735,4.63,MF
GO:0051018,protein kinase A binding,54,5,1.1,0.00471,1,0.05101538461538461,4.55,MF
GO:0019904,protein domain specific binding,813,28,16.5,0.00476,1,0.05101538461538461,1.7,MF
GO:0003755,peptidyl-prolyl cis-trans isomerase acti...,34,4,0.69,0.00480,1,0.05101538461538461,5.8,MF
GO:0016776,"phosphotransferase activity, phosphate g...",34,4,0.69,0.00480,1,0.05101538461538461,5.8,MF
GO:0046914,transition metal ion binding,971,32,19.71,0.00505,1,0.0521962962962963,1.62,MF
GO:0008135,"translation factor activity, RNA binding",78,6,1.58,0.00507,1,0.0521962962962963,3.8,MF
GO:0047485,protein N-terminus binding,130,8,2.64,0.00510,1,0.0521962962962963,3.03,MF
GO:0042162,telomeric DNA binding,36,4,0.73,0.00590,1,0.059647560975609755,5.48,MF
GO:0043169,cation binding,3631,94,73.71,0.00627,1,0.06262445783132531,1.28,MF
GO:0050840,extracellular matrix binding,59,5,1.2,0.00686,1,0.06758788235294119,4.17,MF
GO:0019207,kinase regulator activity,196,10,3.98,0.00693,1,0.06758788235294119,2.51,MF
GO:0016859,cis-trans isomerase activity,38,4,0.77,0.00717,1,0.06911546511627907,5.19,MF
GO:0005547,"phosphatidylinositol-3,4,5-trisphosphate...",41,4,0.83,0.00938,1,0.08842666666666665,4.82,MF
GO:0004003,ATP-dependent DNA helicase activity,22,3,0.45,0.00960,1,0.08842666666666665,6.67,MF
GO:0008026,ATP-dependent helicase activity,22,3,0.45,0.00960,1,0.08842666666666665,6.67,MF
GO:0070035,purine NTP-dependent helicase activity,22,3,0.45,0.00960,1,0.08842666666666665,6.67,MF
GO:0051020,GTPase binding,527,19,10.7,0.01180,1,0.10749670329670329,1.78,MF
GO:0035255,ionotropic glutamate receptor binding,45,4,0.91,0.01295,1,0.1166907608695652,4.4,MF
GO:0035254,glutamate receptor binding,70,5,1.42,0.01386,1,0.12311531914893618,3.52,MF
GO:0035091,phosphatidylinositol binding,251,11,5.1,0.01396,1,0.12311531914893618,2.16,MF
GO:0042623,"ATPase activity, coupled",286,12,5.81,0.01442,1,0.12583347368421052,2.07,MF
GO:0003743,translation initiation factor activity,47,4,0.95,0.01502,1,0.12836680412371135,4.21,MF
GO:0016538,cyclin-dependent protein serine/threonin...,47,4,0.95,0.01502,1,0.12836680412371135,4.21,MF
GO:0008094,DNA-dependent ATPase activity,72,5,1.46,0.01551,1,0.1312019387755102,3.42,MF
GO:0043130,ubiquitin binding,74,5,1.5,0.01728,1,0.1433341,3.33,MF
GO:0019894,kinesin binding,49,4,0.99,0.01729,1,0.1433341,4.04,MF
GO:0017048,Rho GTPase binding,166,8,3.37,0.02033,1,0.16523107843137255,2.37,MF
GO:1901981,phosphatidylinositol phosphate binding,166,8,3.37,0.02033,1,0.16523107843137255,2.37,MF
GO:0044325,ion channel binding,139,7,2.82,0.02353,1,0.18938223300970872,2.48,MF
GO:0008022,protein C-terminus binding,238,10,4.83,0.02406,1,0.19178596153846153,2.07,MF
GO:0030507,spectrin binding,32,3,0.65,0.02666,1,0.21048704761904763,4.62,MF
GO:0003697,single-stranded DNA binding,113,6,2.29,0.02780,1,0.21741698113207547,2.62,MF
GO:0051959,dynein light intermediate chain binding,33,3,0.67,0.02890,1,0.223907476635514,4.48,MF
GO:0008200,ion channel inhibitor activity,35,3,0.71,0.03366,1,0.25837166666666667,4.23,MF
GO:0003678,DNA helicase activity,61,4,1.24,0.03530,1,0.2684743119266055,3.23,MF
GO:0070273,phosphatidylinositol-4-phosphate binding,36,3,0.73,0.03618,1,0.27266563636363633,4.11,MF
GO:0019787,ubiquitin-like protein transferase activ...,405,14,8.22,0.03802,1,0.28395117117117114,1.7,MF
GO:0016248,channel inhibitor activity,37,3,0.75,0.03880,1,0.28655522123893806,4,MF
GO:0005200,structural constituent of cytoskeleton,63,4,1.28,0.03906,1,0.28655522123893806,3.12,MF
GO:0030234,enzyme regulator activity,973,28,19.75,0.04086,1,0.29713105263157896,1.42,MF
GO:0019205,nucleobase-containing compound kinase ac...,38,3,0.77,0.04151,1,0.2992329565217391,3.9,MF
GO:0003677,DNA binding,2059,53,41.8,0.04248,1,0.30198273504273504,1.27,MF
GO:0051117,ATPase binding,94,5,1.91,0.04262,1,0.30198273504273504,2.62,MF
GO:0004842,ubiquitin-protein transferase activity,383,13,7.78,0.05008,1,0.34797275,1.67,MF
GO:0032266,phosphatidylinositol-3-phosphate binding,41,3,0.83,0.05019,1,0.34797275,3.61,MF
GO:0019887,protein kinase regulator activity,164,7,3.33,0.05037,1,0.34797275,2.1,MF
GO:0004674,protein serine/threonine kinase activity,463,15,9.4,0.05197,1,0.3560589256198347,1.6,MF
GO:0016740,transferase activity,2276,57,46.2,0.05557,1,0.37726185483870966,1.23,MF
GO:0070491,repressing transcription factor binding,71,4,1.44,0.05629,1,0.37726185483870966,2.78,MF
GO:0019212,phosphatase inhibitor activity,43,3,0.87,0.05643,1,0.37726185483870966,3.45,MF
GO:0003824,catalytic activity,5780,132,117.34,0.06132,1,0.40085740157480315,1.12,MF
GO:0017116,single-stranded DNA-dependent ATP-depend...,20,2,0.41,0.06141,1,0.40085740157480315,4.88,MF
GO:0043142,single-stranded DNA-dependent ATPase act...,20,2,0.41,0.06141,1,0.40085740157480315,4.88,MF
GO:0004715,non-membrane spanning protein tyrosine k...,45,3,0.91,0.06303,1,0.4076237984496124,3.3,MF
GO:0001085,RNA polymerase II transcription factor b...,173,7,3.51,0.06343,1,0.4076237984496124,1.99,MF
GO:0005525,GTP binding,360,12,7.31,0.06481,1,0.41089290076335877,1.64,MF
GO:0051219,phosphoprotein binding,106,5,2.15,0.06493,1,0.41089290076335877,2.33,MF
GO:0031072,heat shock protein binding,140,6,2.84,0.06619,1,0.4113682222222222,2.11,MF
GO:0032813,tumor necrosis factor receptor superfami...,46,3,0.93,0.06645,1,0.4113682222222222,3.23,MF
GO:0008134,transcription factor binding,726,21,14.74,0.06693,1,0.4113682222222222,1.42,MF
GO:0043138,3'-5' DNA helicase activity,21,2,0.43,0.06699,1,0.4113682222222222,4.65,MF
GO:0019783,ubiquitin-like protein-specific protease...,109,5,2.21,0.07136,1,0.43066550000000003,2.26,MF
GO:0019003,GDP binding,77,4,1.56,0.07149,1,0.43066550000000003,2.56,MF
GO:0032550,purine ribonucleoside binding,367,12,7.45,0.07250,1,0.43066550000000003,1.61,MF
GO:0034237,protein kinase A regulatory subunit bind...,22,2,0.45,0.07273,1,0.43066550000000003,4.44,MF
GO:0050998,nitric-oxide synthase binding,22,2,0.45,0.07273,1,0.43066550000000003,4.44,MF
GO:1902936,phosphatidylinositol bisphosphate bindin...,111,5,2.25,0.07584,1,0.445896170212766,2.22,MF
GO:0030544,Hsp70 protein binding,49,3,0.99,0.07721,1,0.44641082191780823,3.03,MF
GO:0001883,purine nucleoside binding,372,12,7.55,0.07834,1,0.44641082191780823,1.59,MF
GO:0032549,ribonucleoside binding,372,12,7.55,0.07834,1,0.44641082191780823,1.59,MF
GO:0003688,DNA replication origin binding,23,2,0.47,0.07862,1,0.44641082191780823,4.26,MF
GO:0030506,ankyrin binding,23,2,0.47,0.07862,1,0.44641082191780823,4.26,MF
GO:0005509,calcium ion binding,621,18,12.61,0.08385,1,0.45871333333333336,1.43,MF
GO:0004129,cytochrome-c oxidase activity,24,2,0.49,0.08466,1,0.45871333333333336,4.08,MF
GO:0015002,heme-copper terminal oxidase activity,24,2,0.49,0.08466,1,0.45871333333333336,4.08,MF
GO:0016676,"oxidoreductase activity, acting on a hem...",24,2,0.49,0.08466,1,0.45871333333333336,4.08,MF
GO:0031683,G-protein beta/gamma-subunit complex bin...,24,2,0.49,0.08466,1,0.45871333333333336,4.08,MF
GO:0048027,mRNA 5'-UTR binding,24,2,0.49,0.08466,1,0.45871333333333336,4.08,MF
GO:0070840,dynein complex binding,24,2,0.49,0.08466,1,0.45871333333333336,4.08,MF
GO:0003713,transcription coactivator activity,261,9,5.3,0.08588,1,0.4623020779220779,1.7,MF
GO:0016853,isomerase activity,152,6,3.09,0.08995,1,0.4735727672955975,1.94,MF
GO:0099106,ion channel regulator activity,117,5,2.38,0.09015,1,0.4735727672955975,2.1,MF
GO:0005543,phospholipid binding,422,13,8.57,0.09065,1,0.4735727672955975,1.52,MF
GO:0016675,"oxidoreductase activity, acting on a hem...",25,2,0.51,0.09083,1,0.4735727672955975,3.92,MF
GO:0030515,snoRNA binding,25,2,0.51,0.09083,1,0.4735727672955975,3.92,MF
GO:0001882,nucleoside binding,383,12,7.78,0.09222,1,0.4757849693251534,1.54,MF
GO:0030276,clathrin binding,53,3,1.08,0.09266,1,0.4757849693251534,2.78,MF
GO:0019001,guanyl nucleotide binding,384,12,7.8,0.09355,1,0.4757849693251534,1.54,MF
GO:0032561,guanyl ribonucleotide binding,384,12,7.8,0.09355,1,0.4757849693251534,1.54,MF
GO:0003725,double-stranded RNA binding,86,4,1.75,0.09776,1,0.4911699393939394,2.29,MF
GO:0019208,phosphatase regulator activity,86,4,1.75,0.09776,1,0.4911699393939394,2.29,MF
GO:0080025,"phosphatidylinositol-3,5-bisphosphate bi...",27,2,0.55,0.10354,1,0.514377125748503,3.64,MF
GO:0031267,small GTPase binding,432,13,8.77,0.10362,1,0.514377125748503,1.48,MF
GO:0045182,translation regulator activity,57,3,1.16,0.10926,1,0.5359558579881657,2.59,MF
GO:0045309,protein phosphorylated amino acid bindin...,57,3,1.16,0.10926,1,0.5359558579881657,2.59,MF
GO:0004407,histone deacetylase activity,28,2,0.57,0.11006,1,0.5366199415204679,3.51,MF
GO:0004843,thiol-dependent ubiquitin-specific prote...,90,4,1.83,0.11069,1,0.5366199415204679,2.19,MF
GO:0060090,molecular adaptor activity,200,7,4.06,0.11387,1,0.5488269186046512,1.72,MF
GO:0033558,protein deacetylase activity,29,2,0.59,0.11670,1,0.5592156069364161,3.39,MF
GO:0004713,protein tyrosine kinase activity,129,5,2.62,0.12259,1,0.5748509550561798,1.91,MF
GO:0004693,cyclin-dependent protein serine/threonin...,30,2,0.61,0.12343,1,0.5748509550561798,3.28,MF
GO:0045503,dynein light chain binding,30,2,0.61,0.12343,1,0.5748509550561798,3.28,MF
GO:0050681,androgen receptor binding,30,2,0.61,0.12343,1,0.5748509550561798,3.28,MF
GO:0098918,structural constituent of synapse,30,2,0.61,0.12343,1,0.5748509550561798,3.28,MF
GO:0008289,lipid binding,748,20,15.18,0.12894,1,0.5971578770949721,1.32,MF
GO:0097472,cyclin-dependent protein kinase activity,31,2,0.63,0.13025,1,0.599873611111111,3.17,MF
GO:0004197,cysteine-type endopeptidase activity,96,4,1.95,0.13142,1,0.6019181215469613,2.05,MF
GO:0140030,modification-dependent protein binding,171,6,3.47,0.13573,1,0.6179203804347826,1.73,MF
GO:0046983,protein dimerization activity,1422,35,28.87,0.13712,1,0.6179203804347826,1.21,MF
GO:0016504,peptidase activator activity,32,2,0.65,0.13715,1,0.6179203804347826,3.08,MF
GO:0008234,cysteine-type peptidase activity,172,6,3.49,0.13840,1,0.6201816216216216,1.72,MF
GO:0036459,thiol-dependent ubiquitinyl hydrolase ac...,99,4,2.01,0.14234,1,0.6344078494623656,1.99,MF
GO:0035035,histone acetyltransferase binding,33,2,0.67,0.14414,1,0.6348648677248677,2.99,MF
GO:0045505,dynein intermediate chain binding,33,2,0.67,0.14414,1,0.6348648677248677,2.99,MF
GO:0016787,hydrolase activity,2534,59,51.44,0.14474,1,0.6348648677248677,1.15,MF
GO:0003724,RNA helicase activity,65,3,1.32,0.14551,1,0.6348831052631579,2.27,MF
GO:0101005,ubiquitinyl hydrolase activity,101,4,2.05,0.14982,1,0.6460644845360825,1.95,MF
GO:0043022,ribosome binding,66,3,1.34,0.15029,1,0.6460644845360825,2.24,MF
GO:0005164,tumor necrosis factor receptor binding,34,2,0.69,0.15119,1,0.6460644845360825,2.9,MF
GO:0051019,mitogen-activated protein kinase binding,34,2,0.69,0.15119,1,0.6460644845360825,2.9,MF
GO:0001103,RNA polymerase II repressing transcripti...,35,2,0.71,0.15832,1,0.6665326633165829,2.82,MF
GO:0097718,disordered domain specific binding,35,2,0.71,0.15832,1,0.6665326633165829,2.82,MF
GO:0042803,protein homodimerization activity,950,24,19.29,0.15995,1,0.6665326633165829,1.24,MF
GO:0005518,collagen binding,68,3,1.38,0.16000,1,0.6665326633165829,2.17,MF
GO:0048365,Rac GTPase binding,68,3,1.38,0.16000,1,0.6665326633165829,2.17,MF
GO:0003924,GTPase activity,303,9,6.15,0.16519,1,0.6792054455445544,1.46,MF
GO:0005154,epidermal growth factor receptor binding,36,2,0.73,0.16550,1,0.6792054455445544,2.74,MF
GO:0061980,regulatory RNA binding,36,2,0.73,0.16550,1,0.6792054455445544,2.74,MF
GO:0045296,cadherin binding,70,3,1.42,0.16989,1,0.6937872413793104,2.11,MF
GO:0003899,DNA-directed 5'-3' RNA polymerase activi...,37,2,0.75,0.17274,1,0.7019679411764705,2.67,MF
GO:0048306,calcium-dependent protein binding,71,3,1.44,0.17491,1,0.7073189756097561,2.08,MF
GO:0016247,channel regulator activity,146,5,2.96,0.17630,1,0.7094791262135922,1.69,MF
GO:0051721,protein phosphatase 2A binding,38,2,0.77,0.18003,1,0.7209897101449275,2.6,MF
GO:0019888,protein phosphatase regulator activity,73,3,1.48,0.18505,1,0.7326874056603774,2.03,MF
GO:0004712,protein serine/threonine/tyrosine kinase...,39,2,0.79,0.18737,1,0.7326874056603774,2.53,MF
GO:0004864,protein phosphatase inhibitor activity,39,2,0.79,0.18737,1,0.7326874056603774,2.53,MF
GO:0034062,5'-3' RNA polymerase activity,39,2,0.79,0.18737,1,0.7326874056603774,2.53,MF
GO:0097747,RNA polymerase activity,39,2,0.79,0.18737,1,0.7326874056603774,2.53,MF
GO:0005516,calmodulin binding,191,6,3.88,0.19345,1,0.7509197674418605,1.55,MF
GO:0031369,translation initiation factor binding,40,2,0.81,0.19475,1,0.7509197674418605,2.47,MF
GO:0098631,cell adhesion mediator activity,40,2,0.81,0.19475,1,0.7509197674418605,2.47,MF
GO:0043021,ribonucleoprotein complex binding,152,5,3.09,0.19710,1,0.7564624999999999,1.62,MF
GO:0046982,protein heterodimerization activity,579,15,11.75,0.20138,1,0.765973287671233,1.28,MF
GO:0043531,ADP binding,41,2,0.83,0.20216,1,0.765973287671233,2.41,MF
GO:0061630,ubiquitin protein ligase activity,235,7,4.77,0.20235,1,0.765973287671233,1.47,MF
GO:0019213,deacetylase activity,42,2,0.85,0.20960,1,0.7898109090909091,2.35,MF
GO:0043548,phosphatidylinositol 3-kinase binding,43,2,0.87,0.21708,1,0.8142955656108597,2.3,MF
GO:0005546,"phosphatidylinositol-4,5-bisphosphate bi...",80,3,1.62,0.22165,1,0.827693018018018,1.85,MF
GO:0005102,signaling receptor binding,1644,38,33.37,0.22282,1,0.8283308520179371,1.14,MF
GO:0018024,histone-lysine N-methyltransferase activ...,44,2,0.89,0.22457,1,0.8311095089285714,2.25,MF
GO:0061659,ubiquitin-like protein ligase activity,244,7,4.95,0.22853,1,0.8375091189427314,1.41,MF
GO:0000287,magnesium ion binding,202,6,4.1,0.22858,1,0.8375091189427314,1.46,MF
GO:0017016,Ras GTPase binding,417,11,8.47,0.22933,1,0.8375091189427314,1.3,MF
GO:0042826,histone deacetylase binding,122,4,2.48,0.23595,1,0.8579059210526315,1.61,MF
GO:0015485,cholesterol binding,47,2,0.95,0.24715,1,0.8883521120689655,2.11,MF
GO:0016879,"ligase activity, forming carbon-nitrogen...",47,2,0.95,0.24715,1,0.8883521120689655,2.11,MF
GO:0019209,kinase activator activity,85,3,1.73,0.24861,1,0.8883521120689655,1.73,MF
GO:0043178,alcohol binding,85,3,1.73,0.24861,1,0.8883521120689655,1.73,MF
GO:0008013,beta-catenin binding,86,3,1.75,0.25406,1,0.8946877118644068,1.71,MF
GO:0008276,protein methyltransferase activity,86,3,1.75,0.25406,1,0.8946877118644068,1.71,MF
GO:0005246,calcium channel regulator activity,48,2,0.97,0.25470,1,0.8946877118644068,2.06,MF
GO:0015459,potassium channel regulator activity,48,2,0.97,0.25470,1,0.8946877118644068,2.06,MF
GO:0140110,transcription regulator activity,1354,31,27.49,0.26822,1,0.9382041350210971,1.13,MF
GO:0035258,steroid hormone receptor binding,89,3,1.81,0.27052,1,0.9422734453781512,1.66,MF
GO:0001221,transcription cofactor binding,51,2,1.04,0.27736,1,0.9620562343096234,1.92,MF
GO:0030674,"protein binding, bridging",132,4,2.68,0.28045,1,0.9687210416666666,1.49,MF
GO:0033613,activating transcription factor binding,92,3,1.87,0.28708,1,0.98750755186722,1.6,MF
GO:0008237,metallopeptidase activity,177,5,3.59,0.29110,1,0.989555306122449,1.39,MF
GO:0008235,metalloexopeptidase activity,53,2,1.08,0.29245,1,0.989555306122449,1.85,MF
GO:0031491,nucleosome binding,53,2,1.08,0.29245,1,0.989555306122449,1.85,MF
GO:0032934,sterol binding,53,2,1.08,0.29245,1,0.989555306122449,1.85,MF
GO:0003727,single-stranded RNA binding,95,3,1.93,0.30372,1,1,1.55,MF
GO:0003730,mRNA 3'-UTR binding,95,3,1.93,0.30372,1,1,1.55,MF
GO:0098772,molecular function regulator,1760,39,35.73,0.30598,1,1,1.09,MF
GO:0001102,RNA polymerase II activating transcripti...,55,2,1.12,0.30749,1,1,1.79,MF
GO:0031593,polyubiquitin modification-dependent pro...,55,2,1.12,0.30749,1,1,1.79,MF
GO:0035591,signaling adaptor activity,55,2,1.12,0.30749,1,1,1.79,MF
GO:0016278,lysine N-methyltransferase activity,56,2,1.14,0.31499,1,1,1.75,MF
GO:0016279,protein-lysine N-methyltransferase activ...,56,2,1.14,0.31499,1,1,1.75,MF
GO:0033218,amide binding,364,9,7.39,0.32127,1,1,1.22,MF
GO:0042054,histone methyltransferase activity,57,2,1.16,0.32247,1,1,1.72,MF
GO:0008047,enzyme activator activity,457,11,9.28,0.32542,1,1,1.19,MF
GO:0051087,chaperone binding,100,3,2.03,0.33154,1,1,1.48,MF
GO:0015278,calcium-release channel activity,20,1,0.41,0.33660,1,1,2.44,MF
GO:0017049,GTP-Rho binding,20,1,0.41,0.33660,1,1,2.44,MF
GO:0035014,phosphatidylinositol 3-kinase regulator ...,20,1,0.41,0.33660,1,1,2.44,MF
GO:0070300,phosphatidic acid binding,20,1,0.41,0.33660,1,1,2.44,MF
GO:0004222,metalloendopeptidase activity,101,3,2.05,0.33710,1,1,1.46,MF
GO:0140097,"catalytic activity, acting on DNA",191,5,3.88,0.34684,1,1,1.29,MF
GO:0008327,methyl-CpG binding,21,1,0.43,0.35008,1,1,2.33,MF
GO:0008569,ATP-dependent microtubule motor activity...,21,1,0.43,0.35008,1,1,2.33,MF
GO:0050431,transforming growth factor beta binding,21,1,0.43,0.35008,1,1,2.33,MF
GO:0001540,amyloid-beta binding,61,2,1.24,0.35217,1,1,1.61,MF
GO:0070851,growth factor receptor binding,148,4,3,0.35376,1,1,1.33,MF
GO:0005080,protein kinase C binding,62,2,1.26,0.35952,1,1,1.59,MF
GO:0001223,transcription coactivator binding,22,1,0.45,0.36329,1,1,2.22,MF
GO:0008157,protein phosphatase 1 binding,22,1,0.45,0.36329,1,1,2.22,MF
GO:0030215,semaphorin receptor binding,22,1,0.45,0.36329,1,1,2.22,MF
GO:0032947,protein-containing complex scaffold acti...,22,1,0.45,0.36329,1,1,2.22,MF
GO:0044183,protein binding involved in protein fold...,22,1,0.45,0.36329,1,1,2.22,MF
GO:0017025,TBP-class protein binding,23,1,0.47,0.37623,1,1,2.13,MF
GO:0017056,structural constituent of nuclear pore,23,1,0.47,0.37623,1,1,2.13,MF
GO:0090079,"translation regulator activity, nucleic ...",23,1,0.47,0.37623,1,1,2.13,MF
GO:0015026,coreceptor activity,24,1,0.49,0.38890,1,1,2.04,MF
GO:0015491,cation:cation antiporter activity,24,1,0.49,0.38890,1,1,2.04,MF
GO:0004181,metallocarboxypeptidase activity,25,1,0.51,0.40132,1,1,1.96,MF
GO:0005212,structural constituent of eye lens,25,1,0.51,0.40132,1,1,1.96,MF
GO:0008307,structural constituent of muscle,25,1,0.51,0.40132,1,1,1.96,MF
GO:0016722,"oxidoreductase activity, oxidizing metal...",25,1,0.51,0.40132,1,1,1.96,MF
GO:0030742,GTP-dependent protein binding,25,1,0.51,0.40132,1,1,1.96,MF
GO:0031210,phosphatidylcholine binding,25,1,0.51,0.40132,1,1,1.96,MF
GO:0050997,quaternary ammonium group binding,25,1,0.51,0.40132,1,1,1.96,MF
GO:0033293,monocarboxylic acid binding,69,2,1.4,0.41005,1,1,1.43,MF
GO:0000062,fatty-acyl-CoA binding,26,1,0.53,0.41349,1,1,1.89,MF
GO:0004709,MAP kinase kinase kinase activity,26,1,0.53,0.41349,1,1,1.89,MF
GO:0005104,fibroblast growth factor receptor bindin...,26,1,0.53,0.41349,1,1,1.89,MF
GO:0005158,insulin receptor binding,26,1,0.53,0.41349,1,1,1.89,MF
GO:0016878,acid-thiol ligase activity,26,1,0.53,0.41349,1,1,1.89,MF
GO:0017134,fibroblast growth factor binding,26,1,0.53,0.41349,1,1,1.89,MF
GO:0046625,sphingolipid binding,26,1,0.53,0.41349,1,1,1.89,MF
GO:0099604,ligand-gated calcium channel activity,26,1,0.53,0.41349,1,1,1.89,MF
GO:0005089,Rho guanyl-nucleotide exchange factor ac...,70,2,1.42,0.41712,1,1,1.41,MF
GO:0008143,poly(A) binding,27,1,0.55,0.42541,1,1,1.82,MF
GO:0017075,syntaxin-1 binding,27,1,0.55,0.42541,1,1,1.82,MF
GO:0019239,deaminase activity,27,1,0.55,0.42541,1,1,1.82,MF
GO:0031435,mitogen-activated protein kinase kinase ...,27,1,0.55,0.42541,1,1,1.82,MF
GO:0030165,PDZ domain binding,118,3,2.4,0.43044,1,1,1.25,MF
GO:0009055,electron transfer activity,72,2,1.46,0.43112,1,1,1.37,MF
GO:0001530,lipopolysaccharide binding,28,1,0.57,0.43709,1,1,1.75,MF
GO:0005070,SH3/SH2 adaptor activity,28,1,0.57,0.43709,1,1,1.75,MF
GO:0045499,chemorepellent activity,28,1,0.57,0.43709,1,1,1.75,MF
GO:0005506,iron ion binding,167,4,3.39,0.44069,1,1,1.18,MF
GO:0015078,proton transmembrane transporter activit...,121,3,2.46,0.44648,1,1,1.22,MF
GO:0008266,poly(U) RNA binding,29,1,0.59,0.44853,1,1,1.69,MF
GO:0015298,solute:cation antiporter activity,29,1,0.59,0.44853,1,1,1.69,MF
GO:0019706,protein-cysteine S-palmitoyltransferase ...,29,1,0.59,0.44853,1,1,1.69,MF
GO:0019707,protein-cysteine S-acyltransferase activ...,29,1,0.59,0.44853,1,1,1.69,MF
GO:0030291,protein serine/threonine kinase inhibito...,29,1,0.59,0.44853,1,1,1.69,MF
GO:0035198,miRNA binding,29,1,0.59,0.44853,1,1,1.69,MF
GO:0071813,lipoprotein particle binding,29,1,0.59,0.44853,1,1,1.69,MF
GO:0071814,protein-lipid complex binding,29,1,0.59,0.44853,1,1,1.69,MF
GO:0071889,14-3-3 protein binding,29,1,0.59,0.44853,1,1,1.69,MF
GO:0120013,intermembrane lipid transfer activity,29,1,0.59,0.44853,1,1,1.69,MF
GO:0030971,receptor tyrosine kinase binding,75,2,1.52,0.45177,1,1,1.32,MF
GO:0042287,MHC protein binding,30,1,0.61,0.45974,1,1,1.64,MF
GO:0030246,carbohydrate binding,269,6,5.46,0.46566,1,1,1.1,MF
GO:0043565,sequence-specific DNA binding,1145,24,23.24,0.46578,1,1,1.03,MF
GO:0001968,fibronectin binding,31,1,0.63,0.47073,1,1,1.59,MF
GO:0050699,WW domain binding,31,1,0.63,0.47073,1,1,1.59,MF
GO:0030295,protein kinase activator activity,79,2,1.6,0.47863,1,1,1.25,MF
GO:0005217,intracellular ligand-gated ion channel a...,32,1,0.65,0.48149,1,1,1.54,MF
GO:0008198,ferrous iron binding,32,1,0.65,0.48149,1,1,1.54,MF
GO:0005088,Ras guanyl-nucleotide exchange factor ac...,128,3,2.6,0.48318,1,1,1.15,MF
GO:0005484,SNAP receptor activity,33,1,0.67,0.49203,1,1,1.49,MF
GO:0016417,S-acyltransferase activity,33,1,0.67,0.49203,1,1,1.49,MF
GO:0019956,chemokine binding,33,1,0.67,0.49203,1,1,1.49,MF
GO:0016811,"hydrolase activity, acting on carbon-nit...",82,2,1.66,0.49824,1,1,1.2,MF
GO:0017124,SH3 domain binding,131,3,2.66,0.49855,1,1,1.13,MF
GO:0008187,poly-pyrimidine tract binding,34,1,0.69,0.50236,1,1,1.45,MF
GO:0016831,carboxy-lyase activity,34,1,0.69,0.50236,1,1,1.45,MF
GO:0016810,"hydrolase activity, acting on carbon-nit...",133,3,2.7,0.50866,1,1,1.11,MF
GO:0038024,cargo receptor activity,84,2,1.71,0.51105,1,1,1.17,MF
GO:0004857,enzyme inhibitor activity,381,8,7.73,0.51144,1,1,1.03,MF
GO:0070717,poly-purine tract binding,35,1,0.71,0.51248,1,1,1.41,MF
GO:1901567,fatty acid derivative binding,35,1,0.71,0.51248,1,1,1.41,MF
GO:0016209,antioxidant activity,85,2,1.73,0.51738,1,1,1.16,MF
GO:0016877,"ligase activity, forming carbon-sulfur b...",37,1,0.75,0.53210,1,1,1.33,MF
GO:0051393,alpha-actinin binding,37,1,0.75,0.53210,1,1,1.33,MF
GO:0008170,N-methyltransferase activity,88,2,1.79,0.53602,1,1,1.12,MF
GO:0035064,methylated histone binding,88,2,1.79,0.53602,1,1,1.12,MF
GO:0140034,methylation-dependent protein binding,88,2,1.79,0.53602,1,1,1.12,MF
GO:0000979,RNA polymerase II core promoter sequence...,38,1,0.77,0.54162,1,1,1.3,MF
GO:0017112,Rab guanyl-nucleotide exchange factor ac...,38,1,0.77,0.54162,1,1,1.3,MF
GO:0043014,alpha-tubulin binding,38,1,0.77,0.54162,1,1,1.3,MF
GO:0005096,GTPase activator activity,241,5,4.89,0.54299,1,1,1.02,MF
GO:0015085,calcium ion transmembrane transporter ac...,140,3,2.84,0.54321,1,1,1.06,MF
GO:0016409,palmitoyltransferase activity,39,1,0.79,0.55094,1,1,1.27,MF
GO:0042169,SH2 domain binding,39,1,0.79,0.55094,1,1,1.27,MF
GO:0004520,endodeoxyribonuclease activity,40,1,0.81,0.56007,1,1,1.23,MF
GO:0060590,ATPase regulator activity,40,1,0.81,0.56007,1,1,1.23,MF
GO:0042277,peptide binding,298,6,6.05,0.56515,1,1,0.99,MF
GO:0060589,nucleoside-triphosphatase regulator acti...,299,6,6.07,0.56843,1,1,0.99,MF
GO:0005085,guanyl-nucleotide exchange factor activi...,198,4,4.02,0.57330,1,1,1,MF
GO:0008083,growth factor activity,147,3,2.98,0.57630,1,1,1.01,MF
GO:0016874,ligase activity,147,3,2.98,0.57630,1,1,1.01,MF
GO:0004180,carboxypeptidase activity,42,1,0.85,0.57779,1,1,1.18,MF
GO:0016620,"oxidoreductase activity, acting on the a...",42,1,0.85,0.57779,1,1,1.18,MF
GO:0008168,methyltransferase activity,201,4,4.08,0.58519,1,1,0.98,MF
GO:1901681,sulfur compound binding,253,5,5.14,0.58620,1,1,0.97,MF
GO:0004177,aminopeptidase activity,44,1,0.89,0.59479,1,1,1.12,MF
GO:0015932,nucleobase-containing compound transmemb...,44,1,0.89,0.59479,1,1,1.12,MF
GO:0001784,phosphotyrosine residue binding,45,1,0.91,0.60303,1,1,1.1,MF
GO:0005504,fatty acid binding,45,1,0.91,0.60303,1,1,1.1,MF
GO:0140098,"catalytic activity, acting on RNA",362,7,7.35,0.60447,1,1,0.95,MF
GO:0000980,RNA polymerase II distal enhancer sequen...,100,2,2.03,0.60553,1,1,0.99,MF
GO:0030695,GTPase regulator activity,259,5,5.26,0.60696,1,1,0.95,MF
GO:0035257,nuclear hormone receptor binding,154,3,3.13,0.60786,1,1,0.96,MF
GO:0008238,exopeptidase activity,101,2,2.05,0.61096,1,1,0.98,MF
GO:0048020,CCR chemokine receptor binding,46,1,0.93,0.61111,1,1,1.08,MF
GO:0051879,Hsp90 protein binding,46,1,0.93,0.61111,1,1,1.08,MF
GO:0008201,heparin binding,156,3,3.17,0.61659,1,1,0.95,MF
GO:1990782,protein tyrosine kinase binding,103,2,2.09,0.62163,1,1,0.96,MF
GO:0042805,actinin binding,48,1,0.97,0.62677,1,1,1.03,MF
GO:0050661,NADP binding,48,1,0.97,0.62677,1,1,1.03,MF
GO:0016741,"transferase activity, transferring one-c...",213,4,4.32,0.63078,1,1,0.93,MF
GO:0001046,core promoter sequence-specific DNA bind...,49,1,0.99,0.63437,1,1,1.01,MF
GO:0008408,3'-5' exonuclease activity,50,1,1.02,0.64181,1,1,0.98,MF
GO:0016763,"transferase activity, transferring pento...",50,1,1.02,0.64181,1,1,0.98,MF
GO:0030331,estrogen receptor binding,50,1,1.02,0.64181,1,1,0.98,MF
GO:0005496,steroid binding,107,2,2.17,0.64230,1,1,0.92,MF
GO:0042562,hormone binding,107,2,2.17,0.64230,1,1,0.92,MF
GO:0016830,carbon-carbon lyase activity,51,1,1.04,0.64910,1,1,0.96,MF
GO:0005245,voltage-gated calcium channel activity,52,1,1.06,0.65624,1,1,0.94,MF
GO:0005548,phospholipid transporter activity,52,1,1.06,0.65624,1,1,0.94,MF
GO:0016903,"oxidoreductase activity, acting on the a...",52,1,1.06,0.65624,1,1,0.94,MF
GO:0017046,peptide hormone binding,52,1,1.06,0.65624,1,1,0.94,MF
GO:0004860,protein kinase inhibitor activity,53,1,1.08,0.66323,1,1,0.93,MF
GO:0005160,transforming growth factor beta receptor...,54,1,1.1,0.67009,1,1,0.91,MF
GO:0099516,ion antiporter activity,54,1,1.1,0.67009,1,1,0.91,MF
GO:0003690,double-stranded DNA binding,1014,19,20.58,0.67360,1,1,0.92,MF
GO:0017137,Rab GTPase binding,170,3,3.45,0.67393,1,1,0.87,MF
GO:0003684,damaged DNA binding,56,1,1.14,0.68338,1,1,0.88,MF
GO:0008146,sulfotransferase activity,56,1,1.14,0.68338,1,1,0.88,MF
GO:0004721,phosphoprotein phosphatase activity,175,3,3.55,0.69282,1,1,0.85,MF
GO:0000149,SNARE binding,118,2,2.4,0.69455,1,1,0.83,MF
GO:0019210,kinase inhibitor activity,58,1,1.18,0.69614,1,1,0.85,MF
GO:1990837,sequence-specific double-stranded DNA bi...,925,17,18.78,0.69785,1,1,0.91,MF
GO:0004536,deoxyribonuclease activity,59,1,1.2,0.70233,1,1,0.83,MF
GO:0004714,transmembrane receptor protein tyrosine ...,59,1,1.2,0.70233,1,1,0.83,MF
GO:0030145,manganese ion binding,59,1,1.2,0.70233,1,1,0.83,MF
GO:0070011,"peptidase activity, acting on L-amino ac...",613,11,12.44,0.70351,1,1,0.88,MF
GO:0005507,copper ion binding,60,1,1.22,0.70839,1,1,0.82,MF
GO:0005262,calcium channel activity,123,2,2.5,0.71613,1,1,0.8,MF
GO:0016779,nucleotidyltransferase activity,123,2,2.5,0.71613,1,1,0.8,MF
GO:0001047,core promoter binding,62,1,1.26,0.72014,1,1,0.79,MF
GO:0051427,hormone receptor binding,183,3,3.71,0.72131,1,1,0.81,MF
GO:0000049,tRNA binding,63,1,1.28,0.72584,1,1,0.78,MF
GO:0051287,NAD binding,63,1,1.28,0.72584,1,1,0.78,MF
GO:0030374,nuclear receptor transcription coactivat...,64,1,1.3,0.73142,1,1,0.77,MF
GO:0001158,enhancer sequence-specific DNA binding,127,2,2.58,0.73247,1,1,0.78,MF
GO:0004521,endoribonuclease activity,65,1,1.32,0.73689,1,1,0.76,MF
GO:0043621,protein self-association,65,1,1.32,0.73689,1,1,0.76,MF
GO:0001012,RNA polymerase II regulatory region DNA ...,845,15,17.15,0.73890,1,1,0.87,MF
GO:0004519,endonuclease activity,129,2,2.62,0.74033,1,1,0.76,MF
GO:0042379,chemokine receptor binding,66,1,1.34,0.74225,1,1,0.75,MF
GO:0019955,cytokine binding,131,2,2.66,0.74800,1,1,0.75,MF
GO:0008233,peptidase activity,640,11,12.99,0.75431,1,1,0.85,MF
GO:0004722,protein serine/threonine phosphatase act...,70,1,1.42,0.76261,1,1,0.7,MF
GO:0016597,amino acid binding,72,1,1.46,0.77218,1,1,0.68,MF
GO:0035326,enhancer binding,138,2,2.8,0.77332,1,1,0.71,MF
GO:0016782,"transferase activity, transferring sulfu...",74,1,1.5,0.78137,1,1,0.67,MF
GO:0016705,"oxidoreductase activity, acting on paire...",203,3,4.12,0.78351,1,1,0.73,MF
GO:0004527,exonuclease activity,75,1,1.52,0.78583,1,1,0.66,MF
GO:0017022,myosin binding,75,1,1.52,0.78583,1,1,0.66,MF
GO:0019199,transmembrane receptor protein kinase ac...,76,1,1.54,0.79019,1,1,0.65,MF
GO:0097110,scaffold protein binding,76,1,1.54,0.79019,1,1,0.65,MF
GO:0004175,endopeptidase activity,440,7,8.93,0.79267,1,1,0.78,MF
GO:0000976,transcription regulatory region sequence...,882,15,17.9,0.79394,1,1,0.84,MF
GO:0015297,antiporter activity,78,1,1.58,0.79865,1,1,0.63,MF
GO:0019838,growth factor binding,146,2,2.96,0.79951,1,1,0.68,MF
GO:0044212,transcription regulatory region DNA bind...,995,17,20.2,0.80053,1,1,0.84,MF
GO:0005539,glycosaminoglycan binding,210,3,4.26,0.80239,1,1,0.7,MF
GO:0019905,syntaxin binding,79,1,1.6,0.80275,1,1,0.62,MF
GO:0005126,cytokine receptor binding,330,5,6.7,0.80282,1,1,0.75,MF
GO:0031406,carboxylic acid binding,211,3,4.28,0.80497,1,1,0.7,MF
GO:0001067,regulatory region nucleic acid binding,999,17,20.28,0.80557,1,1,0.84,MF
GO:0008757,S-adenosylmethionine-dependent methyltra...,148,2,3,0.80562,1,1,0.67,MF
GO:0000977,RNA polymerase II regulatory region sequ...,837,14,16.99,0.80664,1,1,0.82,MF
GO:0070405,ammonium ion binding,80,1,1.62,0.80677,1,1,0.62,MF
GO:0016651,"oxidoreductase activity, acting on NAD(P...",84,1,1.71,0.82205,1,1,0.58,MF
GO:0050660,flavin adenine dinucleotide binding,85,1,1.73,0.82568,1,1,0.58,MF
GO:0000978,RNA polymerase II proximal promoter sequ...,573,9,11.63,0.82582,1,1,0.77,MF
GO:0046332,SMAD binding,86,1,1.75,0.82923,1,1,0.57,MF
GO:0043177,organic acid binding,224,3,4.55,0.83602,1,1,0.66,MF
GO:0008081,phosphoric diester hydrolase activity,90,1,1.83,0.84274,1,1,0.55,MF
GO:0000987,proximal promoter sequence-specific DNA ...,585,9,11.88,0.84310,1,1,0.76,MF
GO:0050662,coenzyme binding,295,4,5.99,0.85241,1,1,0.67,MF
GO:0031490,chromatin DNA binding,96,1,1.95,0.86102,1,1,0.51,MF
GO:0004725,protein tyrosine phosphatase activity,98,1,1.99,0.86663,1,1,0.5,MF
GO:0099094,ligand-gated cation channel activity,99,1,2.01,0.86935,1,1,0.5,MF
GO:0001227,DNA-binding transcription repressor acti...,241,3,4.89,0.87013,1,1,0.61,MF
GO:0140101,"catalytic activity, acting on a tRNA",113,1,2.29,0.90211,1,1,0.44,MF
GO:0004540,ribonuclease activity,116,1,2.35,0.90798,1,1,0.43,MF
GO:0016791,phosphatase activity,266,3,5.4,0.90893,1,1,0.56,MF
GO:0004867,serine-type endopeptidase inhibitor acti...,118,1,2.4,0.91170,1,1,0.42,MF
GO:0030545,receptor regulator activity,527,7,10.7,0.91314,1,1,0.65,MF
GO:0004518,nuclease activity,200,2,4.06,0.91592,1,1,0.49,MF
GO:0005179,hormone activity,129,1,2.62,0.92963,1,1,0.38,MF
GO:0015276,ligand-gated ion channel activity,133,1,2.7,0.93520,1,1,0.37,MF
GO:0042578,phosphoric ester hydrolase activity,359,4,7.29,0.93559,1,1,0.55,MF
GO:0016616,"oxidoreductase activity, acting on the C...",134,1,2.72,0.93653,1,1,0.37,MF
GO:0048018,receptor ligand activity,492,6,9.99,0.93659,1,1,0.6,MF
GO:0019842,vitamin binding,135,1,2.74,0.93782,1,1,0.36,MF
GO:0005319,lipid transporter activity,136,1,2.76,0.93909,1,1,0.36,MF
GO:0022834,ligand-gated channel activity,136,1,2.76,0.93909,1,1,0.36,MF
GO:0001664,G protein-coupled receptor binding,296,3,6.01,0.94148,1,1,0.5,MF
GO:0005201,extracellular matrix structural constitu...,141,1,2.86,0.94507,1,1,0.35,MF
GO:0016614,"oxidoreductase activity, acting on CH-OH...",143,1,2.9,0.94729,1,1,0.34,MF
GO:0052689,carboxylic ester hydrolase activity,143,1,2.9,0.94729,1,1,0.34,MF
GO:0022843,voltage-gated cation channel activity,146,1,2.96,0.95046,1,1,0.34,MF
GO:0008194,UDP-glycosyltransferase activity,151,1,3.07,0.95532,1,1,0.33,MF
GO:0061134,peptidase regulator activity,239,2,4.85,0.95657,1,1,0.41,MF
GO:0020037,heme binding,155,1,3.15,0.95886,1,1,0.32,MF
GO:0016491,oxidoreductase activity,796,10,16.16,0.96407,1,1,0.62,MF
GO:0046906,tetrapyrrole binding,164,1,3.33,0.96585,1,1,0.3,MF
GO:0003700,DNA-binding transcription factor activit...,999,13,20.28,0.97000,1,1,0.64,MF
GO:0016746,"transferase activity, transferring acyl ...",270,2,5.48,0.97469,1,1,0.36,MF
GO:0016829,lyase activity,185,1,3.76,0.97788,1,1,0.27,MF
GO:0015077,monovalent inorganic cation transmembran...,363,3,7.37,0.97931,1,1,0.41,MF
GO:0005244,voltage-gated ion channel activity,195,1,3.96,0.98202,1,1,0.25,MF
GO:0022832,voltage-gated channel activity,195,1,3.96,0.98202,1,1,0.25,MF
GO:0004866,endopeptidase inhibitor activity,197,1,4,0.98275,1,1,0.25,MF
GO:0061135,endopeptidase regulator activity,204,1,4.14,0.98507,1,1,0.24,MF
GO:0030414,peptidase inhibitor activity,208,1,4.22,0.98626,1,1,0.24,MF
GO:0005125,cytokine activity,217,1,4.41,0.98860,1,1,0.23,MF
GO:0000981,DNA-binding transcription factor activit...,767,8,15.57,0.98888,1,1,0.51,MF
GO:0005261,cation channel activity,317,2,6.44,0.98905,1,1,0.31,MF
GO:0022839,ion gated channel activity,323,2,6.56,0.99017,1,1,0.3,MF
GO:0022890,inorganic cation transmembrane transport...,575,5,11.67,0.99163,1,1,0.43,MF
GO:0022836,gated channel activity,335,2,6.8,0.99210,1,1,0.29,MF
GO:0015291,secondary active transmembrane transport...,235,1,4.77,0.99215,1,1,0.21,MF
GO:0016747,"transferase activity, transferring acyl ...",236,1,4.79,0.99231,1,1,0.21,MF
GO:0046873,metal ion transmembrane transporter acti...,433,3,8.79,0.99342,1,1,0.34,MF
GO:0016788,"hydrolase activity, acting on ester bond...",741,7,15.04,0.99371,1,1,0.47,MF
GO:0001228,DNA-binding transcription activator acti...,443,3,8.99,0.99444,1,1,0.33,MF
GO:0048037,cofactor binding,542,4,11,0.99575,1,1,0.36,MF
GO:0008324,cation transmembrane transporter activit...,627,5,12.73,0.99614,1,1,0.39,MF
GO:0016757,"transferase activity, transferring glyco...",278,1,5.64,0.99679,1,1,0.18,MF
GO:0005216,ion channel activity,407,2,8.26,0.99791,1,1,0.24,MF
GO:0022838,substrate-specific channel activity,420,2,8.53,0.99836,1,1,0.23,MF
GO:0015267,channel activity,444,2,9.01,0.99895,1,1,0.22,MF
GO:0022803,passive transmembrane transporter activi...,444,2,9.01,0.99895,1,1,0.22,MF
GO:0022804,active transmembrane transporter activit...,355,1,7.21,0.99935,1,1,0.14,MF
GO:0015318,inorganic molecular entity transmembrane...,796,5,16.16,0.99973,1,1,0.31,MF
GO:0015075,ion transmembrane transporter activity,855,5,17.36,0.99990,1,1,0.29,MF
GO:0022857,transmembrane transporter activity,1013,6,20.56,0.99997,1,1,0.29,MF
GO:0005215,transporter activity,1099,7,22.31,0.99997,1,1,0.31,MF
GO:0060089,molecular transducer activity,2344,7,47.58,1.00000,1,1,0.15,MF
GO:0003674,molecular_function,20837,423,423,1.00000,1,1,1,MF
GO:0004888,transmembrane signaling receptor activit...,2107,3,42.77,1.00000,1,1,0.07,MF
GO:0038023,signaling receptor activity,2295,5,46.59,1.00000,1,1,0.11,MF
GO:0000030,mannosyltransferase activity,26,0,0.53,1.00000,1,1,0,MF
GO:0000175,3'-5'-exoribonuclease activity,29,0,0.59,1.00000,1,1,0,MF
GO:0000217,DNA secondary structure binding,25,0,0.51,1.00000,1,1,0,MF
GO:0001091,RNA polymerase II basal transcription fa...,22,0,0.45,1.00000,1,1,0,MF
GO:0001222,transcription corepressor binding,20,0,0.41,1.00000,1,1,0,MF
GO:0001614,purinergic nucleotide receptor activity,20,0,0.41,1.00000,1,1,0,MF
GO:0001618,virus receptor activity,20,0,0.41,1.00000,1,1,0,MF
GO:0001637,G protein-coupled chemoattractant recept...,25,0,0.51,1.00000,1,1,0,MF
GO:0001653,peptide receptor activity,149,0,3.02,1.00000,1,1,0,MF
GO:0001671,ATPase activator activity,26,0,0.53,1.00000,1,1,0,MF
GO:0001786,phosphatidylserine binding,63,0,1.28,1.00000,1,1,0,MF
GO:0001848,complement binding,22,0,0.45,1.00000,1,1,0,MF
GO:0001871,pattern binding,21,0,0.43,1.00000,1,1,0,MF
GO:0001965,G-protein alpha-subunit binding,35,0,0.71,1.00000,1,1,0,MF
GO:0003707,steroid hormone receptor activity,55,0,1.12,1.00000,1,1,0,MF
GO:0003785,actin monomer binding,27,0,0.55,1.00000,1,1,0,MF
GO:0003823,antigen binding,57,0,1.16,1.00000,1,1,0,MF
GO:0003887,DNA-directed DNA polymerase activity,27,0,0.55,1.00000,1,1,0,MF
GO:0003950,NAD+ ADP-ribosyltransferase activity,23,0,0.47,1.00000,1,1,0,MF
GO:0003954,NADH dehydrogenase activity,29,0,0.59,1.00000,1,1,0,MF
GO:0004033,aldo-keto reductase (NADP) activity,28,0,0.57,1.00000,1,1,0,MF
GO:0004112,cyclic-nucleotide phosphodiesterase acti...,31,0,0.63,1.00000,1,1,0,MF
GO:0004114,"3',5'-cyclic-nucleotide phosphodiesteras...",30,0,0.61,1.00000,1,1,0,MF
GO:0004190,aspartic-type endopeptidase activity,29,0,0.59,1.00000,1,1,0,MF
GO:0004252,serine-type endopeptidase activity,181,0,3.67,1.00000,1,1,0,MF
GO:0004298,threonine-type endopeptidase activity,21,0,0.43,1.00000,1,1,0,MF
GO:0004364,glutathione transferase activity,34,0,0.69,1.00000,1,1,0,MF
GO:0004402,histone acetyltransferase activity,65,0,1.32,1.00000,1,1,0,MF
GO:0004497,monooxygenase activity,141,0,2.86,1.00000,1,1,0,MF
GO:0004529,exodeoxyribonuclease activity,25,0,0.51,1.00000,1,1,0,MF
GO:0004532,exoribonuclease activity,32,0,0.65,1.00000,1,1,0,MF
GO:0004553,"hydrolase activity, hydrolyzing O-glycos...",100,0,2.03,1.00000,1,1,0,MF
GO:0004601,peroxidase activity,52,0,1.06,1.00000,1,1,0,MF
GO:0004602,glutathione peroxidase activity,22,0,0.45,1.00000,1,1,0,MF
GO:0004620,phospholipase activity,89,0,1.81,1.00000,1,1,0,MF
GO:0004623,phospholipase A2 activity,31,0,0.63,1.00000,1,1,0,MF
GO:0004683,calmodulin-dependent protein kinase acti...,27,0,0.55,1.00000,1,1,0,MF
GO:0004745,retinol dehydrogenase activity,21,0,0.43,1.00000,1,1,0,MF
GO:0004806,triglyceride lipase activity,27,0,0.55,1.00000,1,1,0,MF
GO:0004812,aminoacyl-tRNA ligase activity,41,0,0.83,1.00000,1,1,0,MF
GO:0004869,cysteine-type endopeptidase inhibitor ac...,68,0,1.38,1.00000,1,1,0,MF
GO:0004879,nuclear receptor activity,40,0,0.81,1.00000,1,1,0,MF
GO:0004896,cytokine receptor activity,98,0,1.99,1.00000,1,1,0,MF
GO:0004930,G protein-coupled receptor activity,750,0,15.23,1.00000,1,1,0,MF
GO:0004950,chemokine receptor activity,25,0,0.51,1.00000,1,1,0,MF
GO:0004984,olfactory receptor activity,1110,0,22.53,1.00000,1,1,0,MF
GO:0004993,G protein-coupled serotonin receptor act...,39,0,0.79,1.00000,1,1,0,MF
GO:0005044,scavenger receptor activity,45,0,0.91,1.00000,1,1,0,MF
GO:0005048,signal sequence binding,39,0,0.79,1.00000,1,1,0,MF
GO:0005109,frizzled binding,43,0,0.87,1.00000,1,1,0,MF
GO:0005112,Notch binding,25,0,0.51,1.00000,1,1,0,MF
GO:0005132,type I interferon receptor binding,24,0,0.49,1.00000,1,1,0,MF
GO:0005148,prolactin receptor binding,27,0,0.55,1.00000,1,1,0,MF
GO:0005184,neuropeptide hormone activity,25,0,0.51,1.00000,1,1,0,MF
GO:0005227,calcium activated cation channel activit...,29,0,0.59,1.00000,1,1,0,MF
GO:0005230,extracellular ligand-gated ion channel a...,71,0,1.44,1.00000,1,1,0,MF
GO:0005231,excitatory extracellular ligand-gated io...,36,0,0.73,1.00000,1,1,0,MF
GO:0005242,inward rectifier potassium channel activ...,20,0,0.41,1.00000,1,1,0,MF
GO:0005248,voltage-gated sodium channel activity,21,0,0.43,1.00000,1,1,0,MF
GO:0005249,voltage-gated potassium channel activity,86,0,1.75,1.00000,1,1,0,MF
GO:0005251,delayed rectifier potassium channel acti...,30,0,0.61,1.00000,1,1,0,MF
GO:0005253,anion channel activity,80,0,1.62,1.00000,1,1,0,MF
GO:0005254,chloride channel activity,69,0,1.4,1.00000,1,1,0,MF
GO:0005267,potassium channel activity,123,0,2.5,1.00000,1,1,0,MF
GO:0005272,sodium channel activity,40,0,0.81,1.00000,1,1,0,MF
GO:0005310,dicarboxylic acid transmembrane transpor...,36,0,0.73,1.00000,1,1,0,MF
GO:0005326,neurotransmitter transporter activity,50,0,1.02,1.00000,1,1,0,MF
GO:0005328,neurotransmitter:sodium symporter activi...,26,0,0.53,1.00000,1,1,0,MF
GO:0005342,organic acid transmembrane transporter a...,150,0,3.05,1.00000,1,1,0,MF
GO:0005343,organic acid:sodium symporter activity,25,0,0.51,1.00000,1,1,0,MF
GO:0005355,glucose transmembrane transporter activi...,23,0,0.47,1.00000,1,1,0,MF
GO:0005385,zinc ion transmembrane transporter activ...,22,0,0.45,1.00000,1,1,0,MF
GO:0005402,carbohydrate:cation symporter activity,20,0,0.41,1.00000,1,1,0,MF
GO:0005501,retinoid binding,32,0,0.65,1.00000,1,1,0,MF
GO:0005520,insulin-like growth factor binding,28,0,0.57,1.00000,1,1,0,MF
GO:0005537,mannose binding,26,0,0.53,1.00000,1,1,0,MF
GO:0005540,hyaluronic acid binding,21,0,0.43,1.00000,1,1,0,MF
GO:0005544,calcium-dependent phospholipid binding,54,0,1.1,1.00000,1,1,0,MF
GO:0005549,odorant binding,578,0,11.73,1.00000,1,1,0,MF
GO:0005550,pheromone binding,216,0,4.38,1.00000,1,1,0,MF
GO:0008009,chemokine activity,43,0,0.87,1.00000,1,1,0,MF
GO:0008028,monocarboxylic acid transmembrane transp...,52,0,1.06,1.00000,1,1,0,MF
GO:0008066,glutamate receptor activity,27,0,0.55,1.00000,1,1,0,MF
GO:0008080,N-acetyltransferase activity,94,0,1.91,1.00000,1,1,0,MF
GO:0008106,alcohol dehydrogenase (NADP+) activity,25,0,0.51,1.00000,1,1,0,MF
GO:0008137,NADH dehydrogenase (ubiquinone) activity,26,0,0.53,1.00000,1,1,0,MF
GO:0008138,protein tyrosine/serine/threonine phosph...,40,0,0.81,1.00000,1,1,0,MF
GO:0008171,O-methyltransferase activity,25,0,0.51,1.00000,1,1,0,MF
GO:0008173,RNA methyltransferase activity,63,0,1.28,1.00000,1,1,0,MF
GO:0008175,tRNA methyltransferase activity,32,0,0.65,1.00000,1,1,0,MF
GO:0008188,neuropeptide receptor activity,45,0,0.91,1.00000,1,1,0,MF
GO:0008227,G protein-coupled amine receptor activit...,72,0,1.46,1.00000,1,1,0,MF
GO:0008236,serine-type peptidase activity,203,0,4.12,1.00000,1,1,0,MF
GO:0008373,sialyltransferase activity,21,0,0.43,1.00000,1,1,0,MF
GO:0008374,O-acyltransferase activity,43,0,0.87,1.00000,1,1,0,MF
GO:0008375,acetylglucosaminyltransferase activity,56,0,1.14,1.00000,1,1,0,MF
GO:0008376,acetylgalactosaminyltransferase activity,44,0,0.89,1.00000,1,1,0,MF
GO:0008378,galactosyltransferase activity,36,0,0.73,1.00000,1,1,0,MF
GO:0008391,arachidonic acid monooxygenase activity,38,0,0.77,1.00000,1,1,0,MF
GO:0008392,arachidonic acid epoxygenase activity,34,0,0.69,1.00000,1,1,0,MF
GO:0008395,steroid hydroxylase activity,73,0,1.48,1.00000,1,1,0,MF
GO:0008483,transaminase activity,22,0,0.45,1.00000,1,1,0,MF
GO:0008509,anion transmembrane transporter activity,313,0,6.35,1.00000,1,1,0,MF
GO:0008514,organic anion transmembrane transporter ...,210,0,4.26,1.00000,1,1,0,MF
GO:0008519,ammonium transmembrane transporter activ...,32,0,0.65,1.00000,1,1,0,MF
GO:0008527,taste receptor activity,36,0,0.73,1.00000,1,1,0,MF
GO:0008528,G protein-coupled peptide receptor activ...,140,0,2.84,1.00000,1,1,0,MF
GO:0008536,Ran GTPase binding,38,0,0.77,1.00000,1,1,0,MF
GO:0008553,"proton-exporting ATPase activity, phosph...",20,0,0.41,1.00000,1,1,0,MF
GO:0009975,cyclase activity,25,0,0.51,1.00000,1,1,0,MF
GO:0010485,H4 histone acetyltransferase activity,23,0,0.47,1.00000,1,1,0,MF
GO:0015020,glucuronosyltransferase activity,33,0,0.67,1.00000,1,1,0,MF
GO:0015036,disulfide oxidoreductase activity,42,0,0.85,1.00000,1,1,0,MF
GO:0015079,potassium ion transmembrane transporter ...,159,0,3.23,1.00000,1,1,0,MF
GO:0015081,sodium ion transmembrane transporter act...,143,0,2.9,1.00000,1,1,0,MF
GO:0015101,organic cation transmembrane transporter...,23,0,0.47,1.00000,1,1,0,MF
GO:0015103,inorganic anion transmembrane transporte...,132,0,2.68,1.00000,1,1,0,MF
GO:0015106,bicarbonate transmembrane transporter ac...,20,0,0.41,1.00000,1,1,0,MF
GO:0015108,chloride transmembrane transporter activ...,96,0,1.95,1.00000,1,1,0,MF
GO:0015125,bile acid transmembrane transporter acti...,20,0,0.41,1.00000,1,1,0,MF
GO:0015144,carbohydrate transmembrane transporter a...,38,0,0.77,1.00000,1,1,0,MF
GO:0015145,monosaccharide transmembrane transporter...,25,0,0.51,1.00000,1,1,0,MF
GO:0015149,hexose transmembrane transporter activit...,23,0,0.47,1.00000,1,1,0,MF
GO:0015171,amino acid transmembrane transporter act...,75,0,1.52,1.00000,1,1,0,MF
GO:0015175,neutral amino acid transmembrane transpo...,32,0,0.65,1.00000,1,1,0,MF
GO:0015179,L-amino acid transmembrane transporter a...,57,0,1.16,1.00000,1,1,0,MF
GO:0015238,drug transmembrane transporter activity,89,0,1.81,1.00000,1,1,0,MF
GO:0015248,sterol transporter activity,31,0,0.63,1.00000,1,1,0,MF
GO:0015293,symporter activity,145,0,2.94,1.00000,1,1,0,MF
GO:0015294,solute:cation symporter activity,99,0,2.01,1.00000,1,1,0,MF
GO:0015295,solute:proton symporter activity,22,0,0.45,1.00000,1,1,0,MF
GO:0015301,anion:anion antiporter activity,29,0,0.59,1.00000,1,1,0,MF
GO:0015370,solute:sodium symporter activity,70,0,1.42,1.00000,1,1,0,MF
GO:0015399,primary active transmembrane transporter...,119,0,2.42,1.00000,1,1,0,MF
GO:0015405,P-P-bond-hydrolysis-driven transmembrane...,118,0,2.4,1.00000,1,1,0,MF
GO:0015464,acetylcholine receptor activity,22,0,0.45,1.00000,1,1,0,MF
GO:0015605,organophosphate ester transmembrane tran...,27,0,0.55,1.00000,1,1,0,MF
GO:0015662,"ATPase activity, coupled to transmembran...",39,0,0.79,1.00000,1,1,0,MF
GO:0016229,steroid dehydrogenase activity,45,0,0.91,1.00000,1,1,0,MF
GO:0016289,CoA hydrolase activity,27,0,0.55,1.00000,1,1,0,MF
GO:0016298,lipase activity,122,0,2.48,1.00000,1,1,0,MF
GO:0016405,CoA-ligase activity,23,0,0.47,1.00000,1,1,0,MF
GO:0016407,acetyltransferase activity,117,0,2.38,1.00000,1,1,0,MF
GO:0016408,C-acyltransferase activity,22,0,0.45,1.00000,1,1,0,MF
GO:0016410,N-acyltransferase activity,115,0,2.33,1.00000,1,1,0,MF
GO:0016493,C-C chemokine receptor activity,24,0,0.49,1.00000,1,1,0,MF
GO:0016502,nucleotide receptor activity,20,0,0.41,1.00000,1,1,0,MF
GO:0016503,pheromone receptor activity,99,0,2.01,1.00000,1,1,0,MF
GO:0016627,"oxidoreductase activity, acting on the C...",56,0,1.14,1.00000,1,1,0,MF
GO:0016628,"oxidoreductase activity, acting on the C...",24,0,0.49,1.00000,1,1,0,MF
GO:0016638,"oxidoreductase activity, acting on the C...",24,0,0.49,1.00000,1,1,0,MF
GO:0016641,"oxidoreductase activity, acting on the C...",21,0,0.43,1.00000,1,1,0,MF
GO:0016645,"oxidoreductase activity, acting on the C...",28,0,0.57,1.00000,1,1,0,MF
GO:0016655,"oxidoreductase activity, acting on NAD(P...",37,0,0.75,1.00000,1,1,0,MF
GO:0016667,"oxidoreductase activity, acting on a sul...",57,0,1.16,1.00000,1,1,0,MF
GO:0016684,"oxidoreductase activity, acting on perox...",56,0,1.14,1.00000,1,1,0,MF
GO:0016701,"oxidoreductase activity, acting on singl...",31,0,0.63,1.00000,1,1,0,MF
GO:0016702,"oxidoreductase activity, acting on singl...",30,0,0.61,1.00000,1,1,0,MF
GO:0016706,"oxidoreductase activity, acting on paire...",45,0,0.91,1.00000,1,1,0,MF
GO:0016709,"oxidoreductase activity, acting on paire...",45,0,0.91,1.00000,1,1,0,MF
GO:0016712,"oxidoreductase activity, acting on paire...",61,0,1.24,1.00000,1,1,0,MF
GO:0016725,"oxidoreductase activity, acting on CH or...",23,0,0.47,1.00000,1,1,0,MF
GO:0016758,"transferase activity, transferring hexos...",209,0,4.24,1.00000,1,1,0,MF
GO:0016765,"transferase activity, transferring alkyl...",64,0,1.3,1.00000,1,1,0,MF
GO:0016769,"transferase activity, transferring nitro...",25,0,0.51,1.00000,1,1,0,MF
GO:0016790,thiolester hydrolase activity,46,0,0.93,1.00000,1,1,0,MF
GO:0016796,"exonuclease activity, active with either...",52,0,1.06,1.00000,1,1,0,MF
GO:0016798,"hydrolase activity, acting on glycosyl b...",125,0,2.54,1.00000,1,1,0,MF
GO:0016799,"hydrolase activity, hydrolyzing N-glycos...",22,0,0.45,1.00000,1,1,0,MF
GO:0016814,"hydrolase activity, acting on carbon-nit...",29,0,0.59,1.00000,1,1,0,MF
GO:0016835,carbon-oxygen lyase activity,67,0,1.36,1.00000,1,1,0,MF
GO:0016836,hydro-lyase activity,55,0,1.12,1.00000,1,1,0,MF
GO:0016849,phosphorus-oxygen lyase activity,25,0,0.51,1.00000,1,1,0,MF
GO:0016860,intramolecular oxidoreductase activity,46,0,0.93,1.00000,1,1,0,MF
GO:0016866,intramolecular transferase activity,27,0,0.55,1.00000,1,1,0,MF
GO:0016875,"ligase activity, forming carbon-oxygen b...",41,0,0.83,1.00000,1,1,0,MF
GO:0016891,"endoribonuclease activity, producing 5'-...",28,0,0.57,1.00000,1,1,0,MF
GO:0016893,"endonuclease activity, active with eithe...",40,0,0.81,1.00000,1,1,0,MF
GO:0016895,"exodeoxyribonuclease activity, producing...",23,0,0.47,1.00000,1,1,0,MF
GO:0016896,"exoribonuclease activity, producing 5'-p...",31,0,0.63,1.00000,1,1,0,MF
GO:0016917,GABA receptor activity,22,0,0.45,1.00000,1,1,0,MF
GO:0016922,nuclear receptor binding,26,0,0.53,1.00000,1,1,0,MF
GO:0017069,snRNA binding,39,0,0.79,1.00000,1,1,0,MF
GO:0017080,sodium channel regulator activity,33,0,0.67,1.00000,1,1,0,MF
GO:0017091,AU-rich element binding,31,0,0.63,1.00000,1,1,0,MF
GO:0017127,cholesterol transporter activity,20,0,0.41,1.00000,1,1,0,MF
GO:0017147,Wnt-protein binding,38,0,0.77,1.00000,1,1,0,MF
GO:0017171,serine hydrolase activity,208,0,4.22,1.00000,1,1,0,MF
GO:0019200,carbohydrate kinase activity,21,0,0.43,1.00000,1,1,0,MF
GO:0019789,SUMO transferase activity,22,0,0.45,1.00000,1,1,0,MF
GO:0019825,oxygen binding,23,0,0.47,1.00000,1,1,0,MF
GO:0019829,cation-transporting ATPase activity,61,0,1.24,1.00000,1,1,0,MF
GO:0019840,isoprenoid binding,38,0,0.77,1.00000,1,1,0,MF
GO:0019865,immunoglobulin binding,22,0,0.45,1.00000,1,1,0,MF
GO:0019957,C-C chemokine binding,25,0,0.51,1.00000,1,1,0,MF
GO:0022824,transmitter-gated ion channel activity,58,0,1.18,1.00000,1,1,0,MF
GO:0022829,wide pore channel activity,22,0,0.45,1.00000,1,1,0,MF
GO:0022835,transmitter-gated channel activity,58,0,1.18,1.00000,1,1,0,MF
GO:0022853,active ion transmembrane transporter act...,61,0,1.24,1.00000,1,1,0,MF
GO:0030020,extracellular matrix structural constitu...,39,0,0.79,1.00000,1,1,0,MF
GO:0030170,pyridoxal phosphate binding,53,0,1.08,1.00000,1,1,0,MF
GO:0030247,polysaccharide binding,21,0,0.43,1.00000,1,1,0,MF
GO:0030332,cyclin binding,32,0,0.65,1.00000,1,1,0,MF
GO:0030371,translation repressor activity,25,0,0.51,1.00000,1,1,0,MF
GO:0030547,receptor inhibitor activity,26,0,0.53,1.00000,1,1,0,MF
GO:0030551,cyclic nucleotide binding,36,0,0.73,1.00000,1,1,0,MF
GO:0030552,cAMP binding,22,0,0.45,1.00000,1,1,0,MF
GO:0030594,neurotransmitter receptor activity,117,0,2.38,1.00000,1,1,0,MF
GO:0031420,alkali metal ion binding,22,0,0.45,1.00000,1,1,0,MF
GO:0031489,myosin V binding,21,0,0.43,1.00000,1,1,0,MF
GO:0031492,nucleosomal DNA binding,23,0,0.47,1.00000,1,1,0,MF
GO:0031624,ubiquitin conjugating enzyme binding,34,0,0.69,1.00000,1,1,0,MF
GO:0031681,G-protein beta-subunit binding,23,0,0.47,1.00000,1,1,0,MF
GO:0031690,adrenergic receptor binding,21,0,0.43,1.00000,1,1,0,MF
GO:0032451,demethylase activity,42,0,0.85,1.00000,1,1,0,MF
GO:0032452,histone demethylase activity,27,0,0.55,1.00000,1,1,0,MF
GO:0032794,GTPase activating protein binding,20,0,0.41,1.00000,1,1,0,MF
GO:0033038,bitter taste receptor activity,29,0,0.59,1.00000,1,1,0,MF
GO:0033612,receptor serine/threonine kinase binding,28,0,0.57,1.00000,1,1,0,MF
GO:0033764,"steroid dehydrogenase activity, acting o...",37,0,0.75,1.00000,1,1,0,MF
GO:0034061,DNA polymerase activity,33,0,0.67,1.00000,1,1,0,MF
GO:0034212,peptide N-acetyltransferase activity,76,0,1.54,1.00000,1,1,0,MF
GO:0034593,phosphatidylinositol bisphosphate phosph...,21,0,0.43,1.00000,1,1,0,MF
GO:0035250,UDP-galactosyltransferase activity,25,0,0.51,1.00000,1,1,0,MF
GO:0035259,glucocorticoid receptor binding,21,0,0.43,1.00000,1,1,0,MF
GO:0035586,purinergic receptor activity,25,0,0.51,1.00000,1,1,0,MF
GO:0035925,mRNA 3'-UTR AU-rich region binding,29,0,0.59,1.00000,1,1,0,MF
GO:0036002,pre-mRNA binding,35,0,0.71,1.00000,1,1,0,MF
GO:0036442,proton-exporting ATPase activity,31,0,0.63,1.00000,1,1,0,MF
GO:0042056,chemoattractant activity,40,0,0.81,1.00000,1,1,0,MF
GO:0042165,neurotransmitter binding,61,0,1.24,1.00000,1,1,0,MF
GO:0042605,peptide antigen binding,35,0,0.71,1.00000,1,1,0,MF
GO:0042625,ATPase coupled ion transmembrane transpo...,61,0,1.24,1.00000,1,1,0,MF
GO:0042626,"ATPase activity, coupled to transmembran...",113,0,2.29,1.00000,1,1,0,MF
GO:0042887,amide transmembrane transporter activity,43,0,0.87,1.00000,1,1,0,MF
GO:0042923,neuropeptide binding,25,0,0.51,1.00000,1,1,0,MF
GO:0042974,retinoic acid receptor binding,33,0,0.67,1.00000,1,1,0,MF
GO:0042975,peroxisome proliferator activated recept...,21,0,0.43,1.00000,1,1,0,MF
GO:0043015,gamma-tubulin binding,29,0,0.59,1.00000,1,1,0,MF
GO:0043027,cysteine-type endopeptidase inhibitor ac...,28,0,0.57,1.00000,1,1,0,MF
GO:0043028,cysteine-type endopeptidase regulator ac...,39,0,0.79,1.00000,1,1,0,MF
GO:0043274,phospholipase binding,20,0,0.41,1.00000,1,1,0,MF
GO:0043394,proteoglycan binding,37,0,0.75,1.00000,1,1,0,MF
GO:0043425,bHLH transcription factor binding,32,0,0.65,1.00000,1,1,0,MF
GO:0043492,"ATPase activity, coupled to movement of ...",114,0,2.31,1.00000,1,1,0,MF
GO:0043539,protein serine/threonine kinase activato...,29,0,0.59,1.00000,1,1,0,MF
GO:0044390,ubiquitin-like protein conjugating enzym...,39,0,0.79,1.00000,1,1,0,MF
GO:0044769,"ATPase activity, coupled to transmembran...",34,0,0.69,1.00000,1,1,0,MF
GO:0046875,ephrin receptor binding,31,0,0.63,1.00000,1,1,0,MF
GO:0046915,transition metal ion transmembrane trans...,37,0,0.75,1.00000,1,1,0,MF
GO:0046943,carboxylic acid transmembrane transporte...,150,0,3.05,1.00000,1,1,0,MF
GO:0046961,"proton-transporting ATPase activity, rot...",21,0,0.43,1.00000,1,1,0,MF
GO:0046965,retinoid X receptor binding,23,0,0.47,1.00000,1,1,0,MF
GO:0046966,thyroid hormone receptor binding,26,0,0.53,1.00000,1,1,0,MF
GO:0047555,"3',5'-cyclic-GMP phosphodiesterase activ...",20,0,0.41,1.00000,1,1,0,MF
GO:0047617,acyl-CoA hydrolase activity,25,0,0.51,1.00000,1,1,0,MF
GO:0048029,monosaccharide binding,85,0,1.73,1.00000,1,1,0,MF
GO:0048156,tau protein binding,21,0,0.43,1.00000,1,1,0,MF
GO:0048487,beta-tubulin binding,43,0,0.87,1.00000,1,1,0,MF
GO:0050136,NADH dehydrogenase (quinone) activity,26,0,0.53,1.00000,1,1,0,MF
GO:0050321,tau-protein kinase activity,20,0,0.41,1.00000,1,1,0,MF
GO:0050750,low-density lipoprotein particle recepto...,26,0,0.53,1.00000,1,1,0,MF
GO:0050780,dopamine receptor binding,24,0,0.49,1.00000,1,1,0,MF
GO:0051059,NF-kappaB binding,32,0,0.65,1.00000,1,1,0,MF
GO:0051119,sugar transmembrane transporter activity,26,0,0.53,1.00000,1,1,0,MF
GO:0051213,dioxygenase activity,94,0,1.91,1.00000,1,1,0,MF
GO:0051371,muscle alpha-actinin binding,21,0,0.43,1.00000,1,1,0,MF
GO:0051428,peptide hormone receptor binding,21,0,0.43,1.00000,1,1,0,MF
GO:0051536,iron-sulfur cluster binding,63,0,1.28,1.00000,1,1,0,MF
GO:0051537,"2 iron, 2 sulfur cluster binding",25,0,0.51,1.00000,1,1,0,MF
GO:0051539,"4 iron, 4 sulfur cluster binding",39,0,0.79,1.00000,1,1,0,MF
GO:0051540,metal cluster binding,63,0,1.28,1.00000,1,1,0,MF
GO:0051787,misfolded protein binding,24,0,0.49,1.00000,1,1,0,MF
GO:0051861,glycolipid binding,21,0,0.43,1.00000,1,1,0,MF
GO:0052745,inositol phosphate phosphatase activity,20,0,0.41,1.00000,1,1,0,MF
GO:0052866,phosphatidylinositol phosphate phosphata...,25,0,0.51,1.00000,1,1,0,MF
GO:0061631,ubiquitin conjugating enzyme activity,39,0,0.79,1.00000,1,1,0,MF
GO:0061650,ubiquitin-like protein conjugating enzym...,41,0,0.83,1.00000,1,1,0,MF
GO:0061733,peptide-lysine-N-acetyltransferase activ...,67,0,1.36,1.00000,1,1,0,MF
GO:0070001,aspartic-type peptidase activity,30,0,0.61,1.00000,1,1,0,MF
GO:0070003,threonine-type peptidase activity,21,0,0.43,1.00000,1,1,0,MF
GO:0070279,vitamin B6 binding,54,0,1.1,1.00000,1,1,0,MF
GO:0070325,lipoprotein particle receptor binding,30,0,0.61,1.00000,1,1,0,MF
GO:0070330,aromatase activity,35,0,0.71,1.00000,1,1,0,MF
GO:0070412,R-SMAD binding,25,0,0.51,1.00000,1,1,0,MF
GO:0070530,K63-linked polyubiquitin modification-de...,22,0,0.45,1.00000,1,1,0,MF
GO:0070566,adenylyltransferase activity,30,0,0.61,1.00000,1,1,0,MF
GO:0070696,transmembrane receptor protein serine/th...,20,0,0.41,1.00000,1,1,0,MF
GO:0070888,E-box binding,47,0,0.95,1.00000,1,1,0,MF
GO:0071837,HMG box domain binding,25,0,0.51,1.00000,1,1,0,MF
GO:0071855,neuropeptide receptor binding,32,0,0.65,1.00000,1,1,0,MF
GO:0071949,FAD binding,37,0,0.75,1.00000,1,1,0,MF
GO:0072341,modified amino acid binding,104,0,2.11,1.00000,1,1,0,MF
GO:0072509,divalent inorganic cation transmembrane ...,27,0,0.55,1.00000,1,1,0,MF
GO:0090482,vitamin transmembrane transporter activi...,22,0,0.45,1.00000,1,1,0,MF
GO:0098531,"transcription factor activity, direct li...",40,0,0.81,1.00000,1,1,0,MF
GO:0098632,cell-cell adhesion mediator activity,31,0,0.63,1.00000,1,1,0,MF
GO:0098960,postsynaptic neurotransmitter receptor a...,57,0,1.16,1.00000,1,1,0,MF
GO:0099095,ligand-gated anion channel activity,21,0,0.43,1.00000,1,1,0,MF
GO:0099528,G protein-coupled neurotransmitter recep...,45,0,0.91,1.00000,1,1,0,MF
GO:0099529,neurotransmitter receptor activity invol...,55,0,1.12,1.00000,1,1,0,MF
GO:0099589,serotonin receptor activity,39,0,0.79,1.00000,1,1,0,MF
GO:0104005,hijacked molecular function,20,0,0.41,1.00000,1,1,0,MF
GO:0120015,intermembrane sterol transfer activity,21,0,0.43,1.00000,1,1,0,MF
GO:0120020,intermembrane cholesterol transfer activ...,20,0,0.41,1.00000,1,1,0,MF
GO:0140103,"catalytic activity, acting on a glycopro...",22,0,0.45,1.00000,1,1,0,MF
GO:0140104,molecular carrier activity,50,0,1.02,1.00000,1,1,0,MF
GO:0140142,nucleocytoplasmic carrier activity,29,0,0.59,1.00000,1,1,0,MF
GO:1901338,catecholamine binding,21,0,0.43,1.00000,1,1,0,MF
GO:1901505,carbohydrate derivative transmembrane tr...,46,0,0.93,1.00000,1,1,0,MF
GO:1901618,organic hydroxy compound transmembrane t...,43,0,0.87,1.00000,1,1,0,MF
GO:1901682,sulfur compound transmembrane transporte...,31,0,0.63,1.00000,1,1,0,MF
GO:1904315,transmitter-gated ion channel activity i...,52,0,1.06,1.00000,1,1,0,MF
GO:1904680,peptide transmembrane transporter activi...,27,0,0.55,1.00000,1,1,0,MF
GO:0043229,intracellular organelle,11997,370,243.09, 1e-30,6.300000000000001e-28,1.05e-28,1.52,CC
GO:0044424,intracellular part,13717,394,277.94, 1e-30,6.300000000000001e-28,1.05e-28,1.42,CC
GO:0005622,intracellular,13747,394,278.55, 1e-30,6.300000000000001e-28,1.05e-28,1.41,CC
GO:0043226,organelle,12314,371,249.51, 1e-30,6.300000000000001e-28,1.05e-28,1.49,CC
GO:0044446,intracellular organelle part,7228,273,146.46, 1e-30,6.300000000000001e-28,1.05e-28,1.86,CC
GO:0044422,organelle part,7595,280,153.89, 1e-30,6.300000000000001e-28,1.05e-28,1.82,CC
GO:0005634,nucleus,6846,253,138.72,3.8e-30,2.3940000000000004e-27,3.4200000000000004e-28,1.82,CC
GO:0043228,non-membrane-bounded organelle,4161,187,84.31,4.5e-30,2.8349999999999998e-27,3.5437499999999997e-28,2.22,CC
GO:0043232,intracellular non-membrane-bounded organ...,4141,186,83.91,7.8e-30,4.914e-27,5.460000000000001e-28,2.22,CC
GO:0043227,membrane-bounded organelle,11062,336,224.14,4.3e-29,2.709e-26,2.709e-27,1.5,CC
GO:0043231,intracellular membrane-bounded organelle,10334,320,209.39,8.7e-28,5.481e-25,4.982727272727273e-26,1.53,CC
GO:0044464,cell part,16127,411,326.77,1.1e-27,6.93e-25,5.775e-26,1.26,CC
GO:0005623,cell,16132,411,326.87,1.3e-27,8.190000000000001e-25,6.3e-26,1.26,CC
GO:0005737,cytoplasm,10993,330,222.74,1.1e-26,6.93e-24,4.95e-25,1.48,CC
GO:0044444,cytoplasmic part,8386,271,169.92,3.8e-23,2.3940000000000002e-20,1.596e-21,1.59,CC
GO:0032991,protein-containing complex,5422,204,109.86,5.5e-23,3.465e-20,2.165625e-21,1.86,CC
GO:0044428,nuclear part,3985,167,80.75,1.1e-22,6.93e-20,4.076470588235295e-21,2.07,CC
GO:0005856,cytoskeleton,2118,109,42.92,2.0e-20,1.2599999999999999e-17,6.999999999999999e-19,2.54,CC
GO:0005829,cytosol,3292,142,66.7,7.2e-20,4.536e-17,2.387368421052631e-18,2.13,CC
GO:0044430,cytoskeletal part,1561,85,31.63,3.1e-17,1.953e-14,9.765e-16,2.69,CC
GO:0031981,nuclear lumen,3506,138,71.04,8.4e-16,5.292e-13,2.5200000000000002e-14,1.94,CC
GO:0070013,intracellular organelle lumen,3883,147,78.68,1.7e-15,1.071e-12,4.4625e-14,1.87,CC
GO:0031974,membrane-enclosed lumen,3884,147,78.7,1.7e-15,1.071e-12,4.4625e-14,1.87,CC
GO:0043233,organelle lumen,3884,147,78.7,1.7e-15,1.071e-12,4.4625e-14,1.87,CC
GO:0015630,microtubule cytoskeleton,1156,64,23.42,2.2e-13,1.386e-10,5.544e-12,2.73,CC
GO:0005654,nucleoplasm,2607,101,52.82,6.3e-11,3.969e-8,1.5265384615384616e-9,1.91,CC
GO:0022626,cytosolic ribosome,109,17,2.21,7.1e-11,4.473e-8,1.6566666666666665e-9,7.69,CC
GO:0099513,polymeric cytoskeletal fiber,679,39,13.76,5.7e-09,3.591e-6,1.2825e-7,2.83,CC
GO:0099512,supramolecular fiber,899,46,18.22,8.6e-09,5.418e-6,1.8682758620689655e-7,2.52,CC
GO:1990904,ribonucleoprotein complex,967,48,19.59,1.0e-08,6.3e-6,2.1e-7,2.45,CC
GO:0099081,supramolecular polymer,905,46,18.34,1.1e-08,6.93e-6,2.165625e-7,2.51,CC
GO:0099080,supramolecular complex,906,46,18.36,1.1e-08,6.93e-6,2.165625e-7,2.51,CC
GO:0005730,nucleolus,821,43,16.64,1.4e-08,8.82e-6,2.672727272727273e-7,2.58,CC
GO:0005874,microtubule,429,29,8.69,1.7e-08,1.071e-5,3.1500000000000005e-7,3.34,CC
GO:0097458,neuron part,1982,77,40.16,1.8e-08,1.134e-5,3.24e-7,1.92,CC
GO:0005815,microtubule organizing center,680,38,13.78,1.9e-08,1.197e-5,3.3250000000000005e-7,2.76,CC
GO:0005813,centrosome,517,32,10.48,2.5e-08,1.575e-5,4.2567567567567566e-7,3.05,CC
GO:0044445,cytosolic part,265,22,5.37,2.7e-08,1.701e-5,4.476315789473684e-7,4.1,CC
GO:0015629,actin cytoskeleton,494,31,10.01,3.1e-08,1.953e-5,5.007692307692308e-7,3.1,CC
GO:0042995,cell projection,2473,89,50.11,4.2e-08,2.646e-5,6.607317073170731e-7,1.78,CC
GO:0005840,ribosome,227,20,4.6,4.3e-08,2.709e-5,6.607317073170731e-7,4.35,CC
GO:1902494,catalytic complex,1365,58,27.66,7.1e-08,4.473e-5,1.0402325581395349e-6,2.1,CC
GO:0048471,perinuclear region of cytoplasm,656,36,13.29,7.1e-08,4.473e-5,1.0402325581395349e-6,2.71,CC
GO:0012505,endomembrane system,3805,120,77.1,1.8e-07,1.1339999999999999e-4,2.5772727272727274e-6,1.56,CC
GO:0120025,plasma membrane bounded cell projection,2273,81,46.06,3.0e-07,1.8899999999999999e-4,4.021276595744681e-6,1.76,CC
GO:0044463,cell projection part,1567,62,31.75,3.0e-07,1.8899999999999999e-4,4.021276595744681e-6,1.95,CC
GO:0120038,plasma membrane bounded cell projection ...,1567,62,31.75,3.0e-07,1.8899999999999999e-4,4.021276595744681e-6,1.95,CC
GO:0022625,cytosolic large ribosomal subunit,61,10,1.24,3.8e-07,2.3940000000000002e-4,4.9875e-6,8.06,CC
GO:0044391,ribosomal subunit,192,17,3.89,4.1e-07,2.583e-4,5.271428571428571e-6,4.37,CC
GO:0005875,microtubule associated complex,150,15,3.04,4.2e-07,2.646e-4,5.2919999999999995e-6,4.93,CC
GO:0005938,cell cortex,316,22,6.4,5.8e-07,3.654e-4,7.164705882352941e-6,3.44,CC
GO:0045202,synapse,1417,56,28.71,1.2e-06,7.559999999999999e-4,1.4538461538461538e-5,1.95,CC
GO:0099568,cytoplasmic region,481,27,9.75,2.1e-06,0.001323,2.4962264150943394e-5,2.77,CC
GO:0022627,cytosolic small ribosomal subunit,44,8,0.89,2.5e-06,0.0015750000000000002,2.9166666666666666e-5,8.99,CC
GO:0044441,ciliary part,464,26,9.4,3.4e-06,0.0021420000000000002,3.8945454545454547e-05,2.77,CC
GO:0005681,spliceosomal complex,194,15,3.93,1.0e-05,0.006300000000000001,1.1250000000000001e-4,3.82,CC
GO:0043005,neuron projection,1523,56,30.86,1.1e-05,0.0069299999999999995,1.1948275862068966e-4,1.81,CC
GO:0000785,chromatin,588,29,11.91,1.1e-05,0.0069299999999999995,1.1948275862068966e-4,2.43,CC
GO:0005871,kinesin complex,57,8,1.15,1.8e-05,0.011340000000000001,1.9220338983050848e-4,6.96,CC
GO:0030175,filopodium,93,10,1.88,1.9e-05,0.011970000000000001,1.9950000000000002e-4,5.32,CC
GO:0030027,lamellipodium,168,13,3.4,4.0e-05,0.025200000000000004,4.1311475409836065e-4,3.82,CC
GO:0000775,"chromosome, centromeric region",195,14,3.95,4.7e-05,0.029609999999999997,4.6265624999999996e-4,3.54,CC
GO:0031252,cell leading edge,387,21,7.84,4.7e-05,0.029609999999999997,4.6265624999999996e-4,2.68,CC
GO:1990234,transferase complex,770,33,15.6,4.7e-05,0.029609999999999997,4.6265624999999996e-4,2.12,CC
GO:0035145,exon-exon junction complex,21,5,0.43,5.2e-05,0.03276,5.039999999999999e-4,11.63,CC
GO:0014069,postsynaptic density,397,21,8.04,6.8e-05,0.04284,6.490909090909091e-4,2.61,CC
GO:0032279,asymmetric synapse,400,21,8.1,7.5e-05,0.04724999999999999,7.052238805970148e-4,2.59,CC
GO:0005694,chromosome,1111,42,22.51,8.0e-05,0.05040000000000001,7.411764705882354e-4,1.87,CC
GO:0070161,anchoring junction,316,18,6.4,8.8e-05,0.055439999999999996,8.034782608695651e-4,2.81,CC
GO:0099572,postsynaptic specialization,436,22,8.83,9.1e-05,0.05733,8.190000000000001e-4,2.49,CC
GO:0005929,cilium,632,28,12.81,0.00010,0.063,8.873239436619719e-4,2.19,CC
GO:0044448,cell cortex part,212,14,4.3,0.00011,0.0693,9.625e-4,3.26,CC
GO:0098794,postsynapse,740,31,14.99,0.00012,0.0756,0.0010216216216216217,2.07,CC
GO:0005635,nuclear envelope,414,21,8.39,0.00012,0.0756,0.0010216216216216217,2.5,CC
GO:0044427,chromosomal part,991,38,20.08,0.00013,0.08189999999999999,0.0010919999999999999,1.89,CC
GO:0015935,small ribosomal subunit,76,8,1.54,0.00015,0.09449999999999999,0.0012115384615384614,5.19,CC
GO:0005912,adherens junction,301,17,6.1,0.00015,0.09449999999999999,0.0012115384615384614,2.79,CC
GO:0005868,cytoplasmic dynein complex,26,5,0.53,0.00015,0.09449999999999999,0.0012115384615384614,9.43,CC
GO:0098984,neuron to neuron synapse,425,21,8.61,0.00017,0.1071,0.0013556962025316457,2.44,CC
GO:0097525,spliceosomal snRNP complex,59,7,1.2,0.00018,0.1134,0.0014175000000000001,5.83,CC
GO:0015934,large ribosomal subunit,122,10,2.47,0.00019,0.1197,0.001477777777777778,4.05,CC
GO:0045121,membrane raft,370,19,7.5,0.00022,0.1386,0.00165,2.53,CC
GO:0036064,ciliary basal body,148,11,3,0.00022,0.1386,0.00165,3.67,CC
GO:0098857,membrane microdomain,371,19,7.52,0.00022,0.1386,0.00165,2.53,CC
GO:0044297,cell body,811,32,16.43,0.00028,0.17639999999999997,0.002075294117647059,1.95,CC
GO:0005905,clathrin-coated pit,64,7,1.3,0.00031,0.1953,0.0022448275862068964,5.38,CC
GO:0030532,small nuclear ribonucleoprotein complex,64,7,1.3,0.00031,0.1953,0.0022448275862068964,5.38,CC
GO:0098589,membrane region,383,19,7.76,0.00033,0.2079,0.0023625,2.45,CC
GO:0044451,nucleoplasm part,1017,37,20.61,0.00045,0.2835,0.0031853932584269664,1.8,CC
GO:0043209,myelin sheath,219,13,4.44,0.00056,0.35279999999999995,0.0038347826086956517,2.93,CC
GO:0005814,centriole,115,9,2.33,0.00056,0.35279999999999995,0.0038347826086956517,3.86,CC
GO:0044450,microtubule organizing center part,165,11,3.34,0.00056,0.35279999999999995,0.0038347826086956517,3.29,CC
GO:0030054,cell junction,1144,40,23.18,0.00058,0.3654,0.003929032258064517,1.73,CC
GO:0061695,"transferase complex, transferring phosph...",249,14,5.05,0.00059,0.37170000000000003,0.003954255319148936,2.77,CC
GO:0005819,spindle,280,15,5.67,0.00063,0.39690000000000003,0.004177894736842105,2.65,CC
GO:0032432,actin filament bundle,96,8,1.95,0.00075,0.47250000000000003,0.004921875,4.1,CC
GO:0030424,axon,717,28,14.53,0.00077,0.4851,0.005001030927835051,1.93,CC
GO:0120114,Sm-like protein family complex,75,7,1.52,0.00081,0.5103,0.005207142857142857,4.61,CC
GO:0005911,cell-cell junction,484,21,9.81,0.00096,0.6048,0.006109090909090909,2.14,CC
GO:0099091,"postsynaptic specialization, intracellul...",38,5,0.77,0.00097,0.6111,0.006111,6.49,CC
GO:0016607,nuclear speck,323,16,6.54,0.00098,0.6174,0.006112871287128713,2.45,CC
GO:0070603,SWI/SNF superfamily-type complex,78,7,1.58,0.00102,0.6426000000000001,0.006300000000000001,4.43,CC
GO:0030426,growth cone,206,12,4.17,0.00106,0.6678,0.006483495145631068,2.88,CC
GO:0030286,dynein complex,58,6,1.18,0.00111,0.6993,0.006724038461538462,5.08,CC
GO:0031410,cytoplasmic vesicle,1830,56,37.08,0.00126,0.7938000000000001,0.007513761467889908,1.51,CC
GO:0005721,pericentric heterochromatin,24,4,0.49,0.00128,0.8064000000000001,0.007513761467889908,8.16,CC
GO:0016604,nuclear body,670,26,13.58,0.00129,0.8127,0.007513761467889908,1.91,CC
GO:0030427,site of polarized growth,211,12,4.28,0.00130,0.819,0.007513761467889908,2.8,CC
GO:0098858,actin-based cell projection,211,12,4.28,0.00130,0.819,0.007513761467889908,2.8,CC
GO:0097708,intracellular vesicle,1835,56,37.18,0.00134,0.8442000000000001,0.007674545454545455,1.51,CC
GO:0098687,chromosomal region,308,15,6.24,0.00165,1,0.0093375,2.4,CC
GO:0000922,spindle pole,134,9,2.72,0.00166,1,0.0093375,3.31,CC
GO:0000790,nuclear chromatin,406,18,8.23,0.00171,1,0.009533628318584071,2.19,CC
GO:0044456,synapse part,1098,37,22.25,0.00178,1,0.009751304347826086,1.66,CC
GO:0043025,neuronal cell body,722,27,14.63,0.00178,1,0.009751304347826086,1.85,CC
GO:0000776,kinetochore,137,9,2.78,0.00194,1,0.010536206896551725,3.24,CC
GO:0030425,dendrite,728,27,14.75,0.00200,1,0.010677966101694915,1.83,CC
GO:0098978,glutamatergic synapse,514,21,10.41,0.00200,1,0.010677966101694915,2.02,CC
GO:0005768,endosome,840,30,17.02,0.00203,1,0.010747058823529412,1.76,CC
GO:0097447,dendritic tree,731,27,14.81,0.00211,1,0.011077499999999999,1.82,CC
GO:0005684,U2-type spliceosomal complex,89,7,1.8,0.00221,1,0.011506611570247934,3.89,CC
GO:0097386,glial cell projection,28,4,0.57,0.00232,1,0.011980327868852458,7.02,CC
GO:0019898,extrinsic component of membrane,320,15,6.48,0.00238,1,0.012142741935483873,2.31,CC
GO:0005913,cell-cell adherens junction,115,8,2.33,0.00239,1,0.012142741935483873,3.43,CC
GO:0031982,vesicle,1969,58,39.9,0.00245,1,0.0123,1.45,CC
GO:0033267,axon part,454,19,9.2,0.00246,1,0.0123,2.07,CC
GO:0005794,Golgi apparatus,1398,44,28.33,0.00252,1,0.012500787401574804,1.55,CC
GO:0048786,presynaptic active zone,94,7,1.9,0.00301,1,0.01481484375,3.68,CC
GO:0036477,somatodendritic compartment,1056,35,21.4,0.00307,1,0.014993023255813953,1.64,CC
GO:0000792,heterochromatin,95,7,1.92,0.00320,1,0.015507692307692307,3.65,CC
GO:1904949,ATPase complex,96,7,1.95,0.00339,1,0.016179545454545453,3.59,CC
GO:0042788,polysomal ribosome,31,4,0.63,0.00339,1,0.016179545454545453,6.35,CC
GO:0005776,autophagosome,73,6,1.48,0.00363,1,0.017194736842105263,4.05,CC
GO:0042641,actomyosin,98,7,1.99,0.00380,1,0.01769558823529412,3.52,CC
GO:0034451,centriolar satellite,32,4,0.65,0.00382,1,0.01769558823529412,6.15,CC
GO:0099092,"postsynaptic density, intracellular comp...",32,4,0.65,0.00382,1,0.01769558823529412,6.15,CC
GO:0098805,whole membrane,1114,36,22.57,0.00404,1,0.018578102189781023,1.6,CC
GO:0098562,cytoplasmic side of membrane,182,10,3.69,0.00410,1,0.018717391304347828,2.71,CC
GO:0005844,polysome,75,6,1.52,0.00415,1,0.018809352517985614,3.95,CC
GO:0150034,distal axon,374,16,7.58,0.00426,1,0.01917,2.11,CC
GO:0030864,cortical actin cytoskeleton,101,7,2.05,0.00449,1,0.02006170212765957,3.41,CC
GO:0019897,extrinsic component of plasma membrane,187,10,3.79,0.00496,1,0.0220056338028169,2.64,CC
GO:0099738,cell cortex region,55,5,1.11,0.00506,1,0.022292307692307695,4.5,CC
GO:0000151,ubiquitin ligase complex,282,13,5.71,0.00520,1,0.02275,2.28,CC
GO:0031461,cullin-RING ubiquitin ligase complex,160,9,3.24,0.00544,1,0.02363586206896552,2.78,CC
GO:0008180,COP9 signalosome,36,4,0.73,0.00587,1,0.025329452054794522,5.48,CC
GO:0031967,organelle envelope,1063,34,21.54,0.00599,1,0.02567142857142857,1.58,CC
GO:0030863,cortical cytoskeleton,134,8,2.72,0.00605,1,0.02570738255033557,2.94,CC
GO:0031975,envelope,1064,34,21.56,0.00608,1,0.02570738255033557,1.58,CC
GO:0032153,cell division site,58,5,1.18,0.00634,1,0.026628000000000002,4.24,CC
GO:0009898,cytoplasmic side of plasma membrane,165,9,3.34,0.00662,1,0.027619867549668876,2.69,CC
GO:0071013,catalytic step 2 spliceosome,83,6,1.68,0.00680,1,0.028184210526315787,3.57,CC
GO:0042383,sarcolemma,167,9,3.38,0.00715,1,0.02944117647058823,2.66,CC
GO:0044291,cell-cell contact zone,84,6,1.7,0.00720,1,0.029454545454545452,3.53,CC
GO:0031616,spindle pole centrosome,20,3,0.41,0.00729,1,0.029630322580645158,7.32,CC
GO:0016528,sarcoplasm,85,6,1.72,0.00761,1,0.030732692307692305,3.49,CC
GO:0042734,presynaptic membrane,200,10,4.05,0.00785,1,0.0315,2.47,CC
GO:0000228,nuclear chromosome,655,23,13.27,0.00791,1,0.03153987341772152,1.73,CC
GO:0044454,nuclear chromosome part,621,22,12.58,0.00842,1,0.033211111111111115,1.75,CC
GO:0001725,stress fiber,87,6,1.76,0.00850,1,0.033211111111111115,3.41,CC
GO:0097517,contractile actin filament bundle,87,6,1.76,0.00850,1,0.033211111111111115,3.41,CC
GO:0031672,A band,40,4,0.81,0.00854,1,0.033211111111111115,4.94,CC
GO:0097733,photoreceptor cell cilium,114,7,2.31,0.00860,1,0.03323926380368098,3.03,CC
GO:0034399,nuclear periphery,115,7,2.33,0.00900,1,0.03457317073170731,3,CC
GO:0097731,9+0 non-motile cilium,116,7,2.35,0.00942,1,0.03575060240963855,2.98,CC
GO:0098685,Schaffer collateral - CA1 synapse,116,7,2.35,0.00942,1,0.03575060240963855,2.98,CC
GO:0031430,M band,22,3,0.45,0.00956,1,0.036064670658682636,6.67,CC
GO:0016363,nuclear matrix,90,6,1.82,0.00997,1,0.0373875,3.3,CC
GO:0032154,cleavage furrow,42,4,0.85,0.01014,1,0.0378,4.71,CC
GO:0098590,plasma membrane region,1226,37,24.84,0.01033,1,0.038281764705882355,1.49,CC
GO:0098831,presynaptic active zone cytoplasmic comp...,23,3,0.47,0.01083,1,0.0399,6.38,CC
GO:0030139,endocytic vesicle,179,9,3.63,0.01099,1,0.040057803468208086,2.48,CC
GO:0000307,cyclin-dependent protein kinase holoenzy...,43,4,0.87,0.01100,1,0.040057803468208086,4.6,CC
GO:0005901,caveola,94,6,1.9,0.01219,1,0.043992,3.16,CC
GO:0005923,bicellular tight junction,122,7,2.47,0.01222,1,0.043992,2.83,CC
GO:0097730,non-motile cilium,152,8,3.08,0.01246,1,0.044601136363636364,2.6,CC
GO:0044295,axonal growth cone,45,4,0.91,0.01287,1,0.04572808988764045,4.4,CC
GO:0005925,focal adhesion,153,8,3.1,0.01292,1,0.04572808988764045,2.58,CC
GO:0035327,transcriptionally active chromatin,25,3,0.51,0.01365,1,0.04804189944134079,5.88,CC
GO:0005783,endoplasmic reticulum,1715,48,34.75,0.01417,1,0.049595,1.38,CC
GO:0031594,neuromuscular junction,98,6,1.99,0.01475,1,0.05133977900552486,3.02,CC
GO:0005924,cell-substrate adherens junction,159,8,3.22,0.01597,1,0.05528076923076924,2.48,CC
GO:0070160,tight junction,129,7,2.61,0.01619,1,0.05567282608695652,2.68,CC
GO:0035869,ciliary transition zone,73,5,1.48,0.01626,1,0.05567282608695652,3.38,CC
GO:0099503,secretory vesicle,585,20,11.85,0.01657,1,0.05642756756756757,1.69,CC
GO:0030315,T-tubule,74,5,1.5,0.01716,1,0.0581225806451613,3.33,CC
GO:1902911,protein kinase complex,102,6,2.07,0.01765,1,0.05946256684491979,2.9,CC
GO:0016529,sarcoplasmic reticulum,76,5,1.54,0.01905,1,0.06383776595744681,3.25,CC
GO:0030880,RNA polymerase complex,104,6,2.11,0.01924,1,0.06413333333333333,2.84,CC
GO:0000779,"condensed chromosome, centromeric region",51,4,1.03,0.01965,1,0.06515526315789474,3.88,CC
GO:0030055,cell-substrate junction,166,8,3.36,0.02015,1,0.06646335078534032,2.38,CC
GO:0000780,"condensed nuclear chromosome, centromeri...",29,3,0.59,0.02043,1,0.06668860103626943,5.08,CC
GO:0090568,nuclear transcriptional repressor comple...,29,3,0.59,0.02043,1,0.06668860103626943,5.08,CC
GO:0005881,cytoplasmic microtubule,78,5,1.58,0.02108,1,0.0684556701030928,3.16,CC
GO:0098793,presynapse,564,19,11.43,0.02197,1,0.07098,1.66,CC
GO:0008023,transcription elongation factor complex,53,4,1.07,0.02231,1,0.07124090909090909,3.74,CC
GO:0032155,cell division site part,53,4,1.07,0.02231,1,0.07124090909090909,3.74,CC
GO:0044309,neuron spine,202,9,4.09,0.02239,1,0.07124090909090909,2.2,CC
GO:0030659,cytoplasmic vesicle membrane,309,12,6.26,0.02439,1,0.07686,1.92,CC
GO:1990752,microtubule end,31,3,0.63,0.02440,1,0.07686,4.76,CC
GO:0043296,apical junction complex,142,7,2.88,0.02584,1,0.0809910447761194,2.43,CC
GO:1902554,serine/threonine protein kinase complex,83,5,1.68,0.02674,1,0.0833970297029703,2.98,CC
GO:0030496,midbody,144,7,2.92,0.02762,1,0.08571724137931035,2.4,CC
GO:0030667,secretory granule membrane,84,5,1.7,0.02797,1,0.08637794117647059,2.94,CC
GO:0046540,U4/U6 x U5 tri-snRNP complex,33,3,0.67,0.02876,1,0.08795533980582525,4.48,CC
GO:0097526,spliceosomal tri-snRNP complex,33,3,0.67,0.02876,1,0.08795533980582525,4.48,CC
GO:0016328,lateral plasma membrane,58,4,1.18,0.02990,1,0.09056249999999999,3.39,CC
GO:0045171,intercellular bridge,58,4,1.18,0.02990,1,0.09056249999999999,3.39,CC
GO:0001726,ruffle,147,7,2.98,0.03043,1,0.0917267942583732,2.35,CC
GO:0035770,ribonucleoprotein granule,214,9,4.34,0.03091,1,0.09273,2.07,CC
GO:0000118,histone deacetylase complex,59,4,1.2,0.03158,1,0.0942909952606635,3.33,CC
GO:0031984,organelle subcompartment,913,27,18.5,0.03266,1,0.0970556603773585,1.46,CC
GO:0016459,myosin complex,60,4,1.22,0.03331,1,0.09852253521126761,3.28,CC
GO:0097546,ciliary base,35,3,0.71,0.03350,1,0.09862149532710282,4.23,CC
GO:0097060,synaptic membrane,516,17,10.46,0.03492,1,0.10232372093023255,1.63,CC
GO:0005790,smooth endoplasmic reticulum,36,3,0.73,0.03601,1,0.10495161290322581,4.11,CC
GO:0031970,organelle envelope lumen,90,5,1.82,0.03615,1,0.10495161290322581,2.75,CC
GO:0098796,membrane protein complex,1134,32,22.98,0.03727,1,0.10770688073394495,1.39,CC
GO:0044853,plasma membrane raft,123,6,2.49,0.03934,1,0.11316986301369863,2.41,CC
GO:0030660,Golgi-associated vesicle membrane,64,4,1.3,0.04079,1,0.11680772727272727,3.08,CC
GO:0044433,cytoplasmic vesicle part,527,17,10.68,0.04124,1,0.11756199095022625,1.59,CC
GO:0005884,actin filament,125,6,2.53,0.04202,1,0.11902197309417041,2.37,CC
GO:0012506,vesicle membrane,336,12,6.81,0.04213,1,0.11902197309417041,1.76,CC
GO:0005769,early endosome,266,10,5.39,0.04542,1,0.12774375000000002,1.86,CC
GO:0044431,Golgi apparatus part,497,16,10.07,0.04739,1,0.132692,1.59,CC
GO:0000793,condensed chromosome,197,8,3.99,0.04802,1,0.13386106194690267,2.01,CC
GO:0031234,extrinsic component of cytoplasmic side ...,98,5,1.99,0.04913,1,0.13635198237885462,2.51,CC
GO:0030141,secretory granule,385,13,7.8,0.05121,1,0.14150131578947367,1.67,CC
GO:0016323,basolateral plasma membrane,236,9,4.78,0.05192,1,0.14283668122270743,1.88,CC
GO:0045111,intermediate filament cytoskeleton,166,7,3.36,0.05270,1,0.1438909090909091,2.08,CC
GO:0055029,nuclear DNA-directed RNA polymerase comp...,100,5,2.03,0.05276,1,0.1438909090909091,2.46,CC
GO:0031965,nuclear membrane,237,9,4.8,0.05305,1,0.14405818965517242,1.88,CC
GO:0000428,DNA-directed RNA polymerase complex,101,5,2.05,0.05463,1,0.14771201716738197,2.44,CC
GO:0036464,cytoplasmic ribonucleoprotein granule,203,8,4.11,0.05538,1,0.1491,1.95,CC
GO:0005680,anaphase-promoting complex,20,2,0.41,0.06121,1,0.1620264705882353,4.88,CC
GO:0016010,dystrophin-associated glycoprotein compl...,20,2,0.41,0.06121,1,0.1620264705882353,4.88,CC
GO:0045277,respiratory chain complex IV,20,2,0.41,0.06121,1,0.1620264705882353,4.88,CC
GO:0090665,glycoprotein complex,20,2,0.41,0.06121,1,0.1620264705882353,4.88,CC
GO:0032391,photoreceptor connecting cilium,46,3,0.93,0.06616,1,0.17439665271966526,3.23,CC
GO:0005604,basement membrane,108,5,2.19,0.06876,1,0.18049500000000002,2.28,CC
GO:0030176,integral component of endoplasmic reticu...,143,6,2.9,0.07126,1,0.1862813278008299,2.07,CC
GO:0001741,XY body,22,2,0.45,0.07250,1,0.1887396694214876,4.44,CC
GO:0000794,condensed nuclear chromosome,144,6,2.92,0.07316,1,0.18967407407407408,2.05,CC
GO:0030684,preribosome,78,4,1.58,0.07382,1,0.19060081967213113,2.53,CC
GO:0030135,coated vesicle,181,7,3.67,0.07606,1,0.19558285714285717,1.91,CC
GO:0071005,U2-type precatalytic spliceosome,49,3,0.99,0.07688,1,0.1968878048780488,3.03,CC
GO:0002080,acrosomal membrane,23,2,0.47,0.07837,1,0.1982855421686747,4.26,CC
GO:0035371,microtubule plus-end,23,2,0.47,0.07837,1,0.1982855421686747,4.26,CC
GO:0099243,extrinsic component of synaptic membrane,23,2,0.47,0.07837,1,0.1982855421686747,4.26,CC
GO:0001750,photoreceptor outer segment,80,4,1.62,0.07938,1,0.2000376,2.47,CC
GO:0071011,precatalytic spliceosome,50,3,1.01,0.08061,1,0.20232788844621513,2.97,CC
GO:0031227,intrinsic component of endoplasmic retic...,151,6,3.06,0.08724,1,0.2181,1.96,CC
GO:0017053,transcriptional repressor complex,83,4,1.68,0.08810,1,0.21901181102362205,2.38,CC
GO:0005802,trans-Golgi network,225,8,4.56,0.08830,1,0.21901181102362205,1.75,CC
GO:0030057,desmosome,25,2,0.51,0.09054,1,0.22281328125,3.92,CC
GO:0030687,"preribosome, large subunit precursor",25,2,0.51,0.09054,1,0.22281328125,3.92,CC
GO:0043292,contractile fiber,229,8,4.64,0.09530,1,0.2336147859922179,1.72,CC
GO:0005689,U12-type spliceosomal complex,26,2,0.53,0.09682,1,0.23642093023255814,3.77,CC
GO:0044304,main axon,86,4,1.74,0.09727,1,0.2366027027027027,2.3,CC
GO:0042175,nuclear outer membrane-endoplasmic retic...,554,16,11.23,0.10004,1,0.24240461538461539,1.42,CC
GO:0002102,podosome,27,2,0.55,0.10321,1,0.2472330798479087,3.64,CC
GO:0032839,dendrite cytoplasm,27,2,0.55,0.10321,1,0.2472330798479087,3.64,CC
GO:0097440,apical dendrite,27,2,0.55,0.10321,1,0.2472330798479087,3.64,CC
GO:0043197,dendritic spine,197,7,3.99,0.10670,1,0.254625,1.75,CC
GO:0016342,catenin complex,29,2,0.59,0.11634,1,0.2757134831460674,3.39,CC
GO:0005791,rough endoplasmic reticulum,92,4,1.86,0.11685,1,0.2757134831460674,2.15,CC
GO:0005902,microvillus,92,4,1.86,0.11685,1,0.2757134831460674,2.15,CC
GO:0045335,phagocytic vesicle,93,4,1.88,0.12028,1,0.28274776119402983,2.13,CC
GO:0005789,endoplasmic reticulum membrane,529,15,10.72,0.12127,1,0.28396153846153843,1.4,CC
GO:0001669,acrosomal vesicle,129,5,2.61,0.12190,1,0.28396153846153843,1.92,CC
GO:0005942,phosphatidylinositol 3-kinase complex,30,2,0.61,0.12305,1,0.28396153846153843,3.28,CC
GO:0044665,MLL1/2 complex,30,2,0.61,0.12305,1,0.28396153846153843,3.28,CC
GO:0071339,MLL1 complex,30,2,0.61,0.12305,1,0.28396153846153843,3.28,CC
GO:0097223,sperm part,244,8,4.94,0.12422,1,0.28561532846715326,1.62,CC
GO:0044449,contractile fiber part,206,7,4.17,0.12646,1,0.2897083636363636,1.68,CC
GO:0001650,fibrillar center,131,5,2.65,0.12775,1,0.29160326086956523,1.89,CC
GO:0000407,phagophore assembly site,31,2,0.63,0.12985,1,0.2942643884892086,3.17,CC
GO:0098945,intrinsic component of presynaptic activ...,31,2,0.63,0.12985,1,0.2942643884892086,3.17,CC
GO:0014704,intercalated disc,63,3,1.28,0.13557,1,0.30548297872340424,2.34,CC
GO:0008305,integrin complex,32,2,0.65,0.13674,1,0.30548297872340424,3.08,CC
GO:0070069,cytochrome complex,32,2,0.65,0.13674,1,0.30548297872340424,3.08,CC
GO:0080008,Cul4-RING E3 ubiquitin ligase complex,32,2,0.65,0.13674,1,0.30548297872340424,3.08,CC
GO:0005798,Golgi-associated vesicle,135,5,2.74,0.13982,1,0.31107359154929576,1.82,CC
GO:0034704,calcium channel complex,64,3,1.3,0.14023,1,0.31107359154929576,2.31,CC
GO:0098827,endoplasmic reticulum subcompartment,543,15,11,0.14107,1,0.3118389473684211,1.36,CC
GO:0032838,plasma membrane bounded cell projection ...,174,6,3.53,0.14295,1,0.31488986013986014,1.7,CC
GO:0045211,postsynaptic membrane,376,11,7.62,0.14406,1,0.31622926829268294,1.44,CC
GO:0010494,cytoplasmic stress granule,65,3,1.32,0.14494,1,0.31705625000000004,2.27,CC
GO:0031090,organelle membrane,1753,42,35.52,0.14545,1,0.31707093425605537,1.18,CC
GO:0030016,myofibril,215,7,4.36,0.14792,1,0.3213434482758621,1.61,CC
GO:0000777,condensed chromosome kinetochore,35,2,0.71,0.15785,1,0.34056678082191777,2.82,CC
GO:0051233,spindle midzone,35,2,0.71,0.15785,1,0.34056678082191777,2.82,CC
GO:0019005,SCF ubiquitin ligase complex,68,3,1.38,0.15938,1,0.3426941979522184,2.17,CC
GO:0005793,endoplasmic reticulum-Golgi intermediate...,69,3,1.4,0.16429,1,0.35205,2.14,CC
GO:0031253,cell projection membrane,305,9,6.18,0.16840,1,0.35963389830508474,1.46,CC
GO:0044452,nucleolar part,184,6,3.73,0.17127,1,0.3629137123745819,1.61,CC
GO:0055037,recycling endosome,145,5,2.94,0.17203,1,0.3629137123745819,1.7,CC
GO:0031463,Cul3-RING ubiquitin ligase complex,37,2,0.75,0.17224,1,0.3629137123745819,2.67,CC
GO:0098636,protein complex involved in cell adhesio...,37,2,0.75,0.17224,1,0.3629137123745819,2.67,CC
GO:0032587,ruffle membrane,71,3,1.44,0.17425,1,0.3658798013245033,2.08,CC
GO:0005777,peroxisome,146,5,2.96,0.17539,1,0.3658798013245033,1.69,CC
GO:0042579,microbody,146,5,2.96,0.17539,1,0.3658798013245033,1.69,CC
GO:0008021,synaptic vesicle,227,7,4.6,0.17900,1,0.3696,1.52,CC
GO:0005643,nuclear pore,72,3,1.46,0.17928,1,0.3696,2.05,CC
GO:0001772,immunological synapse,38,2,0.77,0.17952,1,0.3696,2.6,CC
GO:1990391,DNA repair complex,38,2,0.77,0.17952,1,0.3696,2.6,CC
GO:0016605,PML body,73,3,1.48,0.18436,1,0.378328338762215,2.03,CC
GO:0098791,Golgi subcompartment,444,12,9,0.19258,1,0.39391363636363635,1.33,CC
GO:0005739,mitochondrion,1809,42,36.65,0.19711,1,0.4018747572815534,1.15,CC
GO:0060076,excitatory synapse,76,3,1.54,0.19981,1,0.4057562300319489,1.95,CC
GO:0000152,nuclear ubiquitin ligase complex,41,2,0.83,0.20159,1,0.4057562300319489,2.41,CC
GO:0000803,sex chromosome,41,2,0.83,0.20159,1,0.4057562300319489,2.41,CC
GO:0043596,nuclear replication fork,41,2,0.83,0.20159,1,0.4057562300319489,2.41,CC
GO:0005758,mitochondrial intermembrane space,77,3,1.56,0.20503,1,0.41006,1.92,CC
GO:0016591,"RNA polymerase II, holoenzyme",77,3,1.56,0.20503,1,0.41006,1.92,CC
GO:0005771,multivesicular body,42,2,0.85,0.20902,1,0.415402523659306,2.35,CC
GO:0120111,neuron projection cytoplasm,42,2,0.85,0.20902,1,0.415402523659306,2.35,CC
GO:0030662,coated vesicle membrane,79,3,1.6,0.21555,1,0.426195,1.88,CC
GO:0005720,nuclear heterochromatin,43,2,0.87,0.21648,1,0.426195,2.3,CC
GO:0009925,basal plasma membrane,43,2,0.87,0.21648,1,0.426195,2.3,CC
GO:0034708,methyltransferase complex,118,4,2.39,0.21771,1,0.4272813084112149,1.67,CC
GO:0098797,plasma membrane protein complex,545,14,11.04,0.21842,1,0.4273434782608696,1.27,CC
GO:0044432,endoplasmic reticulum part,641,16,12.99,0.23076,1,0.4500416666666666,1.23,CC
GO:0055038,recycling endosome membrane,45,2,0.91,0.23145,1,0.4500416666666666,2.2,CC
GO:0031514,motile cilium,204,6,4.13,0.23394,1,0.4534836923076923,1.45,CC
GO:0070382,exocytic vesicle,247,7,5,0.23615,1,0.4563634969325153,1.4,CC
GO:0048787,presynaptic active zone membrane,46,2,0.93,0.23897,1,0.46040091743119266,2.15,CC
GO:0098588,bounding membrane of organelle,1060,25,21.48,0.24405,1,0.46875457317073166,1.16,CC
GO:0005882,intermediate filament,125,4,2.53,0.24810,1,0.47508510638297874,1.58,CC
GO:0005801,cis-Golgi network,49,2,0.99,0.26156,1,0.4993418181818182,2.02,CC
GO:0005930,axoneme,130,4,2.63,0.27035,1,0.5145634441087613,1.52,CC
GO:0097014,ciliary plasm,131,4,2.65,0.27484,1,0.521533734939759,1.51,CC
GO:0031901,early endosome membrane,51,2,1.03,0.27664,1,0.5233729729729729,1.94,CC
GO:0070062,extracellular exosome,91,3,1.84,0.28061,1,0.5277143283582091,1.63,CC
GO:0070469,respiratory chain,91,3,1.84,0.28061,1,0.5277143283582091,1.63,CC
GO:0043235,receptor complex,396,10,8.02,0.28392,1,0.53235,1.25,CC
GO:0044455,mitochondrial membrane part,219,6,4.44,0.28492,1,0.532639762611276,1.35,CC
GO:0030134,COPII-coated ER to Golgi transport vesic...,53,2,1.07,0.29170,1,0.5437011834319527,1.87,CC
GO:0035097,histone methyltransferase complex,94,3,1.9,0.29719,1,0.5523,1.58,CC
GO:0062023,collagen-containing extracellular matrix,360,9,7.29,0.30820,1,0.5710764705882353,1.23,CC
GO:0098802,plasma membrane receptor complex,182,5,3.69,0.30951,1,0.5718219941348973,1.36,CC
GO:0030136,clathrin-coated vesicle,99,3,2.01,0.32494,1,0.5968285714285715,1.49,CC
GO:1903561,extracellular vesicle,99,3,2.01,0.32494,1,0.5968285714285715,1.49,CC
GO:0030120,vesicle coat,58,2,1.18,0.32912,1,0.5998028328611897,1.69,CC
GO:0030658,transport vesicle membrane,144,4,2.92,0.33408,1,0.5998028328611897,1.37,CC
GO:0000930,gamma-tubulin complex,20,1,0.41,0.33608,1,0.5998028328611897,2.44,CC
GO:0005686,U2 snRNP,20,1,0.41,0.33608,1,0.5998028328611897,2.44,CC
GO:0030904,retromer complex,20,1,0.41,0.33608,1,0.5998028328611897,2.44,CC
GO:0031091,platelet alpha granule,20,1,0.41,0.33608,1,0.5998028328611897,2.44,CC
GO:0033646,host intracellular part,20,1,0.41,0.33608,1,0.5998028328611897,2.44,CC
GO:0043656,intracellular region of host,20,1,0.41,0.33608,1,0.5998028328611897,2.44,CC
GO:0044232,organelle membrane contact site,20,1,0.41,0.33608,1,0.5998028328611897,2.44,CC
GO:0090723,growth cone part,20,1,0.41,0.33608,1,0.5998028328611897,2.44,CC
GO:0005788,endoplasmic reticulum lumen,60,2,1.22,0.34394,1,0.6120966101694916,1.64,CC
GO:0030017,sarcomere,192,5,3.89,0.34941,1,0.6151122905027934,1.29,CC
GO:0000242,pericentriolar material,21,1,0.43,0.34954,1,0.6151122905027934,2.33,CC
GO:0012507,ER to Golgi transport vesicle membrane,21,1,0.43,0.34954,1,0.6151122905027934,2.33,CC
GO:0030673,axolemma,21,1,0.43,0.34954,1,0.6151122905027934,2.33,CC
GO:0071944,cell periphery,5388,113,109.17,0.35222,1,0.6181019498607242,1.04,CC
GO:0030132,clathrin coat of coated pit,22,1,0.45,0.36274,1,0.6312878453038675,2.22,CC
GO:0031307,integral component of mitochondrial oute...,22,1,0.45,0.36274,1,0.6312878453038675,2.22,CC
GO:0033643,host cell part,22,1,0.45,0.36274,1,0.6312878453038675,2.22,CC
GO:0099023,tethering complex,63,2,1.28,0.36598,1,0.6351719008264464,1.56,CC
GO:0031256,leading edge membrane,152,4,3.08,0.37088,1,0.6413707317073171,1.3,CC
GO:0000421,autophagosome membrane,23,1,0.47,0.37566,1,0.6413707317073171,2.13,CC
GO:0005797,Golgi medial cisterna,23,1,0.47,0.37566,1,0.6413707317073171,2.13,CC
GO:0031306,intrinsic component of mitochondrial out...,23,1,0.47,0.37566,1,0.6413707317073171,2.13,CC
GO:0045120,pronucleus,23,1,0.47,0.37566,1,0.6413707317073171,2.13,CC
GO:0046930,pore complex,23,1,0.47,0.37566,1,0.6413707317073171,2.13,CC
GO:0072686,mitotic spindle,110,3,2.23,0.38578,1,0.6489334217506632,1.35,CC
GO:0045178,basal part of cell,66,2,1.34,0.38772,1,0.6489334217506632,1.49,CC
GO:0005858,axonemal dynein complex,24,1,0.49,0.38833,1,0.6489334217506632,2.04,CC
GO:0018995,host,24,1,0.49,0.38833,1,0.6489334217506632,2.04,CC
GO:0033017,sarcoplasmic reticulum membrane,24,1,0.49,0.38833,1,0.6489334217506632,2.04,CC
GO:0036452,ESCRT complex,24,1,0.49,0.38833,1,0.6489334217506632,2.04,CC
GO:0043601,nuclear replisome,24,1,0.49,0.38833,1,0.6489334217506632,2.04,CC
GO:0043657,host cell,24,1,0.49,0.38833,1,0.6489334217506632,2.04,CC
GO:0005770,late endosome,203,5,4.11,0.39359,1,0.6559833333333334,1.22,CC
GO:0030672,synaptic vesicle membrane,112,3,2.27,0.39673,1,0.6574640625,1.32,CC
GO:0099501,exocytic vesicle membrane,112,3,2.27,0.39673,1,0.6574640625,1.32,CC
GO:0030894,replisome,25,1,0.51,0.40074,1,0.6574640625,1.96,CC
GO:0031233,intrinsic component of external side of ...,25,1,0.51,0.40074,1,0.6574640625,1.96,CC
GO:0042588,zymogen granule,25,1,0.51,0.40074,1,0.6574640625,1.96,CC
GO:0060077,inhibitory synapse,25,1,0.51,0.40074,1,0.6574640625,1.96,CC
GO:0043198,dendritic shaft,68,2,1.38,0.40203,1,0.6578672727272727,1.45,CC
GO:0005773,vacuole,536,12,10.86,0.40367,1,0.6588396373056995,1.1,CC
GO:0019866,organelle inner membrane,489,11,9.91,0.40520,1,0.6596279069767442,1.11,CC
GO:0043230,extracellular organelle,114,3,2.31,0.40763,1,0.6618734536082475,1.3,CC
GO:0044306,neuron projection terminus,207,5,4.19,0.40961,1,0.6633786632390745,1.19,CC
GO:0099059,integral component of presynaptic active...,26,1,0.53,0.41289,1,0.6669761538461538,1.89,CC
GO:0005743,mitochondrial inner membrane,446,10,9.04,0.41753,1,0.6727465473145781,1.11,CC
GO:0010008,endosome membrane,210,5,4.26,0.42160,1,0.6775714285714286,1.17,CC
GO:0099524,postsynaptic cytosol,27,1,0.55,0.42480,1,0.6809770992366413,1.82,CC
GO:0005657,replication fork,72,2,1.46,0.43017,1,0.686093924050633,1.37,CC
GO:0032592,integral component of mitochondrial memb...,72,2,1.46,0.43017,1,0.686093924050633,1.37,CC
GO:0030137,COPI-coated vesicle,28,1,0.57,0.43647,1,0.6901421052631579,1.75,CC
GO:0031045,dense core granule,28,1,0.57,0.43647,1,0.6901421052631579,1.75,CC
GO:0071007,U2-type catalytic step 2 spliceosome,28,1,0.57,0.43647,1,0.6901421052631579,1.75,CC
GO:0046658,anchored component of plasma membrane,73,2,1.48,0.43709,1,0.6901421052631579,1.35,CC
GO:0098573,intrinsic component of mitochondrial mem...,74,2,1.5,0.44397,1,0.69925275,1.33,CC
GO:0036126,sperm flagellum,121,3,2.45,0.44527,1,0.6995513715710724,1.22,CC
GO:0030125,clathrin vesicle coat,29,1,0.59,0.44791,1,0.700206699751861,1.69,CC
GO:0030140,trans-Golgi network transport vesicle,29,1,0.59,0.44791,1,0.700206699751861,1.69,CC
GO:0016234,inclusion body,76,2,1.54,0.45758,1,0.70546170731707325,1.3,CC
GO:0030686,90S preribosome,30,1,0.61,0.45911,1,0.70546170731707325,1.64,CC
GO:0044215,other organism,30,1,0.61,0.45911,1,0.70546170731707325,1.64,CC
GO:0044216,other organism cell,30,1,0.61,0.45911,1,0.70546170731707325,1.64,CC
GO:0044217,other organism part,30,1,0.61,0.45911,1,0.70546170731707325,1.64,CC
GO:0044305,calyx of Held,30,1,0.61,0.45911,1,0.70546170731707325,1.64,CC
GO:0097431,mitotic spindle pole,30,1,0.61,0.45911,1,0.70546170731707325,1.64,CC
GO:0042470,melanosome,31,1,0.63,0.47008,1,0.7170711864406779,1.59,CC
GO:0048770,pigment granule,31,1,0.63,0.47008,1,0.7170711864406779,1.59,CC
GO:1902555,endoribonuclease complex,31,1,0.63,0.47008,1,0.7170711864406779,1.59,CC
GO:0000784,"nuclear chromosome, telomeric region",79,2,1.6,0.47764,1,0.7237730769230769,1.25,CC
GO:0005746,mitochondrial respiratory chain,79,2,1.6,0.47764,1,0.7237730769230769,1.25,CC
GO:0098552,side of membrane,615,13,12.46,0.47792,1,0.7237730769230769,1.04,CC
GO:1905348,endonuclease complex,32,1,0.65,0.48084,1,0.7245895734597156,1.54,CC
GO:0097729,9+2 motile cilium,128,3,2.59,0.48192,1,0.7245895734597156,1.16,CC
GO:0098889,intrinsic component of presynaptic membr...,128,3,2.59,0.48192,1,0.7245895734597156,1.16,CC
GO:0005886,plasma membrane,5243,107,106.24,0.48444,1,0.7245895734597156,1.01,CC
GO:0030133,transport vesicle,324,7,6.57,0.48525,1,0.7245895734597156,1.07,CC
GO:0045177,apical part of cell,422,9,8.55,0.48536,1,0.7245895734597156,1.05,CC
GO:0005921,gap junction,33,1,0.67,0.49137,1,0.7295992941176471,1.49,CC
GO:0098688,parallel fiber to Purkinje cell synapse,33,1,0.67,0.49137,1,0.7295992941176471,1.49,CC
GO:0098800,inner mitochondrial membrane protein com...,130,3,2.63,0.49219,1,0.7295992941176471,1.14,CC
GO:0005667,transcription factor complex,426,9,8.63,0.49667,1,0.7345119718309859,1.04,CC
GO:0031012,extracellular matrix,477,10,9.67,0.50136,1,0.7384689252336448,1.03,CC
GO:0032588,trans-Golgi network membrane,34,1,0.69,0.50169,1,0.7384689252336448,1.45,CC
GO:0098803,respiratory chain complex,83,2,1.68,0.50366,1,0.7396405594405594,1.19,CC
GO:0030018,Z disc,133,3,2.69,0.50739,1,0.7433853488372093,1.12,CC
GO:0005719,nuclear euchromatin,35,1,0.71,0.51181,1,0.7481213457076565,1.41,CC
GO:0044440,endosomal part,234,5,4.74,0.51515,1,0.7512604166666667,1.05,CC
GO:0043679,axon terminus,185,4,3.75,0.51818,1,0.7539339491916859,1.07,CC
GO:0016592,mediator complex,36,1,0.73,0.52171,1,0.7573209677419355,1.37,CC
GO:0005903,brush border,137,3,2.78,0.52729,1,0.7636613793103448,1.08,CC
GO:0030665,clathrin-coated vesicle membrane,37,1,0.75,0.53142,1,0.7661203661327232,1.33,CC
GO:0031941,filamentous actin,37,1,0.75,0.53142,1,0.7661203661327232,1.33,CC
GO:0043204,perikaryon,139,3,2.82,0.53707,1,0.7724979452054795,1.06,CC
GO:0005669,transcription factor TFIID complex,38,1,0.77,0.54093,1,0.7762776765375854,1.3,CC
GO:0000139,Golgi membrane,242,5,4.9,0.54497,1,0.7802979545454545,1.02,CC
GO:0031225,anchored component of membrane,192,4,3.89,0.54745,1,0.7820714285714285,1.03,CC
GO:0044447,axoneme part,40,1,0.81,0.55938,1,0.7973063348416289,1.23,CC
GO:0031674,I band,145,3,2.94,0.56570,1,0.8044943566591422,1.02,CC
GO:0099522,region of cytosol,41,1,0.83,0.56833,1,0.8064141891891892,1.2,CC
GO:0005637,nuclear inner membrane,42,1,0.85,0.57709,1,0.8170038202247191,1.18,CC
GO:0031305,integral component of mitochondrial inne...,43,1,0.87,0.58567,1,0.8272917040358745,1.15,CC
GO:0005740,mitochondrial envelope,663,13,13.43,0.58765,1,0.8282315436241611,0.97,CC
GO:0031304,intrinsic component of mitochondrial inn...,44,1,0.89,0.59409,1,0.8354390625,1.12,CC
GO:0000791,euchromatin,45,1,0.91,0.60233,1,0.8406814569536424,1.1,CC
GO:0030285,integral component of synaptic vesicle m...,45,1,0.91,0.60233,1,0.8406814569536424,1.1,CC
GO:0031966,mitochondrial membrane,619,12,12.54,0.60299,1,0.8406814569536424,0.96,CC
GO:0030117,membrane coat,100,2,2.03,0.60449,1,0.8406814569536424,0.99,CC
GO:0048475,coated membrane,100,2,2.03,0.60449,1,0.8406814569536424,0.99,CC
GO:0044798,nuclear transcription factor complex,207,4,4.19,0.60688,1,0.8421462555066078,0.95,CC
GO:0008287,protein serine/threonine phosphatase com...,46,1,0.93,0.61040,1,0.8433157894736842,1.08,CC
GO:1903293,phosphatase complex,46,1,0.93,0.61040,1,0.8433157894736842,1.08,CC
GO:0098982,GABA-ergic synapse,104,2,2.11,0.62584,1,0.8627553610503282,0.95,CC
GO:0030118,clathrin coat,49,1,0.99,0.63366,1,0.8697294117647059,1.01,CC
GO:0031201,SNARE complex,49,1,0.99,0.63366,1,0.8697294117647059,1.01,CC
GO:0035861,site of double-strand break,50,1,1.01,0.64110,1,0.8761236442516268,0.99,CC
GO:0098686,hippocampal mossy fiber to CA3 synapse,50,1,1.01,0.64110,1,0.8761236442516268,0.99,CC
GO:0044459,plasma membrane part,2879,56,58.34,0.65137,1,0.8882318181818181,0.96,CC
GO:0005765,lysosomal membrane,110,2,2.23,0.65618,1,0.8928583153347732,0.9,CC
GO:0098852,lytic vacuole membrane,111,2,2.25,0.66104,1,0.8975327586206897,0.89,CC
GO:0034703,cation channel complex,224,4,4.54,0.66817,1,0.9030179871520342,0.88,CC
GO:0005774,vacuolar membrane,169,3,3.42,0.66879,1,0.9030179871520342,0.88,CC
GO:0031902,late endosome membrane,54,1,1.09,0.66938,1,0.9030179871520342,0.92,CC
GO:0000781,"chromosome, telomeric region",114,2,2.31,0.67529,1,0.9090442307692308,0.87,CC
GO:0031301,integral component of organelle membrane,228,4,4.62,0.68160,1,0.9150817021276595,0.87,CC
GO:0031312,extrinsic component of organelle membran...,56,1,1.13,0.68268,1,0.9150817021276595,0.88,CC
GO:0005876,spindle microtubule,57,1,1.15,0.68912,1,0.9198,0.87,CC
GO:0008328,ionotropic glutamate receptor complex,57,1,1.15,0.68912,1,0.9198,0.87,CC
GO:0001917,photoreceptor inner segment,58,1,1.18,0.69544,1,0.9262731501057082,0.85,CC
GO:0098878,neurotransmitter receptor complex,59,1,1.2,0.70163,1,0.9325462025316456,0.83,CC
GO:0044437,vacuolar part,180,3,3.65,0.70965,1,0.9392426470588235,0.82,CC
GO:0098936,intrinsic component of postsynaptic memb...,180,3,3.65,0.70965,1,0.9392426470588235,0.82,CC
GO:0044438,microbody part,61,1,1.24,0.71363,1,0.9405583682008367,0.81,CC
GO:0044439,peroxisomal part,61,1,1.24,0.71363,1,0.9405583682008367,0.81,CC
GO:0031985,Golgi cisterna,62,1,1.26,0.71945,1,0.9462494780793319,0.79,CC
GO:0034702,ion channel complex,299,5,6.06,0.72735,1,0.9546468750000001,0.83,CC
GO:0090734,site of DNA damage,65,1,1.32,0.73621,1,0.9613800000000001,0.76,CC
GO:0098563,intrinsic component of synaptic vesicle ...,65,1,1.32,0.73621,1,0.9613800000000001,0.76,CC
GO:0099240,intrinsic component of synaptic membrane,246,4,4.98,0.73728,1,0.9613800000000001,0.8,CC
GO:0019867,outer membrane,189,3,3.83,0.74011,1,0.9613800000000001,0.78,CC
GO:0031968,organelle outer membrane,189,3,3.83,0.74011,1,0.9613800000000001,0.78,CC
GO:0044429,mitochondrial part,851,15,17.24,0.74578,1,0.9657369609856263,0.87,CC
GO:0032993,protein-DNA complex,191,3,3.87,0.74653,1,0.9657369609856263,0.78,CC
GO:0098862,cluster of actin-based cell projections,194,3,3.93,0.75591,1,0.9752889570552146,0.76,CC
GO:0032589,neuron projection membrane,69,1,1.4,0.75701,1,0.9752889570552146,0.71,CC
GO:0031300,intrinsic component of organelle membran...,256,4,5.19,0.76488,1,0.9821071283095723,0.77,CC
GO:1902495,transmembrane transporter complex,314,5,6.36,0.76542,1,0.9821071283095723,0.79,CC
GO:0016324,apical plasma membrane,320,5,6.48,0.77948,1,0.9981146341463414,0.77,CC
GO:0098798,mitochondrial protein complex,266,4,5.39,0.79017,1,1,0.74,CC
GO:1990351,transporter complex,325,5,6.59,0.79069,1,1,0.76,CC
GO:0005764,lysosome,440,7,8.92,0.79102,1,1,0.78,CC
GO:0000323,lytic vacuole,441,7,8.94,0.79292,1,1,0.78,CC
GO:0008076,voltage-gated potassium channel complex,78,1,1.58,0.79802,1,1,0.63,CC
GO:0000795,synaptonemal complex,81,1,1.64,0.81010,1,1,0.61,CC
GO:0099086,synaptonemal structure,81,1,1.64,0.81010,1,1,0.61,CC
GO:0016020,membrane,9366,181,189.78,0.81770,1,1,0.95,CC
GO:0005811,lipid droplet,83,1,1.68,0.81774,1,1,0.6,CC
GO:0005795,Golgi stack,86,1,1.74,0.82864,1,1,0.57,CC
GO:0043195,terminal bouton,87,1,1.76,0.83213,1,1,0.57,CC
GO:0034705,potassium channel complex,89,1,1.8,0.83889,1,1,0.56,CC
GO:1905368,peptidase complex,93,1,1.88,0.85161,1,1,0.53,CC
GO:0090575,RNA polymerase II transcription factor c...,166,2,3.36,0.85283,1,1,0.6,CC
GO:0005741,mitochondrial outer membrane,171,2,3.46,0.86413,1,1,0.58,CC
GO:0099055,integral component of postsynaptic membr...,171,2,3.46,0.86413,1,1,0.58,CC
GO:0098839,postsynaptic density membrane,98,1,1.99,0.86611,1,1,0.5,CC
GO:0099056,integral component of presynaptic membra...,116,1,2.35,0.90755,1,1,0.43,CC
GO:0005759,mitochondrial matrix,266,3,5.39,0.90823,1,1,0.56,CC
GO:0016442,RISC complex,123,1,2.49,0.91995,1,1,0.4,CC
GO:0031332,RNAi effector complex,123,1,2.49,0.91995,1,1,0.4,CC
GO:0009986,cell surface,955,14,19.35,0.92110,1,1,0.72,CC
GO:0099634,postsynaptic specialization membrane,137,1,2.78,0.94000,1,1,0.36,CC
GO:0099699,integral component of synaptic membrane,228,2,4.62,0.94715,1,1,0.43,CC
GO:0044421,extracellular region part,1855,26,37.59,0.98519,1,1,0.69,CC
GO:0009897,external side of plasma membrane,434,3,8.79,0.99343,1,1,0.34,CC
GO:0005576,extracellular region,2399,31,48.61,0.99837,1,1,0.64,CC
GO:0005615,extracellular space,1621,18,32.85,0.99880,1,1,0.55,CC
GO:0044425,membrane part,7301,118,147.94,0.99923,1,1,0.8,CC
GO:0031226,intrinsic component of plasma membrane,1604,15,32.5,0.99987,1,1,0.46,CC
GO:0005887,integral component of plasma membrane,1526,12,30.92,0.99998,1,1,0.39,CC
GO:0031224,intrinsic component of membrane,6068,67,122.95,1.00000,1,1,0.54,CC
GO:0016021,integral component of membrane,5896,63,119.47,1.00000,1,1,0.53,CC
GO:0005575,cellular_component,21419,434,434,1.00000,1,1,1,CC
GO:0000123,histone acetyltransferase complex,83,0,1.68,1.00000,1,1,0,CC
GO:0000159,protein phosphatase type 2A complex,20,0,0.41,1.00000,1,1,0,CC
GO:0000178,exosome (RNase complex),23,0,0.47,1.00000,1,1,0,CC
GO:0000313,organellar ribosome,93,0,1.88,1.00000,1,1,0,CC
GO:0000314,organellar small ribosomal subunit,31,0,0.63,1.00000,1,1,0,CC
GO:0000315,organellar large ribosomal subunit,60,0,1.22,1.00000,1,1,0,CC
GO:0000502,proteasome complex,66,0,1.34,1.00000,1,1,0,CC
GO:0000786,nucleosome,88,0,1.78,1.00000,1,1,0,CC
GO:0000788,nuclear nucleosome,38,0,0.77,1.00000,1,1,0,CC
GO:0000932,P-body,73,0,1.48,1.00000,1,1,0,CC
GO:0001533,cornified envelope,56,0,1.13,1.00000,1,1,0,CC
GO:0001673,male germ cell nucleus,23,0,0.47,1.00000,1,1,0,CC
GO:0001891,phagocytic cup,22,0,0.45,1.00000,1,1,0,CC
GO:0005581,collagen trimer,83,0,1.68,1.00000,1,1,0,CC
GO:0005732,small nucleolar ribonucleoprotein comple...,26,0,0.53,1.00000,1,1,0,CC
GO:0005747,mitochondrial respiratory chain complex ...,50,0,1.01,1.00000,1,1,0,CC
GO:0005753,mitochondrial proton-transporting ATP sy...,20,0,0.41,1.00000,1,1,0,CC
GO:0005761,mitochondrial ribosome,93,0,1.88,1.00000,1,1,0,CC
GO:0005762,mitochondrial large ribosomal subunit,60,0,1.22,1.00000,1,1,0,CC
GO:0005763,mitochondrial small ribosomal subunit,31,0,0.63,1.00000,1,1,0,CC
GO:0005778,peroxisomal membrane,45,0,0.91,1.00000,1,1,0,CC
GO:0005834,heterotrimeric G-protein complex,33,0,0.67,1.00000,1,1,0,CC
GO:0005838,proteasome regulatory particle,23,0,0.47,1.00000,1,1,0,CC
GO:0005849,mRNA cleavage factor complex,20,0,0.41,1.00000,1,1,0,CC
GO:0005865,striated muscle thin filament,30,0,0.61,1.00000,1,1,0,CC
GO:0005891,voltage-gated calcium channel complex,45,0,0.91,1.00000,1,1,0,CC
GO:0005922,connexin complex,20,0,0.41,1.00000,1,1,0,CC
GO:0009295,nucleoid,47,0,0.95,1.00000,1,1,0,CC
GO:0015030,Cajal body,35,0,0.71,1.00000,1,1,0,CC
GO:0016235,aggresome,40,0,0.81,1.00000,1,1,0,CC
GO:0016327,apicolateral plasma membrane,22,0,0.45,1.00000,1,1,0,CC
GO:0016469,proton-transporting two-sector ATPase co...,49,0,0.99,1.00000,1,1,0,CC
GO:0022624,proteasome accessory complex,25,0,0.51,1.00000,1,1,0,CC
GO:0030119,AP-type membrane coat adaptor complex,48,0,0.97,1.00000,1,1,0,CC
GO:0030131,clathrin adaptor complex,30,0,0.61,1.00000,1,1,0,CC
GO:0030173,integral component of Golgi membrane,53,0,1.07,1.00000,1,1,0,CC
GO:0030666,endocytic vesicle membrane,32,0,0.65,1.00000,1,1,0,CC
GO:0030964,NADH dehydrogenase complex,50,0,1.01,1.00000,1,1,0,CC
GO:0030990,intraciliary transport particle,29,0,0.59,1.00000,1,1,0,CC
GO:0030992,intraciliary transport particle B,21,0,0.43,1.00000,1,1,0,CC
GO:0031082,BLOC complex,20,0,0.41,1.00000,1,1,0,CC
GO:0031228,intrinsic component of Golgi membrane,55,0,1.11,1.00000,1,1,0,CC
GO:0031231,intrinsic component of peroxisomal membr...,20,0,0.41,1.00000,1,1,0,CC
GO:0031248,protein acetyltransferase complex,93,0,1.88,1.00000,1,1,0,CC
GO:0031362,anchored component of external side of p...,22,0,0.45,1.00000,1,1,0,CC
GO:0031519,PcG protein complex,47,0,0.95,1.00000,1,1,0,CC
GO:0031526,brush border membrane,77,0,1.56,1.00000,1,1,0,CC
GO:0031903,microbody membrane,45,0,0.91,1.00000,1,1,0,CC
GO:0032040,small-subunit processome,37,0,0.75,1.00000,1,1,0,CC
GO:0032281,AMPA glutamate receptor complex,32,0,0.65,1.00000,1,1,0,CC
GO:0032420,stereocilium,54,0,1.09,1.00000,1,1,0,CC
GO:0032421,stereocilium bundle,64,0,1.3,1.00000,1,1,0,CC
GO:0032426,stereocilium tip,20,0,0.41,1.00000,1,1,0,CC
GO:0032590,dendrite membrane,48,0,0.97,1.00000,1,1,0,CC
GO:0032806,carboxy-terminal domain protein kinase c...,21,0,0.43,1.00000,1,1,0,CC
GO:0032809,neuronal cell body membrane,36,0,0.73,1.00000,1,1,0,CC
GO:0032994,protein-lipid complex,36,0,0.73,1.00000,1,1,0,CC
GO:0033176,proton-transporting V-type ATPase comple...,26,0,0.53,1.00000,1,1,0,CC
GO:0033177,proton-transporting two-sector ATPase co...,22,0,0.45,1.00000,1,1,0,CC
GO:0034358,plasma lipoprotein particle,34,0,0.69,1.00000,1,1,0,CC
GO:0034364,high-density lipoprotein particle,23,0,0.47,1.00000,1,1,0,CC
GO:0034706,sodium channel complex,24,0,0.49,1.00000,1,1,0,CC
GO:0034707,chloride channel complex,46,0,0.93,1.00000,1,1,0,CC
GO:0035267,NuA4 histone acetyltransferase complex,21,0,0.43,1.00000,1,1,0,CC
GO:0036379,myofilament,32,0,0.65,1.00000,1,1,0,CC
GO:0042611,MHC protein complex,21,0,0.43,1.00000,1,1,0,CC
GO:0042645,mitochondrial nucleoid,47,0,0.95,1.00000,1,1,0,CC
GO:0043073,germ cell nucleus,30,0,0.61,1.00000,1,1,0,CC
GO:0043083,synaptic cleft,20,0,0.41,1.00000,1,1,0,CC
GO:0043189,H4/H2A histone acetyltransferase complex,21,0,0.43,1.00000,1,1,0,CC
GO:0043194,axon initial segment,22,0,0.45,1.00000,1,1,0,CC
GO:0044292,dendrite terminus,20,0,0.41,1.00000,1,1,0,CC
GO:0044298,cell body membrane,38,0,0.77,1.00000,1,1,0,CC
GO:0044420,extracellular matrix component,52,0,1.05,1.00000,1,1,0,CC
GO:0044815,DNA packaging complex,96,0,1.95,1.00000,1,1,0,CC
GO:0045095,keratin filament,40,0,0.81,1.00000,1,1,0,CC
GO:0045259,proton-transporting ATP synthase complex,21,0,0.43,1.00000,1,1,0,CC
GO:0045271,respiratory chain complex I,50,0,1.01,1.00000,1,1,0,CC
GO:0045334,clathrin-coated endocytic vesicle,31,0,0.63,1.00000,1,1,0,CC
GO:0060170,ciliary membrane,53,0,1.07,1.00000,1,1,0,CC
GO:0061702,inflammasome complex,21,0,0.43,1.00000,1,1,0,CC
GO:0070461,SAGA-type complex,26,0,0.53,1.00000,1,1,0,CC
GO:0070971,endoplasmic reticulum exit site,27,0,0.55,1.00000,1,1,0,CC
GO:0071782,endoplasmic reticulum tubular network,23,0,0.47,1.00000,1,1,0,CC
GO:0097038,perinuclear endoplasmic reticulum,26,0,0.53,1.00000,1,1,0,CC
GO:0097225,sperm midpiece,28,0,0.57,1.00000,1,1,0,CC
GO:0097228,sperm principal piece,32,0,0.65,1.00000,1,1,0,CC
GO:0097346,INO80-type complex,24,0,0.49,1.00000,1,1,0,CC
GO:0097470,ribbon synapse,23,0,0.47,1.00000,1,1,0,CC
GO:0098948,intrinsic component of postsynaptic spec...,113,0,2.29,1.00000,1,1,0,CC
GO:0098993,anchored component of synaptic vesicle m...,20,0,0.41,1.00000,1,1,0,CC
GO:0099060,integral component of postsynaptic speci...,107,0,2.17,1.00000,1,1,0,CC
GO:0099061,integral component of postsynaptic densi...,74,0,1.5,1.00000,1,1,0,CC
GO:0099146,intrinsic component of postsynaptic dens...,80,0,1.62,1.00000,1,1,0,CC
GO:0099523,presynaptic cytosol,25,0,0.51,1.00000,1,1,0,CC
GO:0101031,chaperone complex,21,0,0.43,1.00000,1,1,0,CC
GO:1902493,acetyltransferase complex,93,0,1.88,1.00000,1,1,0,CC
GO:1902562,H4 histone acetyltransferase complex,43,0,0.87,1.00000,1,1,0,CC
GO:1902710,GABA receptor complex,21,0,0.43,1.00000,1,1,0,CC
GO:1905354,exoribonuclease complex,23,0,0.47,1.00000,1,1,0,CC
GO:1905360,GTPase complex,33,0,0.67,1.00000,1,1,0,CC
GO:1905369,endopeptidase complex,67,0,1.36,1.00000,1,1,0,CC
GO:1990204,oxidoreductase complex,109,0,2.21,1.00000,1,1,0,CC
GO:1990777,lipoprotein particle,34,0,0.69,1.00000,1,1,0,CC
